Sentence,class,file
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/99/b9/srep03139.PMC3817439.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3139 | DOI: 10.1038/srep03139 7",Non-OADS,/arxiv_data1/oa_pdf/99/b9/srep03139.PMC3817439.pdf
"Methods TALEN .The TALEN plasmids were designed using the online TAL Effector Nucleotide Targeter 2.0 software program (https://tale-nt.cac.cornell.edu/node/add/ talen-old) with the following parameters: Minimum Spacer Length at 12 bp, Maximum Spacer Length at 16 bp, Minimum Repeat Array Length at 16 and Maximum Repeat Array Length at 20.",OADS,/arxiv_data1/oa_pdf/f3/68/srep03136.PMC3817445.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3136 | DOI: 10.1038/srep03136 8",Non-OADS,/arxiv_data1/oa_pdf/f3/68/srep03136.PMC3817445.pdf
"Taxis Toward Hydrogen Gas by Methanococcus maripaludis Kristen A. Brileya1,2,4*, James M. Connolly1,3, Carey Downey1,2, Robin Gerlach1,3& Matthew W. Fields1,2,4 1Center for Biofilm Engineering, Montana State University, Bozeman, MT, USA,2Department of Microbiology, Montana State University, Bozeman, MT, USA,3Department of Chemical and Biological Engineering, Montana State University, Bozeman, MT, USA,4ENIGMA (http://enigma.lbl.gov).",Non-OADS,/arxiv_data1/oa_pdf/b2/f9/srep03140.PMC3817446.pdf
"This work conducted by ENIGMA- Ecosystems and Networks Integrated with Genes and Molecular Assemblies (http://enigma.lbl.gov), a Scientific Focus Area Program at Lawrence BerkeleyNational Laboratory, was supported by the Office of Science, Office of Biological and Environmental Research, of the U. S. Department of Energy under Contract No.",OADS,/arxiv_data1/oa_pdf/b2/f9/srep03140.PMC3817446.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/b2/f9/srep03140.PMC3817446.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3140 | DOI: 10.1038/srep03140 7",Non-OADS,/arxiv_data1/oa_pdf/b2/f9/srep03140.PMC3817446.pdf
"33. http://res.tagen.tohoku.ac.jp/ ,waseda/scm/LIQ/gr/Al_750_gr.txt, 01/02/2013, Structural Characterization of Materials Liquid Database, Institute of Advanced Materials Processing , Tohoku University, Japan (1979).34.",OADS,/arxiv_data1/oa_pdf/f9/17/srep03135.PMC3817448.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3135 | DOI: 10.1038/srep03135 8",Non-OADS,/arxiv_data1/oa_pdf/f9/17/srep03135.PMC3817448.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/aa/83/srep03143.PMC3817452.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3143 | DOI: 10.1038/srep03143 9",Non-OADS,/arxiv_data1/oa_pdf/aa/83/srep03143.PMC3817452.pdf
"miRNA target sites in 3 0UTR Trp53inp1 gene regions were identi- ﬁed by bioinformatic analysis using the following online databases:Target Scan (http://www.targetscan.org), pictar (http://pictar.mdc-berlin.de/), and MiRBase Sanger (http://microrna.sanger.ac.uk/cgi-bin/targets/v5/search.pl) (only those putative miRNA target sitesresulting from at least two databases were considered as positive).The entire 3 0UTR region (4418 bp) of Trp53inp1 was cloned bymiR-17-92 cluster is a direct Nanog target N Garg et al 2830 The EMBO Journal VOL 32 |NO 21 |2013 &2013 European Molecular Biology Organization",OADS,/arxiv_data1/oa_pdf/55/8b/emboj2013214a.PMC3817465.pdf
Supplementary data Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).,OADS,/arxiv_data1/oa_pdf/55/8b/emboj2013214a.PMC3817465.pdf
To view a copyof this licence visit http://creativecommons.org/licenses/by-nc-nd/3.0/.miR-17-92 cluster is a direct Nanog target N Garg et al 2832 The EMBO Journal VOL 32 |NO 21 |2013 &2013 European Molecular Biology Organization,Non-OADS,/arxiv_data1/oa_pdf/55/8b/emboj2013214a.PMC3817465.pdf
"miR-124 targets STAT3 to attenuate LPS-induced IL-6  production Using TargetScan (http://www.targetscan.org) to  search for targets of miR-124, we found that the 3′-UTR of mouse STAT3 mRNA contains two putative miR-124  target sites (Supplementary information, Figure S4A).",Non-OADS,/arxiv_data1/oa_pdf/91/57/cr2013116a.PMC3817544.pdf
"From an automated meta-analysis of 329studies loading highly on the feature ‘reward ’(http://www.neurosynth.org/ features/reward) an inclusive mask was prepared within which the effect of the group-by-stimulus interaction contrast was tested at a statistical threshold of Po0.005, uncorrected, in combination with a cluster extent of at least 10 contiguously signi ﬁcant voxels (for details, see Supplementary Information).",OADS,/arxiv_data1/oa_pdf/8a/27/tp201388a.PMC3818005.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Developing anorexia nervosa A-K Fladung et al 6 Translational Psychiatry (2013), 1 –6 © 2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/8a/27/tp201388a.PMC3818005.pdf
"Universal 16s rRNA primers, designed to amplify from highly conserved regions corresponding to those ﬂanking the V4 region were used for Taq-based polymerase chain reaction ampliﬁca-tion: forward primer F1 (5 0-AYTGGGYDTAAAGNG-30); reverse primers R1 (50-TACCRGGGTHTCTAATCC-30), R2 (50-TACCAGAGTATCTAATTC-30), R3 (50-CTACDSRGGTMTCTAATC-30) and R4 (50-TACNVGGGTATCTAATC-30) (RDP’s Pyrosequencing Pipeline: http://pyro.cme.msu.edu/pyro/help.jsp).",Non-OADS,/arxiv_data1/oa_pdf/fe/f8/tp201383a.PMC3818006.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Olanzapine-induced weight gain and the microbiota KJ Davey et al 7 &2013 Macmillan Publishers Limited Translational Psychiatry (2013), 1 – 7",Non-OADS,/arxiv_data1/oa_pdf/fe/f8/tp201383a.PMC3818006.pdf
Each experiment was performed minimally in triplicate.RNA and DNA isolation from human postmortem brain samples Fresh-frozen postmortem brain samples were obtained through theAutism Speaks-supported Autism Tissue Program at the Harvard Brain Tissue Resource Center (http://www.brainbank.mclean.org/) or the NICHD Brain and Tissue Bank at the University of Maryland School of Medicine(http://www.medschool.umaryland.edu/BTBank/).,Non-OADS,/arxiv_data1/oa_pdf/4c/35/tp201391a.PMC3818007.pdf
An additional 15 genomic DNA samples from RTT females were purchased from the Coriell Cell Repository (http://www.ccr.coriell.org/).,OADS,/arxiv_data1/oa_pdf/4c/35/tp201391a.PMC3818007.pdf
"AutismGenetic Resource Exchange (AGRE) rs1858830 genotypes were previouslydetermined 10,11and downloaded with permission from the AGRE website (https://research.agre.org).",OADS,/arxiv_data1/oa_pdf/4c/35/tp201391a.PMC3818007.pdf
Population data for rs1858830 were downloadedfrom the 1000 Genomes Browser (http://browser.1000genomes.org (August 2012)).,OADS,/arxiv_data1/oa_pdf/4c/35/tp201391a.PMC3818007.pdf
The Genetic Power Calculator (http://pngu.mgh.harvard.edu/Bpurcell/gpc/)37was used to estimate the power of the case–control association analyses.,OADS,/arxiv_data1/oa_pdf/4c/35/tp201391a.PMC3818007.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Role of MeCP2 in autism and Rett syndrome JT Plummer et al 8 Translational Psychiatry (2013), 1 – 8 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/4c/35/tp201391a.PMC3818007.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Cellular clocks in bipolar disorder MJ McCarthy et al 8 Translational Psychiatry (2013), 1 – 8 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/3f/00/tp201390a.PMC3818008.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Traumatic stress and glycans M Moreno-Villanueva et al 5 &2013 Macmillan Publishers Limited Translational Psychiatry (2013), 1 – 5",Non-OADS,/arxiv_data1/oa_pdf/70/72/tp201393a.PMC3818009.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp) CONSORTIA The data utilized came from three large GWAS done by the ENGAGE, TAG, and OX-GSK consortia (references 15–17).",OADS,/arxiv_data1/oa_pdf/79/e7/tp201381a.PMC3818010.pdf
URLS http://www.who.int/tobacco/mpower/mpower_report_full_2008.pdfhttp://www.who.int/mediacentre/factsheets/fs311/en/index.,OADS,/arxiv_data1/oa_pdf/79/e7/tp201381a.PMC3818010.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Serotonin seasonality, the 5-HTTLPR and depression JJ Luykx et al 6 Translational Psychiatry (2013), 1 – 6 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/49/51/tp201384a.PMC3818011.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Association between immune activation and manic symptoms K Becking et al 9 &2013 Macmillan Publishers Limited Translational Psychiatry (2013), 1 – 9",Non-OADS,/arxiv_data1/oa_pdf/f1/fa/tp201387a.PMC3818012.pdf
"Segmentation of cell nuclei was performedon the Hoechst channel using locally adaptative Otsu thresholding,implemented in Cell Proﬁler (http://www.cellproﬁler.org/).",OADS,/arxiv_data1/oa_pdf/d8/c2/tp201392a.PMC3818013.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)Latrepirdine activates AMPK and reduces neuronal excitability P Weisova ´et al 11 &2013 Macmillan Publishers Limited Translational Psychiatry (2013), 1 – 11",Non-OADS,/arxiv_data1/oa_pdf/d8/c2/tp201392a.PMC3818013.pdf
"We used the pre-builtindex ﬁles of UCSC H. sapiens hg18, which are downloaded from the TopHat homepage (http://tophat.cbcb.umd.edu/index.html).",OADS,/arxiv_data1/oa_pdf/11/0e/tp201394a.PMC3818014.pdf
The quantiﬁcation of gene expression was accomplished by HTseq v0.5.3p9and edger package (http://www.bioconductor.org/packages/2.11/bioc/html/edgeR.html).,OADS,/arxiv_data1/oa_pdf/11/0e/tp201394a.PMC3818014.pdf
"Validation RNA-Seq results using Stanley Neuropathology Consortium Integrative Database The Stanley Neuropathology Consortium Integrative Database (SNCID) (http://sncid.stanleyresearch.org/) is an online archival database with datamining tools for analysing neuropathology markers, microarray data andSNP data from the SNC.",OADS,/arxiv_data1/oa_pdf/11/0e/tp201394a.PMC3818014.pdf
32 Functional annotation and enrichment map DAVID (http://david.abcc.ncifcrf.gov/home.jsp) was used to identify thebiological processes that were signiﬁcantly over-represented by differen-tially expressed genes between schizophrenia and normal controls as wellas genes included in the co-expression modules.,OADS,/arxiv_data1/oa_pdf/11/0e/tp201394a.PMC3818014.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)RNA-Seq of hippocampus of individuals with schizophrenia Y Hwang et al 9 &2013 Macmillan Publishers Limited Translational Psychiatry (2013), 1 – 9",Non-OADS,/arxiv_data1/oa_pdf/11/0e/tp201394a.PMC3818014.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Dynorphins mediate alcohol-induced memory impairment A Kuzmin et al 8 Translational Psychiatry (2013), 1 – 8 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/3e/9a/tp201372a.PMC3818015.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Fusiform connectivity in SAD A Frick et al 6 Translational Psychiatry (2013), 1 – 6 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/1a/7c/tp201385a.PMC3818016.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)ITGB3 is implicated in the mode of action of SSRI antidepressants K Oved et al 6 Translational Psychiatry (2013), 1 – 6 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/c5/60/tp201386a.PMC3818017.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/.,Non-OADS,/arxiv_data1/oa_pdf/f9/1e/ijn-8-4183.PMC3818020.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4183–4195International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4183RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S3597 9Nanomedicine in cerebral palsy Bindu Balakrishnan1 elizabeth Nance1 Michael v Johnston2 Rangaramanujam Kannan3 Sujatha Kannan1 1Department of Anesthesiology  and Critical Care Medicine, Johns  Hopkins University; Baltimore, MD,   USA; 2Department of Neurology and  Pediatrics, Kennedy Krieger Institute,   Baltimore, MD, USA; 3Department  of Ophthalmology, Center for  Nanomedicine, Johns Hopkins  University, Baltimore, MD, USA Correspondence: Sujatha Kannan   Department of Anesthesiology and  Critical Care Medicine, Johns Hopkins  University, Baltimore, MD 21205, USA   Tel +1 410 955 7610   email skannan3@jhmi.ed uAbstract:  Cerebral palsy is a chronic childhood disorder that can have diverse etiologies.",Non-OADS,/arxiv_data1/oa_pdf/f9/1e/ijn-8-4183.PMC3818020.pdf
Available  from: http://clinicaltrials.gov/show/NCT0045318 0.,Non-OADS,/arxiv_data1/oa_pdf/f9/1e/ijn-8-4183.PMC3818020.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT00627 705?term=NCT00627705&rank= 1.,Non-OADS,/arxiv_data1/oa_pdf/f9/1e/ijn-8-4183.PMC3818020.pdf
Available from: http://clinicaltrials.gov/ct2/show/NCT0039773 5.,Non-OADS,/arxiv_data1/oa_pdf/f9/1e/ijn-8-4183.PMC3818020.pdf
Available from:  http://clinicaltrials.gov/ct2/show/NCT0132052 7.,Non-OADS,/arxiv_data1/oa_pdf/f9/1e/ijn-8-4183.PMC3818020.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f9/1e/ijn-8-4183.PMC3818020.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f9/1e/ijn-8-4183.PMC3818020.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/98/31/ijn-8-4131.PMC3818021.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4131–4145International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4131OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5167 9silver nanoparticle/chitosan oligosaccharide/ poly(vinyl alcohol) nanofibers as wound   dressings: a preclinical study chenwen li1,* ruoqiu Fu1,* caiping Yu1 Zhuoheng li1 haiyan guan1 Daqiang hu1 Dehua Zhao2 laichun lu1 1Department of Pharmacy, Institute  of surgery research, Daping hospital,   Third Military Medical University,   2college of Pharmacy, chongqing  Medical University, chongqing,   People’s Republic of China *These authors contributed equally   to this work correspondence: laichun lu   Department of Pharmacy, Institute of  surgery research, Daping hospital,   Third Military Medical University,   10 changjiangzhilu, chongqing 400042,  People’s Republic of China   Tel +86 23 6875 7091   Fax +86 23 6875 7091   email lulaicq@163.co mAbstract:  In this study, a mixture of poly(vinyl alcohol) (PV A) and chitosan oligosaccharides  (COS) was electrospun with silver nanoparticles (AgNPs) to produce fibrous mats for use in  wound healing.",Non-OADS,/arxiv_data1/oa_pdf/98/31/ijn-8-4131.PMC3818021.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/98/31/ijn-8-4131.PMC3818021.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/98/31/ijn-8-4131.PMC3818021.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/01/70/ijn-8-4197.PMC3818022.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4197–4213International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4197OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5068 5selective laser sintering fabrication   of nano-hydroxyapatite/poly- ε-caprolactone   scaffolds for bone tissue engineering applications Yan Xia1,* Panyu Zhou1,* Xiaosong cheng1,* Yang Xie1,* chong liang2 chao li1 shuogui Xu1,2 1Department of Orthopedics,   changhai hospital, second Military  Medical University, shanghai, People’s  republic of china; 2Department of  Neurosurgery, The 81 hospital of  People’s liberation army of china,   Nanjing, People’s republic of china *These authors contributed equally   to this work correspondence: shuogui Xu   Department of Orthopedics, changhai   hospital, second Military Medical   University, shanghai 200433,   People’s republic of china   Tel +86 21 3116 1687   Fax +86 21 5522 6616   email shuogui_xu@163.co mAbstract:  The regeneration of functional tissue in osseous defects is a formidable challenge  in orthopedic surgery.",Non-OADS,/arxiv_data1/oa_pdf/01/70/ijn-8-4197.PMC3818022.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical ﬁeld.",Non-OADS,/arxiv_data1/oa_pdf/01/70/ijn-8-4197.PMC3818022.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/70/ijn-8-4197.PMC3818022.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/19/ijn-8-4215.PMC3818023.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4215–4227International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4215RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S3942 8Nanobodies as novel agents for disease   diagnosis and therapy Christina G Siontorou Department of Industrial Management  and T echnology, University of Piraeus,   Piraeus, Greece Correspondence: Christina G Siontorou   Department of Industrial Management  and Technology, University of Piraeus,  80 Karaoli and Dimitriou Street,   18534 Piraeus, Greece   Tel +30 210 414 2368   Fax +30 210 414 2392   email csiontor@unipi.g rAbstract:  The discovery of naturally occurring, heavy-chain only antibodies in Camelidae , and  their further development into small recombinant nanobodies, presents attractive alternatives  in drug delivery and imaging.",Non-OADS,/arxiv_data1/oa_pdf/b1/19/ijn-8-4215.PMC3818023.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/b1/19/ijn-8-4215.PMC3818023.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b1/19/ijn-8-4215.PMC3818023.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/be/4b/imcrj-6-077.PMC3818024.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2013:6 77–80International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  77Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S4927 8Diagnosis of a t-lineage acute lymphoblastic  leukemia through digitalized cell analysis   of the pleural effusion Benedetta peruzzi1 Ilaria Cutini2 anna Maria Grazia Gelli1 tommaso Rondelli1 Marinella statello1 sara Bencini2 Francesco Mannelli2 Roberto Caporale1 alberto Bosi2 alessandra Fanelli1 1General Laboratory Unit  (Microscopy and Clinical Cytometry  Unit), 2Hematology Unit, azienda  ospedaliero–Universitaria Careggi,   Firenze, Italy Correspondence: Benedetta peruzzi  Largo Brambilla   General Laboratory Unit (Microscopy  and Clinical Cytometry Unit), azienda  ospedaliero–Universitaria Careggi,   3 50134 Firenze, Italy   tel +39 055 794 9023   Fax +39 055 794 9676   email peruzzib@aou-careggi.toscana.i tIntroduction:  Pleural effusion as the first clinical manifestation of acute lymphoblastic leukemia  (ALL) is a relatively rare event.",Non-OADS,/arxiv_data1/oa_pdf/be/4b/imcrj-6-077.PMC3818024.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/be/4b/imcrj-6-077.PMC3818024.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/be/4b/imcrj-6-077.PMC3818024.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/7b/imcrj-6-071.PMC3818025.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2013:6 71–75International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  71Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S5070 8Dengue fever triggering systemic lupus  erythematosus and lupus nephritis: a case report sH talib sR Bhattu R Bhattu sG Deshpande DB Dahiphale Department of Medicine and  Nephrology, MGM Medical  College and Hospital, aurangabad,   Maharashtra, India Correspondence: sH talib   Department of Medicine, MGM Medical  College & Hospital, N-6, Cidco,  aurangabad 431003, Maharashtra, India   email sftalib@gmail.co mAbstract:  We report a rare case of dengue fever triggering systemic lupus erythematosus  and lupus nephritis.",Non-OADS,/arxiv_data1/oa_pdf/7f/7b/imcrj-6-071.PMC3818025.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/7f/7b/imcrj-6-071.PMC3818025.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7f/7b/imcrj-6-071.PMC3818025.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/74/ee/vhrm-9-681.PMC3818026.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2013:9 681–694Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  681ReViewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/VHRM.S4003 5Linagliptin as add-on therapy to insulin   for patients with type 2 diabetes Karoline von websky Christoph Reichetzeder Berthold Hocher institute of Nutritional Science,   University of Potsdam, Potsdam- Rehbrücke, Germany Correspondence: Berthold Hocher   Universität Potsdam, institut für  ernährungswissenschaften, Professur  experimentelle ernährungsmedizin,  Arthur-Scheunert-Allee 114-116,  D-14558 Nuthetal, Germany   Tel +49 33 20088 5508   Fax +49 33 20088 5541   email hocher@uni-potsdam.d eAbstract:  Type 2 diabetes mellitus (T2DM) is a highly prevalent, progressive disease that often  is poorly controlled.",Non-OADS,/arxiv_data1/oa_pdf/74/ee/vhrm-9-681.PMC3818026.pdf
"Available from: http://www.cdc.gov/diabetes/pubs/pdf/ ndfs_2011.pd f. Accessed July 11, 2013.",Non-OADS,/arxiv_data1/oa_pdf/74/ee/vhrm-9-681.PMC3818026.pdf
"Available  from: http://www.nice.org.uk/nicemedia/pdf/CG87ShortGuideline.pd f.  Accessed May 29, 2013.",Non-OADS,/arxiv_data1/oa_pdf/74/ee/vhrm-9-681.PMC3818026.pdf
"Available from: http://www.diabetes.org/for- media/2013/recommendations-for.htm l. Accessed September 25, 2013.",Non-OADS,/arxiv_data1/oa_pdf/74/ee/vhrm-9-681.PMC3818026.pdf
Tradjenta (linagliptin) Prescribing  Information September 2012; Available from: http://www.accessdata.,OADS,/arxiv_data1/oa_pdf/74/ee/vhrm-9-681.PMC3818026.pdf
Available from: http://www.clinicaltrials.gov/ ct2/show/NCT0179251 8.,Non-OADS,/arxiv_data1/oa_pdf/74/ee/vhrm-9-681.PMC3818026.pdf
Available from: http://www.clinicaltrials.gov/ct2/ show/NCT01243424?term =NCT01243424&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/74/ee/vhrm-9-681.PMC3818026.pdf
Available from: http://www.clinicaltrials.gov/ct2/ show/NCT01144338?term =ExenatideStudyofCardiovascularEvent LoweringTrial(EXSCEL)&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/74/ee/vhrm-9-681.PMC3818026.pdf
Available from: http://www.clinicaltrials.gov/ct2/ show/NCT01179048?ter m=LiraglutideEffectandActioninDiabet s(LEADER)&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/74/ee/vhrm-9-681.PMC3818026.pdf
"Available from: http://www.escardio.org/ about/press/esc-congress-2013/press-conferences/Documents/slides/ bhatt.pd f. Accessed September 25, 2013.",Non-OADS,/arxiv_data1/oa_pdf/74/ee/vhrm-9-681.PMC3818026.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/74/ee/vhrm-9-681.PMC3818026.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/74/ee/vhrm-9-681.PMC3818026.pdf
Available from:  http://www.clinicaltrials.gov/ct2/show/NCT00800683?ter m=NCT00800 683&rank =1.,Non-OADS,/arxiv_data1/oa_pdf/74/ee/vhrm-9-681.PMC3818026.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/46/vhrm-9-671.PMC3818028.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2013:9 671–680Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  671ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S5271 3association between triglycerides and  cardiovascular events in primary populations: a  meta-regression analysis and synthesis of evidence Melissa e stauffer lauren Weisenfluh alan Morrison scRiBcO, effort, P a, Usa correspondence: Melissa e stauffer   c/o scRiBcO, PO Box 580, effort,   Pa 18330, Usa   Tel +1 262 394 5258   Fax +1 262 725 4044   email melstauff@charter.ne tBackground:  Triglyceride levels were found to be independently predictive of the development  of primary coronary heart disease in epidemiologic studies.",Non-OADS,/arxiv_data1/oa_pdf/80/46/vhrm-9-671.PMC3818028.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/80/46/vhrm-9-671.PMC3818028.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/46/vhrm-9-671.PMC3818028.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f3/75/ndt-9-1661.PMC3818099.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1661–1670Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1661Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S3889 9Clinical efficacy and safety of fluoxetine in  generalized anxiety disorder in Chinese patients Chuan Zou1 Xiang Ding1 Joseph H Flaherty2 Birong Dong1 1The Center of Gerontology and  Geriatrics, west China Hospital,   Sichuan University, Chengdu,   People’s Republic of China; 2St Louis  University, St Louis, MO, USA Correspondence: Birong Dong   The Center of Gerontology and  Geriatrics, west China Hospital, Sichuan  University, No 37, Guo Xue Xiang   Renmin Nan Lu Chengdu, Sichuan,   People’s Republic of China   Tel +86 189 8060 1332 (mobile);   +86 28 8542 2321 (office)   Fax +86 28 8542 2321   email birongdong@163.co mBackground:  Generalized anxiety disorder (GAD) is a prevalent, disabling disease and is  highly comorbid with other psychiatric disorders both in Western countries and the People’ s  Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/f3/75/ndt-9-1661.PMC3818099.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f3/75/ndt-9-1661.PMC3818099.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f3/75/ndt-9-1661.PMC3818099.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/39/92/ndt-9-1683.PMC3818100.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1683–1698Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1683OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5258 5Possible associations between antioxidant   enzyme polymorphisms and metabolic   abnormalities in patients with schizophrenia Junji saruwatari1,* Norio Yasui-Furukori2,* ryoko Kamihashi1 Yuki Y oshimori1 Kentaro Oniki1 shoko Tsuchimine2 Madoka Noai1 Yasushi sato3 Taku Nakagami4 Norio sugawara2 Manabu saito2 akira Fujii2 ayami Kajiwara1 shuichi Mihara5 Yasuhiro Ogata6 sunao Kaneko2 Kazuko Nakagawa1,7 1Division of Pharmacology and  Therapeutics, graduate school of  Pharmaceutical sciences, Kumamoto  University, Kumamoto, 2Department of  Neuropsychiatry, hirosaki University  school of Medicine, hirosaki, 3Department  of Psychiatry, hirosaki aiseikai hospital,  hirosaki, 4Department of Psychiatry, Odate  Municipal general hospital, Odate, 5Mihara  life care clinic, Kumamoto, 6Japanese  red cross Kumamoto health care  center, Kumamoto, 7center for clinical  Pharmaceutical sciences, Kumamoto  University, Kumamoto, Japan *These authors contributed equally   to this paper correspondence: Junji saruwatari   Division of Pharmacology and Therapeutics,  graduate school of Pharmaceutical sciences,  Kumamoto University, 5-1 Oe-honmachi,  chuo-ku, Kumamoto 862-0973, Japan   Tel +81 96 371 4512   Fax +81 96 371 4512   email junsaru@gpo.kumamoto-u.ac.j pBackground:  This study investigated the possible association between common and potentially  functional polymorphisms of antioxidant enzymes and metabolic abnormalities in patients with  schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/39/92/ndt-9-1683.PMC3818100.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/39/92/ndt-9-1683.PMC3818100.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/39/92/ndt-9-1683.PMC3818100.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c4/fe/ott-6-1471.PMC3818101.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1471–1479OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1471Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5104 1epigenomic analysis of lung adenocarcinoma  reveals novel Dna methylation patterns  associated with smoking Qiang Tan1,* guan Wang1,* Jia huang1 Zhengping Ding1 Qingquan luo1 T ony Mok2 Qian Tao2 shun lu1 1Department of shanghai lung cancer  center, shanghai chest hospital,   school of Medicine, shanghai Jiao Tong  University, shanghai, People’s republic  of china; 2cancer epigenetics  laboratory, Department of clinical  Oncology, state Key laboratory of  Oncology in south china, sir YK Pao  center for cancer and li Ka shing  institute of health sciences, The  chinese University   of hong Kong, hong Kong *These authors contributed equally to  this paper correspondence: shun lu or Qian Tao   shanghai lung Tumor clinical Medical  center, shanghai chest hospital,  shanghai Jiao Tong University, shanghai  200030, People’s republic of china   Tel 86 21 6282 1990   Fax 86 21 6280 4970   email shun_lu@hotmail.co m or qtao@ clo.cuhk.edu.h kAbstract:  The importance of epigenetic regulation has been increasingly recognized in the  development of cancer.",Non-OADS,/arxiv_data1/oa_pdf/c4/fe/ott-6-1471.PMC3818101.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/c4/fe/ott-6-1471.PMC3818101.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/c4/fe/ott-6-1471.PMC3818101.pdf
OncoTargets and Therapy 2013:6submit your manuscript | www.dovepress.co m Dove press Dove press Dove pres s 1479adenocarcinoma lung cancer methylation pattern Supplementary tables Supplementary tables 1–4 http://www.dovepress.com/cr_data/supplementary_file_51041.pd f.,Non-OADS,/arxiv_data1/oa_pdf/c4/fe/ott-6-1471.PMC3818101.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/99/57/ott-6-1481.PMC3818102.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1481–1491OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1481Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5188 7serum proteomic study on egFr-TKis target  treatment for patients with nsclc Xuan Wu1,* Wenhua liang1,* Xue hou1,* Zhong lin2 hongyun Zhao1 Yan huang1 Wenfeng Fang1 Yuanyuan Zhao1 Jingxun Wu3 Yunpeng Yang1 chong Xue1 Zhihuang hu1 Jing Zhang1 Jianwei Zhang1 Yuxiang Ma1 Ting Zhou1 Tao Qin1 li Zhang1 1state Key laboratory of Oncology in  south china, Department of Medical  Oncology, sun Yat-sen University cancer  center, guangzhou, People’s republic of  china; 2Department of Medical Oncology,   Fifth affiliated hospital of sun Yat-sen  University, Zhuhai, People’s republic of  china; 3Department of Medical Oncology,   The First affiliated hospital of Xiamen  University, Xiamen, People’s republic   of china *These authors contributed equally to this  article correspondence: li Zhang   state Key laboratory of Oncology in  south china, Department of Medical  Oncology, sun Yat-sen University   cancer center, 651 east Dongfeng   road, guangzhou, 510060,   People’s republic of china   Tel +86 20 8734 3458   Fax +86 20 8734 3365   email zhangli6@mail.sysu.edu.c nBackground:  Although epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors  (TKIs) are widely used for EGFR mutated non-small-cell lung cancer (NSCLC) patients, tumor  sample availability and heterogeneity of the tumor remain challenging for physicians’ selection  of these patients.",Non-OADS,/arxiv_data1/oa_pdf/99/57/ott-6-1481.PMC3818102.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/99/57/ott-6-1481.PMC3818102.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/99/57/ott-6-1481.PMC3818102.pdf
"Available at:http://ipip.ori.org/ipip/ Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis.",OADS,/arxiv_data1/oa_pdf/b4/3d/11357_2013_Article_9553.PMC3818137.pdf
"Available at:http://www.healthscotland.com/uploads/documents/7551- WEMWBS%20User%20Guide%20Version%201% 20June%202008.pdfStiglitz JE, Sen A, Fitoussi J-P (2009) Report by the Commission on the Measurement of Economic Performance and Social Progress.",Non-OADS,/arxiv_data1/oa_pdf/b4/3d/11357_2013_Article_9553.PMC3818137.pdf
"Available at: http://www.stiglitz-senfitoussi.fr/ documents/rapport_anglais.pdf Accessed 16 January 2013 Studenski S, Perera S, Patel K, Rosano C, Faulkner K, Inzitari M, Brach J, Chandler J, Cawthon P, Connor EB, Nevitt M, Visser M, Kritchevsky S, Badinelli S, Harris T, Newman AB, Cauley J, Ferrucci L, Guralnik J (2011) Gait speed and survival in older adults.",Non-OADS,/arxiv_data1/oa_pdf/b4/3d/11357_2013_Article_9553.PMC3818137.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution   Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits   non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly   cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/0a/djt278.PMC3818171.pdf
"Each brain was sliced into several coronal sections; the section with the larg-est tumor diameter was measured by ImageJ free software (http://rsbweb.nih.gov/ij/), and the intracranial tumor volume was esti-mated by the largest width squared × length × 0.5.",OADS,/arxiv_data1/oa_pdf/bb/0a/djt278.PMC3818171.pdf
"For the in vivo limiting dilution assay, tumor formation frequency and statistical significance were evaluated with the extreme limiting dilution analysis function (http://bioinf.wehi.edu.au/software/elda/).",OADS,/arxiv_data1/oa_pdf/bb/0a/djt278.PMC3818171.pdf
"outcome variables and rtheir mean correlation, that is, Bonferroni correction, taking into account the correlation between these outcomevariables.45) Finally, mediation analyses were performed using both classical Sobel tests with standardized coefﬁcients for use with dichotomous outcomes, and bootstrapping procedures with 5000 resamples using the SPSS macroINDIRECT provided by Andrew Hayes (http://www.afhayes.com; Preacherand Hayes 46) were performed, thresholded at one-sided a0.05.",Non-OADS,/arxiv_data1/oa_pdf/e1/46/tp201389a.PMC3818535.pdf
Mean neuronal activation for each regions of interest was extracted using theMarsBaR toolbox for SPM (http://marsbar.sourceforge.net; Brett et al.47).,OADS,/arxiv_data1/oa_pdf/e1/46/tp201389a.PMC3818535.pdf
http://www.dsm5.org/Proposed%20Revision%20Attachments/Proposal%20for% 20Callous%20and%20Unemotional%20Speciﬁer%20of%20Conduct%20Disorder.,Non-OADS,/arxiv_data1/oa_pdf/e1/46/tp201389a.PMC3818535.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Fear conditioning in antisocial adolescents MD Cohn et al 8 Translational Psychiatry (2013), 1 – 8 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/e1/46/tp201389a.PMC3818535.pdf
"To view a copy  of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/",Non-OADS,/arxiv_data1/oa_pdf/59/1d/aps2013100a.PMC3818586.pdf
"Available from: http://censusindia.gov.in/ Vital_Statistics/SRS_Bulletins/MMR-Bulletin-April-2009.pdf ,  accessed on March 30, 2010.Mat 2. ernal and child mortality and Total fertility Rates.",OADS,/arxiv_data1/oa_pdf/82/0a/IJMR-138-340.PMC3818596.pdf
"Available from: http://www.censusindia.gov.in/vital_ statistics/SRS_Bulletins/MMR_release_070711.pdf , accessed  on January 30, 2012.",OADS,/arxiv_data1/oa_pdf/82/0a/IJMR-138-340.PMC3818596.pdf
"Available from: http://www.mohfw.nic.in/NRHM/ Documents/NRHM%20Mission%20Document.pd f, accessed  on March 30, 2010.",OADS,/arxiv_data1/oa_pdf/82/0a/IJMR-138-340.PMC3818596.pdf
"Available from: http://mohfw.nic.in/dofw%20website/JSY_ features_F AQ_Nov_2006.ht m, accessed on March 30, 2010.",OADS,/arxiv_data1/oa_pdf/82/0a/IJMR-138-340.PMC3818596.pdf
Available  from: http://censusindia.gov.in/2011-prov-results/data_files/ delhi/0_PDFC-Paper-1-2011%20NCT%20of%20Delhi_9.,OADS,/arxiv_data1/oa_pdf/82/0a/IJMR-138-340.PMC3818596.pdf
"Available from: http://www.nihfw.org/pdf/Mamta%20 Report%20full.pd f, accessed on April 6, 2011.",Non-OADS,/arxiv_data1/oa_pdf/82/0a/IJMR-138-340.PMC3818596.pdf
Available from: http://mohfw.nic.in/NRHM/CRM/CRM_files/ Attac hment/3rd%20CRM%20Report/3rd%20CRM%20Report.,OADS,/arxiv_data1/oa_pdf/82/0a/IJMR-138-340.PMC3818596.pdf
Available from: http://www.unicef.,Non-OADS,/arxiv_data1/oa_pdf/82/0a/IJMR-138-340.PMC3818596.pdf
"Available from: http://www.nfhsindia.org/pdf/ Delhi.pd f, accessed on March 30, 2010 Lim SS, Dandona L, Hoisington JA, James SL, Hogan MC, 13.",Non-OADS,/arxiv_data1/oa_pdf/82/0a/IJMR-138-340.PMC3818596.pdf
"Available from:  http://www.who.int/csr/don/2006_10_17/en/index.htm l, accessed  on October 10, 2007.",OADS,/arxiv_data1/oa_pdf/7c/70/IJMR-138-362.PMC3818600.pdf
"Available from:  http://www.nvbdcp.gov.in/Chikun-cases .htm l,  accessed on November 30, 2006.",Non-OADS,/arxiv_data1/oa_pdf/7c/70/IJMR-138-362.PMC3818600.pdf
Available from: http://www.horticulture.kar.nic.in%2FNHM.,Non-OADS,/arxiv_data1/oa_pdf/1c/61/IJMR-138-373.PMC3818606.pdf
"Available 9.  from: ftp://ftp.fao.org/docrep/fao/009/ah630e/ah630e00.pdf ,  accessed on August 22, 2013.",Non-OADS,/arxiv_data1/oa_pdf/1c/61/IJMR-138-373.PMC3818606.pdf
"Available  from:http://www.fao.org/publications/sofi/en /, accessed on  March 13, 2012.",Non-OADS,/arxiv_data1/oa_pdf/1c/61/IJMR-138-373.PMC3818606.pdf
"Available  from: ftp://ftp.fao.org/docrep/fao/009/a0442e/a0442e00.pdf ,  accessed on August 22, 2013.",Non-OADS,/arxiv_data1/oa_pdf/1c/61/IJMR-138-373.PMC3818606.pdf
Available from: http://www.nutritionfoundationofindia.,Non-OADS,/arxiv_data1/oa_pdf/1c/61/IJMR-138-373.PMC3818606.pdf
"http://eands.dacnet.nic.in/Adv_Esti_2010.ht m NA, not available",Non-OADS,/arxiv_data1/oa_pdf/39/f5/IJMR-138-383.PMC3818607.pdf
"Available from: http://www.networkideas.org/featart/jan2007/ fa08_neo-liberalism.ht m, accessed on August 24, 2013.",Non-OADS,/arxiv_data1/oa_pdf/39/f5/IJMR-138-383.PMC3818607.pdf
"Available from: http://monthlyreview.org/2009/07/01/ origins-of-the-food-crisis-in-india-and-developing-countrie s,  accessed on August 24, 2013.",Non-OADS,/arxiv_data1/oa_pdf/39/f5/IJMR-138-383.PMC3818607.pdf
"Available from: http://www.fao.org/fileadmin/ templates/wsfs/docs/expert_paper/How_to_Feed_the_World  in 2050.pd f, accessed on August 24, 2013.",Non-OADS,/arxiv_data1/oa_pdf/39/f5/IJMR-138-383.PMC3818607.pdf
"Available from:  http://eands.dacnet.nic.in/Advance_Estimate-2010.ht m,  accessed on 24 August 24, 2013.",OADS,/arxiv_data1/oa_pdf/39/f5/IJMR-138-383.PMC3818607.pdf
"Available from: 8.  http://planningcommission.nic.in/plans/ planrel/12appdrft/appraoch_12plan.pd f, accessed on August  26, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c4/26/IJMR-138-392.PMC3818608.pdf
"Available from: http://www.fao.org/fileadmin/user_upload/ foodclimate/HLCdocs/HLC08-inf-1-E.pd f, accessed on  August 31, 2013.",Non-OADS,/arxiv_data1/oa_pdf/28/38/IJMR-138-398.PMC3818609.pdf
"Available from:  http://www.fao.org/ docrep/012/i0680e/i0680e00.ht m, accessed on August 31,  2013.",Non-OADS,/arxiv_data1/oa_pdf/28/38/IJMR-138-398.PMC3818609.pdf
"Available from:  ftp://ftp.fao.org/docrep/fao/011/aj284e/aj284e00.pd f, accessed  on August 31, 2013.",OADS,/arxiv_data1/oa_pdf/28/38/IJMR-138-398.PMC3818609.pdf
"Available from: ftp://ftp.fao.org/docrep/ fao/010/ai506e/ai506e00.pd f, accessed on August 30, 2013.",OADS,/arxiv_data1/oa_pdf/28/38/IJMR-138-398.PMC3818609.pdf
http://www.fao.org/docrep/016/i3027e/ i3027e.pd f. A more detailed description of the methodology is  also found in the FAO website.,Non-OADS,/arxiv_data1/oa_pdf/28/38/IJMR-138-398.PMC3818609.pdf
"Available from: http://www.ers.usda.gov/ data-products/state-fact-sheets.asp x, accessed on August 30,  2013.",OADS,/arxiv_data1/oa_pdf/28/38/IJMR-138-398.PMC3818609.pdf
"Available from: http://www.fao.org/cfs/en /, accessed on August  31, 2013.",Non-OADS,/arxiv_data1/oa_pdf/28/38/IJMR-138-398.PMC3818609.pdf
A more detailed description of the methodology  can be found at: http://www.fao.org/economic/ess/ess-fs/fs- methods/fs-methods1/en /.,Non-OADS,/arxiv_data1/oa_pdf/28/38/IJMR-138-398.PMC3818609.pdf
Available from:  http://www.foreignpolicy.,Non-OADS,/arxiv_data1/oa_pdf/28/38/IJMR-138-398.PMC3818609.pdf
"Available from: http://faostat3.fao.org/faostat-gateway/go/to/ home/ E, accessed on August 30, 2013.",Non-OADS,/arxiv_data1/oa_pdf/28/38/IJMR-138-398.PMC3818609.pdf
"Available from:  http://www.thehindubusinessline.com/opinion/columns/alok- ray/growth-has-become-more-inclusive/article2313892.ec e,  accessed on August 31, 2013.",Non-OADS,/arxiv_data1/oa_pdf/28/38/IJMR-138-398.PMC3818609.pdf
"Z.28020/30/2003-CH  dated 2 November  2006  Available  from:  http://www.poshan.nic.in/jspui/bitstream/ DL/389/1/mcn-vitamin-a-ifa-supplementation.pdf , accessed  on September 12, 2013.",Non-OADS,/arxiv_data1/oa_pdf/4a/c0/IJMR-138-411.PMC3818610.pdf
Available from:  http://www.indmedica.,OADS,/arxiv_data1/oa_pdf/4a/c0/IJMR-138-411.PMC3818610.pdf
"Available from: http://www.unitedcalltoaction.org/documents/ Investing_in_the_future.pd f, accessed on July 1, 2011.",Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
"Available from: http://www.un-ngls.org/orf/ pdf/ru92kids.pd f, accessed on July 1, 2011.",Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
Available from: 11.  http://www.iodinenetwork.net/documents/scorecard-2010.,Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
Available from: http://www.whoindia.,Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
"Available from: http://www.unicef.org/ india/health.html , accessed on July 1, 2011.",Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
Available from: http://www.censusindia.gov.,OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
"Available from: http://www.iqplusin.org/ Reports.htm , accessed on July 1, 2011.",Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
"Available from: http://nutritionfoundationofindia.res.in/pdfs/ BulletinArticle/nfi_07_81.pd f, accessed on July 1, 2011.",Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
"Available from: http://www.ncbi.nlm.nih.gov/pubmed /?term=SAARC+Conference+on+Children.+ICCW+News+ Bull.+199 2, accessed on July 1, 2011.",Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
Available from: http://wcd.nic.in/NAP Aug16A.,Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
"Available from:  http://www.britannia.co.in/bnf/images/session-2/Prof-CS- Pandav.pd f, accessed on July 2, 2011.",Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
"Available  from: http://www.unicef.org/india/Coverage_Evaluation_ Survey_2006.pdf , accessed on July 1, 2011.",Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
"Available at URL: http://www.iqplusin.org/downloads/ booklet_english.pd f, accessed on July 1, 2011.Kar 46. markar MG, Pandav CS, Yadav K, Kumar R. ‘Mission  Approach’ to achieve sustainable elimination of iodine  deficiency disorders (IDD) in India.",Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
"Available  from: http://www.jaypeejournals.com/eJournals/ShowText.a s px?ID=3226&Type=FREE&TYP=TOP&IN=_eJournals/ images/JPLOGO.gif&IID=248&isPDF=YE S, accessed on  July 1, 2011.",Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
"Available from: http://www.micronutrient.org/CMFiles/india- salt-coverage-report-2010.pd f, accessed on July 10, 2011.",Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
"Available  from: http://www.iqplusin.org/downloads/m%5B1%5D.p._ report__Executive_Summary__1996.pd f, accessed on June 3,  2011.",OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
"Available from: http://articles.cnn.com/2011- 03-11/world/japan.quake_1_hokkaid otsunami-east-japan- railway?_s=PM:WORLD , accesses on July 29, 2011.",Non-OADS,/arxiv_data1/oa_pdf/b7/f7/IJMR-138-418.PMC3818611.pdf
Available from: http://www.musc.edu/dfm/RCMAR.,Non-OADS,/arxiv_data1/oa_pdf/67/af/JRMS-18-492.PMC3818619.pdf
Available from: http://www.who.int/inf‑fs/en/fact208Htm/.,OADS,/arxiv_data1/oa_pdf/12/ff/JRMS-18-497.PMC3818620.pdf
Available from: http://www.who.int/mediacentre/factsheets/fs 208/en/[Last accessed 2008 Jul 20].,Non-OADS,/arxiv_data1/oa_pdf/12/ff/JRMS-18-497.PMC3818620.pdf
Available from: http://www.ease.org.uk/publications/author‑guidelines.,Non-OADS,/arxiv_data1/oa_pdf/92/8c/JRMS-18-516.PMC3818625.pdf
Available from: http://www.kb‑merkur.hr/attachments/article/66/ICMJE‑citiranje.pdf.,Non-OADS,/arxiv_data1/oa_pdf/92/8c/JRMS-18-516.PMC3818625.pdf
"Inthe meantime, theHPVflyerusedintheinterventiongroup isavailableontheinternet[13].Finally,asemphasized byvariousauthors,adolescents needhealthliteracyto bepreparedforthecriticalappraisalofhealthinforma- tion.Variousprojectshaveaddressed thisimportantissue [12],[17],[18].Notes Data DataforthisarticleareavailablefromtheDryadReposi- tory:http://dx.doi.org/1 0.5061/dryad.2pm60 [16] Competinginterests Theauthorsdeclarethattheyhavenocompetingin- terests.",Non-OADS,/arxiv_data1/oa_pdf/5e/87/GMS-11-15.PMC3818649.pdf
"Trialregistration CurrentControlledTrialsISRCTN86240771 Attachments Availablefrom http://www.egms.de/en/journals/gms/20 13-11/000183.shtml 1.000183_leafletcontrolgroup.pdf(706KB) Standardleafletwithoutnumerical riskinformation 2.000183_leafletinterventiongroup.pdf(713KB) Leafletfortheinterventiongroupsupplement ed withnumerical riskinformation References 1.BetschC,BrewerNT,BrocardP,DaviesP,Gaissmaier W,Haase N,LeaskJ,RenkewitzF,RennerB,ReynaVF,RossmannC, SachseK,Schachinger A,SiegristM,StrykM.Opportunitiesand challenges ofWeb2.0forvaccination decisions.",OADS,/arxiv_data1/oa_pdf/5e/87/GMS-11-15.PMC3818649.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3153 | DOI: 10.1038/srep03153 10,Non-OADS,/arxiv_data1/oa_pdf/3c/a4/srep03153.PMC3818650.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3153 | DOI: 10.1038/srep03153 11",Non-OADS,/arxiv_data1/oa_pdf/3c/a4/srep03153.PMC3818650.pdf
"Image processing and analysis was performed with ImageJ (v1.43, http://rsb.info.nih.gov/ij).",OADS,/arxiv_data1/oa_pdf/47/7c/srep03155.PMC3818651.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/47/7c/srep03155.PMC3818651.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3155 | DOI: 10.1038/srep03155 7",Non-OADS,/arxiv_data1/oa_pdf/47/7c/srep03155.PMC3818651.pdf
Heat map expression data was displayed using Gene-E softwaredeveloped by Joshua Gould (http://www.broadinstitute.org/cancer/software/GENE-E).,OADS,/arxiv_data1/oa_pdf/f8/41/srep03151.PMC3818652.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f8/41/srep03151.PMC3818652.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3151 | DOI: 10.1038/srep03151 12",Non-OADS,/arxiv_data1/oa_pdf/f8/41/srep03151.PMC3818652.pdf
"http://www.nigms.nih.gov/Research/ FeaturedPrograms/MIDAS/, September 1, 2013.",OADS,/arxiv_data1/oa_pdf/3e/8e/srep03152.PMC3818653.pdf
"http://washington.org, June 15, 2012.",Non-OADS,/arxiv_data1/oa_pdf/3e/8e/srep03152.PMC3818653.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3e/8e/srep03152.PMC3818653.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3152 | DOI: 10.1038/srep03152 10",Non-OADS,/arxiv_data1/oa_pdf/3e/8e/srep03152.PMC3818653.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3046 | DOI: 10.1038/srep03046 5",Non-OADS,/arxiv_data1/oa_pdf/49/dc/srep03046.PMC3818654.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3154 | DOI: 10.1038/srep03154 8",Non-OADS,/arxiv_data1/oa_pdf/dd/de/srep03154.PMC3818655.pdf
All molecular graphics representations were created with the program PyMOL (DeLano Scientific; http://www.pymol.org).,OADS,/arxiv_data1/oa_pdf/a5/75/srep03097.PMC3818656.pdf
Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a5/75/srep03097.PMC3818656.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3097 | DOI: 10.1038/srep03097 9",Non-OADS,/arxiv_data1/oa_pdf/a5/75/srep03097.PMC3818656.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/07/e3/srep03156.PMC3818658.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3156 | DOI: 10.1038/srep03156 6",Non-OADS,/arxiv_data1/oa_pdf/07/e3/srep03156.PMC3818658.pdf
analyzed the resultsand wrote the manuscript.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ca/21/srep03147.PMC3818680.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3147 | DOI: 10.1038/srep03147 6",Non-OADS,/arxiv_data1/oa_pdf/ca/21/srep03147.PMC3818680.pdf
"The scores at all four aggression subscales were positively correlatedwith one another (with r values ranging from 0.386 to 0.497); thus, we used thecorrection for the critical p value for multiple correlated outcomes (http://gump.qimr.edu.au/general/daleN/matSpD/) previously applied by Hurd, Vaillancourt, andDinsdale 41.",OADS,/arxiv_data1/oa_pdf/1f/59/srep03148.PMC3818681.pdf
"J Bioanal Biomed S3, http://dx.doi.org/10.4172/1948-593X.S3-005 (2013).",Non-OADS,/arxiv_data1/oa_pdf/1f/59/srep03148.PMC3818681.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1f/59/srep03148.PMC3818681.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3148 | DOI: 10.1038/srep03148 8",Non-OADS,/arxiv_data1/oa_pdf/1f/59/srep03148.PMC3818681.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3b/bb/srep03150.PMC3818682.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3150 | DOI: 10.1038/srep03150 4",Non-OADS,/arxiv_data1/oa_pdf/3b/bb/srep03150.PMC3818682.pdf
These data are  available at:  http://www.pharmine.org/losse_paginas/Country_Pr ofiles/.,OADS,/arxiv_data1/oa_pdf/47/0b/pharmpract-09-169.PMC3818732.pdf
Estos  datos están disponibles en  http://www.pharmine.org/losse_paginas/Country_P rofiles/.,Non-OADS,/arxiv_data1/oa_pdf/47/0b/pharmpract-09-169.PMC3818732.pdf
"INTRODUCTION  In 1994 the EAFP, under the direction of P.  Bourlioux, University Paris XI, France, brought out a  document surveying the state of pharmacy  education in the EU of that time (document  available at:  http://enzu.pharmine.org/medi a/filebook/files/Bourlio ux_full_report.pdf).",Non-OADS,/arxiv_data1/oa_pdf/47/0b/pharmpract-09-169.PMC3818732.pdf
The population of the different  member states used in the analysis was that as of  1st January 2009 given in the European  Commission Eurostat demography report for 2011  http://epp.eurostat.ec.europ a.eu/portal/page/portal/p opulation/documents/Tab/report.pdf.,OADS,/arxiv_data1/oa_pdf/47/0b/pharmpract-09-169.PMC3818732.pdf
"Statview® (http://statview.com/), GraphPad®  (www.graphpad.com) and nQuery®  (www.statistical-solutions-software.com) programs  were used.",OADS,/arxiv_data1/oa_pdf/47/0b/pharmpract-09-169.PMC3818732.pdf
Complete data for each country can be obtained on  the PHARMINE website at:  http://www.pharmine.org/losse_paginas/Country_Pr ofiles/ .,OADS,/arxiv_data1/oa_pdf/47/0b/pharmpract-09-169.PMC3818732.pdf
"Taking the case of Finland  (http://www.pharmine.org/losse_paginas/Country_P rofiles/Finland/) following the Bologna declaration  (http://enzu.pharmine.org/media/filebook/files/Bolog na%20declaration.pdf), pharmacy education is  divided into two parts.",Non-OADS,/arxiv_data1/oa_pdf/47/0b/pharmpract-09-169.PMC3818732.pdf
These data are available at:  http://www.pharmine.org/losse_paginas/Country_Pr ofiles/.,OADS,/arxiv_data1/oa_pdf/47/0b/pharmpract-09-169.PMC3818732.pdf
"The PHARMINE consortium (see list at the end)  produced country profiles with extensive information  for each country, available at:  http://www.pharmine.org/losse_paginas/Country_Pr ofiles/     Comparable degrees and diploma supplement  The first action of the Bologna declaration proposes  the adoption of comparable degrees with  implementation of a diploma supplement.",Non-OADS,/arxiv_data1/oa_pdf/83/99/pharmpract-09-188.PMC3818733.pdf
ENQA disseminates  information on good practices in the field of quality  assurance in higher education to European quality  assurance agencies and higher education  institutions ( http://www.enqa.eu/ ).,Non-OADS,/arxiv_data1/oa_pdf/83/99/pharmpract-09-188.PMC3818733.pdf
See: http://eur-lex.europa.eu/LexUriServ/LexUriS erv.do?uri=OJ:L:2005: 255:0022:0142:en:PDF         Annex 2.,Non-OADS,/arxiv_data1/oa_pdf/83/99/pharmpract-09-188.PMC3818733.pdf
See:   http://www.ond.vlaanderen.be/hogeronderwijs/bologna/    http://www.eua.be/bologna-universities-reform/    http://ec.europa.eu/education/hi gher-education/ doc1290_en.htm,Non-OADS,/arxiv_data1/oa_pdf/83/99/pharmpract-09-188.PMC3818733.pdf
"Pharmacy Practice  (Internet) 2011 Oct-Dec;9(4):195-199.  www.pharmacypractice.org      (ISSN: 1886-3655)  196Education’:  http://www.fip.org/www/uploads/database_file.php?i d=302&table_id = and the ‘Accreditation Standards  and Guidelines for the Professional Program in  Pharmacy Leading to the Doctor of Pharmacy  Degree’ of the Accreditation Council for Pharmacy  Education (ACPE, USA): http://www.acpe- accredit.org/stand ards/standards1.asp    The QA areas surveyed were:  1.",Non-OADS,/arxiv_data1/oa_pdf/3b/16/pharmpract-09-195.PMC3818734.pdf
Available from:  http://www.fiocruz.br/sinitox _novo/media/tab10_brasil_2007.pdf  6.,Non-OADS,/arxiv_data1/oa_pdf/61/7d/pharmpract-09-200.PMC3818735.pdf
"Available at:  http://www.nlm.nih.gov/archives//20061214/pubs/cbm/hliteracy.pdf  (Accessed  April 2, 2007).",Non-OADS,/arxiv_data1/oa_pdf/fd/2f/pharmpract-09-213.PMC3818737.pdf
"Available at:  http://www.agingsociety.org/agingsociety/publications/fact/fact_low.html  (Accessed February 2, 2011).",Non-OADS,/arxiv_data1/oa_pdf/fd/2f/pharmpract-09-213.PMC3818737.pdf
"Available at:  http://www.healthypeople.gov/document/HTML/Volume2/21Oral.htm  (Accessed: February 12, 2008).",Non-OADS,/arxiv_data1/oa_pdf/fd/2f/pharmpract-09-213.PMC3818737.pdf
"Available from  http://www.goldcopd.org/uploads/users/files/GOLDReport07_Changes.pdf   (Accessed September 24, 2011).",OADS,/arxiv_data1/oa_pdf/88/97/pharmpract-09-221.PMC3818738.pdf
"Available from  http://www.nhlbi.nih.gov/guidelines/asthma/   (Accessed September 22, 2011).",Non-OADS,/arxiv_data1/oa_pdf/88/97/pharmpract-09-221.PMC3818738.pdf
"In: Am erican Pharmacists Association, 1 August 1995. http://www.pharmacist.com    (Accessed on 27 January, 2011).",Non-OADS,/arxiv_data1/oa_pdf/6b/92/pharmpract-09-242.PMC3818741.pdf
"In: Pharmacy Times, 1  August 2006. http://www.pharmacytimes.com   (Accessed on 21 June 2010).",Non-OADS,/arxiv_data1/oa_pdf/6b/92/pharmpract-09-242.PMC3818741.pdf
"http://www.bemedwise.org/about_us/about_us.htm   (Accessed on 30 September, 2011).",Non-OADS,/arxiv_data1/oa_pdf/6b/92/pharmpract-09-242.PMC3818741.pdf
"http://www.cfsan.fda.gov/~dms/ds-overview.html   (Accessed on 3 January, 2001).",OADS,/arxiv_data1/oa_pdf/6b/92/pharmpract-09-242.PMC3818741.pdf
"Dietar y supplement Alerts and Safety Informatio n. In: Office of Dietary Supplements,  6 October 2009. http://www.fda.gov/Food/Dietarysupplement/Alerts/default.htm   (Accessed on 25 January, 2011).",Non-OADS,/arxiv_data1/oa_pdf/6b/92/pharmpract-09-242.PMC3818741.pdf
"In: Na tional Institutes of Health,  1 January 2010. http://nccam.nih.gov/news/alerts/   (Accessed on 5 July, 2010).",Non-OADS,/arxiv_data1/oa_pdf/6b/92/pharmpract-09-242.PMC3818741.pdf
"http://www.jpa.org.jo/index.php/cms/gpp   (Accessed  on 30 September, 2011).",OADS,/arxiv_data1/oa_pdf/6b/92/pharmpract-09-242.PMC3818741.pdf
"http://www.nhlbi.nih.gov/whi/background.htm   (Accessed on 30 September, 2011).",Non-OADS,/arxiv_data1/oa_pdf/6b/92/pharmpract-09-242.PMC3818741.pdf
http://www.ncver.edu.au/research/proj/nr1F12.pdf [accessed August 2009].,Non-OADS,/arxiv_data1/oa_pdf/e1/ea/pharmpract-09-252.PMC3818742.pdf
"Proceedings of ASCILITE Conference 1998, Wollongong,  NSW, 241-249. http://www.ascilite.org.au/conferences/ wollongong98/asc98-pdf/franklinpeast.pdf [accessed August  2009].",Non-OADS,/arxiv_data1/oa_pdf/e1/ea/pharmpract-09-252.PMC3818742.pdf
6) http://www.ice.cam.,Non-OADS,/arxiv_data1/oa_pdf/12/fb/AIM-2010-18-4-11.PMC3818743.pdf
"6. http://www.ice.cam.ac.uk/cours - es/online-study, accessed at 12th january Corresponding author:  ass prof Haris p andza, M d,  phd.",Non-OADS,/arxiv_data1/oa_pdf/12/fb/AIM-2010-18-4-11.PMC3818743.pdf
"Links: http://www.asahq.org/���� ����������������������� Corresponding author: Lejla Tafro, MD.",Non-OADS,/arxiv_data1/oa_pdf/73/53/AIM-2010-18-3-8.PMC3818744.pdf
"[Medline]   [CrossRef] 12) Can Child Centre for Childhood Disability Research: http://motorgrowth.canchild.ca/en/GMFCS/resources/GMFCS-ER.pdf (Accessed, 2007).",Non-OADS,/arxiv_data1/oa_pdf/8b/00/jpts-25-1123.PMC3818755.pdf
"[Medline]   [CrossRef] 29) Web MD, Erectile Dysfunction Guide LL: http://www.webmd.com/erec - tile-dysfunction/guide/erectile-dysfunction-treatment-care (Accessed Jul.",Non-OADS,/arxiv_data1/oa_pdf/4d/48/jpts-25-1087.PMC3818777.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/5c/83/AJM-3-57.PMC3818780.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/5c/83/AJM-3-57.PMC3818780.pdf
Author Help: Online submission of the manuscripts Articles can be submitt ed online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/1c/e1/AJM-3-63.PMC3818781.pdf
The  application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/4b/a9/AJM-3-73.PMC3818783.pdf
Available from: http://www.emro.who.int/images/stories/eha/ documents/Sitrep_7_for_the_Web.pdf  [Last accessed on 2013   Dec 4].4.,Non-OADS,/arxiv_data1/oa_pdf/16/4d/AJM-3-84.PMC3818785.pdf
Available from: http://www.nytimes.com/2013/03/24/world/middleeast/on‑both‑sides‑in‑syrian‑war‑doctors‑are‑often‑the‑target.,Non-OADS,/arxiv_data1/oa_pdf/16/4d/AJM-3-84.PMC3818785.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/df/b2/3460.PMC3818808.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/9d/58/NAJMS-5-499.PMC3818821.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/75/da/NAJMS-5-505.PMC3818822.pdf
"(Accessed October 10,  2012, at http://www.who.int/entity/hiv/pub/surveillance/ pub3/en/index.html).",OADS,/arxiv_data1/oa_pdf/3f/90/NAJMS-5-515.PMC3818823.pdf
"(Accessed October 10, 2012, at http://www.nacoonline.",Non-OADS,/arxiv_data1/oa_pdf/3f/90/NAJMS-5-515.PMC3818823.pdf
"(Accessed October 10, 2012, at http://nacoonline.org/ UNAIDS/templates/NACONewsItem.aspx?id=1260).",OADS,/arxiv_data1/oa_pdf/3f/90/NAJMS-5-515.PMC3818823.pdf
"(Accessed October 10, 2012, at http://www.nacoonline.org/ upload/Publication/MandE%20Surveillance,%20Research/ HIV%20Sentinel%20Surveillance%20and%20HIV%20 Estimation%202007_A%20Technical%20Brief.pdf).",Non-OADS,/arxiv_data1/oa_pdf/3f/90/NAJMS-5-515.PMC3818823.pdf
"(Accessed October 10,  2012, at http://www.nacoonline.org/upload/REPORTS/ NACO%20Annual%20Report%202010-11.pdf).",Non-OADS,/arxiv_data1/oa_pdf/3f/90/NAJMS-5-515.PMC3818823.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/9b/3c/NAJMS-5-523.PMC3818824.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/9b/3c/NAJMS-5-523.PMC3818824.pdf
"The 19th International Nursing Research Congress  Focusing on Evidence-Based Practice, July 2008 (Accessed  July 8, 2008, at https://stti.confex.com/stti/congrs08/ techprogram/paper_38597.htm).",Non-OADS,/arxiv_data1/oa_pdf/ac/ba/NAJMS-5-536.PMC3818826.pdf
"American College of Rheumatology, (Accessed July 9, 2013, at  http://www.rheumatology.org/Practice/Clinical/Patients/ Diseases_And_Conditions/Fibromyalgia).",Non-OADS,/arxiv_data1/oa_pdf/5a/ec/NAJMS-5-546.PMC3818828.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/5e/83/NAJMS-5-567.PMC3818831.pdf
ⓒ The Korean Society of Ginseng 261 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Review Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/81/a8/grosbr-37-261.PMC3818951.pdf
"3, 261-268 (2013) http://dx.doi.org/10.5142/jgr.2013.37.261 E-mail: dcyang@khu.ac.kr Tel: +82-31-201-2100, Fax: +82-31-205-2688*Corresponding author INTRODUCTION Bone remodeling occurs throughout life via synthesis  of bone matrix through the action of two major bone  cells: osteoblasts and osteoclasts [1-3].",Non-OADS,/arxiv_data1/oa_pdf/81/a8/grosbr-37-261.PMC3818951.pdf
http://dx.doi.org/10.5142/jgr.2013.37.261 262J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/81/a8/grosbr-37-261.PMC3818951.pdf
Ginseng saponins mini literature review osteoporosis    http://ginsengres.orgfactor-6 (TRAF-6) and activates different downstream  signaling pathways (Fig.,Non-OADS,/arxiv_data1/oa_pdf/81/a8/grosbr-37-261.PMC3818951.pdf
http://dx.doi.org/10.5142/jgr.2013.37.261 264J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/81/a8/grosbr-37-261.PMC3818951.pdf
"Ginseng saponins mini literature review osteoporosis    http://ginsengres.orgalternative therapies, particularly from herbal sources as  these are cost-effective and have minimal side effects.",Non-OADS,/arxiv_data1/oa_pdf/81/a8/grosbr-37-261.PMC3818951.pdf
http://dx.doi.org/10.5142/jgr.2013.37.261 266J Ginseng Res  Vol.,OADS,/arxiv_data1/oa_pdf/81/a8/grosbr-37-261.PMC3818951.pdf
Available from: http://www.nof.org/node/40.,Non-OADS,/arxiv_data1/oa_pdf/81/a8/grosbr-37-261.PMC3818951.pdf
Available from: http://www.who.int/chp/topics/Osteopo - rosis.pdf.,OADS,/arxiv_data1/oa_pdf/81/a8/grosbr-37-261.PMC3818951.pdf
Ginseng saponins mini literature review osteoporosis    http://ginsengres.org1999;13:1015-1024.,Non-OADS,/arxiv_data1/oa_pdf/81/a8/grosbr-37-261.PMC3818951.pdf
http://dx.doi.org/10.5142/jgr.2013.37.261 268J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/81/a8/grosbr-37-261.PMC3818951.pdf
ⓒ The Korean Society of Ginseng 269 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Note J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/94/89/grosbr-37-269.PMC3818952.pdf
"3, 269-272 (2013) http://dx.doi.org/10.5142/jgr.2013.37.269 E-mail: jdkim303@sookmyung.ac.kr Tel: +82-2-710-9626, Fax: +82-2-710-9080*Corresponding authorsIt was confirmed that Korean ginseng berries, a flesh  part of the berries, contain ginseng saponins such as Rb1,  Rb2, Rd, Re, Rg1, Rg2, and Rh1 [1].",Non-OADS,/arxiv_data1/oa_pdf/94/89/grosbr-37-269.PMC3818952.pdf
http://dx.doi.org/10.5142/jgr.2013.37.269 270J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/94/89/grosbr-37-269.PMC3818952.pdf
Microwave-processed ginseng berries    http://ginsengres.orgflow rate at 0.8 mL/min.,Non-OADS,/arxiv_data1/oa_pdf/94/89/grosbr-37-269.PMC3818952.pdf
http://dx.doi.org/10.5142/jgr.2013.37.269 272J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/94/89/grosbr-37-269.PMC3818952.pdf
ⓒ The Korean Society of Ginseng 273 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/93/ec/grosbr-37-273.PMC3818953.pdf
"3, 273-282 (2013) http://dx.doi.org/10.5142/jgr.2013.37.273 E-mail: jhkim1@chonbuk.ac.kr Tel: +82-63-270-2563, Fax: +82-63-270-3780*Corresponding authorINTRODUCTION Myocardial infarction (MI) is a common symptom  of cardiac ischemia, and occurs when cardiac ischemia  surpasses a critical threshold, resulting in irreversible  myocardial damage [1].",Non-OADS,/arxiv_data1/oa_pdf/93/ec/grosbr-37-273.PMC3818953.pdf
http://dx.doi.org/10.5142/jgr.2013.37.273 274J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/93/ec/grosbr-37-273.PMC3818953.pdf
"Effect for KRG on cardiac injury induced by ISO    http://ginsengres.orgHemodynamics parameters At the end of the above experiments, the rats were  anesthetized with urethane (1 g/kg intraperitoneally),  and electrodes were inserted under the skin for the limb  lead at position II.",Non-OADS,/arxiv_data1/oa_pdf/93/ec/grosbr-37-273.PMC3818953.pdf
http://dx.doi.org/10.5142/jgr.2013.37.273 276J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/93/ec/grosbr-37-273.PMC3818953.pdf
Effect for KRG on cardiac injury induced by ISO    http://ginsengres.orgsignificant decrease in ST segments as compared to ISO- treated alone group rats (Fig.,Non-OADS,/arxiv_data1/oa_pdf/93/ec/grosbr-37-273.PMC3818953.pdf
http://dx.doi.org/10.5142/jgr.2013.37.273 278J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/93/ec/grosbr-37-273.PMC3818953.pdf
Effect for KRG on cardiac injury induced by ISO    http://ginsengres.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/93/ec/grosbr-37-273.PMC3818953.pdf
http://dx.doi.org/10.5142/jgr.2013.37.273 280J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/93/ec/grosbr-37-273.PMC3818953.pdf
"Effect for KRG on cardiac injury induced by ISO    http://ginsengres.orgAs shown in this study, KRG suppressed caspase-3 activ - ity and TNF-α protein production, further demonstrating  the cardioprotective effects of KRG.",Non-OADS,/arxiv_data1/oa_pdf/93/ec/grosbr-37-273.PMC3818953.pdf
http://dx.doi.org/10.5142/jgr.2013.37.273 282J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/93/ec/grosbr-37-273.PMC3818953.pdf
ⓒ The Korean Society of Ginseng 283 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/85/a3/grosbr-37-283.PMC3818954.pdf
"3, 283-292 (2013) http://dx.doi.org/10.5142/jgr.2013.37.283 E-mail: jhkim1@chonbuk.ac.kr Tel: +82-63-270-2563, Fax: +82-63-270-3780*Corresponding authorINTRODUCTION Cardiovascular disease (CVD) is one of the most  pressing dangers that accounts to over 50% of total mor - tality worldwide.",Non-OADS,/arxiv_data1/oa_pdf/85/a3/grosbr-37-283.PMC3818954.pdf
http://dx.doi.org/10.5142/jgr.2013.37.283 284J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/85/a3/grosbr-37-283.PMC3818954.pdf
Ginsenoside-Re increased the cardiac functions against I/R injury   http://ginsengres.orgchemical structure of G-Re was shown in Fig.,Non-OADS,/arxiv_data1/oa_pdf/85/a3/grosbr-37-283.PMC3818954.pdf
http://dx.doi.org/10.5142/jgr.2013.37.283 286J Ginseng Res  Vol.,OADS,/arxiv_data1/oa_pdf/85/a3/grosbr-37-283.PMC3818954.pdf
Ginsenoside-Re increased the cardiac functions against I/R injury   http://ginsengres.org Fig.,Non-OADS,/arxiv_data1/oa_pdf/85/a3/grosbr-37-283.PMC3818954.pdf
http://dx.doi.org/10.5142/jgr.2013.37.283 288J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/85/a3/grosbr-37-283.PMC3818954.pdf
Ginsenoside-Re increased the cardiac functions against I/R injury   http://ginsengres.orgG-Re at 30 µM dose gave no significant effectiveness in  QT interval study for 120 min I/R periods ( p<0.5).,Non-OADS,/arxiv_data1/oa_pdf/85/a3/grosbr-37-283.PMC3818954.pdf
http://dx.doi.org/10.5142/jgr.2013.37.283 290J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/85/a3/grosbr-37-283.PMC3818954.pdf
"Ginsenoside-Re increased the cardiac functions against I/R injury   http://ginsengres.orgthe safety and efficacy of G-Re, prospective further stud - ies for G-Re should be considered to establish the effec - tiveness of G-Re in the treatment of cardiac ischema.",Non-OADS,/arxiv_data1/oa_pdf/85/a3/grosbr-37-283.PMC3818954.pdf
http://dx.doi.org/10.5142/jgr.2013.37.283 292J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/85/a3/grosbr-37-283.PMC3818954.pdf
ⓒ The Korean Society of Ginseng 293 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/51/2a/grosbr-37-293.PMC3818955.pdf
"3, 293-299 (2013) http://dx.doi.org/10.5142/jgr.2013.37.293 E-mail: jaecho@skku.edu Tel: +82-31-290-7868, Fax: +82-31-290-7870*Corresponding authorINTRODUCTION Innate immunity is one of the major responses against  pathogenic infections by bacteria, virus, and fungi.",OADS,/arxiv_data1/oa_pdf/51/2a/grosbr-37-293.PMC3818955.pdf
http://dx.doi.org/10.5142/jgr.2013.37.293 294J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/51/2a/grosbr-37-293.PMC3818955.pdf
2H-PPD enhances monocyte and macrophage functions    http://ginsengres.orgtographed with an inverted light microscope equipped  with a COHU high-performance CCD (Diavert) video  camera.,Non-OADS,/arxiv_data1/oa_pdf/51/2a/grosbr-37-293.PMC3818955.pdf
http://dx.doi.org/10.5142/jgr.2013.37.293 296J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/51/2a/grosbr-37-293.PMC3818955.pdf
"2H-PPD enhances monocyte and macrophage functions    http://ginsengres.orgcellular functions of macrophages/monocytes such as  phagocytic uptake, ROS generation, expression of co - stimulatory molecules, and cell-cell adhesion.",Non-OADS,/arxiv_data1/oa_pdf/51/2a/grosbr-37-293.PMC3818955.pdf
http://dx.doi.org/10.5142/jgr.2013.37.293 298J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/51/2a/grosbr-37-293.PMC3818955.pdf
2H-PPD enhances monocyte and macrophage functions    http://ginsengres.orgtory effect of Hibiscus cannabinus  extract on macrophage  functions.,Non-OADS,/arxiv_data1/oa_pdf/51/2a/grosbr-37-293.PMC3818955.pdf
ⓒ The Korean Society of Ginseng 300 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/27/70/grosbr-37-300.PMC3818956.pdf
"3, 300-307 (2013) http://dx.doi.org/10.5142/jgr.2013.37.300 E-mail: jaecho@skku.edu Tel: +82-31-290-7868, Fax: +82-31-290-7870*Corresponding authorINTRODUCTION Macrophages are important innate immune cells with  various immune functions including anticancer, antibac - terial, and antiviral [1-3].",OADS,/arxiv_data1/oa_pdf/27/70/grosbr-37-300.PMC3818956.pdf
2H-PPT as a macrophage function regulator    http://ginsengres.orgtopanaxatriol (PPT).,Non-OADS,/arxiv_data1/oa_pdf/27/70/grosbr-37-300.PMC3818956.pdf
http://dx.doi.org/10.5142/jgr.2013.37.300 302J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/27/70/grosbr-37-300.PMC3818956.pdf
2H-PPT as a macrophage function regulator    http://ginsengres.orgMorphological change test 2H-PPT-treated RAW264.7 or U937 cells in the pres - ence or absence of LPS or PMA were incubated for in - dicated times.,Non-OADS,/arxiv_data1/oa_pdf/27/70/grosbr-37-300.PMC3818956.pdf
http://dx.doi.org/10.5142/jgr.2013.37.300 304J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/27/70/grosbr-37-300.PMC3818956.pdf
2H-PPT as a macrophage function regulator    http://ginsengres.orgthe RAW264.7 cell cluster was also reduced by 2H-PPT  (Fig.,Non-OADS,/arxiv_data1/oa_pdf/27/70/grosbr-37-300.PMC3818956.pdf
http://dx.doi.org/10.5142/jgr.2013.37.300 306J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/27/70/grosbr-37-300.PMC3818956.pdf
2H-PPT as a macrophage function regulator    http://ginsengres.orglipopolysaccharide-induced interleukin-1beta production  via suppression of the NF-kappaB pathway.,Non-OADS,/arxiv_data1/oa_pdf/27/70/grosbr-37-300.PMC3818956.pdf
ⓒ The Korean Society of Ginseng 308 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/grosbr-37-308.PMC3818957.pdf
"3, 308-314 (2013) http://dx.doi.org/10.5142/jgr.2013.37.308 E-mail: kchsung@cnu.ac.kr Tel: +82-42-821-6722, Fax: +82-42-822-2287*Corresponding authorINTRODUCTION Obesity and being overweight are also associated with  diet-related chronic diseases, including type 2 diabetes,  cardiovascular disease, and several types of cancer, lead - ing to a substantial increase in morbidity, and mortality  [1,2].",Non-OADS,/arxiv_data1/oa_pdf/48/e6/grosbr-37-308.PMC3818957.pdf
"Anti-obesity effects of black ginseng    http://ginsengres.orgtimes drying, at which point it becomes black in color.",Non-OADS,/arxiv_data1/oa_pdf/48/e6/grosbr-37-308.PMC3818957.pdf
http://dx.doi.org/10.5142/jgr.2013.37.308 310J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/grosbr-37-308.PMC3818957.pdf
"Anti-obesity effects of black ginseng    http://ginsengres.orgtaneous fat and retroperitoneal fat mass in the HF group  were 208% and 167% greater than in the NC group, re - spectively.",Non-OADS,/arxiv_data1/oa_pdf/48/e6/grosbr-37-308.PMC3818957.pdf
http://dx.doi.org/10.5142/jgr.2013.37.308 312J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/grosbr-37-308.PMC3818957.pdf
"Anti-obesity effects of black ginseng    http://ginsengres.orgRg3 and Rh2, rich ginsenosides in BG, induced the  inhibition of adipocyte differentiation in 3T3-L1 cells  [24,25].",Non-OADS,/arxiv_data1/oa_pdf/48/e6/grosbr-37-308.PMC3818957.pdf
http://dx.doi.org/10.5142/jgr.2013.37.308 314J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/48/e6/grosbr-37-308.PMC3818957.pdf
ⓒ The Korean Society of Ginseng 315 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/0b/8e/grosbr-37-315.PMC3818958.pdf
"3, 315-323 (2013) http://dx.doi.org/10.5142/jgr.2013.37.315 E-mail: dkrhee@skku.edu Tel: +82-31-290-7707, Fax: +82-31-290-7727*Corresponding authorINTRODUCTION The antistress effects of ginseng are well known, and  its active ingredients have been identified as ginsenosides  [1,2].",Non-OADS,/arxiv_data1/oa_pdf/0b/8e/grosbr-37-315.PMC3818958.pdf
http://dx.doi.org/10.5142/jgr.2013.37.315 316J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/0b/8e/grosbr-37-315.PMC3818958.pdf
PADI4 repression by ginseng via TACE and NF- κB   http://ginsengres.orgpernatants was measured spectrophotometrically by the  Griess reaction.,OADS,/arxiv_data1/oa_pdf/0b/8e/grosbr-37-315.PMC3818958.pdf
http://dx.doi.org/10.5142/jgr.2013.37.315 318J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/0b/8e/grosbr-37-315.PMC3818958.pdf
PADI4 repression by ginseng via TACE and NF- κB   http://ginsengres.orgtive soluble form [23].,Non-OADS,/arxiv_data1/oa_pdf/0b/8e/grosbr-37-315.PMC3818958.pdf
http://dx.doi.org/10.5142/jgr.2013.37.315 320J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/0b/8e/grosbr-37-315.PMC3818958.pdf
PADI4 repression by ginseng via TACE and NF- κB   http://ginsengres.orgrelease was examined.,OADS,/arxiv_data1/oa_pdf/0b/8e/grosbr-37-315.PMC3818958.pdf
http://dx.doi.org/10.5142/jgr.2013.37.315 322J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/0b/8e/grosbr-37-315.PMC3818958.pdf
"PADI4 repression by ginseng via TACE and NF- κB   http://ginsengres.orgosides in the production of proinflammatory repertoire,  and their potential roles in neuroprotection in vivo .",Non-OADS,/arxiv_data1/oa_pdf/0b/8e/grosbr-37-315.PMC3818958.pdf
ⓒ The Korean Society of Ginseng 324 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/78/73/grosbr-37-324.PMC3818959.pdf
"3, 324-331 (2013) http://dx.doi.org/10.5142/jgr.2013.37.324 E-mail: synah@konkuk.ac.kr Tel: +82-2-450-4154, Fax: +82-2-450-3037*Corresponding authorINTRODUCTION KCNQ1 was first discovered by positional cloning [1].",OADS,/arxiv_data1/oa_pdf/78/73/grosbr-37-324.PMC3818959.pdf
"Ginsenoside metabolite PPT regulates KCNQ1 channels    http://ginsengres.orgcalled ginseng saponins), as a representative ingredient  of ginseng, also exhibit antihypertension and cardio- protective effects [16-18].",Non-OADS,/arxiv_data1/oa_pdf/78/73/grosbr-37-324.PMC3818959.pdf
http://dx.doi.org/10.5142/jgr.2013.37.324 326J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/78/73/grosbr-37-324.PMC3818959.pdf
Ginsenoside metabolite PPT regulates KCNQ1 channels    http://ginsengres.orgprotocol were slowly activating delayed rectifier K+  channel ( IKs) currents with no apparent inactivation (Fig.,OADS,/arxiv_data1/oa_pdf/78/73/grosbr-37-324.PMC3818959.pdf
http://dx.doi.org/10.5142/jgr.2013.37.324 328J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/78/73/grosbr-37-324.PMC3818959.pdf
"Ginsenoside metabolite PPT regulates KCNQ1 channels    http://ginsengres.orgin both concentration- and voltage-dependent man - ners, but the PPT blockade of the IKs current had an IC50  value of 5.18±0.13 µM, which was 2-fold less than that  of KCNQ1 alone K+ current.",OADS,/arxiv_data1/oa_pdf/78/73/grosbr-37-324.PMC3818959.pdf
http://dx.doi.org/10.5142/jgr.2013.37.324 330J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/78/73/grosbr-37-324.PMC3818959.pdf
"Ginsenoside metabolite PPT regulates KCNQ1 channels    http://ginsengres.orgtestinal bacteria, in rat plasma after oral administration:  measurement of compound K by enzyme immunoassay.",Non-OADS,/arxiv_data1/oa_pdf/78/73/grosbr-37-324.PMC3818959.pdf
ⓒ The Korean Society of Ginseng 332 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/35/82/grosbr-37-332.PMC3818960.pdf
"3, 332-340 (2013) http://dx.doi.org/10.5142/jgr.2013.37.332 E-mail: bioplant@kaeri.re.kr Tel: +82-63-570-3311, Fax: +82-63-570-3319*Corresponding authorINTRODUCTION Panax ginseng  Meyer is a perennial herb that belongs  to the family Araliceae.",Non-OADS,/arxiv_data1/oa_pdf/35/82/grosbr-37-332.PMC3818960.pdf
"Ginsenoside accumulation by γ-irradiation in ginseng    http://ginsengres.orgbeen isolated and studied [6,7].",Non-OADS,/arxiv_data1/oa_pdf/35/82/grosbr-37-332.PMC3818960.pdf
http://dx.doi.org/10.5142/jgr.2013.37.332 334J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/35/82/grosbr-37-332.PMC3818960.pdf
Ginsenoside accumulation by γ-irradiation in ginseng    http://ginsengres.orgtreated with 50 Gy of gamma rays.,Non-OADS,/arxiv_data1/oa_pdf/35/82/grosbr-37-332.PMC3818960.pdf
http://dx.doi.org/10.5142/jgr.2013.37.332 336J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/35/82/grosbr-37-332.PMC3818960.pdf
"Ginsenoside accumulation by γ-irradiation in ginseng    http://ginsengres.orgrevealed that the ginsenoside pattern was similar in the  NG, NAR, and 2 MAR lines, although the bands of the  NAR line and the MAR 5-2 line were smears.",OADS,/arxiv_data1/oa_pdf/35/82/grosbr-37-332.PMC3818960.pdf
http://dx.doi.org/10.5142/jgr.2013.37.332 338J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/35/82/grosbr-37-332.PMC3818960.pdf
Ginsenoside accumulation by γ-irradiation in ginseng    http://ginsengres.org2002;172:149-156.,Non-OADS,/arxiv_data1/oa_pdf/35/82/grosbr-37-332.PMC3818960.pdf
http://dx.doi.org/10.5142/jgr.2013.37.332 340J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/35/82/grosbr-37-332.PMC3818960.pdf
ⓒ The Korean Society of Ginseng 341 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/a0/grosbr-37-341.PMC3818961.pdf
"3, 341-348 (2013) http://dx.doi.org/10.5142/jgr.2013.37.341 E-mail: seiryang@kribb.re.kr Tel: +82-43-240-6110, Fax: +82-43-240-6009*Corresponding authorINTRODUCTION  Ginseng is a plant in the genus Panax  found in the  Northern Hemisphere and in East Asian countries.",Non-OADS,/arxiv_data1/oa_pdf/6f/a0/grosbr-37-341.PMC3818961.pdf
http://dx.doi.org/10.5142/jgr.2013.37.341 342J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/a0/grosbr-37-341.PMC3818961.pdf
Metabolomics approach for the differentiation of ginseng origins    http://ginsengres.orgdirectly into the UPLC system.,Non-OADS,/arxiv_data1/oa_pdf/6f/a0/grosbr-37-341.PMC3818961.pdf
http://dx.doi.org/10.5142/jgr.2013.37.341 344J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/a0/grosbr-37-341.PMC3818961.pdf
Metabolomics approach for the differentiation of ginseng origins    http://ginsengres.org(Table 1 and Fig.,Non-OADS,/arxiv_data1/oa_pdf/6f/a0/grosbr-37-341.PMC3818961.pdf
http://dx.doi.org/10.5142/jgr.2013.37.341 346J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/a0/grosbr-37-341.PMC3818961.pdf
Metabolomics approach for the differentiation of ginseng origins    http://ginsengres.orgclose on borderline.,Non-OADS,/arxiv_data1/oa_pdf/6f/a0/grosbr-37-341.PMC3818961.pdf
http://dx.doi.org/10.5142/jgr.2013.37.341 348J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/6f/a0/grosbr-37-341.PMC3818961.pdf
ⓒ The Korean Society of Ginseng 349 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/43/b6/grosbr-37-349.PMC3818962.pdf
"3, 349-354 (2013) http://dx.doi.org/10.5142/jgr.2013.37.349 E-mail: honghd@kfri.re.kr Tel: +82- 31-780-9285 , Fax: +82- 31-709-9876*Corresponding authorINTRODUCTION Korean ginseng ( Panax ginseng  Meyer) is a perennial  plant in the family Araliaceae  and a medicinal herb cul - tivated primarily in the Northeast Asia, including Korea.",Non-OADS,/arxiv_data1/oa_pdf/43/b6/grosbr-37-349.PMC3818962.pdf
http://dx.doi.org/10.5142/jgr.2013.37.349 350J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/43/b6/grosbr-37-349.PMC3818962.pdf
Chemical components of Korean curved ginseng    http://ginsengres.orgaccording to the previous method [18].,Non-OADS,/arxiv_data1/oa_pdf/43/b6/grosbr-37-349.PMC3818962.pdf
http://dx.doi.org/10.5142/jgr.2013.37.349 352J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/43/b6/grosbr-37-349.PMC3818962.pdf
"Chemical components of Korean curved ginseng    http://ginsengres.orgCG products by piece-grade, chemical component char - acteristics did not show significant differences.",OADS,/arxiv_data1/oa_pdf/43/b6/grosbr-37-349.PMC3818962.pdf
http://dx.doi.org/10.5142/jgr.2013.37.349 354J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/43/b6/grosbr-37-349.PMC3818962.pdf
ⓒ The Korean Society of Ginseng 355 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/grosbr-37-355.PMC3818963.pdf
"3, 355-360 (2013) http://dx.doi.org/10.5142/jgr.2013.37.355 E-mail: Deqiangdou@126.com Tel: +86-411-87406497, Fax: +86-411-87586014*Corresponding authorINTRODUCTION Ginseng, the dried root and rhizome of Panax ginseng ,  has long been used in the belief that it is tonic and con - ducive to longevity in Chinese folks.",Non-OADS,/arxiv_data1/oa_pdf/5b/8a/grosbr-37-355.PMC3818963.pdf
http://dx.doi.org/10.5142/jgr.2013.37.355 356J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/grosbr-37-355.PMC3818963.pdf
Antioxidant activity of Lin-Xia-Shan-Shen    http://ginsengres.orgDetermination of starch contents The content of starch was determined by the micro- amount method with spectrophotometer [9].,OADS,/arxiv_data1/oa_pdf/5b/8a/grosbr-37-355.PMC3818963.pdf
http://dx.doi.org/10.5142/jgr.2013.37.355 358J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/grosbr-37-355.PMC3818963.pdf
Antioxidant activity of Lin-Xia-Shan-Shen    http://ginsengres.orgACKNOWLEDGEMENTS This research was supported by the funding of 2013  Program for Liaoning Innovative Research Team in Uni - versity.,OADS,/arxiv_data1/oa_pdf/5b/8a/grosbr-37-355.PMC3818963.pdf
http://dx.doi.org/10.5142/jgr.2013.37.355 360J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/5b/8a/grosbr-37-355.PMC3818963.pdf
ⓒ The Korean Society of Ginseng 361 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/c7/32/grosbr-37-361.PMC3818964.pdf
"3, 361-370 (2013) http://dx.doi.org/10.5142/jgr.2013.37.361 E-mail: luo_zhiyong@hotmail.com Tel: +86-731-84805025, Fax: +86-731-84484492*Corresponding authorINTRODUCTION Amino acids play central roles both as building blocks  of proteins and as intermediates in metabolism.",Non-OADS,/arxiv_data1/oa_pdf/c7/32/grosbr-37-361.PMC3818964.pdf
http://dx.doi.org/10.5142/jgr.2013.37.361 362J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/c7/32/grosbr-37-361.PMC3818964.pdf
The open reading frame (ORF) was analyzed using an  ORF finder tool from the web (http://www.ncbi.nlm.nih.,OADS,/arxiv_data1/oa_pdf/c7/32/grosbr-37-361.PMC3818964.pdf
Prediction of transmembrane domains was  generated using the TMHMM 2.0 (http://www.cbs.dtu.,OADS,/arxiv_data1/oa_pdf/c7/32/grosbr-37-361.PMC3818964.pdf
"Panax ginseng  LHT-type amino acid transporter gene    http://ginsengres.orgHis, Arg, Asp 2 μM each).",Non-OADS,/arxiv_data1/oa_pdf/c7/32/grosbr-37-361.PMC3818964.pdf
http://dx.doi.org/10.5142/jgr.2013.37.361 364J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/c7/32/grosbr-37-361.PMC3818964.pdf
"Panax ginseng  LHT-type amino acid transporter gene    http://ginsengres.orgMeJA treatment and increased slowly until 12 h and  reached 26.05-fold at 24 h. As well-known, MeJA is a  lipid-based hormone signals that regulate a wide range of  processes in plants, ranging from controlling plant insect  defense, wounding responses, development to second - ary metabolite synthesis [24].",Non-OADS,/arxiv_data1/oa_pdf/c7/32/grosbr-37-361.PMC3818964.pdf
http://dx.doi.org/10.5142/jgr.2013.37.361 366J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/c7/32/grosbr-37-361.PMC3818964.pdf
Panax ginseng  LHT-type amino acid transporter gene    http://ginsengres.orgA mixture of 18 amino acids was added to the culture  of the hairy roots to investigate the expression pattern of  PgLHT .,Non-OADS,/arxiv_data1/oa_pdf/c7/32/grosbr-37-361.PMC3818964.pdf
http://dx.doi.org/10.5142/jgr.2013.37.361 368J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/c7/32/grosbr-37-361.PMC3818964.pdf
"Panax ginseng  LHT-type amino acid transporter gene    http://ginsengres.organalyze the effect on the initial stage of overexpression- PgLHT  line, the growth curves until 10 days after sub - culture were studied.",Non-OADS,/arxiv_data1/oa_pdf/c7/32/grosbr-37-361.PMC3818964.pdf
http://dx.doi.org/10.5142/jgr.2013.37.361 370J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/c7/32/grosbr-37-361.PMC3818964.pdf
ⓒ The Korean Society of Ginseng 371 http://ginsengres.org   pISSN: 1226-8453   eISSN: 2093-4947Research Article J Ginseng Res Vol.,Non-OADS,/arxiv_data1/oa_pdf/84/56/grosbr-37-371.PMC3818965.pdf
"3, 371-378 (2013) http://dx.doi.org/10.5142/jgr.2013.37.371 E-mail: ckhan@kfri.re.kr Tel: +82-31-780-9236, Fax: +82-31-709-9876*Corresponding authorINTRODUCTION With increasing scientific evidence of the health ben - efits of ginseng ( Panax ginseng  Meyer), widely used in  traditional medicine in Asia, its global market is growing.",Non-OADS,/arxiv_data1/oa_pdf/84/56/grosbr-37-371.PMC3818965.pdf
http://dx.doi.org/10.5142/jgr.2013.37.371 372J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/84/56/grosbr-37-371.PMC3818965.pdf
"Metabolomic analysis of RG-fed rats    http://ginsengres.org(556.2771 Da in ESI positive mode, 200 ρmole) was  used as the lock spray for all analyses with a flow rate  of 3 μL/min and a frequency of 10 s. MS/MS spectra  were obtained by a collision energy ramp of 10 to 30 eV .",OADS,/arxiv_data1/oa_pdf/84/56/grosbr-37-371.PMC3818965.pdf
http://dx.doi.org/10.5142/jgr.2013.37.371 374J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/84/56/grosbr-37-371.PMC3818965.pdf
"Metabolomic analysis of RG-fed rats    http://ginsengres.orgRESUL TS Animal characteristics The effect of oral administration of RG containing  16.4±0.2 g of ginsenosides (Rb1, Rb2, Rb3, Rc, Rd, Re,  Rf, Rg1, Rg2, Rg3, Rh1, and Rh2) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/84/56/grosbr-37-371.PMC3818965.pdf
http://dx.doi.org/10.5142/jgr.2013.37.371 376J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/84/56/grosbr-37-371.PMC3818965.pdf
Metabolomic analysis of RG-fed rats    http://ginsengres.org[21-23].,Non-OADS,/arxiv_data1/oa_pdf/84/56/grosbr-37-371.PMC3818965.pdf
http://dx.doi.org/10.5142/jgr.2013.37.371 378J Ginseng Res  Vol.,Non-OADS,/arxiv_data1/oa_pdf/84/56/grosbr-37-371.PMC3818965.pdf
Available at: http://www.nice.org.uk/CG103; last accessed15 May 2013.,Non-OADS,/arxiv_data1/oa_pdf/36/ff/S1041610213001415a.PMC3819184.pdf
"Unauthorized reproduction of this article is prohibited.The characteristics of the cohort stratified by sex are shown in Supplemental Tables 1 and 2, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/15/ef/jhype-31-2251.PMC3819311.pdf
"Women exhibited significantly lower levels of lysozyme and PGE 2than men, whereas other salivarybiomarkers were not significantly different between sexes (Supplemental Table 2, http://links.lww.com/HJH/A271).",Non-OADS,/arxiv_data1/oa_pdf/15/ef/jhype-31-2251.PMC3819311.pdf
"In these analyses, CRP remained significantly correlated with PWV, IMT and meta- bolic syndrome, and PGE 2remained significantly correlated with PP (Supplemental Table 3, http://links.lww.com/HJH/ A271).",OADS,/arxiv_data1/oa_pdf/15/ef/jhype-31-2251.PMC3819311.pdf
"In order to further characterize the relation of salivary CRP with arterial stiffness, metabolic syndrome and subclinical atherosclerosis, salivary CRP was divided into tertiles (Supplemental Fig 1, http://links.lww.com/HJH/ A271).",Non-OADS,/arxiv_data1/oa_pdf/15/ef/jhype-31-2251.PMC3819311.pdf
"The geographic location, sampling year, and risk groups for the sequences used in this study are summarized in Table 1 and Supplemental Table S1, http://links.lww.com/ QAD/A341.",OADS,/arxiv_data1/oa_pdf/a6/7e/aids-27-1793.PMC3819312.pdf
An initial alignment of all sequences was performed using Gene Cutter from the Los Alamos HIV sequence database (http://www.hiv.lanl.gov/content/ sequence/GENE_CUTTER/cutter.html).,OADS,/arxiv_data1/oa_pdf/a6/7e/aids-27-1793.PMC3819312.pdf
The ﬁnal maximum likelihood tree was visualized using the program FigTree v1.3.1 (http://beast.bio.ed.ac.uk).,OADS,/arxiv_data1/oa_pdf/a6/7e/aids-27-1793.PMC3819312.pdf
Web-based software Hypermut (http://www.hiv.lanl.,Non-OADS,/arxiv_data1/oa_pdf/a6/7e/aids-27-1793.PMC3819312.pdf
"Convergence was checked using Tracer v1.5 (http://beast.bio.ed.ac.uk/Tracer), and most parameters had effective sample sizes more than 200, except the tMRCA of the envregion of cluster 6 (ESS¼196) (Supplemental Table S2, http://links.lww.",OADS,/arxiv_data1/oa_pdf/a6/7e/aids-27-1793.PMC3819312.pdf
"Unauthorized reproduction of this article is prohibited.supplemental Figure S1, http://links.lww.com/QAD/ A341.",Non-OADS,/arxiv_data1/oa_pdf/a6/7e/aids-27-1793.PMC3819312.pdf
"3 (see also supplemental Table S2, http://links.lww.com/QAD/ A341).",Non-OADS,/arxiv_data1/oa_pdf/a6/7e/aids-27-1793.PMC3819312.pdf
"3; supplemental Table S2, http://links.lww.",Non-OADS,/arxiv_data1/oa_pdf/a6/7e/aids-27-1793.PMC3819312.pdf
"In general, the substitution and evolutionary models and genomic regions used for the analyses had no signiﬁcant impact on tMRCA estimates (supplemental Table S2, http://links.lww.com/QAD/ A341).",OADS,/arxiv_data1/oa_pdf/a6/7e/aids-27-1793.PMC3819312.pdf
cData from Thailand Bureau of Epidemiology (http://www.boe.moph.go.th/).,Non-OADS,/arxiv_data1/oa_pdf/a6/7e/aids-27-1793.PMC3819312.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2013.33.6.393 www.annlabmed.org  393Ann Lab Med 2013;33:393-400 http://dx.doi.org/10.3343/alm.2013.33.6.393Review Article Clinical Chemistry HbA1c: A Review of Analytical and Clinical Aspects Cas Weykamp, Ph.D. MCA Laboratory, Queen Beatrix Hospital, Winterswijk, Netherlands After the relationship between glycemic control and the HbA1c concentration was demon - strated, many tests have been developed to determine the HbA1c concentration.",OADS,/arxiv_data1/oa_pdf/af/2c/alm-33-393.PMC3819436.pdf
Weykamp C HbA1c: analytical and clinical aspects 394  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.393actions (Fig.,OADS,/arxiv_data1/oa_pdf/af/2c/alm-33-393.PMC3819436.pdf
"Weykamp C HbA1c: analytical and clinical aspects http://dx.doi.org/10.3343/alm.2013.33.6.393 www.annlabmed.org  395quality as IEC, and variants are not seen.",Non-OADS,/arxiv_data1/oa_pdf/af/2c/alm-33-393.PMC3819436.pdf
Weykamp C HbA1c: analytical and clinical aspects 396  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.393RMP to patient is created (Fig.,Non-OADS,/arxiv_data1/oa_pdf/af/2c/alm-33-393.PMC3819436.pdf
"Weykamp C HbA1c: analytical and clinical aspects http://dx.doi.org/10.3343/alm.2013.33.6.393 www.annlabmed.org  397field-collection (e.g., filter paper and micro-cups with lysing buf - fer).",OADS,/arxiv_data1/oa_pdf/af/2c/alm-33-393.PMC3819436.pdf
Weykamp C HbA1c: analytical and clinical aspects 398  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.393managed glycemic control [31].,Non-OADS,/arxiv_data1/oa_pdf/af/2c/alm-33-393.PMC3819436.pdf
"Weykamp C HbA1c: analytical and clinical aspects http://dx.doi.org/10.3343/alm.2013.33.6.393 www.annlabmed.org  3993) Individualized targets Targets are derived from the balance of minimum long-term  complications, minimum risk of hypoglycemia, and quality of life.",Non-OADS,/arxiv_data1/oa_pdf/af/2c/alm-33-393.PMC3819436.pdf
http://www.ngsp.org/interf.asp (Up -,Non-OADS,/arxiv_data1/oa_pdf/af/2c/alm-33-393.PMC3819436.pdf
Weykamp C HbA1c: analytical and clinical aspects 400  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.393dated on Jul 2013).,OADS,/arxiv_data1/oa_pdf/af/2c/alm-33-393.PMC3819436.pdf
http://www.who.int/diabetes/publications/report-hba1c_2011.,Non-OADS,/arxiv_data1/oa_pdf/af/2c/alm-33-393.PMC3819436.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2013.33.6.401 www.annlabmed.org  401Ann Lab Med 2013;33:401-405 http://dx.doi.org/10.3343/alm.2013.33.6.401Original Article Clinical Chemistry Random Urinary Calcium/Creatinine Ratio for  Screening Hypercalciuria in Children with Hematuria In Su Choi, M.D., Eui Seok Jung, M.D., Young Earl Choi, M.D., Young Kuk Cho, M.D., Eun Mi Yang, M.D.,   and Chan Jong Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/76/a5/alm-33-401.PMC3819437.pdf
Screening for hypercalciuria 402  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.401screening children of 3 yr or more with hypercalciuria [16].,Non-OADS,/arxiv_data1/oa_pdf/76/a5/alm-33-401.PMC3819437.pdf
Screening for hypercalciuria http://dx.doi.org/10.3343/alm.2013.33.6.401 www.annlabmed.org  4030.597 ( P<0.001) and 0.596 in 77 patients with gross hematu - ria (P<0.001).,Non-OADS,/arxiv_data1/oa_pdf/76/a5/alm-33-401.PMC3819437.pdf
Screening for hypercalciuria 404  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.401caused by hypercalciuria [1].,Non-OADS,/arxiv_data1/oa_pdf/76/a5/alm-33-401.PMC3819437.pdf
Screening for hypercalciuria http://dx.doi.org/10.3343/alm.2013.33.6.401 www.annlabmed.org  4052001;90:643-8.,Non-OADS,/arxiv_data1/oa_pdf/76/a5/alm-33-401.PMC3819437.pdf
"ISSN 2234-3806 • eISSN 2234-3814  406  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.406Ann Lab Med 2013;33:406-409 http://dx.doi.org/10.3343/alm.2013.33.6.406Original Article Clinical Microbiology Growth Dynamics of Staphylococcus aureus,  Escherichia coli , and Pseudomonas aeruginosa  as a  Function of Time to Detection in BacT/Alert 3D Blood  Culture Bottles with Various Preincubation Conditions Dong-Hyun Lee, M.D., Eun-Ha Koh, M.D., Sae-Rom Choi, M.T., and Sunjoo Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/7d/78/alm-33-406.PMC3819438.pdf
"Dynamics of TTD in blood culture http://dx.doi.org/10.3343/alm.2013.33.6.406 www.annlabmed.org  407METHODS The effects of preincubation of blood culture bottles under aero - bic or anaerobic conditions were investigated using S. aureus   (ATCC 29213), E. coli  (ATCC 25922), and P. aeruginosa  (ATCC  27853) inocula at concentrations of 150 colony-forming units  (CFU)/mL or 15 CFU/mL in brain-heart infusion broth.",Non-OADS,/arxiv_data1/oa_pdf/7d/78/alm-33-406.PMC3819438.pdf
Dynamics of TTD in blood culture 408  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.406 P. aeruginosa  exhibited a different TTD pattern from those of  S. aureus  and E. coli .,Non-OADS,/arxiv_data1/oa_pdf/7d/78/alm-33-406.PMC3819438.pdf
"Dynamics of TTD in blood culture http://dx.doi.org/10.3343/alm.2013.33.6.406 www.annlabmed.org  409coli, and P. aeruginosa  were profoundly affected by changes in  preincubation temperature and storage times at input concen - trations of 15 or 150 CFU/mL.",OADS,/arxiv_data1/oa_pdf/7d/78/alm-33-406.PMC3819438.pdf
"ISSN 2234-3806 • eISSN 2234-3814  410  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.410Ann Lab Med 2013;33:410-414 http://dx.doi.org/10.3343/alm.2013.33.6.410Original Article Clinical Microbiology Macrolide Resistance of Mycoplasma pneumoniae  and  Its Detection Rate by Real-Time PCR in Primary and  Tertiary Care Hospitals Young Uh, M.D.1, Joo Hee Hong, M.D.2, Ki Jin Oh, M.T.1, Hyun Mi Cho, M.T.1, Soon Deok Park, M.S.1, Juwon Kim, M.D.1,  and Kap Jun Yoon, M.D.1 Department of Laboratory Medicine1, Yonsei University Wonju College of Medicine; Department of Pediatrics2, Wonju Medical Center, Wonju, Korea Background:  This study aimed to evaluate the prevalence of Mycoplasma pneumoniae  in  primary and tertiary care hospitals and its macrolide resistance rate.",Non-OADS,/arxiv_data1/oa_pdf/26/0c/alm-33-410.PMC3819439.pdf
"Macrolide resistance of M. pneumoniae http://dx.doi.org/10.3343/alm.2013.33.6.410 www.annlabmed.org  411 Despite the advances in molecular technology, acute care fa - cilities and primary care hospitals rarely perform molecular tests,  because it requires specialized equipment and highly trained  personnel, as well as longer processing time to obtain results.",Non-OADS,/arxiv_data1/oa_pdf/26/0c/alm-33-410.PMC3819439.pdf
"Macrolide resistance of M. pneumoniae 412  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.410RESULTS Among a total of 195 specimens, 17 (8.7%) were positive for M.  pneumoniae .",Non-OADS,/arxiv_data1/oa_pdf/26/0c/alm-33-410.PMC3819439.pdf
"Macrolide resistance of M. pneumoniae http://dx.doi.org/10.3343/alm.2013.33.6.410 www.annlabmed.org  413gene, have been developed in Europe and United States [10].",Non-OADS,/arxiv_data1/oa_pdf/26/0c/alm-33-410.PMC3819439.pdf
Macrolide resistance of M. pneumoniae 414  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.410moniae  between children and adults with community-acquired pneu - monia: clinical impact of mutations conferring macrolide resistance.,Non-OADS,/arxiv_data1/oa_pdf/26/0c/alm-33-410.PMC3819439.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2013.33.6.415 www.annlabmed.org  415Ann Lab Med 2013;33:415-419 http://dx.doi.org/10.3343/alm.2013.33.6.415Original Article Clinical Microbiology Antibiotic Resistance in Helicobacter pylori  Strains and  its Effect on H. pylori  Eradication Rates in a Single  Center in Korea Byoungrak An, Ph.D.1, Byung Soo Moon, M.D.2, Heejung Kim, M.D.3, Hyun Chul Lim, M.D.2, Yong Chan Lee, M.D.2,   Gyusang Lee, Ph.D.4, Sa-Hyun Kim, Ph.D.4, Min Park, B.S.4, and Jong Bae Kim, Ph.D.4 Department of Laboratory Medicine1, Yongin Severance Hospital, Yongin; Departments of Internal Medicine2 and Laboratory Medicine3, Yonsei University  College of Medicine, Seoul; Department of Biomedical Laboratory Sciences4, College of Health Science, Yonsei University, Wonju, Korea Background:  Clarithromycin, amoxicillin, metronidazole, tetracycline, and levofloxacin  have been commonly used for the eradication of Helicobacter pylori .",Non-OADS,/arxiv_data1/oa_pdf/33/f5/alm-33-415.PMC3819440.pdf
"Antibiotic resistance and eradication of H. pylori 416  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.415treatment regimen is used [3, 4].",Non-OADS,/arxiv_data1/oa_pdf/33/f5/alm-33-415.PMC3819440.pdf
"Antibiotic resistance and eradication of H. pylori http://dx.doi.org/10.3343/alm.2013.33.6.415 www.annlabmed.org  417from 45.1% to 56.3% for the 2 periods, respectively (Fig.",Non-OADS,/arxiv_data1/oa_pdf/33/f5/alm-33-415.PMC3819440.pdf
"Antibiotic resistance and eradication of H. pylori 418  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.41566 patients, no significant differences were found with respect to  sex, age, and endoscopic diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/33/f5/alm-33-415.PMC3819440.pdf
"Antibiotic resistance and eradication of H. pylori http://dx.doi.org/10.3343/alm.2013.33.6.415 www.annlabmed.org  419strains (42.9%, 3/7) was significantly lower than that for the clar - ithromycin-susceptible strains (79.7%, 47/59) ( P<0.001).",Non-OADS,/arxiv_data1/oa_pdf/33/f5/alm-33-415.PMC3819440.pdf
"ISSN 2234-3806 • eISSN 2234-3814  420  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.420Ann Lab Med 2013;33:420-425 http://dx.doi.org/10.3343/alm.2013.33.6.420Original Article Diagnostic Immunology Reduction of the HIV Seroconversion Window Period  and False Positive Rate by Using ADVIA Centaur HIV  Antigen/Antibody Combo Assay  Kyunghoon Lee, M.D., Hyung-Doo Park, M.D., and Eun-Suk Kang, M.D.",OADS,/arxiv_data1/oa_pdf/b2/c2/alm-33-420.PMC3819441.pdf
Centaur HIV combo assay for early HIV detection http://dx.doi.org/10.3343/alm.2013.33.6.420 www.annlabmed.org  421duced; these can be detected at least 3 weeks later by third- generation antibody assays [6].,Non-OADS,/arxiv_data1/oa_pdf/b2/c2/alm-33-420.PMC3819441.pdf
Centaur HIV combo assay for early HIV detection 422  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.4202.,OADS,/arxiv_data1/oa_pdf/b2/c2/alm-33-420.PMC3819441.pdf
"Centaur HIV combo assay for early HIV detection http://dx.doi.org/10.3343/alm.2013.33.6.420 www.annlabmed.org  423active results for the 100 hospitalized patients by using the CHIV  assay, but four of the 600 healthy subjects were initially reactive  (three of the four subjects were nonreactive on repeating the  test).",Non-OADS,/arxiv_data1/oa_pdf/b2/c2/alm-33-420.PMC3819441.pdf
Centaur HIV combo assay for early HIV detection 424  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.420this varied across the studies.,OADS,/arxiv_data1/oa_pdf/b2/c2/alm-33-420.PMC3819441.pdf
http://www.cdc.go.kr/CDC/notice/CdcKrTogeth - er0302.jsp?menuIds=HOME001-MNU0004-MNU0085-MNU0088&   cid=21276 (Updated on Jul 2013).,OADS,/arxiv_data1/oa_pdf/b2/c2/alm-33-420.PMC3819441.pdf
Centaur HIV combo assay for early HIV detection http://dx.doi.org/10.3343/alm.2013.33.6.420 www.annlabmed.org  425by new fourth-generation human immunodeficiency virus screening as - says.,Non-OADS,/arxiv_data1/oa_pdf/b2/c2/alm-33-420.PMC3819441.pdf
"ISSN 2234-3806 • eISSN 2234-3814  426  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.426Ann Lab Med 2013;33:426-430 http://dx.doi.org/10.3343/alm.2013.33.6.426Original Article Transfusion Medicine Frequency of FCGR3B  Alleles in Thai Blood Donors Chollanot Kaset, Ph.D.1, Nipapan Leetrakool, M.S.2, Kamphon Intharanut, M.S.3, and Oytip Nathalang, Ph.D.1 Department of Medical Technology1, Faculty of Allied Health Sciences, Thammasat University, Pathumtani; Blood Bank Section2, Faculty of Medicine,  Chiang Mai University, Chiang Mai; Graduate Program in Biomedical Sciences3, Faculty of Allied Health Sciences,Thammasat University, Pathumtani,  Thailand  Background:  Human neutrophil antigens (HNAs) are involved in autoimmune and alloim - mune neutropenia and transfusion-related acute lung injury.",Non-OADS,/arxiv_data1/oa_pdf/47/5a/alm-33-426.PMC3819442.pdf
"FCGR3B  alleles in Thais http://dx.doi.org/10.3343/alm.2013.33.6.426 www.annlabmed.org  427the HNA-1 system, 3 antigens, HNA-1a, HNA-1b and HNA-1c,  are located on the neutrophil low-affinity Fc- γ-IIIb receptor (CD  16) glycoprotein [7].",Non-OADS,/arxiv_data1/oa_pdf/47/5a/alm-33-426.PMC3819442.pdf
FCGR3B  alleles in Thais 428  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.426ered statistically significant.,Non-OADS,/arxiv_data1/oa_pdf/47/5a/alm-33-426.PMC3819442.pdf
FCGR3B  alleles in Thais http://dx.doi.org/10.3343/alm.2013.33.6.426 www.annlabmed.org  429allele in 800 Thai blood donors.,Non-OADS,/arxiv_data1/oa_pdf/47/5a/alm-33-426.PMC3819442.pdf
FCGR3B  alleles in Thais 430  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.426tracting DNA for human nucleated cells.,Non-OADS,/arxiv_data1/oa_pdf/47/5a/alm-33-426.PMC3819442.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2013.33.6.431 www.annlabmed.org  431Ann Lab Med 2013;33:431-440 http://dx.doi.org/10.3343/alm.2013.33.6.431Original Article Diagnostic Genetics Comparison of Methylation Profiling in Cancerous and  Their Corresponding Normal Tissues from Korean  Patients with Breast Cancer Eun-Jung Jung, M.D.1, In-Suk Kim, M.D.2, Eun Yup Lee, M.D.2, Jeong-Eun Kang, M.D.3, Sun-Min Lee, M.D.3,   Dong Chul Kim, M.D.4, Ju-Yeon Kim, M.D.1, and Soon-Tae Park, M.D.1 Division of Surgical Oncology1, Department of Surgery, Gyeongsang National University Hospital, Jinju; Department of Laboratory Medicine2, Biomedical  Research Institute, Pusan National University Hospital, Busan; Department of Laboratory Medicine3, Pusan National University Yangsan Hospital, Yangsan;  Department of Pathology4, Gyeongsang National University Hospital, Jinju, Korea Background:  Aberrant DNA hypermethylation plays a pivotal role in carcinogenesis and  disease progression; therefore, accurate measurement of differential gene methylation  patterns among many genes is likely to reveal biomarkers for improved risk assessment.",Non-OADS,/arxiv_data1/oa_pdf/04/7e/alm-33-431.PMC3819443.pdf
Methylation profiling in breast cancer 432  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.431contributors to breast carcinogenesis [2-6].,Non-OADS,/arxiv_data1/oa_pdf/04/7e/alm-33-431.PMC3819443.pdf
"Methylation profiling in breast cancer http://dx.doi.org/10.3343/alm.2013.33.6.431 www.annlabmed.org  433(ABI 3100; Applied Biosystems, Foster City, CA, USA).",Non-OADS,/arxiv_data1/oa_pdf/04/7e/alm-33-431.PMC3819443.pdf
Methylation profiling in breast cancer 434  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.431Twenty one of 24 genes (87.5%) displayed promoter hyper - methylation in one or more of the cancerous tissues (Fig.,Non-OADS,/arxiv_data1/oa_pdf/04/7e/alm-33-431.PMC3819443.pdf
Methylation profiling in breast cancer http://dx.doi.org/10.3343/alm.2013.33.6.431 www.annlabmed.org  435groups demonstrated no statistical significance between tumor  types and RASSF1  hypermethylation.,OADS,/arxiv_data1/oa_pdf/04/7e/alm-33-431.PMC3819443.pdf
Methylation profiling in breast cancer 436  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.431Table 4.,Non-OADS,/arxiv_data1/oa_pdf/04/7e/alm-33-431.PMC3819443.pdf
Methylation profiling in breast cancer http://dx.doi.org/10.3343/alm.2013.33.6.431 www.annlabmed.org  437sis.,Non-OADS,/arxiv_data1/oa_pdf/04/7e/alm-33-431.PMC3819443.pdf
"Methylation profiling in breast cancer 438  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.431tains information and statistics about DNA hypermethylation in  various cancers, and a review of the literature, the frequency of  RASSF1  hypermethylation of breast cancer was determined to  be 72.0% [22] and 71.4% [4], respectively.",OADS,/arxiv_data1/oa_pdf/04/7e/alm-33-431.PMC3819443.pdf
"Methylation profiling in breast cancer http://dx.doi.org/10.3343/alm.2013.33.6.431 www.annlabmed.org  439study also suggests that gene methylation may be linked to vari - ous pathological features of breast cancer; however, this re - quires confirmation in a larger study group.",Non-OADS,/arxiv_data1/oa_pdf/04/7e/alm-33-431.PMC3819443.pdf
Methylation profiling in breast cancer 440  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.431leukemia.,Non-OADS,/arxiv_data1/oa_pdf/04/7e/alm-33-431.PMC3819443.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2013.33.6.441 www.annlabmed.org  441Ann Lab Med 2013;33:441-448 http://dx.doi.org/10.3343/alm.2013.33.6.441Original Article Laboratory Informatics Development of a Document Management System for  the Standardization of Clinical Laboratory Documents Sang-Hyun Hwang, M.D.1, Seon-Kyung Jung, M.D.1, Soo-Jin Kang, M.T.1, Hyo Soung Cha, M.S.2, Seung Hyun Chung, M.D.3,  and Do-Hoon Lee, M.D.1 Department of Laboratory Medicine, Center for Diagnostic Oncology1, Department of Information Technology Team2, Rehabilitation Clinic, Center for Clinical  Specialty3, National Cancer Center, Goyang, Korea Background:  Documentation is very important; a considerable number of documents ex - ist for use in accreditation inspection.",OADS,/arxiv_data1/oa_pdf/9e/c4/alm-33-441.PMC3819444.pdf
"Document management system  442  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.441human resources, and equipment management; and laboratory  standardization.",OADS,/arxiv_data1/oa_pdf/9e/c4/alm-33-441.PMC3819444.pdf
Document management system  http://dx.doi.org/10.3343/alm.2013.33.6.441 www.annlabmed.org  443  Questions   1.,Non-OADS,/arxiv_data1/oa_pdf/9e/c4/alm-33-441.PMC3819444.pdf
Document management system  444  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.4412.,Non-OADS,/arxiv_data1/oa_pdf/9e/c4/alm-33-441.PMC3819444.pdf
Document management system  http://dx.doi.org/10.3343/alm.2013.33.6.441 www.annlabmed.org  4453.,OADS,/arxiv_data1/oa_pdf/9e/c4/alm-33-441.PMC3819444.pdf
Document management system  446  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.441 Image converter NCC-LMDM-EC01-1111 NCC-LMDM-EC01-1111 NCC-LMDM-EC01-1111 NCC-LMDM-EC01-1111Document serverDocument server DB serverWPFLMDMSDocument  code automatic  extractionAutomatic code extraction Fig.,OADS,/arxiv_data1/oa_pdf/9e/c4/alm-33-441.PMC3819444.pdf
Document management system  http://dx.doi.org/10.3343/alm.2013.33.6.441 www.annlabmed.org  447 Fig.,OADS,/arxiv_data1/oa_pdf/9e/c4/alm-33-441.PMC3819444.pdf
"Document management system  448  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.441to prevent confusion with “one” and “zero,” respectively, and  any resulting computerization errors.",Non-OADS,/arxiv_data1/oa_pdf/9e/c4/alm-33-441.PMC3819444.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2013.33.6.449 www.annlabmed.org  449Ann Lab Med 2013;33:449-454 http://dx.doi.org/10.3343/alm.2013.33.6.449Original Article General Laboratory Medicine Procalcitonin and C-Reactive Protein in the Diagnosis  and Prediction of Spontaneous Bacterial Peritonitis  Associated With Chronic Severe Hepatitis B Le-Yong Yuan, M.D.1, Zun-Qiong Ke, M.D.2, Ming Wang, Ph.D.1, and Yan Li, Ph.D.1 Department of Clinical Laboratory1, Renmin Hospital of Wuhan University, Wuhan; Department of Pharmacy2, Renmin Hospital, Hubei University of  Medicine, Shiyan, P.R.",OADS,/arxiv_data1/oa_pdf/69/e1/alm-33-449.PMC3819445.pdf
"Markers for diagnosis of CSHB with SBP 450  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.449calcitonin, PCT is normally synthesized in the C cells of the thy - roid gland.",Non-OADS,/arxiv_data1/oa_pdf/69/e1/alm-33-449.PMC3819445.pdf
"Markers for diagnosis of CSHB with SBP http://dx.doi.org/10.3343/alm.2013.33.6.449 www.annlabmed.org  451800 (Beckman Coulter, Pasadena, CA, USA).",OADS,/arxiv_data1/oa_pdf/69/e1/alm-33-449.PMC3819445.pdf
"Markers for diagnosis of CSHB with SBP 452  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.449were 64% and 95%, respectively, at the cutoff of 16.15 mg/L.",Non-OADS,/arxiv_data1/oa_pdf/69/e1/alm-33-449.PMC3819445.pdf
"Markers for diagnosis of CSHB with SBP http://dx.doi.org/10.3343/alm.2013.33.6.449 www.annlabmed.org  453SBP, but the median value was low: 0.62 ng/mL.",OADS,/arxiv_data1/oa_pdf/69/e1/alm-33-449.PMC3819445.pdf
Markers for diagnosis of CSHB with SBP 454  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.449nostic criterion in febrile neutropenia: experience from a multicentre  study.,Non-OADS,/arxiv_data1/oa_pdf/69/e1/alm-33-449.PMC3819445.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2013.33.6.455 www.annlabmed.org  455Ann Lab Med 2013;33:455-456 http://dx.doi.org/10.3343/alm.2013.33.6.455Letter to the Editor  Clinical Chemistry  Evaluation of Leukocyte and Bacterial Interference in  Point-of-Care Human Chorionic Gonadotropin Tests John V. Mitsios, Ph.D., Ann M. Gronowski, Ph.D., and Carey-Ann D. Burnham, Ph.D. Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, USA We read with interest the Letter to the Editor by Jao et al.",Non-OADS,/arxiv_data1/oa_pdf/11/85/alm-33-455.PMC3819446.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/85/alm-33-455.PMC3819446.pdf
"Interference in POC hCG tests 456  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.455mens, when tested with the hCG Combo Rapid Test, also gave  negative results.",Non-OADS,/arxiv_data1/oa_pdf/11/85/alm-33-455.PMC3819446.pdf
"ISSN 2234-3806 • eISSN 2234-3814  http://dx.doi.org/10.3343/alm.2013.33.6.457 www.annlabmed.org  457Ann Lab Med 2013;33:457-458 http://dx.doi.org/10.3343/alm.2013.33.6.457Letter to the Editor  Clinical Chemistry  It’s Not Easy Being Blue-Green Qing H. Meng, M.D., Beverly Handy, M.D., and Elizabeth A. Wagar, D.D.",Non-OADS,/arxiv_data1/oa_pdf/c0/f9/alm-33-457.PMC3819447.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c0/f9/alm-33-457.PMC3819447.pdf
It’s not easy being blue-green 458  www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.457REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c0/f9/alm-33-457.PMC3819447.pdf
"ISSN 2234-3806  • eISSN 2234-3814 459 http://dx.doi.org/10.3343/alm.2013.33.6.459 www.annlabmed.orgAnn Lab Med 2013;33:459-462 http://dx.doi.org/10.3343/alm.2013.33.6.459Letter to the Editor Clinical Microbiology Received:  November 23, 2012 Revision received:  February 14, 2013 Accepted:  July 3, 2013 Corresponding author:  Dongeun Yong Department of Laboratory Medicine and Research Institute of Bacterial   Resistance, Yonsei University College of Medicine, 50 Yonsei-ro,   Seodaemun-gu, Seoul 120-752, Korea Tel: +82-2-2228-2442, Fax: +82-2-364-1583, E-mail: deyong@yuhs.ac© The Korean Society for Laboratory Medicine.",Non-OADS,/arxiv_data1/oa_pdf/f3/8c/alm-33-459.PMC3819448.pdf
"This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Weissella confusa  Bacteremia in an Immune-Competent  Patient with Underlying Intramural Hematomas of the  Aorta Wonmok Lee, M.D.1,2, Sun-Mi Cho, M.D.1, Myungsook Kim, M.T.2, Young-Guk Ko, Ph.D.3, Dongeun Yong, Ph.D.1,2,   and Kyungwon Lee, Ph.D.1,2 Department of Laboratory Medicine1, Research Institute of Bacterial Resistance2, Cardiology Division, Yonsei Cardiovascular Center and Cardiovascular  Research Institute3, Yonsei University College of Medicine, Seoul, Korea Weissella confusa  is a catalase-negative and gram-positive coc - cobacillus that is intrinsically resistant to vancomycin [1].",Non-OADS,/arxiv_data1/oa_pdf/f3/8c/alm-33-459.PMC3819448.pdf
"Weissella confusa  bacteremia460 www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.459ance mass spectrometer (Shimadzu Corporation, Kyoto, Japan)  and analyzed with the VITEK MS IVD v1 database (bioMérieux  Inc.).",OADS,/arxiv_data1/oa_pdf/f3/8c/alm-33-459.PMC3819448.pdf
Weissella confusa  bacteremia 461 http://dx.doi.org/10.3343/alm.2013.33.6.459 www.annlabmed.orgfrom clinical specimens.,Non-OADS,/arxiv_data1/oa_pdf/f3/8c/alm-33-459.PMC3819448.pdf
Weissella confusa  bacteremia462 www.annlabmed.org http://dx.doi.org/10.3343/alm.2013.33.6.4598.,Non-OADS,/arxiv_data1/oa_pdf/f3/8c/alm-33-459.PMC3819448.pdf
Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.,Non-OADS,/arxiv_data1/oa_pdf/69/96/hr201370a.PMC3819519.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/83/e1/eht258.PMC3819591.pdf
"Available from: http://www.nice.org.uk/guidance/index.jsp?Action= byID&o=10958 (last accessed April 30, 2013).",Non-OADS,/arxiv_data1/oa_pdf/83/e1/eht258.PMC3819591.pdf
"Available from: http://data.worldbank.org/about/country-classiﬁcations (last accessed April 30, 2013).",OADS,/arxiv_data1/oa_pdf/83/e1/eht258.PMC3819591.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f0/2f/srep03160.PMC3819604.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3160 | DOI: 10.1038/srep03160 5",Non-OADS,/arxiv_data1/oa_pdf/f0/2f/srep03160.PMC3819604.pdf
URL http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/e5/b5/srep03168.PMC3819605.pdf
URL http://dx.doi.org/10.1103/PhysRevB.84.155207.,Non-OADS,/arxiv_data1/oa_pdf/e5/b5/srep03168.PMC3819605.pdf
URL http://dx.doi.org/10.1002/pssb.2220430202.,OADS,/arxiv_data1/oa_pdf/e5/b5/srep03168.PMC3819605.pdf
URL http://dx.doi.org/10.1039/C0EE00456A.,OADS,/arxiv_data1/oa_pdf/e5/b5/srep03168.PMC3819605.pdf
URL http://dx.doi.org/10.1039/C1EE02465E.,OADS,/arxiv_data1/oa_pdf/e5/b5/srep03168.PMC3819605.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3168 | DOI: 10.1038/srep03168 6",Non-OADS,/arxiv_data1/oa_pdf/e5/b5/srep03168.PMC3819605.pdf
"Gaussian, Inc., Wallingford CT, (2004), http://www.gaussian.com/g_misc/g03/citation_g03.htm, September 10, 2013.",Non-OADS,/arxiv_data1/oa_pdf/a1/5e/srep03162.PMC3819606.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3162 | DOI: 10.1038/srep03162 8",Non-OADS,/arxiv_data1/oa_pdf/a1/5e/srep03162.PMC3819606.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3161 | DOI: 10.1038/srep03161 5",Non-OADS,/arxiv_data1/oa_pdf/2e/97/srep03161.PMC3819607.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3166 | DOI: 10.1038/srep03166 5",Non-OADS,/arxiv_data1/oa_pdf/bb/75/srep03166.PMC3819609.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/95/96/srep03167.PMC3819611.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3167 | DOI: 10.1038/srep03167 5",Non-OADS,/arxiv_data1/oa_pdf/95/96/srep03167.PMC3819611.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/92/6a/srep03129.PMC3819613.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3129 | DOI: 10.1038/srep03129 8",Non-OADS,/arxiv_data1/oa_pdf/92/6a/srep03129.PMC3819613.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/31/85/srep03164.PMC3819614.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3164 | DOI: 10.1038/srep03164 7",Non-OADS,/arxiv_data1/oa_pdf/31/85/srep03164.PMC3819614.pdf
http://www.eetcorp.com/heepm/RO_ TheoryE.pdf on 11/22/2011 (2003).,Non-OADS,/arxiv_data1/oa_pdf/21/ac/srep03163.PMC3819615.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/21/ac/srep03163.PMC3819615.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3163 | DOI: 10.1038/srep03163 7",Non-OADS,/arxiv_data1/oa_pdf/21/ac/srep03163.PMC3819615.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3159 | DOI: 10.1038/srep03159 7",Non-OADS,/arxiv_data1/oa_pdf/d3/8c/srep03159.PMC3819616.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/58/13/srep03165.PMC3819617.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3165 | DOI: 10.1038/srep03165 6",Non-OADS,/arxiv_data1/oa_pdf/58/13/srep03165.PMC3819617.pdf
"©2013TheAuthors.PublishedbyElsevierIrelandLtd.International Journal of Cardiology 168 (2013) 3599 –3608 ☆☆ Funding: This work was supported by the Wellcome Trust [BH092142 to MGDB, 096919Z/11/Z and 074454/Z/04/Z to DMT and RWT]; the Medical Research Council [G1100160 to KGH, G0601943 to DMT and G0800674 to DMT and RWT]; the UK National Institute for Health Research Biomedical Research Centre for Ageing and Age-related Diseases award to Newcastle upon Tyne Hospitals NHS Foundation Trust [for DMT, GSG and cardiac tagging software]; the British Heart Foundation [CH/07/001 to BDK]; and the UK NHS Specialized Services and Newcastle upon Tyne Hospitals NHS Foundation Trust that support the ‘Rare Mitochondrial Disorders of Adults and Children ’Diagnostic Service [ http://www.mitochondrialncg.nhs.uk ].",Non-OADS,/arxiv_data1/oa_pdf/5f/49/main.PMC3819621.pdf
http://dx.doi.org/10.1016/j.ijcard.2013.05.062 Contents lists available at ScienceDirect International Journal of Cardiology journal homepage: www.elsevier.com/locate/ijcard Open access under CC BY-NC-ND license .Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/5f/49/main.PMC3819621.pdf
"Eur Heart J Cardiovasc Imaging 2012, http://dx.doi.org/10.1093/ ehjci/jes226 (accessed 28th January 2013).",Non-OADS,/arxiv_data1/oa_pdf/5f/49/main.PMC3819621.pdf
"396 http://dx.doi.org/10.3345/kjp.2013.56.9.396Transcatheter closure of small ductus arteriosus  with amplatzer vascular plug   Eun Hyun Cho, MD1, Jinyoung Song, MD, PhD1, I-Seok Kang, MD1, June Huh, MD, PhD1, Sang Yoon Lee, MD2, Eun Young Choi, MD3,  Soo Jin Kim, MD, PhD4 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, 2Department of Pediatrics, Sejong General Hospital,  Bucheon, 3Department of Pediatrics, Seoul National University Bundang Hospital, Seongnam, 4Department of Pediatrics, Konkuk University Medical Center, Seoul,  Korea Purpose: The purpose of this study was to share our experience of transcatheter closure of small  patent ductus arteriosus (PDA) by using an Amplatzer vascular plug (AVP).",Non-OADS,/arxiv_data1/oa_pdf/17/90/kjped-56-396.PMC3819676.pdf
"Key words: Patent ductus arteriosus, Cardiac catheterization, Vascular access devicesCorresponding author: Jinyoung Song, MD, PhD Department of Pediatrics, Samsung Medical Cen-ter, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: +82-2-3410-3538, Fax: +82-2-3410-0043, E-mail: amyjys@naver.com  Received: 26 June, 2013 Revised: 24 July, 2013Accepted: 5 August, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2013;56(9):396-400 http://dx.doi.org/10.3345/kjp.2013.56.9.396 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction It has been more than four decades since transcatheter closure of patent ductus  arteriosus (PDA) was introduced1).",Non-OADS,/arxiv_data1/oa_pdf/17/90/kjped-56-396.PMC3819676.pdf
"397 http://dx.doi.org/10.3345/kjp.2013.56.9.396Korean J Pediatr 2013;56(9):396-400 AGA Medical Co., Golden Valley, MN, USA).",Non-OADS,/arxiv_data1/oa_pdf/17/90/kjped-56-396.PMC3819676.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.396Cho EH, et al.",OADS,/arxiv_data1/oa_pdf/17/90/kjped-56-396.PMC3819676.pdf
399 http://dx.doi.org/10.3345/kjp.2013.56.9.396Korean J Pediatr 2013;56(9):396-400 3.,Non-OADS,/arxiv_data1/oa_pdf/17/90/kjped-56-396.PMC3819676.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.396Cho EH, et al.",OADS,/arxiv_data1/oa_pdf/17/90/kjped-56-396.PMC3819676.pdf
"401 http://dx.doi.org/10.3345/kjp.2013.56.9.401High-dose chemotherapy and autologous  peripheral blood stem cell transplantation in  the treatment of children and adolescents with  Ewing sarcoma family of tumors Juhee Seo, MD1, Dong Ho Kim, MD1, Jung Sub Lim, MD1, Jae-Soo Koh, MD2, Ji Young Yoo, MD3, Chang-Bae Kong, MD4, Won Seok  Song, MD4, Wan Hyeong Cho, MD4, Dae-Geun Jeon, MD4, Soo-Yong Lee, MD4, Jun Ah Lee, MD1 Departments of 1Pediatrics, 2Pathology, 3Diagnostic Radiology, and 4Orthopedic Surgery, Korea Cancer Center Hospital, Seoul, Korea  Purpose:  We performed a pilot study to determine the benefit of high-dose chemotherapy and  autologous peripheral blood stem cell transplantation (HDCT/autoPBSCT) for patients with Ewing  sarcoma family of tumors.",Non-OADS,/arxiv_data1/oa_pdf/92/86/kjped-56-401.PMC3819677.pdf
"Key words: Ewing sarcoma, High-dose chemotherapy, Stem cell transplantationCorresponding author: Jun Ah Lee, MD Department of Pediatrics, Korea Cancer Center  Hospital, 75 Nowon-ro, Nowon-gu, Seoul 139- 706, Korea  Tel: +82-2-970-1248 Fax: +82-2-970-1970 E-mail: junahlee@kcch.re.kr  Received: 1 January, 2013 Revised: 14 March, 2013 Accepted: 16 April, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2013;56(9):401-406 http://dx.doi.org/10.3345/kjp.2013.56.9.401 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction Combination chemotherapy significantly improved the outcome of patients with  Ewing sarcoma family of tumors (ESFT)1).",Non-OADS,/arxiv_data1/oa_pdf/92/86/kjped-56-401.PMC3819677.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.401Seo J, et al.",OADS,/arxiv_data1/oa_pdf/92/86/kjped-56-401.PMC3819677.pdf
403 http://dx.doi.org/10.3345/kjp.2013.56.9.401Korean J Pediatr 2013;56(9):401-406 surgery.,Non-OADS,/arxiv_data1/oa_pdf/92/86/kjped-56-401.PMC3819677.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.401Seo J, et al.",OADS,/arxiv_data1/oa_pdf/92/86/kjped-56-401.PMC3819677.pdf
405 http://dx.doi.org/10.3345/kjp.2013.56.9.401Korean J Pediatr 2013;56(9):401-406 cyclophosphamide.,Non-OADS,/arxiv_data1/oa_pdf/92/86/kjped-56-401.PMC3819677.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.401Seo J, et al.",OADS,/arxiv_data1/oa_pdf/92/86/kjped-56-401.PMC3819677.pdf
"407 http://dx.doi.org/10.3345/kjp.2013.56.9.407Klebsiella pneumoniae  liver abscess in an  immunocompetent child Jang-Mi Kwon, MD, Hye Lim Jung, MD, PhD, Jae Won Shim, MD, PhD, Deok Soo Kim, MD, PhD, Jung Yeon Shim, MD, PhD, Moon Soo  Park, MD, PhD Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea Klebsiella pneumoniae  has emerged as a leading pathogen that causes pyogenic liver abscesses  (PLAs) in Korea.",Non-OADS,/arxiv_data1/oa_pdf/b2/96/kjped-56-407.PMC3819678.pdf
"Key words: Klebsiella pneumoniae, Liver Abscess, Immunity, ChildCorresponding author: Hye Lim Jung, MD, PhD  Department of Pediatrics, Kangbuk Samsung Hos-pital, Sungkyunkwan University School of Medi - cine, 29 Saemunan-ro, Jongno-gu, Seoul 110-746, KoreaTel: +82-2-2001-2483Fax: +82-2-2001-2199E-mail: hl.jung@samsung.com Received: 21 November, 2012 Revised: 28 December, 2012Accepted: 29 January, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2013;56(9):407-410 http://dx.doi.org/10.3345/kjp.2013.56.9.407 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction Pyogenic liver abscess (PLA) in children is rare in developed countries and has been  frequently associated with disorders of granulocyte function and ascending pylephlebitis,  complicating previous abdominal infection1).",Non-OADS,/arxiv_data1/oa_pdf/b2/96/kjped-56-407.PMC3819678.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.407Kwon JM, et al.",OADS,/arxiv_data1/oa_pdf/b2/96/kjped-56-407.PMC3819678.pdf
409 http://dx.doi.org/10.3345/kjp.2013.56.9.407Korean J Pediatr 2013;56(9):407-410 ultrasound-guided percutaneous catheter drainage (PCD) of the  liver abscess.,Non-OADS,/arxiv_data1/oa_pdf/b2/96/kjped-56-407.PMC3819678.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.407Kwon JM, et al.",OADS,/arxiv_data1/oa_pdf/b2/96/kjped-56-407.PMC3819678.pdf
"369 http://dx.doi.org/10.3345/kjp.2013.56.9.369Clinical efficacy and mechanism of probiotics in  allergic diseases Ha-Jung Kim, PhD1,*, Hyung Young Kim, MD.2,*, So-Yeon Lee, MD, PhD3, Ju-Hee Seo, MD4, Eun Lee, MD5, Soo-Jong Hong, MD, PhD5,6 1Asan Institute for Life Sciences, University of Ulsan College of Medicine, Seoul, 2Department of Pediatrics, Kosin University College of Medicine, Busan, 3Department  of Pediatrics, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, 4Department of Pediatrics, Korea Cancer Center Hospital,  Seoul, 5Department of Pediatrics, Childhood Asthma Atopy Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 6Research Center for  Standardization of Allergic Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea A complex interplay between genetic and environmental factors partially contributes to the  development of allergic diseases by affecting development during prenatal and early life.",Non-OADS,/arxiv_data1/oa_pdf/8c/cb/kjped-56-369.PMC3819679.pdf
"Received: 3 May, 2013 Accepted: 11 June, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2013;56(9):369-376 http://dx.doi.org/10.3345/kjp.2013.56.9.369 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction  The Developmental Origins Hypothesis for Health and Disease proposes that all organ  systems undergo developmental programming in utero that predetermines subsequent  physiologic and metabolic adaptations during adult life1).",Non-OADS,/arxiv_data1/oa_pdf/8c/cb/kjped-56-369.PMC3819679.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.369Kim HJ, et al.",OADS,/arxiv_data1/oa_pdf/8c/cb/kjped-56-369.PMC3819679.pdf
"371 http://dx.doi.org/10.3345/kjp.2013.56.9.369Korean J Pediatr 2013;56(9):369-376 mouse model, induced immune regulation by a CD4(+)CD25(+) Foxp3(+) regulatory T (Treg) cell ­mediated mechanism16), and  effectively suppressed airway hyperresponsiveness2).",Non-OADS,/arxiv_data1/oa_pdf/8c/cb/kjped-56-369.PMC3819679.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.369Kim HJ, et al.",OADS,/arxiv_data1/oa_pdf/8c/cb/kjped-56-369.PMC3819679.pdf
373 http://dx.doi.org/10.3345/kjp.2013.56.9.369Korean J Pediatr 2013;56(9):369-376 Table 1.,Non-OADS,/arxiv_data1/oa_pdf/8c/cb/kjped-56-369.PMC3819679.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.369Kim HJ, et al.",OADS,/arxiv_data1/oa_pdf/8c/cb/kjped-56-369.PMC3819679.pdf
375 http://dx.doi.org/10.3345/kjp.2013.56.9.369Korean J Pediatr 2013;56(9):369-376 Acknowledgments This study was supported by a National Research Foundation  of Korea (NRF) grant funded by the Korean government (2012 ­ 0007128).,Non-OADS,/arxiv_data1/oa_pdf/8c/cb/kjped-56-369.PMC3819679.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.369Kim HJ, et al.",OADS,/arxiv_data1/oa_pdf/8c/cb/kjped-56-369.PMC3819679.pdf
http://dx.doi.org/10.1 1 1 1/jam.12268.,Non-OADS,/arxiv_data1/oa_pdf/8c/cb/kjped-56-369.PMC3819679.pdf
"377 http://dx.doi.org/10.3345/kjp.2013.56.9.377Kawasaki disease in infants Jung Sook Yeom, MD, Hyang Ok Woo, MD, Ji Sook Park, MD, Eun Sil Park, MD, Ji-Hyun Seo, MD, Hee-Shang Youn, MD Department of Pediatrics, Gyeongsang Institute of Health Science, Gyeongsang National University School of Medicine, Jinju, Korea Kawasaki disease (KD) is an acute febrile illness that is the predominant cause of pediatric acquired  heart disease in infants and young children.",Non-OADS,/arxiv_data1/oa_pdf/6c/97/kjped-56-377.PMC3819680.pdf
"Key words: Kawasaki disease, Diagnosis, InfantCorresponding author: Hyang Ok Woo, MD Department of Pediatrics, Gyeongsang Institute of Health Science, Gyeongsang National University School of Medicine, 15 Jinju ­daero 816beon ­gil,  Jinju 660­751, Korea Tel: +82­55­750­8157Fax: +82­55­952­9339E­mail: howoo@gnu.ac.kr Received: 12 February, 2013 Accepted: 12 June, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article  Korean J Pediatr 2013;56(9):377-382 http://dx.doi.org/10.3345/kjp.2013.56.9.377 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction Kawasaki disease (KD) is an acute febrile vasculitis.",Non-OADS,/arxiv_data1/oa_pdf/6c/97/kjped-56-377.PMC3819680.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.377Yeom JS, et al.",OADS,/arxiv_data1/oa_pdf/6c/97/kjped-56-377.PMC3819680.pdf
379 http://dx.doi.org/10.3345/kjp.2013.56.9.377Korean J Pediatr 2013;56(9):377-382 pared with those who had the complete clinical presentation (7%).,OADS,/arxiv_data1/oa_pdf/6c/97/kjped-56-377.PMC3819680.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.377Yeom JS, et al.",OADS,/arxiv_data1/oa_pdf/6c/97/kjped-56-377.PMC3819680.pdf
381 http://dx.doi.org/10.3345/kjp.2013.56.9.377Korean J Pediatr 2013;56(9):377-382 Conflict of interest No potential conflict of interest relevant to this article was  reported.,Non-OADS,/arxiv_data1/oa_pdf/6c/97/kjped-56-377.PMC3819680.pdf
Available from: http://www.uptodate.com/contents/kawasaki ­disease ­ clinical ­features ­and­diagnosis?detectedLanguage=en&source=se arch_result&search=Clinical+manifestations+and+diagnosis+of+Kawasaki+disease&selectedTitle=1%7E150&provider=noProvider.,OADS,/arxiv_data1/oa_pdf/6c/97/kjped-56-377.PMC3819680.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.377Yeom JS, et al.",OADS,/arxiv_data1/oa_pdf/6c/97/kjped-56-377.PMC3819680.pdf
"383 http://dx.doi.org/10.3345/kjp.2013.56.9.383Acute viral gastroenteritis in children hospitalized  in Iksan, Korea during December 2010–June  2011  Cheol Whoan So, MD1, Dong Sup Kim, MD1, Seung Taek Yu, MD, PhD1, Ji-Hyun Cho, MD, PhD2, Jong Duck Kim, MD, PhD1 Departments of 1Pediatrics and 2Laboratory Medicine, Wonkwang University College of Medicine, Iksan, Korea  Purpose: Viral etiology is common in cases of children with acute diarrhea, and antibiotic therapy is  usually not required.",Non-OADS,/arxiv_data1/oa_pdf/54/60/kjped-56-383.PMC3819681.pdf
"Key words: Rotavirus, Norovirus, Reverse transcriptase polymerase chain reactionCorresponding author: Jong Duck Kim, MD, PhD Department of Pediatrics, Wonkwang University  College of Medicine, 460 Iksan-daero, Iksan 570- 974, Korea Tel: +82-63-859-1511,  Fax: +82-63-853-3670,  E-mail: kjd20104@wku.ac.kr Received: 10 January, 2013 Revised: 16 April, 2013 Accepted: 13 July, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2013;56(9):383-388 http://dx.doi.org/10.3345/kjp.2013.56.9.383 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction Acute diarrhea is a common disease among infants and children due to age-specific  differences in host defense mechanisms1).",Non-OADS,/arxiv_data1/oa_pdf/54/60/kjped-56-383.PMC3819681.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.383So CW, et al.",OADS,/arxiv_data1/oa_pdf/54/60/kjped-56-383.PMC3819681.pdf
385 http://dx.doi.org/10.3345/kjp.2013.56.9.383Korean J Pediatr 2013;56(9):383-388 detected in any of the cases.,Non-OADS,/arxiv_data1/oa_pdf/54/60/kjped-56-383.PMC3819681.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.383So CW, et al.",OADS,/arxiv_data1/oa_pdf/54/60/kjped-56-383.PMC3819681.pdf
387 http://dx.doi.org/10.3345/kjp.2013.56.9.383Korean J Pediatr 2013;56(9):383-388 abruptly increased cases.,Non-OADS,/arxiv_data1/oa_pdf/54/60/kjped-56-383.PMC3819681.pdf
Available from: http://www.cdc.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/54/60/kjped-56-383.PMC3819681.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.383So CW, et al.",OADS,/arxiv_data1/oa_pdf/54/60/kjped-56-383.PMC3819681.pdf
"389 http://dx.doi.org/10.3345/kjp.2013.56.9.389Changes of clinical characteristics and outcomes  in patients with Kawasaki disease over the past  7 years in a single center study Hye Jin Kang, MD1, Gee Na Kim, MD2, Hong Ryang Kil, MD, PhD1 1Department of Pediatrics, Chungnam National University School of Medicine, Daejeon, 2Department of Pediatrics, Inje University Pusan Paik Hospital, Inje University  College of Medicine, Busan, Korea Purpose: This single-center study was conducted to assess the changes in epidemiological and  clinical characteristics and outcomes of patients with Kawasaki disease (KD) over the past 7 years.",Non-OADS,/arxiv_data1/oa_pdf/c0/68/kjped-56-389.PMC3819682.pdf
"Key words: Kawasaki disease, Incidence, EpidemiologyCorresponding author: Hong Ryang Kil, MD, PhD Department of Pediatrics, Chungnam National University Hospital, Chungnam National University School of Medicine, 282 Munhwa-ro, Jung-gu, Daejeon 301-721, KoreaTel: +82-42-280-7251,Fax: +82-42-255-3158, E-mail: gilhongr@gmail.com Received: 12 February, 2013 Revised: 29 May, 2013Accepted: 8 July, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2013;56(9):389-395 http://dx.doi.org/10.3345/kjp.2013.56.9.389 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction Since Kawasaki disease (KD) was first reported as “mucocutaneous lymph node  syndrome” in 19671), its etiology and pathophysiology have remained unknown and no  specific diagnostic laboratory markers have been developed, despite intensive efforts to  establish KD-specific markers.",Non-OADS,/arxiv_data1/oa_pdf/c0/68/kjped-56-389.PMC3819682.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.389Kang HJ, et al.",OADS,/arxiv_data1/oa_pdf/c0/68/kjped-56-389.PMC3819682.pdf
391 http://dx.doi.org/10.3345/kjp.2013.56.9.389Korean J Pediatr 2013;56(9):389-395 were adjusted for body surface area and expressed in standard  deviation units (z scores)13).,OADS,/arxiv_data1/oa_pdf/c0/68/kjped-56-389.PMC3819682.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.389Kang HJ, et al.",OADS,/arxiv_data1/oa_pdf/c0/68/kjped-56-389.PMC3819682.pdf
"393 http://dx.doi.org/10.3345/kjp.2013.56.9.389Korean J Pediatr 2013;56(9):389-395 in group A, the total dose of IVIG was significantly higher in  patients with complete KD than in those with incomplete KD  (P=0.008).",Non-OADS,/arxiv_data1/oa_pdf/c0/68/kjped-56-389.PMC3819682.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.389Kang HJ, et al.",OADS,/arxiv_data1/oa_pdf/c0/68/kjped-56-389.PMC3819682.pdf
395 http://dx.doi.org/10.3345/kjp.2013.56.9.389Korean J Pediatr 2013;56(9):389-395 23.,Non-OADS,/arxiv_data1/oa_pdf/c0/68/kjped-56-389.PMC3819682.pdf
"Key words:  Mycoplasma pneumoniae, Stroke, ChildCorresponding author: So-Hee Eun, MD, PhD Department of Pediatrics, Korea University Ansan  Hospital, Korea University College of Medicine,  123 Jeokgeum-ro, Danwon-gu, Ansan 425-707,  Korea Tel: +82-31-412-5096 Fax: +82-31-405-8591 E-mail: sheun@korea.ac.kr Received: 14 September, 2012 Revised: 10 December, 2012 Accepted: 15 January, 2013 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2013;56(9):411-415 http://dx.doi.org/10.3345/kjp.2013.56.9.411 eISSN 1738-1061•pISSN 2092-7258 Korean J Pediatr Introduction Childhood stroke, by definition, is a cerebrovascular event that happens between  30 days and 18 years of age.",Non-OADS,/arxiv_data1/oa_pdf/2f/c9/kjped-56-411.PMC3819683.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.411Kim GH, et al.",OADS,/arxiv_data1/oa_pdf/2f/c9/kjped-56-411.PMC3819683.pdf
413 http://dx.doi.org/10.3345/kjp.2013.56.9.411Korean J Pediatr 2013;56(9):411-415 regional vessels.,OADS,/arxiv_data1/oa_pdf/2f/c9/kjped-56-411.PMC3819683.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.9.411Kim GH, et al.",OADS,/arxiv_data1/oa_pdf/2f/c9/kjped-56-411.PMC3819683.pdf
415 http://dx.doi.org/10.3345/kjp.2013.56.9.411Korean J Pediatr 2013;56(9):411-415 Mycoplasma pneumoniae infection.,Non-OADS,/arxiv_data1/oa_pdf/2f/c9/kjped-56-411.PMC3819683.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.3.178 Pediatric Gastroenterology, Hepatology & Nutrition 2013 Septemb er 16(3):178-184PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Pre-diagnostic Clinical Presen tations and Medi cal History Prio r to the Diagnosis of Inflammatory Bowel Disease in Children Yong Hoon Kwon and Yong Joo Kim Department of Pediatrics, Hanyang Univer sity College of Medicine, Seoul, Korea Purpose: The clinical presentations of inflammatory bowel dise ase (IBD) prior to diagnosis are so diverse or vague  that many of them waste time before final diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/2e/06/pghn-16-178.PMC3819689.pdf
"Tel: +82-2-2290-8390, Fax: +82-2-2297-238 0, E-mail: kyjoo@hanyang.ac.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　The number of pediatric patients with in- flammatory bowel disease (IBD) has gradually in-creased over the last several decades.",Non-OADS,/arxiv_data1/oa_pdf/2e/06/pghn-16-178.PMC3819689.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.3.162 Pediatric Gastroenterology, Hepatology & Nutrition 2013 Septemb er 16(3):162-170PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Received：September 6, 2013, Accepted：September 14, 2013 Corresponding author: Jae Young Kim, Department of Pediatrics, Chungnam National Univ ersity School of Medicine, 266,  Munhwa-ro, Jung-gu , Daejeon 301-747, Korea.",Non-OADS,/arxiv_data1/oa_pdf/58/d0/pghn-16-162.PMC3819690.pdf
"Tel: 82-42-280-7249, Fax: 82-42-255-315 8, E-mail: pedkim@cnuh.co.kr   Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.Clinical Features and Role of Vi ral Isolates from Stool Samples  of Intussuception in Children Yong Wook Lee, Soo In Yang, Ji Myoung Kim* and Jae Young Kim Departments of Pediatrics and *Laborator y Medicine, Chungnam National Universi ty School of Medicine, Daejeon, Korea Purpose: To detect major acute gastroenteritis virus (rotav irus, norovirus, astrovirus, and enteric adenovirus) and  non-enteric type of adenovirus (AdV) in the stools of intussusception patients and to investigate the clinical role of detected viruses.",Non-OADS,/arxiv_data1/oa_pdf/58/d0/pghn-16-162.PMC3819690.pdf
[cited 2013 Sep 1] Available from: http://www.cdc.go.kr/CDC/info/CdcKrInfo0502.,OADS,/arxiv_data1/oa_pdf/58/d0/pghn-16-162.PMC3819690.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.3.171 Pediatric Gastroenterology, Hepatology & Nutrition 2013 Septemb er 16(3):171-177PGHN Original Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Adverse Events Associated with  Azathioprine Treatment in  Korean Pediatric Inflammatory Bowel Disease Patients Ji Young Chun, Ben Kang, Yoo Min Lee, Soo Youn Lee *, Mi Jin Kim† and Yon Ho Choe Departments of Pediatrics, *Laboratory Medicine a nd Genetics, Samsung Medical Center , Sungkyunkwan University Schoo l  of Medicine, Seoul, †Department of Pediatrics, Ilsan Paik Hospital, In je University College of Medicine, Goyang, Korea Purpose: This study was aimed to evaluate the frequency and course of adverse events associated with azathioprine  treatment in Korean pediatric patients with inflammatory bowel disease.",Non-OADS,/arxiv_data1/oa_pdf/25/78/pghn-16-171.PMC3819691.pdf
"Tel: +82-2-3410-3 539, Fax: +82-2-3410-0043, E-mail: i101016@skku.edu Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Azathioprine (AZA) is wi dely used in the treat-ment of inflammatory bowe l disease (IBD).",Non-OADS,/arxiv_data1/oa_pdf/25/78/pghn-16-171.PMC3819691.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.3.143 Pediatric Gastroenterology, Hepatology & Nutrition 2013 Septemb er 16(3):143-152PGHN Review Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Obesity, Inflammation and Diet Hansongyi Lee *,†, In Seok Lee‡ and Ryowon Choue *,† *Department of Medical Nutrition, Graduate School of East-West Medical Science, Ky ung Hee University, Yongin,  †Research Institute of Medical Nutrition, Kyung Hee University, ‡Nutrition Team, Kyung Hee University Medical Center, Seoul, Korea Obesity is a state in which there is an over-accumulation of subcutaneous and/or abdominal adipose tissue.",Non-OADS,/arxiv_data1/oa_pdf/85/89/pghn-16-143.PMC3819692.pdf
"Tel: +82-31-201-2317, Fax: +82-2-969-7717, E-mail: rw cho@  khu.ac.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Obesity is a major global burden, at a worldwide  cost of approximately $147 billion annually [1].",Non-OADS,/arxiv_data1/oa_pdf/85/89/pghn-16-143.PMC3819692.pdf
Available from:  http://www.who.int/ topics/obesity/en/.,Non-OADS,/arxiv_data1/oa_pdf/85/89/pghn-16-143.PMC3819692.pdf
Available from: http://kosis.kr/statisticsL-ist/statisticsList_01List.jsp?vwcd=MT_ZTITLE& parentId=D.,OADS,/arxiv_data1/oa_pdf/85/89/pghn-16-143.PMC3819692.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.3.190 Pediatric Gastroenterology, Hepatology & Nutrition 2013 Septemb er 16(3):190-194PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Congenital Internal Hernia Pr esented with Life Threatening  Extensive Small Bowel Strangulation Narae Lee, Su-Gon Kim, Yeoun Joo Lee, Jae-Ho ng Park, Seung-Kook Son, Soo-Hong Kim* and  Jae-Yeon Hwang† Departments of Pediatrics, *Surgery, and †Radiology, Pusan National University  Yangsan Hospital, Yangsan, Korea  Internal hernia (IH) is a rare cause of small bowel obstr uction occurs when there is protrusion of an internal organ  into a retroperitoneal fossa or a foramen in the abdominal ca vity.",Non-OADS,/arxiv_data1/oa_pdf/d1/d6/pghn-16-190.PMC3819693.pdf
"Tel: 82-55-360-2180, Fax: 82-55-360-218 1, E-mail: moonmissing@gmail.com Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Internal hernia (IH) is defined as herniation of vis- cera through a normal or abnormal aperture within  the peritoneal cavity.",Non-OADS,/arxiv_data1/oa_pdf/d1/d6/pghn-16-190.PMC3819693.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.3.195 Pediatric Gastroenterology, Hepatology & Nutrition 2013 Septemb er 16(3):195-199PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Congenital Chloride Diarrhea in Dizygotic Twins Kyung Ah Seo, Na Mi Lee, Gwang Jun Kim*, Sin Weon Yun, Soo Ahn Chae, In Seok Lim,  Eung Sang Choi and Byoung Hoon Yoo Departments of Pediatrics, *Obstetrics and Gynecology, Co llege of Medicine, Chung-Ang University, Seoul, Korea  Congenital chloride diarrhea (CLD) is a rare inherited auto somal recessive disorder.",Non-OADS,/arxiv_data1/oa_pdf/8e/cb/pghn-16-195.PMC3819694.pdf
"Tel: +82-2-6299-3181, Fax: +82-2-6264-2167, E-mail: pien a81@hotmail.com  Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　 　Congenital chloride diarrhea (CLD) is a rare in- herited autosomal re cessive disorder [1].",Non-OADS,/arxiv_data1/oa_pdf/8e/cb/pghn-16-195.PMC3819694.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.3.200 Pediatric Gastroenterology, Hepatology & Nutrition 2013 Septemb er 16(3):200-205PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Acute Urinary Retention in a 47-month-old Girl Caused by the  Giant Fecaloma Ji Sook Park, Tae-Jin Park *, Jung Seok Hwa†, Ji-Hyun Seo, Chan-Hoo Park and Hee-Shang Youn Departments of Pediatrics, *General Surgery and †Urology, Gyeongsang Institute of Health Sciences, Gyeongsang  National University School of Medicine, Jinju, Korea  We present a case of a 47-month-old female suffering from  acute urinary bladder neck obstruction and bilateral hydro- nephrosis secondary to a fecaloma.",Non-OADS,/arxiv_data1/oa_pdf/03/21/pghn-16-200.PMC3819695.pdf
"Tel:+82-55-750-8731, Fax: +82-55- 752-9339, E-mail:  seozee@gnu.a c.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Acute urinary retention is infrequent in children.",Non-OADS,/arxiv_data1/oa_pdf/03/21/pghn-16-200.PMC3819695.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.3.185 Pediatric Gastroenterology, Hepatology & Nutrition 2013 Septemb er 16(3):185-189PGHN Case Report PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION A Case of Esophageal Candidiasis in an Adolescent Who Had  Frequently Received Budesonide Nebulizing Therapy  Hae Ryong Kang, Yong Hoon  Kwon and Yong Joo Kim Department of Pediatrics, Hanyang Univer sity College of Medicine, Seoul, Korea Corticosteroid (budesonide) nebulizer therapy is commonly performed.",Non-OADS,/arxiv_data1/oa_pdf/e5/88/pghn-16-185.PMC3819696.pdf
"Tel: +82-2-2290-8390, Fax: +82-2-2297-238 0, E-mail: kyjoo@hanyang.ac.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　Recently, nebulizer therapy with short-acting cor- ticosteroids such as budesonide or fluticasone is com- monly being administered to or over-prescribed for  pediatric patients presenti ng with a simple cough,  even in private local pediat ric clinics.",Non-OADS,/arxiv_data1/oa_pdf/e5/88/pghn-16-185.PMC3819696.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.3.153 Pediatric Gastroenterology, Hepatology & Nutrition 2013 Septemb er 16(3):153-161PGHN Review Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Polyunsaturated Fatty Acids in Children Ji-Hyuk Lee Department of Pediatrics, College of Medicine and Medical Research Institute, Chungbuk National University, Cheong ju, Korea Polyunsaturated fatty acids (PUFAs) are the major components of brain and retina, and are the essential fatty acids  with important physiologically active functions.",Non-OADS,/arxiv_data1/oa_pdf/bb/94/pghn-16-153.PMC3819697.pdf
"Tel: +82-43-269-6050, Fa x: +82-43-264-6620, E-mail: e-z-up@daum.net Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　In recent years, with the increasing concern about  health, the concern about fats is also increasing.",Non-OADS,/arxiv_data1/oa_pdf/bb/94/pghn-16-153.PMC3819697.pdf
Available from: http://www.sciencedaily.,Non-OADS,/arxiv_data1/oa_pdf/bb/94/pghn-16-153.PMC3819697.pdf
"pISSN: 2234-8646 eISSN: 2234-8840 http://dx.doi.org/10.5223/pghn.2013.16.3.137 Pediatric Gastroenterology, Hepatology & Nutrition 2013 Septemb er 16(3):137-142PGHN Review Article PEDIATRIC GASTROENTEROLOGY, HEPATOLOGY & NUTRITION Reappraisal of Regional Growth  Charts in the Era of WHO  Growth Standards Jin Soo Moon Division of Pediatric Gastroenterology, Hepatology and Nutr ition, Department of Pediatri cs, Seoul National Universit y  Children’s Hospital, Seoul, Korea After the WHO Growth Standards (WHOGS) was published in  2006, many countries in the world endorsed and adopt- ed the new growth references as a standard measure for the growth of infants and young children.",Non-OADS,/arxiv_data1/oa_pdf/1a/58/pghn-16-137.PMC3819698.pdf
"Te l: +89-2-2072-7230, Fax: +82-2-2072-0274, Email:  mjschj@snu.ac.kr Copyright ⓒ 2013 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition This is an open ­access article distributed under the terms of the Creative Commons Attribution Non ­Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits  unrestricted non ­commercial use, distribution, and reproduction in any medium, provided the original  work is properly cited.INTRODUCTION 　World Health Organization (WHO) has published  the current WHO Growth Standards (WHOGS) in  2006 [1].",Non-OADS,/arxiv_data1/oa_pdf/1a/58/pghn-16-137.PMC3819698.pdf
Available from: http://www.rcpch.ac.uk/child-health/research- proj-ects/uk-who-growth-charts/uk-who-growth-chart- re-sources/ uk-who-growth-ch-0.,Non-OADS,/arxiv_data1/oa_pdf/1a/58/pghn-16-137.PMC3819698.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/86/e0/JOACP-29-435.PMC3819834.pdf
Available from: http://www.molecularpain.com/content/ pdf/1744‑8069‑5‑32.pdf.,Non-OADS,/arxiv_data1/oa_pdf/22/77/JOACP-29-465.PMC3819839.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/d0/b2/JOACP-29-485.PMC3819842.pdf
Available from: http://www.mayoclinic.com/health/caffeine/ AN01211 [Last accessed on 2008 Jan 8].,Non-OADS,/arxiv_data1/oa_pdf/ca/e7/JOACP-29-526.PMC3819849.pdf
Available from: http://www.orpha.net/consor/cgibin/ Disease_Search.php?lng=EN and data_id=1288 and Disease_ Disease_Search_diseaseGroup=Maroteaux and Disease_ Disease_Search_diseaseType=Pat and Disease (s)%20 concerned=Acromesomelic‑dysplasia‑‑Maroteaux‑type  and title=Acromesomelic‑dysplasia‑‑Maroteaux‑type and  search=Disease_Search_Simple [Last updated on 2005 Apr].,OADS,/arxiv_data1/oa_pdf/c2/26/JOACP-29-555.PMC3819856.pdf
Available  from: http://www.asahq.org.,Non-OADS,/arxiv_data1/oa_pdf/bb/d1/JOACP-29-560.PMC3819859.pdf
Available  from: http://www.asahq.org.,Non-OADS,/arxiv_data1/oa_pdf/57/12/JOACP-29-561.PMC3819860.pdf
"Review Biomol  Ther 21(4), 251-257 (2013) *Corresponding Author E-mail: ymleefn@cbnu.ac.kr Tel: +82-43-261-2825, Fax: +82-43-268-2732Received  Jul 17, 2013  Revised  Jul 24, 2013  Accepted  Jul 25, 2013http://dx.doi.org/10.4062/biomolther.2013.058 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4f/d8/ooomb4-21-251.PMC3819896.pdf
"252Biomol  Ther  21(4), 251-257 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.058These tissues have developed protective mechanisms that in- clude antimicrobial peptides (AMP) (also called host defense peptides) that exhibit a broad-spectrum antimicrobial activ-ity against multiple pathogens, including Gram-positive and Gram-negative bacteria, fungi, enveloped viruses and even transformed or cancerous cells.",Non-OADS,/arxiv_data1/oa_pdf/4f/d8/ooomb4-21-251.PMC3819896.pdf
"254Biomol  Ther  21(4), 251-257 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.058MAIN SPHINGOLIPID METABOLITES IN SKIN Ceramide structure in skin The stratum corneum (SC) is the outmost upper layer of  the skin and provides the rate-limiting barrier function for pen-etration into and out of the skin.",Non-OADS,/arxiv_data1/oa_pdf/4f/d8/ooomb4-21-251.PMC3819896.pdf
"256Biomol  Ther  21(4), 251-257 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.058Gomb art, A. F., Borregaard, N. and Koef ﬂ er, H. P. (2005) Human cat- helicidin antimicrobial peptide (CAMP ) gene is a direct target of the  vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3.",Non-OADS,/arxiv_data1/oa_pdf/4f/d8/ooomb4-21-251.PMC3819896.pdf
"Silibinin blocks the activation of  NF-κB, JNK, p38 MAPK, and ERK in osteoclast precursors in Original Article Biomol  Ther 21(4), 258-263 (2013) *Corresponding Author E-mail: yjjeon@chosun.ac.k r Tel: +82-62-230-6338, Fax: +82-62-232-9213  The fi  rst two authors contributed equally to this work.Received  May 16, 2013  Revised  May 28, 2013  Accepted  May 30, 2013http://dx.doi.org/10.4062/biomolther.2013.044 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/82/ooomb4-21-258.PMC3819897.pdf
"260Biomol  Ther  21(4), 258-263 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.044presence of LPS (200 ng/ml) for 3, 6, or 18 hours on cover  slides in 12 well plates.",OADS,/arxiv_data1/oa_pdf/84/82/ooomb4-21-258.PMC3819897.pdf
"262Biomol  Ther  21(4), 258-263 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.044TNF- α, IL-1, and IL-10 and TNF-induced IL-6 production in  ﬁ broblasts (Beyaert et al.",OADS,/arxiv_data1/oa_pdf/84/82/ooomb4-21-258.PMC3819897.pdf
"Anhydrous ethanol was purchased from Shang-Original Article Biomol  Ther 21(4), 264-269 (2013) *Corresponding Author E-mail: hongrutaoah@126.com Tel: +86-551-62922039, Fax: +86-551-63633742Received  Mar 5, 2013  Revised  Jun 5, 2013  Accepted  Jul 5, 2013http://dx.doi.org/10.4062/biomolther.2013.020 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a8/11/ooomb4-21-264.PMC3819898.pdf
"266Biomol  Ther  21(4), 264-269 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.020the study.",Non-OADS,/arxiv_data1/oa_pdf/a8/11/ooomb4-21-264.PMC3819898.pdf
"268Biomol  Ther  21(4), 264-269 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.020ally presented as the total level of lipid peroxidation products.",OADS,/arxiv_data1/oa_pdf/a8/11/ooomb4-21-264.PMC3819898.pdf
"Reactive oxygen species (ROS) are chemically reactive  molecules containing oxygen, including the singlet oxygen, the hydroxyl radical (•OH), H 2O2, and the superoxide anion Original Article Biomol  Ther 21(4), 270-276 (2013) Copyright  © 2013 The Korean Society of Applied Pharmacology*Corresponding Author E-mail: jinwonh@jejunu.ac.kr (Hyun JW), hyisun@snu.ac.kr (Kim HS) Tel: +82-64-754-3838 (Hyun JW), +82-2-740-8298 (Kim HS)Fax: +82-64-702-2687 (Hyun JW), +82-2-741-8298 (Kim HS)These two authors equally contributed to this work.Received  Apr 16, 2013  Revised  May 5, 2013  Accepted  May 8, 2013 http://dx.doi.org/10.4062/biomolther.2013.030 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/9f/ooomb4-21-270.PMC3819899.pdf
"272Biomol  Ther  21(4), 270-276 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.030for 30 min in 100 μl of lysis buffer (120 mM NaCl, 40 mM Tris  (pH 8), 0.1% NP 40) and then centrifuged at 13,000× g for 15  min.",Non-OADS,/arxiv_data1/oa_pdf/e2/9f/ooomb4-21-270.PMC3819899.pdf
"274Biomol  Ther  21(4), 270-276 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.030augmented in H2O2-treated cells relative to that in control cells,  as shown by an increase in JC-1 ﬂ uorescence.",OADS,/arxiv_data1/oa_pdf/e2/9f/ooomb4-21-270.PMC3819899.pdf
"276Biomol  Ther  21(4), 270-276 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.030print] Liu, C. L., Chiu, Y. T. and Hu, M. L. (2011) Fucoxanthin enhances HO-1  and NQO1 expression in murine hepatic BNL CL.",Non-OADS,/arxiv_data1/oa_pdf/e2/9f/ooomb4-21-270.PMC3819899.pdf
"Original Article Biomol  Ther 21(4), 277-283 (2013) *Corresponding Author E-mail: yisjung@ajou.ac.kr Tel: +82-31-219-3444, Fax: +82-31-219-3435Received  Jun 14, 2013  Revised  Jun 25, 2013  Accepted  Jul 4, 2013http://dx.doi.org/10.4062/biomolther.2013.051 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a6/3a/ooomb4-21-277.PMC3819900.pdf
"278Biomol  Ther  21(4), 277-283 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.051In this study, we investigated the role of UII and UT antagonist  SB-657510 in UII-induced in ﬂ ammatory responses in human  vascular endothelial cells.",Non-OADS,/arxiv_data1/oa_pdf/a6/3a/ooomb4-21-277.PMC3819900.pdf
"280Biomol  Ther  21(4), 277-283 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.051sion of TF in endothelial cells.",Non-OADS,/arxiv_data1/oa_pdf/a6/3a/ooomb4-21-277.PMC3819900.pdf
"282Biomol  Ther  21(4), 277-283 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.051(You et al.",OADS,/arxiv_data1/oa_pdf/a6/3a/ooomb4-21-277.PMC3819900.pdf
"Dietary anthocyanin-rich bilberry  extract reported to ameliorate hyperglycemia and insulin sen-Original Article Biomol  Ther 21(4), 284-289 (2013) *Corresponding Author E-mail: jyolee@hallym.ac.kr Tel: +82-33-248-2540, Fax: +82-33-244-8425The fi  rst two authors contributed equally to this work.Received  Feb 7, 2013  Revised  May 15, 2013  Accepted  Jun 18, 2013http://dx.doi.org/10.4062/biomolther.2013.016 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/b5/ooomb4-21-284.PMC3819901.pdf
"286Biomol  Ther  21(4), 284-289 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.016each well of 24-well plate containing 200 μl of medium and 1  mg/ml of MTT.",Non-OADS,/arxiv_data1/oa_pdf/cf/b5/ooomb4-21-284.PMC3819901.pdf
"288Biomol  Ther  21(4), 284-289 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.016The mechanism of insulin secretion by PCA in HIT-T15 cells GLP-1R-mediated cAMP/PKA activation has been reported  to be one of major mechanism of insulin secretion in addi-tion to K channel blocking (Szecowka et al.",OADS,/arxiv_data1/oa_pdf/cf/b5/ooomb4-21-284.PMC3819901.pdf
"Ca chloride used in the treat- ment of urticaria, acute edema, pruritus and erythema (Soll-mann, 1942), Ca carbonate and Ca gluconate have been used to treat insect stings (Binder, 1989) and Ca hydroxide Original Article Biomol  Ther 21(4), 290-298 (2013) Copyright  © 2013 The Korean Society of Applied Pharmacology*Corresponding Author E-mail: guc ci200@hanmail.net (Ku SK), gksxntk@dhu.ac.kr (Lee YJ) Tel: +82-53-819-1549 (Ku SK), +82-53-819-1296 (Lee YJ)Fax: +82-53-819-1576 (Ku SK), +82-53-819-1576 (Lee YJ)The fi  rst two authors contributed equally to this work.Received  May 8, 2013  Revised  Jun 10, 2013  Accepted  Jun 12, 2013 http://dx.doi.org/10.4062/biomolther.2013.040 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2d/55/ooomb4-21-290.PMC3819902.pdf
"292Biomol  Ther  21(4), 290-298 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.04037oC, using a microplate reader (Liaudet et al.",OADS,/arxiv_data1/oa_pdf/2d/55/ooomb4-21-290.PMC3819902.pdf
"294Biomol  Ther  21(4), 290-298 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.040challenge also decreased signi ﬁ cantly in the ENBREL group,  and in all three Ca gluconate-treated groups, as compared with the CIA control (Fig.",Non-OADS,/arxiv_data1/oa_pdf/2d/55/ooomb4-21-290.PMC3819902.pdf
"296Biomol  Ther  21(4), 290-298 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.040creased dramatically after ENBREL and Ca gluconate treat- ment (Fig.",Non-OADS,/arxiv_data1/oa_pdf/2d/55/ooomb4-21-290.PMC3819902.pdf
"298Biomol  Ther  21(4), 290-298 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.040cal acid burns in rats.",Non-OADS,/arxiv_data1/oa_pdf/2d/55/ooomb4-21-290.PMC3819902.pdf
"Jujubogenin, which easily pen-Original Article Biomol  Ther 21(4), 299-306 (2013) *Corresponding Author E-mail: jhryu63@khu.ac.kr Tel: +82-2-961-9230, Fax: +82-2-966-3885Received  May 15, 2013  Revised  Jul 8, 2013  Accepted  Jul 22, 2013http://dx.doi.org/10.4062/biomolther.2013.043 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/eb/ooomb4-21-299.PMC3819903.pdf
"300Biomol  Ther  21(4), 299-306 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.043etrates into blood brain barrier, is one of active constituents in  Z. jujuba  var.",Non-OADS,/arxiv_data1/oa_pdf/8f/eb/ooomb4-21-299.PMC3819903.pdf
"302Biomol  Ther  21(4), 299-306 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.043were analyzed by two-way ANOVA, and Tukey’s post-hoc  test  was used to perform pair-wise comparisons to determine an-tagonist or agonist effects.",OADS,/arxiv_data1/oa_pdf/8f/eb/ooomb4-21-299.PMC3819903.pdf
"304Biomol  Ther  21(4), 299-306 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.043pus, mice were sacri ﬁ ced 0 h, 1 h, 3 h, 9 h and 12 h after the  administration of EEZS (200 mg/kg).",Non-OADS,/arxiv_data1/oa_pdf/8f/eb/ooomb4-21-299.PMC3819903.pdf
"306Biomol  Ther  21(4), 299-306 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.043G., Lee, C. H., Lee, K. R. and Ryu, J. H. (2012) The ameliorating ef- fects of stigmasterol on scopolamine-induced memory impairments in mice.",Non-OADS,/arxiv_data1/oa_pdf/8f/eb/ooomb4-21-299.PMC3819903.pdf
"Quetiapine is an atypical second-generation antipsychotic  agent that has an approved labeling from the Food and Drug Administration in 1997 for the on-label treatment of schizo-Original Article Biomol  Ther 21(4), 307-312 (2013) *Corresponding Author E-mail: hosa33@korea.kr Tel: +82-43-719-5202, Fax: +82-43-719-5200Received  Apr 19, 2013  Revised  Jul 11, 2013  Accepted  Jul 15, 2013http://dx.doi.org/10.4062/biomolther.2013.035 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/ab/ooomb4-21-307.PMC3819904.pdf
"308Biomol  Ther  21(4), 307-312 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.035phrenia and the on-label short-term treatment (as mono- therapy or adjunct therapy to lithium or valporic acid) of acute manic episodes associated with bipolar I disorder (Morin, 2007; Sansone and Sansone, 2010).",Non-OADS,/arxiv_data1/oa_pdf/66/ab/ooomb4-21-307.PMC3819904.pdf
"310Biomol  Ther  21(4), 307-312 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.035compared with the corresponding saline treated animals but it  was not statistically signi ﬁ cant.",Non-OADS,/arxiv_data1/oa_pdf/66/ab/ooomb4-21-307.PMC3819904.pdf
"312Biomol  Ther  21(4), 307-312 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.035Arango, C. and Bobes, J.",Non-OADS,/arxiv_data1/oa_pdf/66/ab/ooomb4-21-307.PMC3819904.pdf
http://www.accessdata.fda.gov/scripts/cder/ob/de-fault.cfm.,OADS,/arxiv_data1/oa_pdf/66/ab/ooomb4-21-307.PMC3819904.pdf
"Key Words:  Corticosterone, Depression, Anxiety, Hypothalamus-pituitary-adrenal axis, Tyrosine hydroxylase, CatechinChronic Administration of Catechin Decreases Depression and  Anxiety-Like Behaviors in a Rat Model Using Chronic Corticosterone Injections Bombi Lee1,*, Bongjun Sur2, Sunoh Kwon1, Mijung Yeom1, Insop Shim1,2, Hyejung Lee1,2 and Dae-Hyun Hahm1,2,* 1Acupuncture and Meridian Science Research Center, 2The Graduate School of Basic Science of Oriental Medicine, College of Ori- ental Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea Abstract Copyright  © 2013 The Korean Society of Applied Pharmacology*Corresponding Author E-mail: bombi@khu.ac.kr (Lee BB), dhhahm@khu.ac.kr (Hahm DH) Tel: +82-2-961-0943 (Lee BB), +82-2-961-0336 (Hahm DH)Fax: +82-2-963-2175 (Lee BB), +82-2-963-2175 (Hahm  DH)Received  Jan 9, 2013  Revised  Jun 3, 2013  Accepted  Jun 7, 2013 http://dx.doi.org/10.4062/biomolther.2013.004 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/aa/ooomb4-21-313.PMC3819905.pdf
"314Biomol  Ther  21(4), 313-322 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.004ated with the development of psychic-related disorders, such  as depression (Kutiyanawalla et al.",Non-OADS,/arxiv_data1/oa_pdf/73/aa/ooomb4-21-313.PMC3819905.pdf
"316Biomol  Ther  21(4), 313-322 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.004maze was cleaned with alcohol after each rat had been tested.",Non-OADS,/arxiv_data1/oa_pdf/73/aa/ooomb4-21-313.PMC3819905.pdf
"318Biomol  Ther  21(4), 313-322 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.004gradual reduction in consumed sucrose intake over 21 days in  the CORT group compared to the SAL group ( p<0.01 on days  16 and 21; p<0.001 on day 19).",Non-OADS,/arxiv_data1/oa_pdf/73/aa/ooomb4-21-313.PMC3819905.pdf
"320Biomol  Ther  21(4), 313-322 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.004an alteration of HPA axis activity that affects behavioral activity  and sucrose consumption (Liu et al.",Non-OADS,/arxiv_data1/oa_pdf/73/aa/ooomb4-21-313.PMC3819905.pdf
"322Biomol  Ther  21(4), 313-322 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.004The effects of chronic stress on hippocampal morphology and func- tion: an evaluation of chronic restraint paradigms.",Non-OADS,/arxiv_data1/oa_pdf/73/aa/ooomb4-21-313.PMC3819905.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/70/ntt094.PMC3819976.pdf
http://dx.doi.org/10.1016/j.neuron.2013.10.036 The elaborate morphology of neurons together with the information processing that occurs in remote dendritic and axonal compartments makes the use of decentralized cell biological machines necessary.,OADS,/arxiv_data1/oa_pdf/72/ba/main.PMC3820025.pdf
"Published online April 13, 2013. http://dx.doi.org/10.1038/nn.3379 .",Non-OADS,/arxiv_data1/oa_pdf/72/ba/main.PMC3820025.pdf
Neurobiol.. http://dx.doi.org/10.1002/dneu.22113.,OADS,/arxiv_data1/oa_pdf/72/ba/main.PMC3820025.pdf
http://dx.doi.org/10.1016/j.mce.2013.06.004⇑Corresponding authors.,OADS,/arxiv_data1/oa_pdf/a2/dd/main.PMC3820028.pdf
We have also developed Best Practice Guidelines for mitochondrial diabetes which are available online ( http://www.newcastle-mitochon- dria.com/service/patient-care-guidelines/ ).,Non-OADS,/arxiv_data1/oa_pdf/a2/dd/main.PMC3820028.pdf
Published by Elsevier Inc. http://dx.doi.org/10.1016/j.ymeth.2013.04.002⇑Corresponding author.,Non-OADS,/arxiv_data1/oa_pdf/ac/c8/main.PMC3820032.pdf
"2 (2011) 340, http://dx.doi.org/10.1038/ncomms1340 .",Non-OADS,/arxiv_data1/oa_pdf/ac/c8/main.PMC3820032.pdf
http://www.wormatlas.org/hermaphrodite/hermaphroditehomepage.html.,Non-OADS,/arxiv_data1/oa_pdf/ac/c8/main.PMC3820032.pdf
"2 (2011) 339, http://dx.doi.org/10.1038/ncomms1337 .",Non-OADS,/arxiv_data1/oa_pdf/ac/c8/main.PMC3820032.pdf
http://dx.doi.org/10.1016/j.placenta.2013.08.003Placenta 34 (2013) 1105 e1109 Open access under CC BY-NC-SA license.,OADS,/arxiv_data1/oa_pdf/50/ba/main.PMC3820039.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided theoriginal work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/72/dkt270.PMC3820106.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, providedthe original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/ca/dkt380.PMC3820110.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/68/d5/ddt331.PMC3820136.pdf
"In hippocampal and neocortical PV interneurons, PV ex-pression is detectable in the second postnatal week and progres-sively up-regulated thereafter ( 43–45; Allen Developing Mouse Brain, http://developingmouse.brain-map.org/).",Non-OADS,/arxiv_data1/oa_pdf/68/d5/ddt331.PMC3820136.pdf
"Compared with Scn1aﬂ/ﬂ,PV-Cre-TG mice, Scn1aﬂ/ﬂ,VGAT -Cre mice had an earlier onset of a reduction in Nav1.1 expression levels in both the hippocampus and neocortex, consistent with RNA in situ hybridization data showing detectable VGAT expression in the forebrain in theﬁrst postnatal week, before the onset of PV expression (AllenDeveloping Mouse Brain, http://developingmouse.brain-map.org/).",Non-OADS,/arxiv_data1/oa_pdf/68/d5/ddt331.PMC3820136.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/64/jet062.PMC3820150.pdf
http://www.ehow.com/print/about_4745077_effects-wearing_flat_shoes.html (Accessed MMM.,Non-OADS,/arxiv_data1/oa_pdf/9b/a0/jpts-25-1309.PMC3820172.pdf
"http://emedicine.medscape.com/article/318994-overview (Accessed Nov.  10, 2012)  9) Barnes MP: Management of spasticity.",Non-OADS,/arxiv_data1/oa_pdf/dc/93/jpts-25-1279.PMC3820174.pdf
"http://kostat.go.kr/ (Accessed Oct. 23, 2011).",Non-OADS,/arxiv_data1/oa_pdf/48/3f/jpts-25-1339.PMC3820177.pdf
http://www.stat.go.jp/data/jinsui/2011np/pdf/gaiyou.pdf (Accessed Mar.,OADS,/arxiv_data1/oa_pdf/e6/5c/jpts-25-1285.PMC3820185.pdf
"5,  2013) 2) National Institute of Population and Social Security Research 2012. http://www.ipss.go.jp/syoushika/tohkei/newest04/con2h.html (Accessed Mar.",Non-OADS,/arxiv_data1/oa_pdf/e6/5c/jpts-25-1285.PMC3820185.pdf
"5,  2013) 3) Ministry of Health, Labour and Welfare 2011. http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/kakutei11/dl/10_h6.pdf (Accessed Mar.",Non-OADS,/arxiv_data1/oa_pdf/e6/5c/jpts-25-1285.PMC3820185.pdf
The online version of this article is published within an Open Access environment subject to the conditions of theCreative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/ by-nc-sa/3.0/ >.,Non-OADS,/arxiv_data1/oa_pdf/b3/30/S0033583513000061a.PMC3820380.pdf
REFERENCES 1) National institute of population and social security research: Demographic  material in 2012. http://www.ipss.go.jp/syoushika/tohkei/newest04/con2h.,Non-OADS,/arxiv_data1/oa_pdf/4b/f8/jpts-25-807.PMC3820399.pdf
"http://www.mhlw.go.jp/topics/kaigo/osirase/jigyo/m11/1103.html (Accessed Dec. 18, 2012) 5) Ministry of Health, General condition of national life base investigation in 2010 http://www.mhlw.go.jp/toukei/saikin/hw/k-kyosa/k-kyosa10/4-3.",Non-OADS,/arxiv_data1/oa_pdf/4b/f8/jpts-25-807.PMC3820399.pdf
"REFERENCES 1) HUMAINE Association: Emotion in Human-Computer Interaction,  http://emotion-research.net/workshops_folder/workshop.2007–06-29.",Non-OADS,/arxiv_data1/oa_pdf/f2/d7/jpts-25-753.PMC3820413.pdf
"19) MRC: Cognition and Brain Sciences Unit, Facial Expression Perception, http://www.mrc-cbu.cam.ac.uk/research/emotion/san/perception.html  (Accessed Jul.",Non-OADS,/arxiv_data1/oa_pdf/f2/d7/jpts-25-753.PMC3820413.pdf
"http://www.kinesiotape.ca/whatitdoes.htm (Accessed Jan. 5, 2013) 11) Danaka N: Spiral balance taping therapy.",Non-OADS,/arxiv_data1/oa_pdf/6a/9a/jpts-25-761.PMC3820414.pdf
"http://en.wikipedia.org/wiki/Prostaglandin (Accessed Feb. 14, 2013) 20) Kinesio-taping.",Non-OADS,/arxiv_data1/oa_pdf/6a/9a/jpts-25-761.PMC3820414.pdf
"http://physiotherapymumbai.blogspot.kr/2012/10/kinesio-taping.html#!/2012/10/kinesio-taping.html (Assessed Feb. 18, 2013) 21) Spiral taping.",Non-OADS,/arxiv_data1/oa_pdf/6a/9a/jpts-25-761.PMC3820414.pdf
"http://www.krishnaya.com/spiral_taping_62.html (Ac - cessed Dec. 29, 2012)",Non-OADS,/arxiv_data1/oa_pdf/6a/9a/jpts-25-761.PMC3820414.pdf
http://f-marc.com/11plus/11plus/ (Accessed Jun.,Non-OADS,/arxiv_data1/oa_pdf/4e/34/jpts-25-775.PMC3820415.pdf
"Posterior microphthalmia and nanophthalmos  are characterized by extreme hyperopia ranging from +8.00  D to +25.00 D due to a shortened axial length between 14 and  20 mm (23.44 mm in normal adults [ 54]) [42,43,55-58].Molecular Vision  2013; 19:2217-2226 <http://www.molvis.org/molvis/v 19/2217 > Received 6 May 2013 | Accepted 5 November 2013 | Published 7 November 2013© 2013 Molecular Vision 2217Evaluation of PRSS56  in Chinese subjects with high hyperopia or  primary angle-closure glaucoma Dan Jiang, Zhikuan Yang, Shiqiang Li, Xueshan Xiao, Xiaoyun Jia, Panfeng Wang, Xiangming Guo, Xing  Liu, Qingjiong Zhang (The first two and last two authors contributed equally to this work.)",Non-OADS,/arxiv_data1/oa_pdf/50/9f/mv-v19-2217.PMC3820428.pdf
"Molecular Vision  2013; 19:2217-2226 <http://www.molvis.org/molvis/v 19/2217 > © 2013 Molecular Vision  2218Thus, the aim of this study was to evaluate PRSS56   variations in patients with PACG or high hyperopia.",Non-OADS,/arxiv_data1/oa_pdf/50/9f/mv-v19-2217.PMC3820428.pdf
"Molecular Vision  2013; 19:2217-2226 <http://www.molvis.org/molvis/v 19/2217 > © 2013 Molecular Vision  2219no significant p value was obtained when the frequencies of  the variants were compared between patients with PACG and  normal controls (p=0.336, Table 2), four variants were found  in patients with PACG but not in normal controls, including  a known mutation and a homozygous variation.",Non-OADS,/arxiv_data1/oa_pdf/50/9f/mv-v19-2217.PMC3820428.pdf
Molecular Vision  2013; 19:2217-2226 <http://www.molvis.org/molvis/v 19/2217 > © 2013 Molecular Vision  2220Table  1.,Non-OADS,/arxiv_data1/oa_pdf/50/9f/mv-v19-2217.PMC3820428.pdf
"Molecular Vision  2013; 19:2217-2226 <http://www.molvis.org/molvis/v 19/2217 > © 2013 Molecular Vision  2221and 22.95 mm in the right and left eye, respectively, and  the patient with high hyperopia and heterozygous mutation  c.1066dupC had spherical refractions of +6.25 D in the right  eye and +6.75D in the left eye.",Non-OADS,/arxiv_data1/oa_pdf/50/9f/mv-v19-2217.PMC3820428.pdf
Molecular Vision  2013; 19:2217-2226 <http://www.molvis.org/molvis/v 19/2217 > © 2013 Molecular Vision  2222hyperopia significantly differed from that in the controls  (p=0.003).,Non-OADS,/arxiv_data1/oa_pdf/50/9f/mv-v19-2217.PMC3820428.pdf
Molecular Vision  2013; 19:2217-2226 <http://www.molvis.org/molvis/v 19/2217 > © 2013 Molecular Vision  2223Table  4. c linical  daTa of Probands  wiTh PacG and Prss 56 Varia Tions.,OADS,/arxiv_data1/oa_pdf/50/9f/mv-v19-2217.PMC3820428.pdf
Molecular Vision  2013; 19:2217-2226 <http://www.molvis.org/molvis/v 19/2217 > © 2013 Molecular Vision  2224REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/50/9f/mv-v19-2217.PMC3820428.pdf
Molecular Vision  2013; 19:2217-2226 <http://www.molvis.org/molvis/v 19/2217 > © 2013 Molecular Vision  222526.,Non-OADS,/arxiv_data1/oa_pdf/50/9f/mv-v19-2217.PMC3820428.pdf
Molecular Vision  2013; 19:2217-2226 <http://www.molvis.org/molvis/v 19/2217 > © 2013 Molecular Vision  222653.,Non-OADS,/arxiv_data1/oa_pdf/50/9f/mv-v19-2217.PMC3820428.pdf
"Usher syndrome can be divided into type 1 (2% to 6% of RP  cases), which has profound congenital deafness and vestibular  ataxia, and type 2 (15% of all cases of RP), which has an  associated moderate non-progressive hearing loss [ 5].Molecular Vision  2013; 19:2187-2195 <http://www.molvis.org/molvis/v 19/2187 > Received 21 May 2013 | Accepted 5 November 2013 | Published 7 November 2013© 2013 Molecular Vision 2187Whole-exome sequencing identifies novel compound heterozygous  mutations in USH2A  in Spanish patients with autosomal recessive  retinitis pigmentosa Cristina Méndez-Vidal,1,2 María González-del Pozo,1,2 Alicia Vela-Boza,3 Javier Santoyo-López,3 Francisco J.  López-Domingo,3 Carmen Vázquez-Marouschek,4 Joaquin Dopazo,3,5,6 Salud Borrego,1,2 Guillermo Antiñolo1,2,3 1Department of Genetics, Reproduction and Fetal Medicine, Institute of Biomedicine of Seville, University Hospital Virgen del  Rocío/CSIC/University of Seville, Seville, Spain; 2Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER),  Seville, Spain; 3Medical Genome Project, Genomics and Bioinformatics Platform of Andalusia (GBP A), Seville, Spain;  4Department of Ophthalmology, University Hospital Virgen del Rocío, Seville, Spain; 5Department of Bioinformatics, Centro  de Investigación Príncipe Felipe, Valencia, Spain; 6Functional Genomics Node (INB), Centro de Investigación Príncipe Felipe,  Valencia, Spain Purpose:  Retinitis pigmentosa (RP) is an inherited retinal dystrophy characterized by extreme genetic and clinical  heterogeneity.",Non-OADS,/arxiv_data1/oa_pdf/12/3d/mv-v19-2187.PMC3820429.pdf
"Molecular Vision  2013; 19:2187-2195 <http://www.molvis.org/molvis/v 19/2187 > © 2013 Molecular Vision  2188To date, 36 genes have been implicated in non-syndromic  arRP and three additional loci have been mapped ( RetNet ).",Non-OADS,/arxiv_data1/oa_pdf/12/3d/mv-v19-2187.PMC3820429.pdf
"Molecular Vision  2013; 19:2187-2195 <http://www.molvis.org/molvis/v 19/2187 > © 2013 Molecular Vision  2189Previous molecular genetic analysis::  The DNA sample  from the index patient was first analyzed and excluded  for known mutations by applying commercially available  microarray analysis (Asper Biotech, Tartu, Estonia).",Non-OADS,/arxiv_data1/oa_pdf/12/3d/mv-v19-2187.PMC3820429.pdf
"Molecular Vision  2013; 19:2187-2195 <http://www.molvis.org/molvis/v 19/2187 > © 2013 Molecular Vision  2190II:3, and II:5 (Figure 1) exhibited typical clinical features  of RP, including bilateral visual loss, initial hemeralopia,  and restriction of visual field leaving only the central 10°  functional.",Non-OADS,/arxiv_data1/oa_pdf/12/3d/mv-v19-2187.PMC3820429.pdf
Molecular Vision  2013; 19:2187-2195 <http://www.molvis.org/molvis/v 19/2187 > © 2013 Molecular Vision  2191with the expected genotype–phenotype correlation.,Non-OADS,/arxiv_data1/oa_pdf/12/3d/mv-v19-2187.PMC3820429.pdf
"Molecular Vision  2013; 19:2187-2195 <http://www.molvis.org/molvis/v 19/2187 > © 2013 Molecular Vision  2192DISCUSSION In this report, a Spanish family with five affected siblings  is described.",Non-OADS,/arxiv_data1/oa_pdf/12/3d/mv-v19-2187.PMC3820429.pdf
Molecular Vision  2013; 19:2187-2195 <http://www.molvis.org/molvis/v 19/2187 > © 2013 Molecular Vision  2193mutations in USH2A  segregating with the disease.,Non-OADS,/arxiv_data1/oa_pdf/12/3d/mv-v19-2187.PMC3820429.pdf
Molecular Vision  2013; 19:2187-2195 <http://www.molvis.org/molvis/v 19/2187 > © 2013 Molecular Vision  21942.,Non-OADS,/arxiv_data1/oa_pdf/12/3d/mv-v19-2187.PMC3820429.pdf
Molecular Vision  2013; 19:2187-2195 <http://www.molvis.org/molvis/v 19/2187 > © 2013 Molecular Vision  2195involving human subjects.,Non-OADS,/arxiv_data1/oa_pdf/12/3d/mv-v19-2187.PMC3820429.pdf
"However, hypotheses  still need further evidence to establish that MSCs play a Molecular Vision  2013; 19:2237-2243 <http://www.molvis.org/molvis/v 19/2237 > Received 2 May 2013 | Accepted 5 November 2013 | Published 7 November 2013© 2013 Molecular Vision 2237Review: Mesenchymal stem cells and corneal reconstruction Lin Yao,1 Haiqing Bai2 1Qingdao Eye Hospital, Shandong Eye Institute, Shandong Academy of Medical Sciences, Qingdao, China; 2Department of  Ophthalmology, Affiliated Hospital of Medical College, Qingdao University, Qingdao, China Corneal reconstruction is among the most effective methods for curing corneal injury due to various clinical  disorders.",Non-OADS,/arxiv_data1/oa_pdf/ce/98/mv-v19-2237.PMC3820430.pdf
Molecular Vision  2013; 19:2237-2243 <http://www.molvis.org/molvis/v 19/2237 > © 2013 Molecular Vision  2238role in corneal reconstruction.,Non-OADS,/arxiv_data1/oa_pdf/ce/98/mv-v19-2237.PMC3820430.pdf
"Molecular Vision  2013; 19:2237-2243 <http://www.molvis.org/molvis/v 19/2237 > © 2013 Molecular Vision  2239macrophage chemokine MIP-1α [ 28,46].",Non-OADS,/arxiv_data1/oa_pdf/ce/98/mv-v19-2237.PMC3820430.pdf
Molecular Vision  2013; 19:2237-2243 <http://www.molvis.org/molvis/v 19/2237 > © 2013 Molecular Vision  2240response [ 64].,Non-OADS,/arxiv_data1/oa_pdf/ce/98/mv-v19-2237.PMC3820430.pdf
Molecular Vision  2013; 19:2237-2243 <http://www.molvis.org/molvis/v 19/2237 > © 2013 Molecular Vision  22419.,Non-OADS,/arxiv_data1/oa_pdf/ce/98/mv-v19-2237.PMC3820430.pdf
Molecular Vision  2013; 19:2237-2243 <http://www.molvis.org/molvis/v 19/2237 > © 2013 Molecular Vision  2242rabbits.,Non-OADS,/arxiv_data1/oa_pdf/ce/98/mv-v19-2237.PMC3820430.pdf
Molecular Vision  2013; 19:2237-2243 <http://www.molvis.org/molvis/v 19/2237 > © 2013 Molecular Vision  224356.,Non-OADS,/arxiv_data1/oa_pdf/ce/98/mv-v19-2237.PMC3820430.pdf
"In this study, we describe two distinct dele - tions and the clinical phenotype associated with these defined  genotypes.Molecular Vision  2013; 19:2209-2216 <http://www.molvis.org/molvis/v 19/2209 > Received 2 May 2013 | Accepted 5 November 2013 | Published 7 November 2013© 2013 Molecular Vision 2209Characterization of novel RS1 exonic deletions in juvenile X-linked  retinoschisis Leera D’Souza,1 Catherine Cukras,1 Christian Antolik,1 Candice Craig,1 Ji-Yun Lee,2 Hong He,1 Shibo Li,2  Nizar Smaoui,1 James F. Hejtmancik,1 Paul A. Sieving,3 Xinjing Wang1 1Ophthalmic Genetics and Visual Function Branch, National Eye Institute (NEI), National Institutes of Health (NIH), Bethesda,  MD; 2Department of Pediatrics, The University of Oklahoma, Oklahoma City, OK; 3Office of the Director, National Eye Institute  (NEI), National Institutes of Health (NIH), Bethesda, MD Purpose:  X-linked juvenile retinoschisis (XLRS) is a vitreoretinal dystrophy characterized by schisis (splitting) of  the inner layers of the neuroretina.",Non-OADS,/arxiv_data1/oa_pdf/e9/f5/mv-v19-2209.PMC3820431.pdf
"Molecular Vision  2013; 19:2209-2216 <http://www.molvis.org/molvis/v 19/2209 > © 2013 Molecular Vision  2210METHODS Subjects:  Patients with XLRS and their mothers (if available)  were examined and enrolled at the National Eye Institute,  NIH.",Non-OADS,/arxiv_data1/oa_pdf/e9/f5/mv-v19-2209.PMC3820431.pdf
"Molecular Vision  2013; 19:2209-2216 <http://www.molvis.org/molvis/v 19/2209 > © 2013 Molecular Vision  2211RESULTS Ophthalmological evaluation:  Clinical examinations were  performed in the NEI Ophthalmic Genetics Clinic, and  molecular characterization of XLRS1 was performed in the  NEI DNA Diagnostic Laboratory.",Non-OADS,/arxiv_data1/oa_pdf/e9/f5/mv-v19-2209.PMC3820431.pdf
"Molecular Vision  2013; 19:2209-2216 <http://www.molvis.org/molvis/v 19/2209 > © 2013 Molecular Vision  2212(distal BP: 3′ :18,658,747–18,661,426 // 18,665,836–18,668,498:  5′ proximal BP, hg 19).",Non-OADS,/arxiv_data1/oa_pdf/e9/f5/mv-v19-2209.PMC3820431.pdf
Molecular Vision  2013; 19:2209-2216 <http://www.molvis.org/molvis/v 19/2209 > © 2013 Molecular Vision  2213since this transcript terminates in the final exon.,Non-OADS,/arxiv_data1/oa_pdf/e9/f5/mv-v19-2209.PMC3820431.pdf
Molecular Vision  2013; 19:2209-2216 <http://www.molvis.org/molvis/v 19/2209 > © 2013 Molecular Vision  2214genomic rearrangement in these patients (data not shown).,Non-OADS,/arxiv_data1/oa_pdf/e9/f5/mv-v19-2209.PMC3820431.pdf
Molecular Vision  2013; 19:2209-2216 <http://www.molvis.org/molvis/v 19/2209 > © 2013 Molecular Vision  2215similarity within the Alu components.,Non-OADS,/arxiv_data1/oa_pdf/e9/f5/mv-v19-2209.PMC3820431.pdf
Molecular Vision  2013; 19:2209-2216 <http://www.molvis.org/molvis/v 19/2209 > © 2013 Molecular Vision  221615.,Non-OADS,/arxiv_data1/oa_pdf/e9/f5/mv-v19-2209.PMC3820431.pdf
"It can be cleaved into several biologically active  forms of apelin peptides in vivo, such as apelin-13 (apelin Molecular Vision  2013; 19:2227-2236 <http://www.molvis.org/molvis/v 19/2227 > Received 25 May 2013 | Accepted 5 November 2013 | Published 7 November 2013© 2013 Molecular Vision 2227Apelin-13 induces proliferation, migration, and collagen I mRNA  expression in human RPE cells via PI3K/Akt and MEK/Erk  signaling pathways Dong Qin,1,2 Xiao-xue Zheng,1 Yan-rong Jiang1,2 1Department of Ophthalmology, People’ s Hospital, Peking University, Beijing, China; 2Key Laboratory of Vision Loss and  Restoration, Ministry of Education, Beijing, China Purpose:  Our previous study showed that apelin was increased in the vitreous and fibrotic membranes of patients with  proliferative diabetic retinopathy (PDR) in vivo, which suggested that apelin may be involved in the development of PDR.",Non-OADS,/arxiv_data1/oa_pdf/57/d5/mv-v19-2227.PMC3820432.pdf
"Molecular Vision  2013; 19:2227-2236 <http://www.molvis.org/molvis/v 19/2227 > © 2013 Molecular Vision  222865–77), apelin-17 (apelin 61–77), and apelin-36 (apelin 42–77)  [15-18].",Non-OADS,/arxiv_data1/oa_pdf/57/d5/mv-v19-2227.PMC3820432.pdf
"Molecular Vision  2013; 19:2227-2236 <http://www.molvis.org/molvis/v 19/2227 > © 2013 Molecular Vision  2229s, 61 °C for 30 s, and 72 °C for 30 s. The mRNA expression  was normalized to the expression level of GAPDH and was  calculated using the following equation: Fold change=2-ΔΔCT.",Non-OADS,/arxiv_data1/oa_pdf/57/d5/mv-v19-2227.PMC3820432.pdf
"Molecular Vision  2013; 19:2227-2236 <http://www.molvis.org/molvis/v 19/2227 > © 2013 Molecular Vision  2230significantly increased at concentrations of 10−8 M and 10−7  M, as determined with MTT.",Non-OADS,/arxiv_data1/oa_pdf/57/d5/mv-v19-2227.PMC3820432.pdf
"Molecular Vision  2013; 19:2227-2236 <http://www.molvis.org/molvis/v 19/2227 > © 2013 Molecular Vision  2231at concentrations of 10−8 M, 10−7 M, and 10−6 M. The present  study indicates that apelin can promote proliferation and  migration in RPE cells in vitro.",Non-OADS,/arxiv_data1/oa_pdf/57/d5/mv-v19-2227.PMC3820432.pdf
"Molecular Vision  2013; 19:2227-2236 <http://www.molvis.org/molvis/v 19/2227 > © 2013 Molecular Vision  2232Fibrosis is an important but neglected worldwide health  problem, which is involved in diseases such as post-infection  fibrotic complications, atherosclerosis, and connective tissue  disease.",Non-OADS,/arxiv_data1/oa_pdf/57/d5/mv-v19-2227.PMC3820432.pdf
Molecular Vision  2013; 19:2227-2236 <http://www.molvis.org/molvis/v 19/2227 > © 2013 Molecular Vision  2233mechanism of apelin in RPE cells is unclear.,Non-OADS,/arxiv_data1/oa_pdf/57/d5/mv-v19-2227.PMC3820432.pdf
Molecular Vision  2013; 19:2227-2236 <http://www.molvis.org/molvis/v 19/2227 > © 2013 Molecular Vision  2234in vitro.,Non-OADS,/arxiv_data1/oa_pdf/57/d5/mv-v19-2227.PMC3820432.pdf
Molecular Vision  2013; 19:2227-2236 <http://www.molvis.org/molvis/v 19/2227 > © 2013 Molecular Vision  223523.,Non-OADS,/arxiv_data1/oa_pdf/57/d5/mv-v19-2227.PMC3820432.pdf
"Molecular Vision  2013; 19:2227-2236 <http://www.molvis.org/molvis/v 19/2227 > © 2013 Molecular Vision  2236Articles are provided courtesy of Emory University and the Zhongshan Ophthalmic Center, Sun Yat-sen University, P.R.",Non-OADS,/arxiv_data1/oa_pdf/57/d5/mv-v19-2227.PMC3820432.pdf
The first signs of cataract Molecular Vision  2013; 19:2196-2208 <http://www.molvis.org/molvis/v 19/2196 > Received 5 July 2013 | Accepted 5 November 2013 | Published 7 November 2013© 2013 Molecular Vision 2196Cataract-specific posttranslational modifications and changes in  the composition of urea-soluble protein fraction from the rat lens Lyudmila V .,Non-OADS,/arxiv_data1/oa_pdf/e2/ec/mv-v19-2196.PMC3820433.pdf
"Molecular Vision  2013; 19:2196-2208 <http://www.molvis.org/molvis/v 19/2196 > © 2013 Molecular Vision  2197in OXYS rats appear at the age of 6 weeks; by the age of 12  weeks, 90% of animals are affected by the lens opacifica - tion.",Non-OADS,/arxiv_data1/oa_pdf/e2/ec/mv-v19-2196.PMC3820433.pdf
Molecular Vision  2013; 19:2196-2208 <http://www.molvis.org/molvis/v 19/2196 > © 2013 Molecular Vision  2198system: The US protein mixture was loaded onto the top of  the gels in glass tubes.,Non-OADS,/arxiv_data1/oa_pdf/e2/ec/mv-v19-2196.PMC3820433.pdf
Molecular Vision  2013; 19:2196-2208 <http://www.molvis.org/molvis/v 19/2196 > © 2013 Molecular Vision  2199lenses of different ages (Figure 1) shows that the maps  obtained for Wistar and OXYS lenses at the age of 3 weeks  are very similar.,Non-OADS,/arxiv_data1/oa_pdf/e2/ec/mv-v19-2196.PMC3820433.pdf
Molecular Vision  2013; 19:2196-2208 <http://www.molvis.org/molvis/v 19/2196 > © 2013 Molecular Vision  2200oxidative stress.,Non-OADS,/arxiv_data1/oa_pdf/e2/ec/mv-v19-2196.PMC3820433.pdf
"Molecular Vision  2013; 19:2196-2208 <http://www.molvis.org/molvis/v 19/2196 > © 2013 Molecular Vision  2201LPSNVDQSALSCSLSADGM(Ox)LTFSGPK) was observed  in spots 3, 4, 9, and 10 (Table 2), as well as the oxidation of  Met-68 in αB-crystallin (spot 36).",OADS,/arxiv_data1/oa_pdf/e2/ec/mv-v19-2196.PMC3820433.pdf
Molecular Vision  2013; 19:2196-2208 <http://www.molvis.org/molvis/v 19/2196 > © 2013 Molecular Vision  2202Table  2.,Non-OADS,/arxiv_data1/oa_pdf/e2/ec/mv-v19-2196.PMC3820433.pdf
"Molecular Vision  2013; 19:2196-2208 <http://www.molvis.org/molvis/v 19/2196 > © 2013 Molecular Vision  2203αA-crystallin (Table 2), both with and without oxidation of  the N-terminal methionine.",Non-OADS,/arxiv_data1/oa_pdf/e2/ec/mv-v19-2196.PMC3820433.pdf
"Molecular Vision  2013; 19:2196-2208 <http://www.molvis.org/molvis/v 19/2196 > © 2013 Molecular Vision  2204Phosphorylation of serine and threonine residues:  In the  present work, phosphorylated peptides were found in all  SOIcs corresponding to αA-crystallin (spots 2–5, 9–11, 13,  and 21) and in two SOIcs corresponding to αB-crystallin  (spots 24 and 46).",Non-OADS,/arxiv_data1/oa_pdf/e2/ec/mv-v19-2196.PMC3820433.pdf
Molecular Vision  2013; 19:2196-2208 <http://www.molvis.org/molvis/v 19/2196 > © 2013 Molecular Vision  2205lens aging and cataractogenesis.,Non-OADS,/arxiv_data1/oa_pdf/e2/ec/mv-v19-2196.PMC3820433.pdf
Molecular Vision  2013; 19:2196-2208 <http://www.molvis.org/molvis/v 19/2196 > © 2013 Molecular Vision  2206lenses.,Non-OADS,/arxiv_data1/oa_pdf/e2/ec/mv-v19-2196.PMC3820433.pdf
Molecular Vision  2013; 19:2196-2208 <http://www.molvis.org/molvis/v 19/2196 > © 2013 Molecular Vision  220720.,Non-OADS,/arxiv_data1/oa_pdf/e2/ec/mv-v19-2196.PMC3820433.pdf
Molecular Vision  2013; 19:2196-2208 <http://www.molvis.org/molvis/v 19/2196 > © 2013 Molecular Vision  220849.,Non-OADS,/arxiv_data1/oa_pdf/e2/ec/mv-v19-2196.PMC3820433.pdf
"OncoImmunology 2013; 2:e26245; http://dx.doi.org/10.4161/onci.26245IL-18-based combinatorial adjuvants promote   the intranodal production of CCL19 by NK cells   and dendritic cells of cancer patients Jeffrey L Wong1, ravikumar Muthuswamy1, David L Bartlett1,2, and Pawel Kalinski1,2,3,* 1Department of Surgery; University of Pittsburgh; Pittsburgh, P a US a;   2University of Pittsburgh c ancer Institute; h illman c ancer c enter; University of Pittsburgh; Pittsburgh, P a US a;   3Departments of Immunology and Infectious Diseases and Microbiology; University of Pittsburgh; Pittsburgh, P a US a Keywords:  adjuvant; CCL19; colorectal cancer; dendritic cell; IL-18; lymph node; natural killer cell Abbreviations: CD40L, CD40 ligand; CFSE, carboxyfluorescein diacetate succinimidyl ester; CTL, cytotoxic T lymphocyte; DC,  dendritic cell; GM-CSF, granulocyte macrophage colony-stimulating factor; GzmB, granzyme B; IFN, interferon; IL, interleukin;  LN, lymph node; NK, natural killer; PBMC, peripheral blood mononuclear cell; SEB, staphylococcal enterotoxin B; sIFN γR1,  soluble IFN γ receptor 1; sTNFR1, soluble TNF α receptor 1; TLS, tertiary lymphoid structures; TNF α, tumor necrosis factor α The effective accumulation and interaction of mature dendritic cells (D cs) and naïve T cells within lymph nodes (LNs),  which are driven by the ccr 7-ccL19/ ccL21 chemokine axis, are critical for the induction of adaptive T-cell immunity.",Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J Exp Med 2003; 198:615- 21; PMID:12925677 ; http://dx.doi.org/10.1084/ jem.20030448 2.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J Exp Med 2001; 193:1105-12; PMID:11342595 ; http://dx.doi.org/10.1084/ jem.193.9.1105 3.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J Exp Med  2007; 204:489-95;  PMID:17325198 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J Exp Med 2007; 204:1167-79;  PMID:17485513 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Nat Immunol 2006; 7:1101-8;  PMID:16964261 ; http://dx.doi.org/10.1038/ni13848.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J  Exp Med 2004; 199:1113-20; PMID :15096537 ;  http://dx.doi.org/10.1084/jem.20031645 9.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Immunity  2003; 19:561-9;  PMID:14563320 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Nat Immunol 2004; 5:1260-5;  PMID :15531883 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Blood 2005; 106:338- 44; PMID :15769894 ; http://dx.doi.org/10.1182/ blood-2004-09-3775 13.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J Leukoc Biol 2011; 89:383- 92; PMID:20952658 ; http://dx.doi.org/10.1189/ jlb.0810470 14.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Cell 2012;  150 :1235-48 ;  PMID:22980983 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J Exp Med  2005; 202:941-53;  PMID:16203865 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Immunity 1998; 8:383- 90; PMID :9529155 ; http://dx.doi.org/10.1016/ S1074-7613(00)80543-9 17.,OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J Immunother 2011; 34:270-8; PMID:21389871 ;  http://dx.doi.org/10.1097/CJI.0b013e31820b370b 18.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Nat Immunol 2008; 9:970-80; PMID:18711434 ;  http://dx.doi.org/10.1038/ni.f.213 19.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Immunity 2006; 25:373-81;  PMID:16979569 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Trends Immunol 2013; 34:67- 73; PMID:23122052 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Eur J Immunol 2003; 33:474-82; PMID:12645946 ; http://dx.doi.org/10.1002/ immu.200310023 24.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Eur J Immunol 1999; 29:1617-25; PMID:10359116 ; http://dx.doi.org/10.1002/ (SICI)1521-4141(199905)29:05<1617::AID-IMMU1617>3.0.CO;2-3 25.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J Exp Med 1998; 188:181-91;  PMID:9653094 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J Pathol  2003; 199:98-106;  PMID:12474232 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Nat Rev Immunol 2009; 9:568-80;  PMID:19629084 ; http://dx.doi.org/10.1038/ nri2604 32.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J Immunol 2012; 189:2099-109; PMID:22869906 ; http://dx.doi.org/10.4049/ jimmunol.1103474 33.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J Exp Med 2002; 195:327-33; PMID:11828007 ;  http://dx.doi.org/10.1084/jem.20010938 34.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Proc Natl Acad Sci U S A  2013; 110:E50-9;  PMID:23248310 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Eur J Immunol 2010; 40:3138-49; PMID:20865789 ; http://dx.doi.org/10.1002/ eji.201040496 38.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Cancer Gene Ther  2007; 14:523-32;  PMID:17384577 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J Gene Med 2012; 14:128-37; PMID:22228591 ;  http://dx.doi.org/10.1002/jgm.1651 43.,OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Clin Cancer Res 2004; 10:7466-74; PMID:15569976 ; http://dx.doi.org/10.1158/1078- 0432.CCR-04-0684 44.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Cancer 2009; 115:859-68;  PMID:19140204 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J Exp Med 2004; 200:1325-35; PMID :15545356 ;  http://dx.doi.org/10.1084/jem.20041522 46.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Cancer Res 2011; 71:5393-9;  PMID:21724589 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Cancer Res 2012; 72:2757-67; PMID:22427351 ;  http://dx.doi.org/10.1158/0008-5472.CAN-11-3379 48.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Nat Rev Cancer 2012; 12:298- 306; PMID:22419253 ; http://dx.doi.org/10.1038/ nrc3245 49.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
J Clin Oncol  2008; 26:4410-7;  PMID :18802153 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Cancer Res  2011; 71:6391-9;  PMID:21900403 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Cancer Res 2011; 71:5678-87;  PMID:21846823 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
BMC Cancer  2010; 10:578;  PMID:20969772 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Clin Cancer Res  2012; 18:850-7;  PMID:22142823 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Cancer Res 2004; 64:5934-7;  PMID :15342370 ; http://dx.doi.org/10.1158/0008- 5472.CAN-04-1261 55.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Blood 2010; 116:1454- 9; PMID:20498301 ; http://dx.doi.org/10.1182/ blood-2009-12-258038 56.,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
Cancer Res 2008; 68:5972-8;  PMID:18632653 ; http://dx.doi.org/10.1158/0008- 5472.CAN-07-6818,Non-OADS,/arxiv_data1/oa_pdf/43/8e/onci-2-e26245.PMC3820810.pdf
OncoImmunology 2013; 2:e25564; http://dx.doi.org/10.4161/onci.25564The current version of the American  Joint Committee on Cancer (AJCC)  Melanoma Staging System (as of 2010) was based on the analysis of prognostic factors in a large number of melanoma patients treated in centers throughout the world.,Non-OADS,/arxiv_data1/oa_pdf/dc/ee/onci-2-e25564.PMC3820811.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992;  http://dx.doi.org/10.1056/NEJMoa10034663.,OADS,/arxiv_data1/oa_pdf/dc/ee/onci-2-e25564.PMC3820811.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127;  http://dx.doi.org/10.1056/NEJMoa1200690 4.,OADS,/arxiv_data1/oa_pdf/dc/ee/onci-2-e25564.PMC3820811.pdf
J Invest Dermatol  2013; 133:509-17; PMID:22931913; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dc/ee/onci-2-e25564.PMC3820811.pdf
Lancet Oncol  2012; 13:589-97; PMID:22575589; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dc/ee/onci-2-e25564.PMC3820811.pdf
J Clin Oncol 2012; 30:2678- 83; PMID:22711850; http://dx.doi.org/10.1200/ JCO.2011.37.85398.,Non-OADS,/arxiv_data1/oa_pdf/dc/ee/onci-2-e25564.PMC3820811.pdf
N Engl J Med  2012; 366:925-31; PMID:22397654; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/dc/ee/onci-2-e25564.PMC3820811.pdf
"OncoImmunology 2013; 2:e26137; http://dx.doi.org/10.4161/onci.26137Early onset and enhanced growth   of autochthonous mammary carcinomas   in C3-deficient Her2/neu transgenic mice Silvio Bandini1,†, claudia c urcio2,†, Marco Macagno1, elena Quaglino1, Maddalena a rigoni1, Stefania Lanzardo1,   albana h ysi2, Giuseppina Barutello1, Lorena c onsolino1, Dario Livio Longo1, Piero Musiani2, Guido Forni1, Manuela Iezzi2,   and Federica cavallo1,* 1Department of Molecular Biotechnology and h ealth Sciences; Molecular Biotechnology c enter; University of Torino; Torino, Italy;   2aging r esearch c enter; G. D’ annunzio University Foundation; c hieti, Italy †These authors equally contributed to this work Keywords:  complement; genetically engineered mice; Her2/neu; immunosurveillance; mammary cancer Abbreviations: ADC, apparent diffusion coefficient; α SMA, α -smooth muscle actin; C3, complement component 3; CR3,  complement receptor 3; DCE-MRI, dynamic contrast enhanced magnetic resonance imaging; FoxP3, forkhead box P3; IL-1 β,  interleukin 1 β; IFNγ, interferon γ ; KO, knockout; Ktrans, volume transfer constant; MCP-1/CCL2, monocyte chemoattractant  protein 1; MDSC, myeloid-derived suppressor cell; NK, natural killer; TNF α, tumor-necrosis factor α ; Treg, regulatory T cell;  VEGF, vascular endothelial growth factor; Vp, plasmatic volume aside from its classical role in fighting infections, complement is an important, although poorly understood, com - ponent of the tumor microenvironment.",Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Carcinogenesis  2009; 30:1073-81;  PMID:19468060 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Lancet 2001; 357:539-45; PMID:11229684 ; http://dx.doi.org/10.1016/ S0140-6736(00)04046-0 3.,OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Immunity 2004; 21:137-48; PMID:15308095 ;  http://dx.doi.org/10.1016/j.immuni.2004.07.0174.,OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Science 2011; 331:1565-70; PMID:21436444 ; http://dx.doi.org/10.1126/ science.1203486,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Annu Rev Immunol 2011; 29:235-71;  PMID:21219185 ; http://dx.doi.org/10.1146/ annurev-immunol-031210-101324 6.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Jpn J Cancer Res  1995; 86:187-92;  PMID:7730143 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Mol Immunol  2013; 55:16-21;  PMID:23062612 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
N Biotechnol 2009; 25:294-8;  PMID:19442595 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Int J Mol Med 2010; 25:307-13;  PMID:20127033 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Nat Immunol 2010; 11:785-97; PMID:20720586 ; http://dx.doi.org/10.1038/ ni.1923 14.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Nat Rev Cancer 2006; 6:204- 16; PMID:16498443 ; http://dx.doi.org/10.1038/ nrc1815 17.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Adv Immunol 2006; 90:175-213;  PMID:16730264 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Cancer Cell 2008; 13:58-68; PMID:18167340 ;  http://dx.doi.org/10.1016/j.ccr.2007.12.003 21.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Cancer Res 2010; 70:7764-75; PMID :20924115 ;  http://dx.doi.org/10.1158/0008-5472.CAN-10-0471 22.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
J Cell Mol Med 2010; 14:2803-15; PMID:19818098 ;  http://dx.doi.org/10.1111/j.1582-4934.2009.00926.x 23.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Cancer Res  2007; 67:5454-60;  PMID:17545627 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
J Immunol 2010; 184:6124-32;  PMID:20435927 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Cancer Res 2006; 66:7734-40;  PMID:16885376 ;  http://dx.doi.org/10.1158/0008-5472.CAN-06-1432 26.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Clin  Cancer Res 2005; 11:1941-52; PMID:15756020 ;  http://dx.doi.org/10.1158/1078-0432.CCR-04-1873 27.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Breast Cancer Res 2007; 9:211;  PMID:17705881 ; http://dx.doi.org/10.1186/bcr1745 28.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Nat Immunol  2013; 14:162-71;  PMID:23263555 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
J Exp Med 2013; 210:257-68; PMID:23382542 ; http://dx.doi.org/10.1084/ jem.20121525 30.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Blood 2010; 116:4395-403; PMID:20625009 ;  http://dx.doi.org/10.1182/blood-2010-01-261503 31.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Blood 2003; 102:2138-45; PMID:12750171 ;  http://dx.doi.org/10.1182/blood-2003-01-019032.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Circ Res  2008; 102:823-30;  PMID:18292602 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Biol Pharm Bull 1999; 22:347-52; PMID:10328552 ;  http://dx.doi.org/10.1248/bpb.22.347 34.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
J Clin Invest 1993; 91:1974- 8; PMID:8486768 ; http://dx.doi.org/10.1172/ JCI116418 35.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Eur J Immunol  1992; 22:1207-13;  PMID :1577063 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Nat Immunol  2008; 9:1225-35;  PMID:18820683 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
J Immunol  2012; 189:2985-94;  PMID:22914051 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Autoimmun Rev 2008; 7:491-5; PMID:18558368 ;  http://dx.doi.org/10.1016/j.autrev.2008.03.012 39.,OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
J Immunol 2010; 184:4170-7;  PMID:20220087 ; http://dx.doi.org/10.4049/ jimmunol.0903375 41.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Cancer Immunol Immunother 2006; 55:987-95;  PMID:16485129 ;  http://dx.doi.org/10.1007/s00262-006-0136-8 42.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Clin Exp Immunol  1999; 115:229-35;  PMID:9933447 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Oncoimmunology 2012; 1:1104-10;  PMID:23170258 ; http://dx.doi.org/10.4161/ onci.21056 44.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
J Immunol 2012; 188:2136- 45; PMID:22301547 ; http://dx.doi.org/10.4049/ jimmunol.1102237,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Immunity 2008; 28:425- 35; PMID:18328742 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
J Immunol 2010; 185:5628-36; PMID:20870944 ;  http://dx.doi.org/10.4049/jimmunol.0903678 47.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
J Exp Med 2012; 209:1869- 82; PMID:22927549 ; http://dx.doi.org/10.1084/ jem.20112738 49.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
J  Immunol 2012; 189:4674-83;  PMID:23028051 ;  http://dx.doi.org/10.4049/jimmunol.1201654 50.,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
Angiogenesis 2012; 15:305-16;  PMID:22426512 ;  http://dx.doi.org/10.1007/s10456-012-9263-3,Non-OADS,/arxiv_data1/oa_pdf/9e/48/onci-2-e26137.PMC3820812.pdf
"OncoImmunology 2013; 2:e26198; http://dx.doi.org/10.4161/onci.26198Zinc supplementation is required for the cytotoxic  and immunogenic effects of chemotherapy   in chemoresistant p53-functionally deficient cells Mara cirone,1,* alessia Garufi,2 Livia Di r enzo,1 Marisa Granato,1 alberto Faggioni,1 and Gabriella D’Orazi2,3,* 1Department of e xperimental Medicine; Istituto Pasteur-Fondazione c enci Bolognetti; Sapienza University; r ome, Italy;   2Department of e xperimental Oncology; Molecular Oncogenesis Laboratory; r egina e lena National cancer Institute; r ome, Italy;   3Department of Medical, Oral and Biotechnological Sciences; University “G.",Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Oncoimmunology 2013; 2:e23510;  PMID:23687621 ; http://dx.doi.org/10.4161/ onci.23510 2.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Nat Rev Cancer 2009 ; 9:862-73;  PMID:19935675 ; http://dx.doi.org/10.1038/nrc2763 3.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Oncogene  2007 ; 26:2243 -54; PMID:17401433 ;  http://dx.doi.org/10.1038/sj.onc.12102954.,OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Cancer Res 2008 ; 68:3707 -14;  PMID:18483253 ; http://dx.doi.org/10.1158/0008- 5472.CAN-07-6776 5.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
PLoS  One 2009 ; 4:e6819 ; PMID:19714248 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Int J Cancer 2012 ; 131:E562 - 8; PMID:21932419 ; http://dx.doi.org/10.1002/ ijc.26441 8.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Adv Immunol  2004 ; 84:131- 79; PMID:15246252 ; http://dx.doi.org/10.1016/ S0065-2776(04)84004-5 9.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Curr  Opin Immunol  2011 ; 23:146-52; PMID:20970973 ;  http://dx.doi.org/10.1016/j.coi.2010.09.008,OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
EMBO J 2012 ;  31:1062 -79; PMID:22252128 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
EMBO J 2009 ; 28:578-90; PMID:19165151 ;  http://dx.doi.org/10.1038/emboj.2009.1 13.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Oncoimmunology  2012 ; 1:1218 -9; PMID:23170286 ;  http://dx.doi.org/10.4161/onci.20428 15.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Cancer Lett 2006 ; 231:102-12; PMID:16356835 ;  http://dx.doi.org/10.1016/j.canlet.2005.01.033 17.,OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Science   1999 ; 285:1733 -7; PMID:10481009 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
J Exp Med 2000 ; 191:411- 6; PMID:10662786 ; http://dx.doi.org/10.1084/ jem.191.3.41119.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
PLoS Biol  2005 ; 3:e185 ;  PMID:15839733 ; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Clin Cancer Res 2010 ; 16:3100 -4;  PMID:20421432 ; http://dx.doi.org/10.1158/1078- 0432.CCR-09-2891 21.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Cell  1989 ; 56:801-13; PMID:2647301 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
J  Biol Chem  2004 ; 279:25935 -8; PMID :15070890 ;  http://dx.doi.org/10.1074/jbc.R400008200 23.,OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Cell  Death Differ 2008 ; 15:1499 -509; PMID:18464797 ;  http://dx.doi.org/10.1038/cdd.2008.67 24.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Autophagy  2012 ; 8:413-5;  PMID :22361584 ; http://dx.doi.org/10.4161/ auto.19009 25.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Oncogene  2000 ; 19:5227 - 36; PMID:11077439 ; http://dx.doi.org/10.1038/ sj.onc.120390729.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Crit Rev  Immunol  2010 ; 30:345-86; PMID:20666707 ;  http://dx.doi.org/10.1615/CritRevImmunol.v30.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Cell Death Differ 2008 ; 15:3-12; PMID:18007663 ;  http://dx.doi.org/10.1038/sj.cdd.4402269 31.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Immunol Lett  2008 ; 120:37-41; PMID:18680763 ;  http://dx.doi.org/10.1016/j.imlet.2008.06.011 32.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
PLoS One  2012 ; 7:e48342 ; PMID:23144866 ;  http://dx.doi.org/10.1371/journal.pone.0048342 34.,Non-OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Exp Cell Res  2004 ; 293:311-20; PMID:14729469 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
Free Radic Biol Med 2010 ;  48:1338 -46; PMID:20171273 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/77/onci-2-e26198.PMC3820813.pdf
"OncoImmunology 2013; 2:e26014; http://dx.doi.org/10.4161/onci.26014Clonal expansion of renal cell   carcinoma-infiltrating T lymphocytes Simone P Sittig1, Tania Køllgaard1, Kirsten Grønbæk2, Manja Idorn1, Jörg h ennenlotter3, arnulf Stenzl3,   cécile Gouttefangeas4, and Per thor Straten1,* 1center for c ancer Immune Therapy ( ccIT); Department of h ematology; c openhagen University h ospital h erlev; h erlev, Denmark; 2Department of h ematology;  rigshospitalet; c openhagen, Denmark; 3Department of Urology; e berhard-Karls University; Tübingen, Germany; 4Department of Immunology; Institute for c ell Biology;  eberhard-Karls University; Tübingen, Germany Keywords:  clonally expanded T cells, renal cell carcinoma, T-cell phenotypes,   T-cell receptor clonotype mapping; tumor-infiltrating lymphocytes Abbreviations: BV, β variable; CTLA-4, cytotoxic T-lymphocyte associated protein 4; DGGE, denaturing gradient gel  electrophoresis; IL-2, interleukin-2; LAG3, lymphocyte-activation gene 3; PD-1, programmed cell death 1; PBMC, peripheral  blood mononuclear cell; RCC, renal cell carcinoma; TAA, tumor-associated antigen; TCR, T-cell receptor; TCM, central memory T;  TEM, effector memory T; TEMRA, CD45RA+ effector memory T; TIL, tumor-infiltrating lymphocyte T lymphocytes can mediate the destruction of cancer cells by virtue of their ability to recognize tumor-derived anti - genic peptides that are presented on the cell surface in complex with h La molecules and expand.",Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Br J Cancer 2011; 104:741-5;  PMID:21266975 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
N Engl J Med 2010; 363:711-23; PMID:20525992 ;  http://dx.doi.org/10.1056/NEJMoa10034664.,OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Clin Exp Immunol  2009; 157:9-19;  PMID:19659765 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
N Engl J Med 2012; 366:2443-54; PMID:22658127 ;  http://dx.doi.org/10.1056/NEJMoa1200690 8.,OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
N Engl J Med  2013; 369:134-44;  PMID:23724846 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Cancer 2006; 107:46- 53; PMID:16708355 ; http://dx.doi.org/10.1002/ cncr.21951 10.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Cancer Immunol Immunother 2009; 58:1407- 17; PMID:19184600 ; http://dx.doi.org/10.1007/ s00262-008-0655-6 11.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Nat Rev Drug Discov 2005; 4:399-409;  PMID :15864269 ; http://dx.doi.org/10.1038/ nrd1717 12.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Clin Cancer Res 2006; 12:4163-70;  PMID:16857787 ; http://dx.doi.org/10.1158/1078- 0432.CCR-05-2470 13.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Clin Cancer Res 2008; 14:6916-23;  PMID:18980986 ; http://dx.doi.org/10.1158/1078- 0432.CCR-08-0466 14.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Scand J Immunol 1996; 44:285-92; PMID:8795723 ;  http://dx.doi.org/10.1046/j.1365-3083.1996.d01-304.x 15.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Mol Ther 2011; 19:990-9; PMID:21189474 ; http://dx.doi.org/10.1038/ mt.2010.289 16.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Cancer Immunol Immunother 2007; 56:117- 28; PMID:16676181 ; http://dx.doi.org/10.1007/ s00262-006-0172-417.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Nat Med 2012; 18; PMID:22842478 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Cancer Immunol Immunother 1999; 48:386-95;  PMID:10501852 ;  http://dx.doi.org/10.1007/s002620050591 20.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
2004; 2:11;  PMID:15072580 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Cancer Res 2009; 69:8412-9;  PMID:19843860 ; http://dx.doi.org/10.1158/0008- 5472.CAN-09-0852 23.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Int J Cancer 2006; 119:831- 8; PMID:16557580 ; http://dx.doi.org/10.1002/ ijc.21894 28.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Cytometry A 2008;  73A:975-83;  PMID:18785267 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
J Exp Med 2011; 208:395-407; PMID:21300912 ;  http://dx.doi.org/10.1084/jem.2010046630.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Clin Cancer Res 2011; 17:4550-7;  PMID:21498393 ; http://dx.doi.org/10.1158/1078- 0432.CCR-11-0116 31.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Nat Rev Cancer 2012; 12:252-64;  PMID:22437870 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Adv Immunol  2006; 92:187-224;  PMID:17145305 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Cancer Res  2012; 72:1642-50;  PMID:22311675 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
J Clin Invest 2010; 120:2230-42; PMID:20458140 ; http://dx.doi.org/10.1172/ JCI37646 37.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Nat Rev Cancer 2012; 12:298- 306; PMID:22419253 ; http://dx.doi.org/10.1038/ nrc3245 38.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
J Clin Oncol 2006; 24:1997- 2005;  PMID:16648500 ; http://dx.doi.org/10.1200/ JCO.2005.03.9594 39.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Cancer Sci  2006; 97:780-6;  PMID:16863511 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Clin Cancer Res 2013; 19:4079-91;  PMID:23785047 ; http://dx.doi.org/10.1158/1078- 0432.CCR-12-3847,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Eur J Immunol 2001;  31:250-8;  PMID:11265641 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Ann Oncol 2012; 23(Suppl 8):viii35- 40; PMID:22918926 ; http://dx.doi.org/10.1093/ annonc/mds261 45.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Cancer Res  2012; 72:6119-29;  PMID:23071066 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Cancer Res 2012; 72:3664-76;  PMID:22628427 ; http://dx.doi.org/10.1158/0008- 5472.CAN-11-2791 47.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Int J Cancer 2006; 119:317-27; PMID:16482562 ;  http://dx.doi.org/10.1002/ijc.2177548.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
J Exp Med 2011; 208:395-407; PMID:21300912 ;  http://dx.doi.org/10.1084/jem.20100466 49.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Int J Cancer 1993; 54:60- 7; PMID:8478148 ; http://dx.doi.org/10.1002/ ijc.2910540111 50.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Int J Cancer 1997; 72:431-40;  PMID:9247286 ; http://dx.doi.org/10.1002/ (SICI)1097-0215(19970729)72:3<431::AID-IJC10>3.0.CO;2-F 51.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
J Immunother  2010; 33:956-64;  PMID:20948441 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Immunotherapy 2009; 1:129-39; PMID:20445772 ;  http://dx.doi.org/10.2217/1750743X.1.1.129 54.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
J Clin Oncol 2010; 28:3167-75;  PMID:20516446 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
"Leukemia 2005; 19:2273-80; PMID:16304575 ;  http://dx.doi.org/10.1038/sj.leu.2403972 56. thor Straten P, Kirkin AF, Siim E, Dahlström K, Drzewiecki KT, Seremet T, Zeuthen J, Becker JC,  Guldberg P. Tumor infiltrating lymphocytes in mela - noma comprise high numbers of T-cell clonotypes that are lost during in vitro culture.",Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
Clin Immunol 2000; 96:94-9;  PMID :10900156 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/f3/onci-2-e26014.PMC3820815.pdf
"OncoImmunology 2013; 2:e25994; http://dx.doi.org/10.4161/onci.25994Strategies to improve the immunogenicity  of anticancer vaccines based  on dendritic cell/malignant cell fusions Shigeo Koido1,2,3,*, Sadamu Homma3, Masato Okamoto4, yoshihisa Namiki2, Kazuki Takakura1, Kan Uchiyama1,   Mikio Kajihara1, Seiji a rihiro1, Hiroo Imazu5, Hiroshi a rakawa1,5, Shin Kan3, Hideo Komita3, yuko Kamata3, Masaki Ito3,   Toshifumi Ohkusa1, Jianlin Gong6, and Hisao Tajiri1 1Division of Gastroenterology and Hepatology; Department of Internal Medicine; The Jikei University School of Medicine; Tokyo, Japan; 2Institute of Clinical Medicine   and r esearch; The Jikei University School of Medicine; Tokyo, Japan; 3Department of Oncology; Institute of DN a Medicine; The Jikei University School of Medicine; Tokyo, Japan;  4Division of Cellular Signaling; Institute for a dvanced Medical r esearch; Keio University School of Medicine; Tokyo, Japan; 5Department of e ndoscopy; The Jikei University  School of Medicine; Tokyo, Japan; 6Department of Medicine; Boston University School of Medicine; Boston, M a US a Keywords:  dendritic cell, whole tumor cell, immunogenicity, cytotoxic T lymphocyte, fusion The rationale for fusing dendritic cells (DCs) with whole  tumor cells to generate anticancer vaccines resides in the  fact that the former operate as potent antigen-presenting  cells, whereas the latter express a constellation of tumor- associated antigens (T aas).",Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Nat Med 1998; 4:328- 32; PMID:9500607 ; http://dx.doi.org/10.1038/ nm0398-328 2.,OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Int J Cancer 2000 ; 86:385-92; PMID:10760827 ;  http://dx.doi.org/10.1002/(SICI)1097- 0215(20000501)86:3<385::AID-IJC13>3.0.CO;2-T3.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
J Immunother   2006 ; 29:545-57; PMID:16971810 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Nat Biotechnol  1998 ; 16:364- 9; PMID:9555728 ; http://dx.doi.org/10.1038/ nbt0498-3645.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Nat Med  1997 ; 3:558- 61; PMID:9142127 ; http://dx.doi.org/10.1038/ nm0597-558,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Oncoimmunology  2013 ; 2:e24437 ;  PMID:23762810 ; http://dx.doi.org/10.4161/ onci.24437 8.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Immunotherapy   2009 ; 1:49-62; PMID:20635973 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Clin Dev Immunol  2009 ; 2009 :1; PMID:20182533 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Clin Immunol  2004 ; 113:261- 9; PMID :15507391 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Clin Dev Immunol  2010 ; 2010 :1; PMID:21048993 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Cancer Res 2008 ; 68:4045 -9;  PMID:18519662 ; http://dx.doi.org/10.1158/0008- 5472.CAN-07-6669 15.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Cancer Res  2007 ; 67:7945 -7; PMID:17804699 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Cancer Res 2006 ; 66:4987 -90;  PMID:16707417 ; http://dx.doi.org/10.1158/0008- 5472.CAN-05-4676 17.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Nat Immunol   2005 ; 6:769-76; PMID :15995707 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Lancet  1994 ; 343:1122 -6; PMID:7910230 ;  http://dx.doi.org/10.1016/S0140-6736(94)90233-X 19.,OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Cancer   1994 ; 74:3097 -103; PMID:7982173 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
PLoS One   2013 ; 8:e59280 ; PMID:23555011 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
J Biol Chem 2011 ;  286:31347 -60; PMID:21768114 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Clin  Cancer Res 2009 ; 15:6560 -9; PMID:19861451 ;  http://dx.doi.org/10.1158/1078-0432.CCR-09-1066 23.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Clin Cancer Res 2009 ; 15:6551-9;  PMID:19861464 ; http://dx.doi.org/10.1158/1078- 0432.CCR-09-1067 24.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Cancer Immunol  Immunother   2012 ; 61:425-31; PMID:22193988 ;  http://dx.doi.org/10.1007/s00262-011-1188-y 25.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Science  1989 ; 243:1056 -9; PMID:2922595 ;  http://dx.doi.org/10.1126/science.2922595 32.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Nat Med  2007 ;  13:1050 -9; PMID:17704786 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
J Immunol  2010 ;  184:488-96; PMID:19949080 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Immunology   2000 ; 101:316-24; PMID:11106934 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
N Engl J Med 2012 ; 366:2443 -54; PMID:22658127 ;  http://dx.doi.org/10.1056/NEJMoa1200690 38.,OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
Oncoimmunology  2012 ; 1:1223 -5; PMID:23243584 ;  http://dx.doi.org/10.4161/onci.21335 39.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
N Engl J Med  2013 ; 369:122-33; PMID:23724867 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a5/49/onci-2-e25994.PMC3820816.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Mild H7N9 patients in Shanghai XY uet al 3 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/e3/87/emi201341a.PMC3820982.pdf
Available at http://www.mtnstopshiv.org/node/3909 (accessed 30January 2013).,Non-OADS,/arxiv_data1/oa_pdf/64/4b/emi201342a.PMC3820983.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0A new safety evaluation system for microbicides LZ Li et al 10 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/64/4b/emi201342a.PMC3820983.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 Supplementary Information for this article can be found on Emerging Microbes & Infections ’s website (http://www.nature.com/EMI/).EV71-infected CD141cells activate immune response JJ Wang et al 7 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/66/fe/emi201344a.PMC3820984.pdf
"In Shenyang, Liaoning Province, northeast China, CRF01_AE accounted for 81.3%–87.6% of HIV strains among MSM.47,48Similar trends were observed in studies from Hebei Province49and Henan Province, north and central China.50In addi- tion, new CRF01_AE/B recombinant strains have also been reported among MSM.53Two new CRFs: CRF55_01B39,54and CRF59_01B (http://www.hiv.lanl.gov) were identified in Chinese MSM.",OADS,/arxiv_data1/oa_pdf/c8/74/emi201345a.PMC3820985.pdf
Available at: http://www.unaids.org.cn/pics/20130521161757.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c8/74/emi201345a.PMC3820985.pdf
Available at http://data.unaids.org/pub/Report/2009/20091127_stigmaindexsummaryreport_ en.pdf (accessed 1 April 2013).,Non-OADS,/arxiv_data1/oa_pdf/c8/74/emi201345a.PMC3820985.pdf
Available athttps://cdc.confex.com/cdc/std2012/flvgateway.cgi/id/8221?recordingid 58221 (accessed 1 April 2013).,OADS,/arxiv_data1/oa_pdf/c8/74/emi201345a.PMC3820985.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0New HIV epidemic among MSM population in China JJ Xu et al 6 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/c8/74/emi201345a.PMC3820985.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0HBV polymerase functions and antiviral development SA Jones and J Hu 9 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/b1/ef/emi201356a.PMC3820986.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0IL-17 cytokines in immunity and inflammation W Jin and C Dong 5 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/0c/2d/emi201358a.PMC3820987.pdf
"A phylogenetic tree was constructed from the putatively hypermutation-free alignment using FastTree 2.1.7.21,22 This tree was visualized using Archeopteryx (https://sites.google.",OADS,/arxiv_data1/oa_pdf/14/df/emi201360a.PMC3820988.pdf
"An iterative recentering algorithm, suggested by the UCLUST author at http://drive5.com/usearch/manual/recenter.html, was implemented which dealt well with this issue.",OADS,/arxiv_data1/oa_pdf/14/df/emi201360a.PMC3820988.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Zoonotic simian foamy virus in Bangladesh GA Engel et al 10 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/14/df/emi201360a.PMC3820988.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Clostridium difficle infection C Ghose 8 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/4b/c5/emi201362a.PMC3820989.pdf
(http://www.cancer.,Non-OADS,/arxiv_data1/oa_pdf/71/49/srep03169.PMC3821017.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/71/49/srep03169.PMC3821017.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3169 | DOI: 10.1038/srep03169 11",Non-OADS,/arxiv_data1/oa_pdf/71/49/srep03169.PMC3821017.pdf
http://dx.doi.org/10.1016/j.fob.2013.08.003,OADS,/arxiv_data1/oa_pdf/22/6c/main.PMC3821019.pdf
http://dx.doi.org/10.1016/j.fob.2013.09.007,OADS,/arxiv_data1/oa_pdf/7a/3c/main.PMC3821020.pdf
http://dx.doi.org/10.1093/pcp  / pct098 .,Non-OADS,/arxiv_data1/oa_pdf/7a/3c/main.PMC3821020.pdf
http://dx.doi.org/10.1016/j.fob.2013.07.008,OADS,/arxiv_data1/oa_pdf/ab/7b/main.PMC3821021.pdf
http://dx.doi.org/10.1016/j.fob.2013.08.002,OADS,/arxiv_data1/oa_pdf/15/5a/main.PMC3821022.pdf
http://dx.doi.org/10.1016/j.fob.2013.08.001,OADS,/arxiv_data1/oa_pdf/49/47/main.PMC3821026.pdf
http://dx.doi.org/10.1016/j.fob.2013.09.005,OADS,/arxiv_data1/oa_pdf/0e/a8/main.PMC3821027.pdf
http://dx.doi.org/10.1371/journal.pgen.1001150  .,Non-OADS,/arxiv_data1/oa_pdf/0e/a8/main.PMC3821027.pdf
http://dx.doi.org/10.1016/j.fob.2013.07.007,OADS,/arxiv_data1/oa_pdf/34/8e/main.PMC3821029.pdf
http://dx.doi.org/10.1016/j.fob.2013.10.001,OADS,/arxiv_data1/oa_pdf/20/57/main.PMC3821031.pdf
http://dx.doi.org/10.1016/j.fob.2013.09.006,OADS,/arxiv_data1/oa_pdf/f1/9a/main.PMC3821032.pdf
http://dx.doi.org/10.1016/j.fob.2013.08.005,OADS,/arxiv_data1/oa_pdf/ec/ed/main.PMC3821033.pdf
http://dx.doi.org/10.1016/j.fob.2013.09.001,OADS,/arxiv_data1/oa_pdf/bd/07/main.PMC3821035.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Gene Therapy website (http://www.nature.com/gt)HDL-raising gene transfer and cardiac function SC Gordts et al 1061 &2013 Macmillan Publishers Limited Gene Therapy (2013) 1053 – 1061",Non-OADS,/arxiv_data1/oa_pdf/d2/db/gt201330a.PMC3821036.pdf
"Available   from: http://www.pewinternet.org/Commentary/2011/November/Pe  w-Internet-Health.aspx [4] Hesse BW, Nelson DE, Kreps GL, et al .",Non-OADS,/arxiv_data1/oa_pdf/e5/40/TOAIDJ-7-42.PMC3821080.pdf
Available  from: http://aspe.hhs.gov/poverty/11poverty.shtml  [17] Bowen D. Predictors of women's Internet access and Internet health  seeking.,Non-OADS,/arxiv_data1/oa_pdf/e5/40/TOAIDJ-7-42.PMC3821080.pdf
"[13] Cara Therapeutics: http://www.caratherapeutics.com/ [accessed  May 13, 2012].",Non-OADS,/arxiv_data1/oa_pdf/86/e0/TOMCJ-7-16.PMC3821081.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/ba/CPEMH-9-171.PMC3821084.pdf
"http://www.woc.co.jp/pr oduct/d5000.ht  ml [Accessed: April 2, 2013].",Non-OADS,/arxiv_data1/oa_pdf/0b/51/TOOPHTJ-7-69.PMC3821097.pdf
" S335 Surgical Neurology International Editor: Michel Kliot,  MD UCSF Medical Center San Francisco, CA 94143OPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comSNI: Neurosurgical Developments on the Horizon,  a supplement to  SNIHEAVEN: The head anastomosis venture Project outline for the first human head transplantation with  spinal linkage (GEMINI) Sergio Canavero Turin Advanced Neuromodulation Group, Turin, Italy E‑mail: *Sergio Canavero ‑ sercan@inwind.it   *Corresponding author Received: 29 March 13   Accepted: 10 May 2013  Published: 13 June 13 Abstract In 1970, the first cephalosomatic linkage was achieved in the monkey.",Non-OADS,/arxiv_data1/oa_pdf/37/87/SNI-4-335.PMC3821155.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2013/4/2/335/113444 Copyright: © 2013 Canavero S.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,   distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/37/87/SNI-4-335.PMC3821155.pdf
"Available from: http://publicationethics.org [Last accessed on  September 1, 2013.",Non-OADS,/arxiv_data1/oa_pdf/17/f3/JAIM-4-129.PMC3821183.pdf
We have attempted it on our newly launched website program (http://www.arhcm.org/LearningVideos.aspx).,Non-OADS,/arxiv_data1/oa_pdf/85/6b/JAIM-4-132.PMC3821184.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/12/fc/JAIM-4-134.PMC3821186.pdf
Available from: http://kishorpatwardhan.blogspot.in/2011/02/is- biomedicine-on-its-way-of-becoming.html.,Non-OADS,/arxiv_data1/oa_pdf/15/6c/JAIM-4-138.PMC3821187.pdf
Available from: http://www.whoindia.org/EN/Section102/Section201_888.htm.,Non-OADS,/arxiv_data1/oa_pdf/2a/e6/JAIM-4-165.PMC3821191.pdf
Available from: http://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3132461/ [Last cited date on 2013 Feb 19].,OADS,/arxiv_data1/oa_pdf/db/4f/JAIM-4-176.PMC3821193.pdf
Available from:  http://www.inchem.org/documents/pims/plant/jcurc.,OADS,/arxiv_data1/oa_pdf/db/4f/JAIM-4-176.PMC3821193.pdf
Available from: http://r1mc.doh.gov.ph/index.php?option=com_content&view=article&id=102&Itemid=101 [Last updated date on 2013 Jan 10; Last cited date on 2012 Dec 21].,OADS,/arxiv_data1/oa_pdf/db/4f/JAIM-4-176.PMC3821193.pdf
Available from: http://ghr.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/ee/73/JAIM-4-181.PMC3821194.pdf
Available from: http://dermnetnz.org/lesions/epidermal-naevi.html.,Non-OADS,/arxiv_data1/oa_pdf/ee/73/JAIM-4-181.PMC3821194.pdf
"For more information, please visit http://selectbiosciences.com/conferences/index.",Non-OADS,/arxiv_data1/oa_pdf/45/32/JAIM-4-186.PMC3821195.pdf
"For further details, please  visit http://www.omicsgroup.com/conferences/ pharmacognosy-phytochemistry-natural-products-2013 or contact: pharmacognosy2013@omicsgroup.com or  call +91-7799788355 seconD global ayurveDa Festival Kerala 2014  Global Ayurveda Festival is a biennial get-together of  the Ayurveda fraternity in the State of  Kerala, India.",Non-OADS,/arxiv_data1/oa_pdf/45/32/JAIM-4-186.PMC3821195.pdf
Please visit http://www.gaf.co.in for  more details.,Non-OADS,/arxiv_data1/oa_pdf/45/32/JAIM-4-186.PMC3821195.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/c0/00/IJPsyM-35-227.PMC3821198.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/08/45/IJPsyM-35-241.PMC3821199.pdf
Available from: http://www.cdsco.nic.in/html/ Notoifi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/a0/IJPsyM-35-248.PMC3821200.pdf
Available from: http://www.deadiversion.usdoj.gov/schedules/orangebook/c_cs_alpha.pdf.,Non-OADS,/arxiv_data1/oa_pdf/c1/a0/IJPsyM-35-248.PMC3821200.pdf
Available from: http://www.auseinet.com/journal/vol4iss2/reid.pdf.,Non-OADS,/arxiv_data1/oa_pdf/01/b0/IJPsyM-35-251.PMC3821201.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/01/b0/IJPsyM-35-251.PMC3821201.pdf
Available from: http://www.jssm.org.,Non-OADS,/arxiv_data1/oa_pdf/ca/b2/IJPsyM-35-273.PMC3821205.pdf
Available from: http://www.biae.clemson.edu/bpc/bp/ Lab/110/reaction.htm#Arousal.,OADS,/arxiv_data1/oa_pdf/ca/b2/IJPsyM-35-273.PMC3821205.pdf
Available from: http://www.data.worldbank.org/indicator/SH.XPD.OOPC.,OADS,/arxiv_data1/oa_pdf/ab/55/IJPsyM-35-278.PMC3821206.pdf
Available from: http://telemed.esanjeevani.in/Telemedicine/Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ab/55/IJPsyM-35-278.PMC3821206.pdf
Available from: http://www.ncbi.nlm.nih.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/IJPsyM-35-299.PMC3821209.pdf
Available from: http://www.ncbi.nlm.nih.gov/pubmed/11435761.,Non-OADS,/arxiv_data1/oa_pdf/05/d4/IJPsyM-35-299.PMC3821209.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/22/b7/IJPsyM-35-314.PMC3821214.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/22/b7/IJPsyM-35-314.PMC3821214.pdf
Available from:  http://www.ijhssnet.com/journals/Vol 2 No 6 Special../23.,Non-OADS,/arxiv_data1/oa_pdf/1f/72/NMJ-54-224.PMC3821221.pdf
Available  from: http://www.cdc.gov/nchs/data/nhanes/nhanes_07_08/ manual_an.pdf [Last accessed on 1 Sep 2012].,OADS,/arxiv_data1/oa_pdf/1f/72/NMJ-54-224.PMC3821221.pdf
Accessed from http://www.punchng.com/news/ nigeria‑   ranks‑second‑to‑eritrea‑in‑road‑accidents‑frsc/[Last accessed  on 12 June 2012].,Non-OADS,/arxiv_data1/oa_pdf/1f/72/NMJ-54-224.PMC3821221.pdf
Accessed from: http://www.viodvla.com/sl/page.php?pg=Driver  licence and subpg=Driver licence process.,Non-OADS,/arxiv_data1/oa_pdf/1f/72/NMJ-54-224.PMC3821221.pdf
"Washington: USDOT,  1991. http://www.fmcsa.dot.gov/documents/pulmonary1.",Non-OADS,/arxiv_data1/oa_pdf/1f/72/NMJ-54-224.PMC3821221.pdf
Available from: http://www.ijem.in/text.,Non-OADS,/arxiv_data1/oa_pdf/c1/70/NMJ-54-254.PMC3821227.pdf
Available from: http://Dspace.uijos.edu.ng/ handle/10485/384 [Last accessed on 20 Jul 2012] 7.,OADS,/arxiv_data1/oa_pdf/4e/93/NMJ-54-261.PMC3821229.pdf
Available from: http://www.slate.com/ articles/2004/01/bringing_up_babes.html [Last assessed on  2013 Jan 28].,Non-OADS,/arxiv_data1/oa_pdf/4e/93/NMJ-54-261.PMC3821229.pdf
Available at http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/3f/bb/AYU-34-133.PMC3821239.pdf
"Panja: Chanda  in Charakasamhita{hÝXr gmam§e  N>ÝXemó Ho$ AZwgma MaH$ g§{hVm H$m ñdamË‘H$ {díbofU >A{gV nmÝOm MaH$g§{hVm Am¶wd}XdmL²>‘¶ H$m ‘hËdnyU© àmUómoV h¡ & ¶h 3000 df© nyd© Cg g‘¶ Ho$ ^mfm, ar{V Ed§ nÕ{V go {d{YdV² boIZ-¶wJ go  nhbo aMr JB© VWm VrZ-àH$ma H$m ‘oYm-¶wº$ N>mÌm| Ho$ {b¶o ì¶dhmamon¶moJr ê$n ‘| àñVwV H$s JB© h¡ & AÜ¶oVmAm| Ho$ ghO Ed§ XrK©H$mb  ñ‘aUmW© MaH$g§{hVm H$m àm¶ Xmo-V¥Vr¶m§e gyÌ N>ÝX-emóm| Ho$ {Z¶‘mZwgma N>ÝX~Õ-ûcmoH$-ñdê$n ‘| {bIm J¶m h¡ & g§{hVm H$m  AÜ¶¶Z Bgr N>ÝX~Õê$n ‘| {ZaÝVa ewÕ-H$boda ‘| MbVm ahm, naÝVw qdedr gXr Ho$ ‘Ü¶-^mJ Ho$ nümV² Bg H$mbO¶r emó H$s  AÜ¶¶Z {d{Y Ho$ AZä¶mg Ho$ H$maU AmYw{ZH$ H$mb ‘| Am¶wd}X H$m àmH¥$V, ñdê$nV… VWm ¶WmdV² kmZmO©Z gå^d Zhr hmo ahm h¡ &  AV… nmR>-gwJ‘mW© MaH$g§{hVm Ho$ g‘ñV N>ÝX~Õ-ûcmoH$m| H$m N>ÝXemónaH$ {d{YdV² {ddoMZ Bg à~ÝY H$m Ü¶o¶ h¡ & Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.",Non-OADS,/arxiv_data1/oa_pdf/2c/fb/AYU-34-134.PMC3821240.pdf
Available from: http://www.who.int/mediacentre/factsheets/ fs312/en/[Last accessed on 2011 Mar 17].4.,Non-OADS,/arxiv_data1/oa_pdf/ec/e2/AYU-34-167.PMC3821245.pdf
Available from: http://www.who.int/topics/anaemia.,Non-OADS,/arxiv_data1/oa_pdf/34/0c/AYU-34-184.PMC3821248.pdf
Available from: http://www.nfhsindia.org/data/india/indch7.pdf; 247.,OADS,/arxiv_data1/oa_pdf/34/0c/AYU-34-184.PMC3821248.pdf
Available from: http://www.ncbi.nlm.nih.gov./pubmed.,Non-OADS,/arxiv_data1/oa_pdf/34/0c/AYU-34-184.PMC3821248.pdf
Available from: http://www.irondisorders.org/elderly.,Non-OADS,/arxiv_data1/oa_pdf/34/0c/AYU-34-184.PMC3821248.pdf
Available from: http://www.irondisorders.org/iron‑defi ciency‑anemia.,Non-OADS,/arxiv_data1/oa_pdf/34/0c/AYU-34-184.PMC3821248.pdf
Available from: http://www.en.wikipedia.org/wiki/Psoralea_corylifolia.,Non-OADS,/arxiv_data1/oa_pdf/71/27/AYU-34-189.PMC3821249.pdf
"ICMR guidelines, Available from: http://www.icmr.nic.in/ethical_guidelines.",Non-OADS,/arxiv_data1/oa_pdf/82/a2/AYU-34-215.PMC3821254.pdf
Available from: http://www.holistichealthtools.com/auto.html.,Non-OADS,/arxiv_data1/oa_pdf/6c/51/AYU-34-220.PMC3821255.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/96/31/AYU-34-229.PMC3821257.pdf
Available  from: http://www.japi.org/january_2012/01_dimond_jubilee_of.html [Last accessed on 2013 Jul 15].,Non-OADS,/arxiv_data1/oa_pdf/76/9d/IJA-57-436.PMC3821259.pdf
Available from: http://www.ncbi.nlm.nih.gov/ pubmed [Last accessed on 2013 Jul 15].,OADS,/arxiv_data1/oa_pdf/76/9d/IJA-57-436.PMC3821259.pdf
Available from: http://www.medin.nic.in.http:// indmed.nic.in/ [Last accessed on 2013 Jul 12].,OADS,/arxiv_data1/oa_pdf/76/9d/IJA-57-436.PMC3821259.pdf
Available from: http://www.frankshospitalworkshop.com/equipment/documents/ecg/user_manuals/GE%20Aisys%20 -  %20User’s%20reference%20manual.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ac/f7/IJA-57-446.PMC3821261.pdf
Available from:  http://www.draeger.ae/media/10/00/91/10009117/primus_br_9049135_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ac/f7/IJA-57-446.PMC3821261.pdf
Available from:  http://www.etherweb.bwh.harvard.edu/education/PHILIP/ Fabius_User_Manual.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ac/f7/IJA-57-446.PMC3821261.pdf
7. http://www.draeger.net/local/products/zeus-ie/en/keyfacts/ index.html.,Non-OADS,/arxiv_data1/oa_pdf/ac/f7/IJA-57-446.PMC3821261.pdf
Available from: http://www.airliquidemedicalsystems.com/file/otherelementcontent/pj/f5/d5/34/ed/air -liquide-   medical-systems-felix-anesthesia-en-5261652112126585400.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ac/f7/IJA-57-446.PMC3821261.pdf
Available  from: http://www.anzca.edu.au/resources/professional-   documents/documents/professional-standards/pdf-files/ ps54 -2012 -minimum-safety -requirements-for -anaesthetic-   machines-for -clinical-practice.,Non-OADS,/arxiv_data1/oa_pdf/dd/75/IJA-57-472.PMC3821264.pdf
Available from: http://update.anaesthesiologists.org/2008/12/01/respiratory -gas-analysis.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/IJA-57-481.PMC3821265.pdf
Available from: http://www.frca.co.uk/article.aspx?articleid=100390.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/IJA-57-481.PMC3821265.pdf
Available from: http://ebookbrowse.com/ anaesthesia-gas-monitoring-evolution-of-a-de-facto-standard-of- care-pdf-d385419618.,Non-OADS,/arxiv_data1/oa_pdf/89/bd/IJA-57-481.PMC3821265.pdf
Available from: http://www.molecularproducts.com/products/eo2.26p100n11/eo2-26/details.,Non-OADS,/arxiv_data1/oa_pdf/18/2e/IJA-57-489.PMC3821266.pdf
Available from: http://www.bbb.co.uk/schools/gcsebitesize/ science/edexcel_pre_2011/oneearth/usefulproductsrev2.,Non-OADS,/arxiv_data1/oa_pdf/18/2e/IJA-57-489.PMC3821266.pdf
Available from: http://www.bocmedical.co.uk.,Non-OADS,/arxiv_data1/oa_pdf/18/2e/IJA-57-489.PMC3821266.pdf
Ravishankar M. http://www.capnography.com/Circuits/breathing circuits.html# Totally closed system.,Non-OADS,/arxiv_data1/oa_pdf/b1/61/IJA-57-516.PMC3821269.pdf
Available from: http://www.anzca.edu.au/ resources/professional-documents/ps31.html.,Non-OADS,/arxiv_data1/oa_pdf/22/f1/IJA-57-533.PMC3821271.pdf
Available from: http://www.update.anaesthesiologists.org/2008/12/01/anaesthetic-gas-scavenging/.,Non-OADS,/arxiv_data1/oa_pdf/22/f1/IJA-57-533.PMC3821271.pdf
Available from: https://www.osha.gov/ Publications/3258-08N-2006-English.html.,Non-OADS,/arxiv_data1/oa_pdf/81/ca/IJA-57-541.PMC3821272.pdf
Available from: http://new.paho.,Non-OADS,/arxiv_data1/oa_pdf/81/ca/IJA-57-541.PMC3821272.pdf
Available  from: http://www.agih.com.br/adm_agi/arquivos/ver_arquivo.php?id_arquivo=157 [Last accessed on 2013 May 28].,Non-OADS,/arxiv_data1/oa_pdf/81/ca/IJA-57-541.PMC3821272.pdf
Available from: http://dhh.louisiana.gov/assets/oph/Center -PHCH/Center -CH/infectious-epi/EpiManual/ DisinfectionSterilization.pdf.,OADS,/arxiv_data1/oa_pdf/81/ca/IJA-57-541.PMC3821272.pdf
Available from: http://www.aana.com/resources2/ professionalpractice/Documents/PPM%20Infection%20Control%20Guide.pdf.,Non-OADS,/arxiv_data1/oa_pdf/81/ca/IJA-57-541.PMC3821272.pdf
Available from: http://data.worldbank.,OADS,/arxiv_data1/oa_pdf/5e/65/ATM-8-181.PMC3821275.pdf
Available from: http://www.abp.,Non-OADS,/arxiv_data1/oa_pdf/5e/65/ATM-8-181.PMC3821275.pdf
Available from: http://esa.un.org/wpp/Excel‑Data/population.,OADS,/arxiv_data1/oa_pdf/5e/65/ATM-8-181.PMC3821275.pdf
"Available from: http://www.health.nsw.gov.au, August 30, 2013.",Non-OADS,/arxiv_data1/oa_pdf/6c/1d/ATM-8-183.PMC3821276.pdf
6. http://www.ahrq.gov/professionals/education/curriculum‑ tools/cusptoolkit/index.html [Cited on 2013 Jun 10].,Non-OADS,/arxiv_data1/oa_pdf/6c/1d/ATM-8-183.PMC3821276.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/f0/0b/ATM-8-186.PMC3821277.pdf
Available from:  http://www.nice.org.uk/page.aspx?o_107650.,Non-OADS,/arxiv_data1/oa_pdf/b0/e3/ATM-8-197.PMC3821278.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/b0/e3/ATM-8-197.PMC3821278.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/b0/e3/ATM-8-197.PMC3821278.pdf
Available from: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/79/fb/ATM-8-204.PMC3821279.pdf
Available from: http://www.nccn.org [Last accessed on 2013  May 14].,Non-OADS,/arxiv_data1/oa_pdf/79/fb/ATM-8-204.PMC3821279.pdf
Available from: http://www.senko.co.kr/ contents/product/product19.html?sm=3_19.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/ATM-8-214.PMC3821281.pdf
Available  from: http://www.ktclearinghouse.ca/cebm/practise/ca/ calculators/statscalc.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/ATM-8-214.PMC3821281.pdf
Available from: http://www.bigstory.ap.org/article/ saudi‑arabia‑bans‑smoking‑most‑public‑places.,Non-OADS,/arxiv_data1/oa_pdf/c8/09/ATM-8-214.PMC3821281.pdf
Highlights from Population Census 1431AH (2010); Central  department of statistics and information; Kingdom of Saudi  Arabia; from URL: http://www.cdsi.gov.sa/2010‑07‑31‑07‑00‑05/cat_view/31‑/138—/342—1431‑2010/300—/343–/310.,OADS,/arxiv_data1/oa_pdf/1c/22/ATM-8-224.PMC3821283.pdf
Highlights from demographics survey 1428AH (2007); Central  department of statistics and information; Kingdom of Saudi Arabia;  from: URL: http://www.cdsi.gov.sa/socandpub/manpower/ cat_view/37—/43—/77—1428 [Last accessed on 2013 April 28].,OADS,/arxiv_data1/oa_pdf/1c/22/ATM-8-224.PMC3821283.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/ id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/93/49/ATM-8-231.PMC3821285.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Influenza SAM (H7) vaccine A Hekele et al 7 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/42/b5/emi201354a.PMC3821287.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Anti-inflammatory drugs to treat influenza A (H1N1) infection G Sharma et al 9 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/90/5e/emi201352a.PMC3821288.pdf
Available at http://www.chinacdc.cn/jkzt/crb/ rgrgzbxqlg_5295/rgrqlgyp/201305/t20130503_80728.htm (accessed 1 July 2013).,Non-OADS,/arxiv_data1/oa_pdf/12/4b/emi201350a.PMC3821289.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0Novel H7N9 avian influenza virus-infected mice Z Zhu et al 7 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/12/4b/emi201350a.PMC3821289.pdf
2007; Walterfang The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/06/c9/S003329171300024Xa.PMC3821374.pdf
Subjects FEP A total of 19 subjects were recruited through the South London and Maudsley National Health Service Trust (http://www.slam.nhs.uk).,Non-OADS,/arxiv_data1/oa_pdf/06/c9/S003329171300024Xa.PMC3821374.pdf
"SVM Each subject ’s data (segmented GM images, FA skeletons, HSCT contrast images, orthogonally coded genotype data or CVLT-II score vectors) were entered separately into SVMs (Burges, 1998) as implemented in the PROBID software package (http://www.brainmap.",OADS,/arxiv_data1/oa_pdf/06/c9/S003329171300024Xa.PMC3821374.pdf
Supplementary material For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S003329171300024X.,Non-OADS,/arxiv_data1/oa_pdf/06/c9/S003329171300024Xa.PMC3821374.pdf
© Cambridge University Press 2013 doi:10.1017/S003329171300038XORIGINAL ARTICLE The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/e3/34/S003329171300038Xa.PMC3821375.pdf
Supplementary material For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S003329171300038X.2682 D. Freeman et al.,Non-OADS,/arxiv_data1/oa_pdf/e3/34/S003329171300038Xa.PMC3821375.pdf
© Cambridge University Press 2013 doi:10.1017/S0033291713000342ORIGINAL ARTICLE The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/53/cf/S0033291713000342a.PMC3821376.pdf
"Available from: http://dx.doi.org/10.1155/2013/580596,Accessed 3 May 2013.",Non-OADS,/arxiv_data1/oa_pdf/34/33/NES-123-792.PMC3821380.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813000447 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.The written permission of Cambridge University Press must be obtained for commercial re-use.,Non-OADS,/arxiv_data1/oa_pdf/ae/98/S0950268813000447a.PMC3821399.pdf
Climate statistics: monthly mean temperature (http://www.data.jma.go.jp/obd/stats/etrn/view/monthly_s3_en.php?block_no=47817&view=1).,OADS,/arxiv_data1/oa_pdf/ae/98/S0950268813000447a.PMC3821399.pdf
Population census [in Japanese](http://www.e-stat.go.jp/SG1/estat/eStatTopPortal.do).,OADS,/arxiv_data1/oa_pdf/ae/98/S0950268813000447a.PMC3821399.pdf
Family income and expenditure sur- vey [in Japanese] (http://www.e-stat.go.jp/SG1/estat/Vector density for the Nagasaki outbreak 2621,Non-OADS,/arxiv_data1/oa_pdf/ae/98/S0950268813000447a.PMC3821399.pdf
© Cambridge University Press 2013 doi:10.1017/S0950268813000563 The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.,Non-OADS,/arxiv_data1/oa_pdf/02/dc/S0950268813000563a.PMC3821400.pdf
(http://www.picornaviridae.com/ enterovirus/enterovirus.htm).,Non-OADS,/arxiv_data1/oa_pdf/02/dc/S0950268813000563a.PMC3821400.pdf
Guidelines for environmental surveillance of poliovirus circulation (http://www.who.int/vaccines-documents/DocsPDF03/www737.pdf).,Non-OADS,/arxiv_data1/oa_pdf/02/dc/S0950268813000563a.PMC3821400.pdf
"22, March 2012: (http://www.euro.who.int/__data/assets/pdf_ ﬁle/0009/ 160758/Epi_Brief_Issue_22.pdf).",Non-OADS,/arxiv_data1/oa_pdf/02/dc/S0950268813000563a.PMC3821400.pdf
"It has been estimated that the crude incidence of SSIs in France, between 1996 and The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence <http://creativecommons.org/licenses/by-nc-sa/3.0/>.",Non-OADS,/arxiv_data1/oa_pdf/fb/0a/S0950268813000253a.PMC3821401.pdf
(http://www.easac.eu/ﬁleadmin/PDF_s/reports_statements/Healthcare- associated.pdf).,Non-OADS,/arxiv_data1/oa_pdf/fb/0a/S0950268813000253a.PMC3821401.pdf
(http://www.invs.sante.fr/publications/2008/iso_raisin/iso_raisin_rapport.pdf).,Non-OADS,/arxiv_data1/oa_pdf/fb/0a/S0950268813000253a.PMC3821401.pdf
December 2009 (http://www.invs.sante.fr/publications/2009/iso_raisin/iso_raisin_2007.pdf).,Non-OADS,/arxiv_data1/oa_pdf/fb/0a/S0950268813000253a.PMC3821401.pdf
Methodological guide for economic evaluation ofhealthcare strategies (http://www.ispor.org/peguidelines/source/PE%20Guide_2003.pdf).,Non-OADS,/arxiv_data1/oa_pdf/fb/0a/S0950268813000253a.PMC3821401.pdf
"23 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Prostate-specific antigen and prostate-specific antigen  density cutoff points among Indonesian population   suspected for prostate cancer Ahmad Anies Shahab, Doddy M. Soebadi, Wahjoe Djatisoesanto, Sunaryo Hardjowijoto, Soetojo Soetojo,   Lukman Hakim Department of Urology, Soetomo Hospital, Airlangga University School of Medicine, Surabaya, Indonesia Purpose:  Racial differences exist in the incidence of prostate cancer (PCa).",Non-OADS,/arxiv_data1/oa_pdf/d9/0b/pi-1-1-6_23-30.PMC3821515.pdf
"Keywords:  Prostate neoplasms, Prostate-specific antigen, Prostate specific antigen density, IndonesiaProstate Int 2013;1(1):23-30 • http://dx.doi.org/10.12954/PI.12003Original Article Corresponding author:  Doddy M. Soebadi Department of Urology, Soetomo Hospital, Airlangga University School of Medicine, Surabaya 60286, Indonesia   E-mail: dmsoebadi@yahoo.com  / Tel: +62-31-5017404  / Fax: +62-31-5024971 Submitted: 12 September 2012  / Accepted after revision: 31 January 2013INTRODUCTION Prostate cancer (PCa) is the most common estimated cancer  among men.",Non-OADS,/arxiv_data1/oa_pdf/d9/0b/pi-1-1-6_23-30.PMC3821515.pdf
PSA  and PSAD  cutoff  points  for indonesian  men suspected  for prostate  cancer 24PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12003The choice of a PSA threshold or cut point above which one  would recommend further evaluation with prostate biopsy to  rule out PCa is controversial.,Non-OADS,/arxiv_data1/oa_pdf/d9/0b/pi-1-1-6_23-30.PMC3821515.pdf
1 / No.1 / March 2013 25PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12003ROC curve was 0.778 for PSA and 0.734 for PSAD.,OADS,/arxiv_data1/oa_pdf/d9/0b/pi-1-1-6_23-30.PMC3821515.pdf
PSA  and PSAD  cutoff  points  for indonesian  men suspected  for prostate  cancer 26PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12003PSA cutoff point and GS ( P=0.893).,Non-OADS,/arxiv_data1/oa_pdf/d9/0b/pi-1-1-6_23-30.PMC3821515.pdf
"1 / No.1 / March 2013 27PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12003specific causes of PCa initiation and progression are not yet  known, considerable evidence suggests that both genetic and  environment play a role in the origin and evolution of this  disease [11].",Non-OADS,/arxiv_data1/oa_pdf/d9/0b/pi-1-1-6_23-30.PMC3821515.pdf
"PSA  and PSAD  cutoff  points  for indonesian  men suspected  for prostate  cancer 28PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12003 In our study, we defined PSA 6.95 ng/mL as the best cutoff  point to detect PCa (sensitivity 97.8%, specificity 42.2%, PPV  13.5%).",Non-OADS,/arxiv_data1/oa_pdf/d9/0b/pi-1-1-6_23-30.PMC3821515.pdf
1 / No.1 / March 2013 29PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12003statistical assessment.,Non-OADS,/arxiv_data1/oa_pdf/d9/0b/pi-1-1-6_23-30.PMC3821515.pdf
PSA  and PSAD  cutoff  points  for indonesian  men suspected  for prostate  cancer 30PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.1200320.,Non-OADS,/arxiv_data1/oa_pdf/d9/0b/pi-1-1-6_23-30.PMC3821515.pdf
"1 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Prostate International , an international academic forum  on prostate diseases Choung-Soo Kim Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, KoreaProstate Int 2013;1(1):1 • http://dx.doi.org/10.12954/PI.13001Preface The Asian Pacific Prostate Society (APPS) was established in 2011 to study prostatic diseases,  such as prostate cancer, benign prostatic hyperplasia, prostatitis, etc., in Asian patients who have  different pathobiology from Western patients.",Non-OADS,/arxiv_data1/oa_pdf/d3/ba/pi-1-1-1_1.PMC3821516.pdf
"10 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Androgen receptor coactivator p120 subtype β is highly  expressed in prostate cancer Kazumichi Muramatsu, Hiroshi Matsui, Yoshitaka Sekine, Hidekazu Koike, Yasuhiro Shibata, Kazuto Ito,   Kazuhiro Suzuki Department of Urology, Gunma University Graduate School of Medicine, Maebashi, Japan Purpose:  The β form of p120 is reported to be a strong coactivator of the androgen receptor.",Non-OADS,/arxiv_data1/oa_pdf/d6/f6/pi-1-1-4_10-15.PMC3821517.pdf
"Keywords:  Androgen receptor, Nuclear coactivator, Prostatic neoplasmsProstate Int 2013;1(1):10-15 • http://dx.doi.org/10.12954/PI.12004Original Article Corresponding author:  Kazuhiro Suzuki Department of Urology, Gunma University Graduate School of Medicine, 39-22 Showa-machi 3-chome, Maebashi 371-851 1, Japan   E-mail: kazu@gunma-u.ac.jp / Tel: +81-27-220-8300 / Fax: +81-27-220-8318 Submitted: 7 October 2012  / Accepted after revision: 3 February 2013INTRODUCTION Prostate cancer is one of the most common types of cancer,  and is second only to lung cancer as the most common non - cutaneous cancer diagnosed in males in the United States [1].",Non-OADS,/arxiv_data1/oa_pdf/d6/f6/pi-1-1-4_10-15.PMC3821517.pdf
"1 / No.1 / March 2013 11PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12004droxyflutamide [9], and potentiation of various AR activations  [10].",Non-OADS,/arxiv_data1/oa_pdf/d6/f6/pi-1-1-4_10-15.PMC3821517.pdf
p120  and prostate  cancer 12PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.120043.,Non-OADS,/arxiv_data1/oa_pdf/d6/f6/pi-1-1-4_10-15.PMC3821517.pdf
"1 / No.1 / March 2013 13PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12004 Next, we compared expression levels of p120 α and p120 β,  and β/α ratios among three groups.",OADS,/arxiv_data1/oa_pdf/d6/f6/pi-1-1-4_10-15.PMC3821517.pdf
p120  and prostate  cancer 14PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12004The previous study showed a PCR product profile after 40  cycles; thus we suggest that the quantification method might  be the reason for the discrepancy.,Non-OADS,/arxiv_data1/oa_pdf/d6/f6/pi-1-1-4_10-15.PMC3821517.pdf
1 / No.1 / March 2013 15PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.1200411.,Non-OADS,/arxiv_data1/oa_pdf/d6/f6/pi-1-1-4_10-15.PMC3821517.pdf
"42 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Early experience photoselective vaporisation of the   prostate using the 180W lithium triborate and   comparison with the 120W lithium triborate laser Nicholas A. Campbell, Amanda S. J. Chung1, Peter D. Yoon1, Isaac Thangasamy1, Henry H. Woo1 Department of Urology, Westmead Hospital University of Sydney, Sydney, Australia 1Discipline of Surgery, Sydney Adventist Hospital Clinical School, University of Sydney, Sydney, Australia Purpose:  There is a paucity of information on the clinical efficacy and safety of the photoselective vaporization (PVP) of the prostate  using the 180W lithium triborate (LBO) laser.",Non-OADS,/arxiv_data1/oa_pdf/28/82/pi-1-1-9_42-45.PMC3821518.pdf
"Keywords:  Prostatic hyperplasia, Photoselective vaporisation of prostate, Lithium triborate laser, Transurethral resection of prostateProstate Int 2013;1(1):42-45 • http://dx.doi.org/10.12954/PI.12006Original Article Corresponding author:  Henry H. Woo Discipline of Surgery, Sydney Adventist Hospital Clinical School, University of Sydney, 185 Fox Valley Road, Wahroonga, NSW 2076, Australia   E-mail: hwoo@urologist.net.au / Tel: +62-2-9473-8765 / Fax: +62-2-9473-8969 Submitted: 26 November 2012  / Accepted after revision: 4 February 2013INTRODUCTION Photoselective vaporisation of the prostate (PVP) has become  an established form of treatment for benign prostatic obstruc - tion and to date has demonstrated equivalence to transurethral  resection of the prostate in randomised controlled trials [1-4].",Non-OADS,/arxiv_data1/oa_pdf/28/82/pi-1-1-9_42-45.PMC3821518.pdf
1 / No.1 / March 2013 43PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12006 There is little data available on the performance of the  180W LBO laser.,OADS,/arxiv_data1/oa_pdf/28/82/pi-1-1-9_42-45.PMC3821518.pdf
Statistical analyses were performed using the Statistical  Online Computational Resource (http://www.socr.ucla.edu).,OADS,/arxiv_data1/oa_pdf/28/82/pi-1-1-9_42-45.PMC3821518.pdf
Prostate  photoselective  vaporization  using  the 180W  lithium  triborate  laser 44PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12006treated with either the 120W or 180W LBO laser.,Non-OADS,/arxiv_data1/oa_pdf/28/82/pi-1-1-9_42-45.PMC3821518.pdf
1 / No.1 / March 2013 45PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12006the time taken.,OADS,/arxiv_data1/oa_pdf/28/82/pi-1-1-9_42-45.PMC3821518.pdf
Available from: http://www.auanet.org/content/clinical- practice-guidelines/clinical-guidelines.cfm?sub=bph.,Non-OADS,/arxiv_data1/oa_pdf/28/82/pi-1-1-9_42-45.PMC3821518.pdf
"31 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Robotic-assisted prostatectomy and open radical   retropubic prostatectomy for locally-advanced   prostate cancer: multi-institution comparison of   oncologic outcomes Anup A. Vora1,2, Daniel Marchalik1,2, Keith J. Kowalczyk2, Hannah Nissim1, Gaurav Bandi2, Kevin G. McGeagh2,  John H. Lynch2, S. Reza Ghasemian1, Mohan Verghese1, Krishnan Venkatesan1, Phillip Borges3,  Edward M. Uchio4, Jonathan J. Hwang1 1Department of Urology, Washington Hospital Center, Washington, DC, USA 2Department of Urology, Georgetown University Hospital, Washington, DC, USA 3Department of Urology, Washington DC Veterans Affairs Medical Center, Washington, DC, USA 4Department of Surgery, Yale University School of Medicine, New Haven, CT, USA Purpose:  Robotic-assisted laparoscopic prostatectomy (RALP) offers reportedly comparable oncologic outcomes for localized disease  compared with open radical retropubic prostatectomy (ORRP).",Non-OADS,/arxiv_data1/oa_pdf/ff/af/pi-1-1-7_31-36.PMC3821519.pdf
"Keywords:  Prostate neoplasms, Oncologic outcomes, ProstatectomyProstate Int 2013;1(1):31-36 • http://dx.doi.org/10.12954/PI.12001Original Article Corresponding author:  Anup A. Vora Department of Urology, Georgetown University - Washington Hospital Center, 3401 38th St NW, Suite 915, Washington, DC 20016, USA   E-mail: anupvora@gmail.com / Tel: +1-202-904-0492 / Fax: +1-202-444-75737 Submitted: 10 September 2012  / Accepted after revision: 21 January 2013INTRODUCTION Prostate cancer (PCa) is the most commonly diagnosed solid malignancy in men and the second leading cause of male  cancer related death in the United States [1].",Non-OADS,/arxiv_data1/oa_pdf/ff/af/pi-1-1-7_31-36.PMC3821519.pdf
Robotic  prostatectomy  versus  open  in T3 disease 32PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12001Table 1.,Non-OADS,/arxiv_data1/oa_pdf/ff/af/pi-1-1-7_31-36.PMC3821519.pdf
1 / No.1 / March 2013 33PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12001 Table 2 compares oncologic outcomes of our initial 300  RALP vs. the latter 700.,Non-OADS,/arxiv_data1/oa_pdf/ff/af/pi-1-1-7_31-36.PMC3821519.pdf
"Robotic  prostatectomy  versus  open  in T3 disease 34PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12001DISCUSSION Historically, surgery has not been the preferred approach in  the treatment locally advanced PCa due to the risk of subclin - ical metastatic disease and elevated rates of positive surgical  margins.",Non-OADS,/arxiv_data1/oa_pdf/ff/af/pi-1-1-7_31-36.PMC3821519.pdf
"1 / No.1 / March 2013 35PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12001after the learning curve for robotic surgery has been reached,  surgical outcomes improve.",Non-OADS,/arxiv_data1/oa_pdf/ff/af/pi-1-1-7_31-36.PMC3821519.pdf
Available from: http://www.nytimes.,Non-OADS,/arxiv_data1/oa_pdf/ff/af/pi-1-1-7_31-36.PMC3821519.pdf
Robotic  prostatectomy  versus  open  in T3 disease 36PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12001tomy versus external-beam radiotherapy for patients with  high-risk prostate cancer.,Non-OADS,/arxiv_data1/oa_pdf/ff/af/pi-1-1-7_31-36.PMC3821519.pdf
"37 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Efficacy and safety of low-dose anticholinergics to treat  men with lower urinary tract symptoms with overactive  bladder: a retrospective study based on real life practice Kyung Kgi Park, Seung Hwan Lee1, Byung Ha Chung1, Su Jin Kim2, Cheol Kwak3, Hwan Cheol Son4,  Sae Woong Kim2, Ji Youl Lee2 Department of Urology, Jeju National University Hospital, Jeju National University College of Medicine, Jeju, Korea 1Department of Urology, Gangnam Severance Hospital, Yonsei University Health System, Seoul, Korea 2Department of Urology, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea 3Department of Urology, Seoul National University College of Medicine, Seoul, Korea 4Department of Urology, SMG-SNU Boramae Medical Center, Seoul, Korea Purpose:  To investigate whether combination treatment using an α-blocker and 2 mg of tolterodine could improve the International  Prostate Symptom Score (IPSS) as much as α-blocker and 4 mg of tolterodine without voiding difficulties in real life practice.",Non-OADS,/arxiv_data1/oa_pdf/9d/66/pi-1-1-8_37-41.PMC3821520.pdf
"Keywords:  Lower urinary tract symptoms, Adrenergic alpha-antagonist, Overactive urinary bladder, Cholinergic antagonistsProstate Int 2013;1(1):37-41 • http://dx.doi.org/10.12954/PI.12005Original Article Corresponding author:  Ji Youl Lee Department of Urology, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Korea   E-mail: uroljy@catholic.ac.kr  / Tel: +82-2-2258-6227  / Fax: +82-2-599-7839 Submitted: 24 November 2012  / Accepted after revision: 2 February 2013INTRODUCTION Lower urinary tract symptoms (LUTS) and overactive blad - der (OAB) are highly prevalent in the adult population, and  the prevalence increases along with age [1,2].",Non-OADS,/arxiv_data1/oa_pdf/9d/66/pi-1-1-8_37-41.PMC3821520.pdf
"Efficacy  and safety  of low-dose  anticholinergics  in men with OAB 38PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12005 Recently, several randomized trial have revealed that mus - carinic receptor antagonists are effective and safe to be used  in male OAB patients [6-8].",Non-OADS,/arxiv_data1/oa_pdf/9d/66/pi-1-1-8_37-41.PMC3821520.pdf
1 / No.1 / March 2013 39PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12005nificant difference in the change in IPSS storage subscores  and QoL between groups II and III (Fig.,Non-OADS,/arxiv_data1/oa_pdf/9d/66/pi-1-1-8_37-41.PMC3821520.pdf
Efficacy  and safety  of low-dose  anticholinergics  in men with OAB 40PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12005DISCUSSION The combination therapy with 2 mg of tolterodine and an  α-blocker was effective and had a lower rate of adverse events  than the one combining 4 mg tolterodine and an α-blocker.,Non-OADS,/arxiv_data1/oa_pdf/9d/66/pi-1-1-8_37-41.PMC3821520.pdf
1 / No.1 / March 2013 41PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12005OAB and patients who present severe storage symptoms and  want to minimize dry mouth symptom and voiding difficulty.,Non-OADS,/arxiv_data1/oa_pdf/9d/66/pi-1-1-8_37-41.PMC3821520.pdf
"2 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Letter to the editor Byung Ha Chung Department of Urology, Yonsei University College of Medicine, Seoul, KoreaProstate Int 2013;1(1):2 • http://dx.doi.org/10.12954/PI.13002Letter I am very pleased to launch the Prostate International (PI) in 2013, which is also the third year of  Asian Pacific Prostate Society (APPS) establishment.",Non-OADS,/arxiv_data1/oa_pdf/04/db/pi-1-1-2_2.PMC3821521.pdf
"16 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL Outcomes and predictors of localized or locally-advanced  prostate cancer treated by radiotherapy in Indonesia Wempy Supit, Chaidir Arif Mochtar, Rachmat Budi Santoso1, Rainy Umbas Department of Urology, Cipto Mangunkusumo Hospital, University of Indonesia Faculty of Medicine, Jakarta, Indonesia 1Department of Urology, Dharmais Hospital National Cancer Center, Jakarta, Indonesia Purpose:  Presently there is no published data on the outcomes of localized or locally-advanced prostate cancer (PCa) treated by  external-beam radiotherapy (RT) in Indonesia.",Non-OADS,/arxiv_data1/oa_pdf/f7/dc/pi-1-1-5_16-22.PMC3821522.pdf
"Keywords:  Prostatic neoplasms, Radiotherapy, SurvivalProstate Int 2013;1(1):16-22 • http://dx.doi.org/10.12954/PI.12012Original Article Corresponding author:  Rainy Umbas Department of Urology, Cipto Mangunkusumo Hospital, University of Indonesia Faculty of Medicine, Jl Salemba Raya No 6, Jakarta 1 1430, Indonesia   E-mail: rainy.umbas@gmail.com / Tel: +62-21-3912681 / Fax:+62-21-3145592 Submitted: 13 December 2012  / Accepted after revision: 4 February 2013INTRODUCTION Prostate cancer (PCa) is the second most frequently diag - nosed cancer of men and the fifth most common cancer  overall cancer worldwide.",Non-OADS,/arxiv_data1/oa_pdf/f7/dc/pi-1-1-5_16-22.PMC3821522.pdf
"1 / No.1 / March 2013 17PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12012diet and lifestyle in developing Asian countries [3,4].",Non-OADS,/arxiv_data1/oa_pdf/f7/dc/pi-1-1-5_16-22.PMC3821522.pdf
Outcomes  of radiotherapy  for localized  prostate  cancer  in Indonesia 18PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12012received 70 Gy or more using 3D-CRT/IMRT (15.6%).,OADS,/arxiv_data1/oa_pdf/f7/dc/pi-1-1-5_16-22.PMC3821522.pdf
"1 / No.1 / March 2013 19PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12012high-risk P=0.014, overall BFS comparisons P=0.016.",Non-OADS,/arxiv_data1/oa_pdf/f7/dc/pi-1-1-5_16-22.PMC3821522.pdf
Outcomes  of radiotherapy  for localized  prostate  cancer  in Indonesia 20PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12012RT+HT resulted in similar long-term cancer control for high- risk PCa [7].,Non-OADS,/arxiv_data1/oa_pdf/f7/dc/pi-1-1-5_16-22.PMC3821522.pdf
1 / No.1 / March 2013 21PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.12012REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f7/dc/pi-1-1-5_16-22.PMC3821522.pdf
Available from: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/f7/dc/pi-1-1-5_16-22.PMC3821522.pdf
Outcomes  of radiotherapy  for localized  prostate  cancer  in Indonesia 22PROSTATE INTERNATIONAL http://dx.doi.org/10.12954/PI.1201224.,Non-OADS,/arxiv_data1/oa_pdf/f7/dc/pi-1-1-5_16-22.PMC3821522.pdf
"3 Copyright © 2013 Asian Pacific Prostate Society (APPS) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.http://p-international.org/ pISSN: 2287-8882 • eISSN: 2287-903X PR O S T A T E   INTERNATIONAL MicroRNAs in prostate cancer Won Tae Kim, Wun-Jae Kim Department of Urology, Chungbuk National University College of Medicine, Cheongju, Korea MicroRNAs (miRNAs) are made up of -22 endogenous nucleotides and are small, noncoding RNAs that are important regulators of  gene expression at the posttranscriptional level by degrading or repressing target miRNAs.",Non-OADS,/arxiv_data1/oa_pdf/55/fe/pi-1-1-3_3-9.PMC3821523.pdf
"Keywords:  Prostatic neoplasms, MicroRNAs, Biological markersProstate Int 2013;1(1):3-9 • http://dx.doi.org/10.12954/PI.12011Review Article Corresponding author:  Wun-Jae Kim Department of Urology, Chungbuk National University College of Medicine, 52 Naesudong-ro, Heungdeok-gu, Cheongju 361-804, Korea   E-mail: wjkim@chungbuk.ac.kr  / Tel: +82-43-269-6371  / Fax: +82-43-269-6144 Submitted: 12 December 2012  / Accepted after revision: 13 December 2012INTRODUCTION Prostate cancer is the most common form of cancer for males  in Western countries, and the incidence is increasing in many  of those countries [1].",Non-OADS,/arxiv_data1/oa_pdf/55/fe/pi-1-1-3_3-9.PMC3821523.pdf
"http://dx.doi.org/10.12954/PI.12011Kim, et al.",OADS,/arxiv_data1/oa_pdf/55/fe/pi-1-1-3_3-9.PMC3821523.pdf
1 / No.1 / March 2013 http://dx.doi.org/10.12954/PI.12011 5PROSTATE INTERNATIONAL duced after nephrectomy.,Non-OADS,/arxiv_data1/oa_pdf/55/fe/pi-1-1-3_3-9.PMC3821523.pdf
"http://dx.doi.org/10.12954/PI.12011Kim, et al.",OADS,/arxiv_data1/oa_pdf/55/fe/pi-1-1-3_3-9.PMC3821523.pdf
"1 / No.1 / March 2013 http://dx.doi.org/10.12954/PI.12011 7PROSTATE INTERNATIONAL Hence, miRNAs can be useful clinical diagnostic and prog - nostic biomarkers.",Non-OADS,/arxiv_data1/oa_pdf/55/fe/pi-1-1-3_3-9.PMC3821523.pdf
"http://dx.doi.org/10.12954/PI.12011Kim, et al.",OADS,/arxiv_data1/oa_pdf/55/fe/pi-1-1-3_3-9.PMC3821523.pdf
1 / No.1 / March 2013 http://dx.doi.org/10.12954/PI.12011 9PROSTATE INTERNATIONAL in human prostate tumours.,Non-OADS,/arxiv_data1/oa_pdf/55/fe/pi-1-1-3_3-9.PMC3821523.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0f/c6/ccid-6-263.PMC3821542.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2013:6 263–271Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  263OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S4927 3The use of local concentrated heat versus topical   acyclovir for a herpes labialis outbreak: results   of a pilot study under real life conditions Johannes Wohlrab1 Franziska Voß2 Christian Müller2 lars C Brenn2 1Department of Dermatology   and Venereology, Martin luther  University of halle-Wittenberg, halle,    2Department of Medical science and   Operations, riemser Pharma gmbh,    greifswald, germany Correspondence: Johannes Wohlrab   Department of Dermatology and   Venereology, Martin luther University   of halle-Wittenberg, ernst-grube-   straße 40, D-06097 halle, germany   T el +49 345 557 3933   Fax +49 345 557 3944   email johannes.wohlrab@medizin.uni- halle.d eBackground:  Frequent outbreak of herpes labialis can affect quality of life by prodromes  like burning, itching, and swelling.",Non-OADS,/arxiv_data1/oa_pdf/0f/c6/ccid-6-263.PMC3821542.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/0f/c6/ccid-6-263.PMC3821542.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0f/c6/ccid-6-263.PMC3821542.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/0c/a8/cpaa-5-161.PMC3821543.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Pharmacology: Advances and Applications 2013:5 161–166Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  161CAse seRIesopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S5368 1High-dose, short-interval daptomycin regimen  was safe and well tolerated in three patients   with chronic renal failure Kaori Yabuno1,2,* Masafumi seki1,* Koji Miyawaki1,2 Y oshihiro Miwa2 Kazunori T omono1 1Division of Infection Control and  Prevention, 2Department of Pharmacy,   Osaka University Hospital, Osaka,   Japan *These authors contributed equally   to this work Correspondence: Masafumi seki   Division of Infection Control and  Prevention, Osaka University Hospital,  2-15 Yamadaoka, suita,   Osaka 565-0871, Japan   Tel +81 6 6879 5093   Fax +81 6 6879 5094   email seki@hp-infect.med.osaka-u.ac.j pBackground:  The recommended daptomycin dosage is 4 or 6 mg/kg/day for the treatment  of complicated skin and soft tissue infections or for Staphylococcus aureus  bacteremia, endo - carditis, and osteomyelitis.",Non-OADS,/arxiv_data1/oa_pdf/0c/a8/cpaa-5-161.PMC3821543.pdf
"Available from: http://www.fda.gov/Drugs/ DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders /  ucm220273.ht m. Accessed October 4, 2013.",Non-OADS,/arxiv_data1/oa_pdf/0c/a8/cpaa-5-161.PMC3821543.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/0c/a8/cpaa-5-161.PMC3821543.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/0c/a8/cpaa-5-161.PMC3821543.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/56/copd-8-537.PMC3821544.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 537–544International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  537OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S5021 3home-based pulmonary rehabilitation in patients  with chronic obstructive pulmonary disease:   a randomized clinical trial Fernanda Dultra Dias1 luciana Maria Malosá  sampaio1 graziela alves da silva1 Évelim lF Dantas gomes1 eloisa sanches Pereira   do nascimento1 Vera lucia santos alves2 roberto stirbulov2 Dirceu Costa1 1Post graduate Program in  rehabilitation sciences, nove de Julho  University – Un InOVe, são Paulo,   Brazil; 2Pneumology Clinic at santa  Casa de Misericórdia de são Paulo  (aMe), são Paulo, Brazil Correspondence: Dirceu Costa   Post graduate Program in rehabilitation  sciences, nove de Julho University,  UnInOVe, lares P, 109 Barra Funda, são  Paulo - sP 01156-050, Brazil   Tel +55 113 665 9871   email dcosta@uninove.b rIntroduction:  Pulmonary rehabilitation (PR) is a multidisciplinary program of care for  patients with chronic obstructive pulmonary disease (COPD) with the goal of improving the  functional capacity and quality of life, as well as maintaining the clinical stability of COPD  sufferers.",Non-OADS,/arxiv_data1/oa_pdf/31/56/copd-8-537.PMC3821544.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/31/56/copd-8-537.PMC3821544.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/56/copd-8-537.PMC3821544.pdf
"Bacteriophage 2013; 3:e25857; http://dx.doi.org/10.4161/bact.25857   *Correspondence to: Jeremy J. Barr;   Email: jeremybarr85@gmail.comWe recently described a novel, non- host-derived, phage-mediated  immunity active at mucosal surfaces, the main site of pathogen entry in metazo - ans.",Non-OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Antimicrob Agents Chemother 2012; 56:6235-42; PMID:23006754; http://dx.doi.org/10.1128/ AAC.00602-12 2.,Non-OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
J Infect Dis 2010;  201:1096-104; PMID:20196657; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Virology  2012; 434:138-42; PMID:23059181; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Science 2012; 337:937-41; PMID:22923574; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Curr Opin Microbiol  2012; 15:57-62; PMID:22177113; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Annu Rev Nutr 2002; 22:283-307; PMID:12055347; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Proc Natl Acad Sci U S A 2013; 110:3229-36; PMID:23391737; http://dx.doi.org/10.1073/ pnas.1218525110 10.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
PLoS Biol  2012; 10:e1001424; PMID:23185130; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Science 2011; 334:255-8; PMID:21998396; http://dx.doi.org/10.1126/science.1209791 12.,Non-OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
J Mol Biol 2006; 359:496-507;  PMID:16631788; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Mucosal Immunol 2008; 1:183-97;  PMID:19079178; http://dx.doi.org/10.1038/ mi.2008.5 15.,Non-OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Immunity 2002; 17:107-15;  PMID:12150896; http://dx.doi.org/10.1016/S1074- 7613(02)00341-2 17.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
FEMS Microbiol Rev 2004; 28:127-81;  PMID:15109783; http://dx.doi.org/10.1016/j.fem - sre.2003.08.001 18.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Aquat Microb Ecol 1997; 13:19- 27; http://dx.doi.org/10.3354/ame013019 19.,Non-OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Environ  Microbiol 2012; 14:1844-54; PMID:22118225;  http://dx.doi.org/10.1111/j.1462-2920.2011.02644.x 20.,Non-OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
J Infect Dis 2010; 201:1096-104; PMID:20196657; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Proc Natl Acad Sci U S A 2012; 109:3962-6;  PMID:22355105; http://dx.doi.org/10.1073/ pnas.1119061109 23.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Nature 2010; 466:334-8; PMID:20631792; http://dx.doi.org/10.1038/nature09199 24.,Non-OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Proc Natl Acad Sci U S A 2012; 109:17621- 6; PMID:23045666; http://dx.doi.org/10.1073/ pnas.1206136109 25.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
PLoS One  2013; 8:e59043; PMID:23536852; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
J Theor Biol 2013; 332:65- 77; PMID:23608631; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
Nature 2013; 499:219-22; PMID:23748443; http://dx.doi.org/10.1038/nature12212 29.,Non-OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
J Bacteriol 2004; 186:3677- 86; PMID:15175280; http://dx.doi.org/10.1128/ JB.186.12.3677-3686.2004 30.,Non-OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
PLoS Genet 2011;  7:e1002149; PMID:21731505; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/ee/68/bact-3-e25857.PMC3821666.pdf
"www.landesbioscience.com Bacteriophage e24697-1Bacteriophage 3:2, e24697; April/May/June 2013; © 2013 Landes Bioscience Meetings Meetings April 2013 1st International Probiotics Prebiotics   and Functional Food CongressApril 11–13, 201Antalya, Turkeywww.ppd2013.org/eng The 7th International Yakult Symposium/   The Intestinal Microbiota and Probiotics:  Exploiting Their Influence on HealthApril 22–23, 2013London, UKwww.yakultsymposium.com 23rd European Congress of Clinical Microbiology   and Infectious DiseasesApril 27–30, 2013Berlin, Germanywww.congrex.ch/eccmid2013.html Positive Strand RNA Viruses April 28–May 3, 2013Boston, MA USAwww.keystonesymposia.org/index.cfm?e=web.Meeting.Program&meetingid=1230 May 2013 Viruses and CellsMay 5–10, 2013Lucca, Italywww.grc.org/programs.aspx?year=2013&program=viruses ASM 113th General Meeting May 18–21, 2013Denver, CO USAwww.gm.asm.org Microbiome and Host Health May 12–14, 2013Lisbon, Portugalhttps://vicinity.picsrv.net/3186/d32221faefee5e21be06cd416883cea0/2886 Probiotics and their Applications May 31–June 1, 2013Hanoi, Vietnamhttp://probioticsconference.comUpcoming meetings Correspondence to: Alexander Sulakvelidze; Email: asulakvelidze@intralytix.com Submitted: 04/04/13; Accepted: 04/04/13Citation: Sulakvelidze A; Upcoming meetings.",Non-OADS,/arxiv_data1/oa_pdf/a9/0a/bact-3-e24697.PMC3821667.pdf
"Bacteriophage 2013; 3:e24697; http://dx.doi.org/10.4161/bact.e24697June 2013 International Scientific Conference on Probiotics   and Prebiotics IPC2013June 11–13, 2013Kosice, Slovakiawww.probiotic-conference.net/Conference ISAPP 2013:   11th Meeting of the International Scientific Association  for Probiotics and Prebiotics, in collaboration  with the New York Academy of Sciences  and the Sackler Institute of Nutrition SciencesJune 12–14, 2013New York, NY USAwww.nyas.org/Events/Detail.aspx?cid=c60ea8d5-44f0-4aaa-a8ff-3e5f008186f6 63rd Annual Conference of the Canadian  Society of MicrobiologistsJune 17–20, 2013Ottawa, Canadawww.csm-scm.org/english/wn_meetings_det.asp?id=44 CRISPR: Evolution, Mechanisms and Infection June 17–19, 2013St.",Non-OADS,/arxiv_data1/oa_pdf/a9/0a/bact-3-e24697.PMC3821667.pdf
"e24697-2 Bacteriophage Volume 3 issue 2July 2013 (Contiuned) ASM Adelaide 2013 July 7–10, 2013Adelaide, Australiawww.theasm.org.au/meetings/asm-adelaide-2013 3rd Viruses of Microbes Meeting July 14–18, 2013Zurich, Switzerlandhttp://www.isvm.org/meetings.html 5th Congress of European Microbiologists July 21–25, 2013Leipzig, Germanywww2.kenes.com/fems2013/pages/home.aspx August 2013 Molecular Genetics of Bacteria and Phages MeetingAugust 6–10, 2013Madison, WI USAwww.union.wisc.edu/phages 20th Biennial Evergreen International Phage Meetings August 4–9, 2013Olympia, WA USAhttp://blogs.evergreen.edu/phage/meetings/2013-2 Society for Industrial Microbiology   and Biotechnology Annual MeetingAugust 11–15, 2013San Diego, CA USAwww.simhq.org/annualSeptember 2013 Probiotics, Prebiotics and New FoodsSeptember 8–10, 2013Rome, Italywww.probiotics-prebiotics-newfood.org/home.php XXIII Biennial Conference on Phage/Virus Assembly September 8–13, 2013Lake Arrowhead, CA USAhttp://pva.scripps.edu Oxford Bacteriophage Conference, Phages 2013 September 10–12, 2013St.",Non-OADS,/arxiv_data1/oa_pdf/a9/0a/bact-3-e24697.PMC3821667.pdf
"Hilda’s College, Oxford UKhttp://lpmhealthcare.com/Phages2013/phagehome.htm ICAAC 2013 September 10–13, 2012Denver, CO USAwww.icaac.org/index.php/scientific-program/meeting-resources/icaac-online October 2013 New Approaches and Concepts in MicrobiologyOctober 14–16, 2013Heidelberg, Germanywww.embo-embl-symposia.org/symposia/2013/EES13-05",Non-OADS,/arxiv_data1/oa_pdf/a9/0a/bact-3-e24697.PMC3821667.pdf
"Commun Integr Biol 2013; 6: e25153; http://dx.doi.org/10.4161/cib.25153*Correspondence to: Anthony N. Imbalzano and Jeffrey A. Nickerson; Email: Anthony.imbalzano@umassmed.edu and Jeffrey.nickerson@umassmed.eduWe recently reported that reducing  the levels of BRG1, the catalytic  subunit of mammalian SWI/SNF chro - matin remodeling enzymes, induces alterations in nuclear shape in a breast epithelial cell line.",Non-OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
Proc Natl Acad Sci USA 2009; 106:2259- 64; PMID:19171905; http://dx.doi.org/10.1073/ pnas.0806420106 21.,OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
Nucleic Acids Res 2009; 37:6019-27; PMID:19696073; http://dx.doi.org/10.1093/nar/ gkp677 22.,Non-OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
Nat Immunol 2008; 9:785-93;  PMID:18500344; http://dx.doi.org/10.1038/ni.1619 24.,Non-OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
Nucleic  Acids Res 2012; 40:7690-704; PMID:22675074;  http://dx.doi.org/10.1093/nar/gks501 25.,Non-OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
Proc Natl Acad Sci USA 2008; 105:19199- 204; PMID:19052240; http://dx.doi.org/10.1073/ pnas.08106341054.,OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
Nat Rev Cancer 2004; 4:677- 87; PMID:15343274; http://dx.doi.org/10.1038/ nrc1430 5.,Non-OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
J Cell Sci  2004; 117:5847-54; PMID:15537831; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
PLoS ONE 2013; 8:e55628; PMID:23405182; http://dx.doi.org/10.1371/journal.pone.0055628 7.,Non-OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
J Cell Sci 2012; 125:2087-93; PMID:22669459; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
Cell 2013; 153:178- 92; PMID:23523135; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
"Genome Res 2013; 23:260- 9; PMID:23152449; http://dx.doi.org/10.1101/ gr.138032.112 11. de la Serna IL, Ohkawa Y, Imbalzano AN.",OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
Nat Rev Genet  2006; 7:461-73; PMID:16708073; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
Nature 2010; 463:474-84;  PMID:20110991; http://dx.doi.org/10.1038/ nature08911 13.,Non-OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
Acta Biochim Biophys Sin (Shanghai) 2012; 44:54- 69; PMID:22194014; http://dx.doi.org/10.1093/ abbs/gmr099 14.,OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
Mol Cell 1999; 3:247-53; PMID:10078207; http://dx.doi.org/10.1016/ S1097-2765(00)80315-9 15.,OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
Cell Res 2011; 21:396-420; PMID:21358755; http://dx.doi.org/10.1038/cr.2011.32 16.,OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
Mol Cell Biol 2011; 31:1512- 27; PMID:21262765; http://dx.doi.org/10.1128/ MCB.00920-10 17.,Non-OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
Cell 2013; 152:248-61; PMID:23332759; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
J Cell Biol  2006; 172:41-53; PMID:16380439; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/56/52/cib-6-e25153.PMC3821668.pdf
" ReseaR ch PaPeR www.landesbioscience.com Bacteriophage e24766-1Bacteriophage 3:2, e24766; a pril/May/June 2013; © 2013 Landes BioscienceReseaR ch PaPeR *Correspondence to: Francisco Rodriguez-Valera; Email: frvalera@umh.es Submitted: 03/21/13; Revised: 04/22/13; Accepted: 04/22/13http://dx.doi.org/10.4161/bact.24766Introduction Marine phages are the most abundant biological entities in the  oceans.",Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
"Acknowledgments This work was supported by projects MAGYK (BIO2008-02444), MICROGEN Programa CONSOLIDER-INGENIO 2010 (CDS2009-00006), (CGL2009-12651-C02-01) from quality regions were clipped using sff_extract (http://bioinf.comav.upv.es/sff_extract/).",OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Sequences were assembled by two dif - ferent assemblers: Geneious v. 5.6.0 (www.geneious.com) (using the default parameters) and MIRA (http://www.chevreux.org/projects_mira.html) to check the consistency of the sequences assembled.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
"Domain predictions in the sequences were performed using the HMMER package 66 (against the Pfam database), the HHpred  server (http://toolkit.tuebingen.mpg.de)67 and the NCBI  Conserved Domains Database.68 Phage annotation was manu - ally inspected, especially those genes initially annotated as hypo - thetical proteins.",OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Curr Opin Microbiol 2003; 6:417-24;  PMID:12941415; http://dx.doi.org/10.1016/S1369- 5274(03)00086-9 2.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Nature 1999; 399:541-8;  PMID:10376593; http://dx.doi.org/10.1038/21119 3.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Nat Rev Microbiol 2009; 7:828-36;  PMID:19834481; http://dx.doi.org/10.1038/nrmi- cro2235 7.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
PLoS Biol 2005; 3:e144; PMID:15828858;  http://dx.doi.org/10.1371/journal.pbio.0030144 8.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Environ Microbiol 2010; 12:3035-56;  PMID:20662890; http://dx.doi.org/10.1111/j.1462-2920.2010.02280.x 9.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Nature 2003; 424:1047-51; PMID:12944965; http://dx.doi.org/10.1038/ nature01929 10.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Environ Microbiol 2013; 15:1356-76;  PMID:23320838; http://dx.doi.org/10.1111/1462- 2920.12053 11.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Environ Microbiol 2002; 4:42-50;  PMID:11966824; http://dx.doi.org/10.1046/j.1462- 2920.2002.00255.x 12.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Mol Ecol 2008; 17:4092-106; PMID:19238708;  http://dx.doi.org/10.1111/j.1365-294X.2008.03883.x 13.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Appl Environ Microbiol 2001; 67:3083-91;  http://dx.doi.org/10.1128/AEM.67.12.5392- 5402.200114.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Appl Environ Microbiol 2005; 71:2813- 23; PMID:15932972; http://dx.doi.org/10.1128/ AEM.71.6.2813-2823.2005 15.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Mol Ecol 2008; 17:4092-106; PMID:19238708;  http://dx.doi.org/10.1111/j.1365-294X.2008.03883.x 16.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Environ Microbiol  2005; 7:649-59; PMID:15819847; http://dx.doi.org/10.1111/j.1462-2920.2005.00733.x 17.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Environ Microbiol  2012; 14:191-206; PMID:21981709; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Proc Natl Acad Sci U S A 2010; 107:16420- 7; PMID:20807744; http://dx.doi.org/10.1073/ pnas.1010732107 20.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Int J Syst Bacteriol  1999; 49:513-9; PMID:10319472; http://dx.doi.org/10.1099/00207713-49-2-513 21.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Arch Microbiol 2000; 173:138-45; PMID:10795685; http://dx.doi.org/10.1007/ s002039900121 22.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
ISME J 2008; 2:1194- 212; PMID:18670397; http://dx.doi.org/10.1038/ ismej.2008.74 23.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Sci  Rep 2012; 2:696; PMID:23019517; http://dx.doi.org/10.1038/srep00696 24.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Virology 1967; 32:723-5;  PMID:18614074; http://dx.doi.org/10.1016/0042-6822(67)90050-525.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
J Virol 2012; 86:13861; PMID:23166261; http://dx.doi.org/10.1128/ JVI.02684-12 26.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Virology 2012; 426:93- 9; PMID:22341309; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Virology 2010; 405:26- 30; PMID:20619867; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Environ  Microbiol 2009; 11:2055-64; PMID:19689706;  http://dx.doi.org/10.1111/j.1462-2920.2009.01927.x 29.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Appl Environ Microbiol 2011; 77:5945-54; PMID:21764969; http://dx.doi.org/10.1128/ AEM.03022-10 30.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
J Bacteriol 2002;  184:4952-61; PMID:12193610; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Biochem Biophys Res Commun  1978; 82:1040-8; PMID:697769; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Methods Enzymol  2003; 370:83-94; PMID:14712636; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
J Mol  Biol 1988; 202:1-10; PMID:3172206; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
J Mol Biol 2007; 366:406-19;  PMID:17174325; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Genome Biol Evol  2012; 4:1360-74; PMID:23212172; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
BMC Bioinformatics 2010; 11:119; PMID:20211023;  http://dx.doi.org/10.1186/1471-2105-11-119 66.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Bioinformatics 1998; 14:755-63; PMID:9918945;  http://dx.doi.org/10.1093/bioinformatics/14.9.755 67.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Nucleic Acids Res 2005; 33(Web  Server issue):W244-8; PMID:15980461; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Nucleic Acids Res 2004;  32(Web Server issue):W327-31; PMID:15215404;  http://dx.doi.org/10.1093/nar/gkh454 69.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Bioinformatics 2005; 21:3422-3;  PMID:15976072; http://dx.doi.org/10.1093/bioinfor- matics/bti553 70.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
T rends Genet  2000; 16:276-7; PMID:10827456; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Nucleic Acids Res 2006;  34(Web Server issue):W609-12; PMID:16845082;  http://dx.doi.org/10.1093/nar/gkl315 75.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
J Mol Biol 2000; 302:205- 17; PMID:10964570; http://dx.doi.org/10.1006/ jmbi.2000.4042 76.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
PLoS One 2011; 6:e23804;  PMID:21887323; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Virol J 2010; 7:290;  PMID:21029434; http://dx.doi.org/10.1186/1743- 422X-7-290 54.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Curr  Opin Genet Dev 2004; 14:609-15; PMID:15531154;  http://dx.doi.org/10.1016/j.gde.2004.09.010 55.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Mol Microbiol  2001; 39:823-34; PMID:11251805; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Appl Environ Microbiol 2013; 79:688-95; PMID:23160125; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Biochemistry (Mosc) 2002;  67:1124-35; PMID:12460110; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
J Mol Biol  2008; 378:726-36; PMID:18374942; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
J Mol Biol 2000; 304:687- 98; PMID:11124018; http://dx.doi.org/10.1006/ jmbi.2000.4309 62.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
J Biol Chem 1998; 273:19371- 4; PMID:9677352; http://dx.doi.org/10.1074/ jbc.273.31.19371 63.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
EMBO J 2002; 21:5815-23; PMID:12411499; http://dx.doi.org/10.1093/emboj/ cdf584 64.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Virology  1998; 250:377-87; PMID:9792848; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Dis Aquat Organ 2003; 54:119-26; PMID:12747637;  http://dx.doi.org/10.3354/dao054119 39.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
T rends Ecol Evol 2000; 15:496-503; PMID:11114436; http://dx.doi.org/10.1016/ S0169-5347(00)01994-7 41.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Environ Microbiol  2009; 11:2863-73; PMID:19659499; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Virology  2003; 310:359-71; PMID:12781722; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
J Biol Chem 1995; 270:22541-7; PMID:7673246;  http://dx.doi.org/10.1074/jbc.270.38.22541 46.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
J Mol Biol  1995; 246:461-71; PMID:7877167; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Genes Dev 2003; 17:2334-45;  PMID:12975320; http://dx.doi.org/10.1101/ gad.1121403 48.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
J Mol Biol 2007; 368:966-81; PMID:17383677; http://dx.doi.org/10.1016/j.jmb.2007.02.046 50.,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
PLoS Biol 2006; 4:e368; PMID:17090214; http://dx.doi.org/10.1371/journal.pbio.0040368 51.,Non-OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
Proc Natl Acad Sci U S A 2011; 108:E757- 64; PMID:21844365; http://dx.doi.org/10.1073/ pnas.1102164108,OADS,/arxiv_data1/oa_pdf/e2/e6/bact-3-e24766.PMC3821669.pdf
"Nucleic Acids Res 2013; In press; PMID:23703205; http://dx.doi.org/10.1093/nar/gkt336The moonlighting function of bacteriophage P4 capsid protein, Psu,   as a transcription antiterminator Amitabh Ranjan,1 Ramanuj Banerjee,2 Bibhusita Pani,1,† Udayditya Sen2 and Ranjan Sen1,* 1Laboratory of Transcription Biology; Center for DNA Fingerprinting and Diagnostics; Nampally, Hyderabad India; 2Crystallography and Molecular Biology   Division; Saha Institute of Nuclear Physics; Bidhannagar, Kolkata India †Current affiliation: Department of Biochemistry; New York University School of Medicine; New York, NY USA Psu, a 20-kD bacteriophage P4 cap - sid decorating protein moonlights  as a transcription antiterminator of  the Rho-dependent termination.",Non-OADS,/arxiv_data1/oa_pdf/d1/e2/bact-3-e25657.PMC3821671.pdf
Bacteriophage 2013; 3:e25657; http://dx.doi.org/10.4161/bact.25657 *Correspondence to: Ranjan Sen;  Email: rsen@cdfd.org.in,Non-OADS,/arxiv_data1/oa_pdf/d1/e2/bact-3-e25657.PMC3821671.pdf
J Mol Biol 2011; 412:793-813; PMID:21439297 ;  http://dx.doi.org/10.1016/j.jmb.2011.03.036 3.,OADS,/arxiv_data1/oa_pdf/d1/e2/bact-3-e25657.PMC3821671.pdf
Mol Cell  2009; 33:97-108;  PMID:19150431 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/e2/bact-3-e25657.PMC3821671.pdf
Nature 2010; 463:245-9;  PMID:20075920 ;  http://dx.doi.org/10.1038/nature08669 5.,OADS,/arxiv_data1/oa_pdf/d1/e2/bact-3-e25657.PMC3821671.pdf
Virology 1993; 194:682-7; PMID:8503181 ;  http://dx.doi.org/10.1006/viro.1993.1308 8.,Non-OADS,/arxiv_data1/oa_pdf/d1/e2/bact-3-e25657.PMC3821671.pdf
Proc Natl Acad Sci U S A 1986; 83:9561-5; PMID:3540944 ; http://dx.doi.org/10.1073/ pnas.83.24.956110.,OADS,/arxiv_data1/oa_pdf/d1/e2/bact-3-e25657.PMC3821671.pdf
Virology  1997; 227:131-41;  PMID:9007066 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/d1/e2/bact-3-e25657.PMC3821671.pdf
J Biol Chem 2012;  287:44667-75;  PMID :23150672 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d1/e2/bact-3-e25657.PMC3821671.pdf
Proc Natl Acad Sci U S A 2010; 107:20732-7;  PMID:21068371 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d1/e2/bact-3-e25657.PMC3821671.pdf
Nucleic Acids Res 2013; In press; PMID:23703205 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/d1/e2/bact-3-e25657.PMC3821671.pdf
Cell 2006; 127:553- 64; PMID:17081977 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/d1/e2/bact-3-e25657.PMC3821671.pdf
Cell 2009; 139:523-34; PMID:19879839 ;  http://dx.doi.org/10.1016/j.cell.2009.08.043,OADS,/arxiv_data1/oa_pdf/d1/e2/bact-3-e25657.PMC3821671.pdf
"Bacteriophage 2013; 3:e25518; http://dx.doi.org/10.4161/bact.25518Lytic bacteriophages Potential interventions against enteric bacterial pathogens   on produce Manan Sharma United States Department of Agricultural; Agricultural Research Service; e nvironmental Microbial and Food Safety Laboratory; Henry A w allace Beltsville Agricultural   Research Center; Beltsville, MD USA Keywords:  bacteriophages, lytic, leafy greens, melons, sprouts, produce, vegetables, Escherichia coli O157: H7, Salmonella ,  Listeria monocytogenes Foodborne illnesses resulting from the consumption of  produce commodities contaminated with enteric pathogens  continue to be a significant public health issue.",Non-OADS,/arxiv_data1/oa_pdf/81/06/bact-3-e25518.PMC3821672.pdf
Available at:  http://cspinet.org/new/pdf/outbreak_alert_2008_report_final.pdf .,Non-OADS,/arxiv_data1/oa_pdf/81/06/bact-3-e25518.PMC3821672.pdf
Comprehensive Reviews in Food  Science and Food Safety 2003; 2(Supplement):13-9;  http://dx.doi.org/10.1111/j.1541-4337.2003.,Non-OADS,/arxiv_data1/oa_pdf/81/06/bact-3-e25518.PMC3821672.pdf
Appl Environ Microbiol 2008; 74:5285- 9; PMID :18641153 ; http://dx.doi.org/10.1128/ AEM.01073-08 6.,Non-OADS,/arxiv_data1/oa_pdf/81/06/bact-3-e25518.PMC3821672.pdf
J Appl Microbiol 2008; 104:613-26;  PMID:17927745 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/81/06/bact-3-e25518.PMC3821672.pdf
Annu Rev Phytopathol 2006; 44:367-92;  PMID:16704355 ; http://dx.doi.org/10.1146/ annurev.phyto.44.070505.14335910.,Non-OADS,/arxiv_data1/oa_pdf/81/06/bact-3-e25518.PMC3821672.pdf
Bacteriophage 2011;  1:46-9;  PMID:21687534 ; http://dx.doi.org/10.4161/ bact.1.1.13980 11.,Non-OADS,/arxiv_data1/oa_pdf/81/06/bact-3-e25518.PMC3821672.pdf
Appl Environ Microbiol 2008; 74:6230- 8; PMID:18723643 ; http://dx.doi.org/10.1128/ AEM.01465-08 13.,Non-OADS,/arxiv_data1/oa_pdf/81/06/bact-3-e25518.PMC3821672.pdf
Bacteriophage 2013; 3:e24323; http://dx.doi.org/10.4161/bact.24323 .,Non-OADS,/arxiv_data1/oa_pdf/81/06/bact-3-e25518.PMC3821672.pdf
Bacteriophage 2013; 3:e24620; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/06/bact-3-e25518.PMC3821672.pdf
J Food Sci 2004; 69:M127-9; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/81/06/bact-3-e25518.PMC3821672.pdf
Appl Environ Microbiol 2003; 69:4519-26; PMID:12902237 ; http://dx.doi.org/10.1128/ AEM.69.8.4519-4526.2003 21.,Non-OADS,/arxiv_data1/oa_pdf/81/06/bact-3-e25518.PMC3821672.pdf
Bacteriophage 2013; 3:e24872; http://dx.doi.org/10.4161/bact.24872 Correspondence to: Alexandra Henein;   Email: a.e.henein@reading.ac.ukBacterial resistance to antibiotics  poses a serious health threat.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Arch Med Res 2005; 36:697- 705; PMID:16216651; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Clin Infect Dis 2008; 46:155-64; PMID:18171244;  http://dx.doi.org/10.1086/524891 4.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
J Med Microbiol 2011; 60:1697- 700; PMID:21737541; http://dx.doi.org/10.1099/ jmm.0.029744-0 12.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Virology  2012; 434:138-42; PMID:23059181; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Internist (Berl) 2012; 53:1420- 30; PMID:23179596; http://dx.doi.org/10.1007/ s00108-012-3107-5 16.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
J Med Ethics 2003; 29:269-74;  PMID:14519835; http://dx.doi.org/10.1136/ jme.29.5.269 19.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Adv Virus Res 2012; 83:3-40; PMID:22748807; http://dx.doi.org/10.1016/B978- 0-12-394438-2.00001-3 21.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Trends Microbiol 1997; 5:268-71;  PMID:9234508; http://dx.doi.org/10.1016/S0966-842X(97)01054-8 23.,OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
In Vitro 1972; 8:91-3; PMID:4567658; http://dx.doi.org/10.1007/BF02615965 25.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Science 1975;  188:8; PMID:17760141; http://dx.doi.org/10.1126/ science.188.4183.8 26.,OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Lett Appl Microbiol 2008; 47:479-85;  PMID:19120914; http://dx.doi.org/10.1111/j.1472-765X.2008.02458.x 27.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Infect Immun 2003; 71:3782-6; PMID:12819060; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Nat Rev Drug Discov 2003; 2:489-97; PMID:12776223;  http://dx.doi.org/10.1038/nrd1111 29.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
J Phys Condens Matter 2006; 18:S2185- 201; http://dx.doi.org/10.1088/0953-8984/18/33/ S34 30.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Nat Nanotechnol 2008; 3:145-50;  PMID:18654486; http://dx.doi.org/10.1038/ nnano.2008.3031.,OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Drug Discov Today  2002; 7:1086-91; PMID:12546840; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Int J Infect Dis  2008; 12:466-71; PMID:18400541; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Transplant Proc 2003; 35:2372-3; PMID:14529945; http://dx.doi.org/10.1016/S0041- 1345(03)00811-X 35.,OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Transplant Proc  2006; 38:331-3; PMID:16504739; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
J Health Econ 2003; 22:151-85; PMID:12606142;  http://dx.doi.org/10.1016/S0167-6296(02)00126-1 39.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Curr Opin Microbiol  2003; 6:427-30; PMID:14572532; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Clin Infect Dis 2004; 38:1279-86; PMID:15127341; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Surgery 2005; 137:639- 46; PMID:15933632; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Antimicrob Agents Chemother  2003; 47:1301-7; PMID:12654662; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Antimicrob Agents Chemother 2006; 50:2087-97; PMID:16723570;  http://dx.doi.org/10.1128/AAC.00169-06 44.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
BMC Oral Health 2006;  6(Suppl 1):S16; PMID:16934117; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Int J Antimicrob Agents 2007; 30:118-28; PMID:17566713; http://dx.doi.org/10.1016/j.ijan - timicag.2007.04.006,OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
J Mol Genet Med 2012; 6:279-86;  PMID:22872803; http://dx.doi.org/10.4172/1747- 0862.1000050 47.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Int  J Microbiol 2010; 2010:624234; PMID:20652074; http://dx.doi.org/10.1155/2010/624234 48.,OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Nat Biotechnol 2004; 22:31-6;  PMID:14704699; http://dx.doi.org/10.1038/ nbt0104-31 50.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
J Chem Technol Biotechnol 2001;  76:673-6; http://dx.doi.org/10.1002/jctb.435 51.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Future Microbiol  2007; 2:485-91; PMID:17927471; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
J Theor Biol 2001; 208:37-48; PMID:11162051;  http://dx.doi.org/10.1006/jtbi.2000.2198 55.,Non-OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Int J Med Microbiol 2006; 296:5-14; PMID:16423684; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/02/c2/bact-3-e24872.PMC3821673.pdf
Bacteriophage 2013; 3:e25697; http://dx.doi.org/10.4161/bact.25697Introduction Illnesses caused by Salmonella  constitute a substantial health  burden in the United States and around the world.,Non-OADS,/arxiv_data1/oa_pdf/7e/6c/bact-3-e25697.PMC3821689.pdf
Available at: http://www.cdc.gov/food- borneburden/PDFs/FACTSHEET_A_FINDINGS_ updated4-13.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/7e/6c/bact-3-e25697.PMC3821689.pdf
Emerg Infect  Dis 1999; 5:607-25; PMID:10511517; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/6c/bact-3-e25697.PMC3821689.pdf
Clin Infect  Dis 2010; 50:882-9; PMID:20158401; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/6c/bact-3-e25697.PMC3821689.pdf
Available at: http://www.cdc.gov/VitalSigns/ FoodSafety/ 5.,Non-OADS,/arxiv_data1/oa_pdf/7e/6c/bact-3-e25697.PMC3821689.pdf
Int  J Food Microbiol 2003; 85:227-36; PMID:12878381; http://dx.doi.org/10.1016/S0168-1605(02)00540-8 6.,OADS,/arxiv_data1/oa_pdf/7e/6c/bact-3-e25697.PMC3821689.pdf
Appl Environ Microbiol 2008; 74:6230- 8; PMID:18723643; http://dx.doi.org/10.1128/ AEM.01465-08 9.,OADS,/arxiv_data1/oa_pdf/7e/6c/bact-3-e25697.PMC3821689.pdf
Bacteriophage 2012; 2:168- 77; PMID:23275868; http://dx.doi.org/10.4161/bact.22240 10.,Non-OADS,/arxiv_data1/oa_pdf/7e/6c/bact-3-e25697.PMC3821689.pdf
J Appl Microbiol 2005; 99:449-59; PMID:16108786;  http://dx.doi.org/10.1111/j.1365-2672.2005.02659.x 11.,OADS,/arxiv_data1/oa_pdf/7e/6c/bact-3-e25697.PMC3821689.pdf
Bacteriophage 2011; 1:130-7; PMID:22164346;  http://dx.doi.org/10.4161/bact.1.3.17629 12.,Non-OADS,/arxiv_data1/oa_pdf/7e/6c/bact-3-e25697.PMC3821689.pdf
Int J Food Microbiol 1997; 34:197- 207; PMID:9039566; http://dx.doi.org/10.1016/ S0168-1605(96)01190-7 19.,Non-OADS,/arxiv_data1/oa_pdf/7e/6c/bact-3-e25697.PMC3821689.pdf
Bacteriophage 2013; 3:e25449; http://dx.doi.org/10.4161/25449The bacteriophage EL is a virus that specifically attacks the human pathogen Pseudomonas aeruginosa .,Non-OADS,/arxiv_data1/oa_pdf/f2/8c/bact-3-e25449.PMC3821690.pdf
Res Microbiol  2003; 154:269-75;  PMID:12798231 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/8c/bact-3-e25449.PMC3821690.pdf
FEMS Microbiol Rev  2013 ; 37:554-71; PMID:23043507 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/8c/bact-3-e25449.PMC3821690.pdf
J Virol 2012 ; 86:10103 -11;  PMID:22787217 ; http://dx.doi.org/10.1128/ JVI.00940-125.,Non-OADS,/arxiv_data1/oa_pdf/f2/8c/bact-3-e25449.PMC3821690.pdf
"Nucleic  Acids Res 2005 ; 33:7066 -73; PMID:16352867 ;  http://dx.doi.org/10.1093/nar/gki1016 6. van Asselt  EJ, Dijkstra  AJ, Kalk  KH, Takacs  B, Keck   W, Dijkstra  BW.",OADS,/arxiv_data1/oa_pdf/f2/8c/bact-3-e25449.PMC3821690.pdf
Structure   1999 ; 7:1167-80; PMID:10545329 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/8c/bact-3-e25449.PMC3821690.pdf
Proc Natl Acad Sci U  S A 1993 ; 90:6493 -7; PMID:8341660 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/8c/bact-3-e25449.PMC3821690.pdf
Nature   1987 ; 327:635-8; PMID:3600760 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f2/8c/bact-3-e25449.PMC3821690.pdf
Antimicrob Agents Chemother  2013 ;  57:2743 -50; PMID :23571534 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f2/8c/bact-3-e25449.PMC3821690.pdf
J exp med 1944;  79:137-58; pmiD:19871359; http://dx.doi.org/10.1084/ jem.79.2.1374.,Non-OADS,/arxiv_data1/oa_pdf/31/3a/bact-3-e25589.PMC3821691.pdf
nature 1989; 342:291-3; pmiD:2812028; http://dx.doi.org/10.1038/342291a05.,Non-OADS,/arxiv_data1/oa_pdf/31/3a/bact-3-e25589.PMC3821691.pdf
virology 1957; 4:509-21; pmiD:13507311; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/31/3a/bact-3-e25589.PMC3821691.pdf
virology 1957; 3:42-61; pmiD:13409759; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/31/3a/bact-3-e25589.PMC3821691.pdf
virology  1970; 42:496-507; pmiD:4923016; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/31/3a/bact-3-e25589.PMC3821691.pdf
J mol biol 1972; 64:551-63; pmiD:5022189; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/31/3a/bact-3-e25589.PMC3821691.pdf
http://dx.doi.org/10.4161/cib.24951Micro-RN as regulate the expression of cellular and tissue phenotypes at a post-transcriptional level through a com - plex process involving complementary interactions between micro-RN as and messenger-RN as.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Supplementary Material Supplementary material may be found here:   http://www.landesbioscience.com/journals/cib/article/24951/  References 1.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Cell  1993; 75:843-54;  PMID:8252621 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Science 2001; 294:853- 8; PMID:11679670 ; http://dx.doi.org/10.1126/ science.1064921 3.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Cancer Res 2009; 69:5553-9;  PMID:19549910 ; http://dx.doi.org/10.1158/0008- 5472.CAN-08-42774.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
J Dent Res 2008 ;  87:1063 -8; PMID:18946016 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
J Clin Invest 2007; 117:2369- 76; PMID:17786230 ; http://dx.doi.org/10.1172/ JCI33099 6.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Genes Dev 2007; 21:744-9;  PMID:17403776 ; http://dx.doi.org/10.1101/ gad.1519107 7.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Cell 2001; 107:823-6; PMID:11779458 ;  http://dx.doi.org/10.1016/S0092-8674(01)00616-X8.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Bioinformatics 2001; 17:913- 9; PMID:11673235 ; http://dx.doi.org/10.1093/ bioinformatics/17.10.913 9.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
RNA 2004; 10:1507-17; PMID:15383676 ;  http://dx.doi.org/10.1261/rna.5248604 10.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Cell 2005; 120:15-20;  PMID:15652477 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Nat Genet 2005; 37:495-500; PMID:15806104 ; http://dx.doi.org/10.1038/ng1536,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
PLoS Comput Biol 2005 ; 1:e13-13;  PMID:16103902 ; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Nucleic Acids Res  2008; 36(Database issue):D165-9;  PMID:18029362 ;  http://dx.doi.org/10.1093/nar/gkm1012 15.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Drug Discov Today 2007; 12:452-8; PMID:17532529 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
J Biomed  Biotechnol 2009; 2009:803069;  PMID:19551154 ;  http://dx.doi.org/10.1155/2009/803069 18.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Virol  J 2009; 6:129; PMID:19691855 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
PLoS Biol  2004; 2:e363-363;  PMID:15502875 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Genes Dev  2002; 16:1616-26;  PMID:12101121 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Cell Res 2012; 22:107-26; PMID:21931358 ; http://dx.doi.org/10.1038/ cr.2011.158 23.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
BMC Plant  Biol 2010; 10:138;  PMID:20594353 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
IEEE Trans Biomed Eng 2010; 57:1547-53; PMID:20199930 ; http://dx.doi.org/10.1109/ TBME.2010.2043734 25.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Eur Food  Res Technol 2006; 222:185-93; http://dx.doi.org/10.1007/s00217-005-0154-3 26.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
J Neuroimmunol 2009 ; 211:66-72;  PMID:19394707 ; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
PLoS One  2010 ; 5:e10041 ; PMID:20386604 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
J Gen Virol  2010 ; 91:32-41; PMID:19793906 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Nucleic Acids Res 2006; 34(Database issue):D382-5;  PMID:16381892 ; http://dx.doi.org/10.1093/nar/ gkj023 30.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Nucleic  Acids Res 2006; 34(Database issue):D140-4;  PMID:16381832 ; http://dx.doi.org/10.1093/nar/ gkj112 31.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
FEMS Microbiol Lett 1999; 174:247-50;  PMID:10339815 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Nucleic Acids Res 2011; 39:4827-35; PMID:21335607 ;  http://dx.doi.org/10.1093/nar/gkr077 34.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
J Biol Chem 2008; 283:22550-6; PMID:18505725 ; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
J Clin Virol 2012; 55:374-6;  PMID:22959216 ; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
PLoS One  2013 ; 8:e60621 ; PMID:23573274 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
PLoS Pathog  2009 ; 5:e1000417 ; PMID:19412526 ;  http://dx.doi.org/10.1371/journal.ppat.1000417 39.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
J Virol 2008; 82:9065- 74; PMID:18596100 ; http://dx.doi.org/10.1128/ JVI.00961-0840.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Genes Dev 2009; 23:1151-64; PMID:19451215 ; http://dx.doi.org/10.1101/ gad.1793309 41.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Nat Methods 2005; 2:269-76;  PMID:15782219 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
FEBS Lett 2007; 581:4603- 10; PMID:17825824 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Cell 2011; 146:353-8; PMID:21802130 ; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Science 2010; 328:1563-6; PMID:20558719 ;  http://dx.doi.org/10.1126/science.1187197 47.,Non-OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Nucleic Acids Res 2011; 39(Database issue):D152-7;  PMID:21037258 ; http://dx.doi.org/10.1093/nar/ gkq1027 49.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Proc Natl Acad Sci U  S A 1990; 87:2264-8; PMID:2315319 ; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
Bioinformatics 2006; 22:1534- 5; PMID:16574695 ; http://dx.doi.org/10.1093/ bioinformatics/btl113,OADS,/arxiv_data1/oa_pdf/bb/6c/cib-6-e24951.PMC3821693.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/69/67/dddt-7-1323.PMC3821694.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1323–1328Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1323Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S5370 5heart rate reduction for 36 months with  ivabradine reduces left ventricular mass in cardiac  allograft recipients: a long-term follow-up study andreas O Doesch1 susanne Mueller1 christian erbel1 christian a gleissner1 lutz Frankenstein1 stefan hardt1 arjang ruhparwar2 Philipp ehlermann1 Thomas Dengler3 hugo a Katus1 1Department of cardiology,   2Department of cardiovascular  surgery, University of heidelberg,   heidelberg, 3slK Plattenwald hospital,   Bad Friedrichshall, germany correspondence: andreas O Doesch   Medizinische Klinik iii, Kardiologie,  angiologie, Pulmologie, im neuenheimer  Feld 410, 69120 heidelberg, germany   Tel +49 622 1563 9936   Fax +49 62 2156 4105   email a ndreas.",Non-OADS,/arxiv_data1/oa_pdf/69/67/dddt-7-1323.PMC3821694.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/69/67/dddt-7-1323.PMC3821694.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/69/67/dddt-7-1323.PMC3821694.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6c/76/jpr-6-765.PMC3821729.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Pain Research 2013:6 765–770Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  765HyPotHesisopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/JPR.S5226 4Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/6c/76/jpr-6-765.PMC3821729.pdf
"Or use: http://dvpr.es/19ZKeG Ftraumatization and chronic pain: a further   model of interaction Niklaus egloff1 Anna Hirschi2 Roland von Känel1 1Department of General internal  Medicine, Division of Psychosomatic  Medicine, inselspital, University  Hospital, Bern, switzerland;   2outpatient Clinic for Victims of  torture and War, swiss Red Cross,   Bern-Wabern, switzerland Correspondence: Niklaus egloff   Department of General internal   Medicine, University Hospital,   CH-3010 Bern, switzerland   tel +41 31 632 20 19   Fax +41 31 382 11 84   email niklaus.egloff@insel.c hAbstract:  Up to 80% of patients with severe posttraumatic stress disorder are suffering from  “unexplained” chronic pain.",Non-OADS,/arxiv_data1/oa_pdf/6c/76/jpr-6-765.PMC3821729.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/6c/76/jpr-6-765.PMC3821729.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6c/76/jpr-6-765.PMC3821729.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f7/b5/ndt-9-1717.PMC3821751.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1717–1723Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1717OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S4964 5Quality of Web-based information on obsessive  compulsive disorder hedi Klila1 anne chatton2 ariane Zermatten2 riaz Khan2 Martin Preisig1,3 Yasser Khazaal2,4 1Department of Psychiatry, lausanne  University hospital, lausanne,   switzerland; 2Department of Mental  health and Psychiatry, geneva  University hospitals, geneva,   switzerland; 3lausanne University,   lausanne, switzerland; 4geneva  University, geneva, switzerland correspondence: Yasser Khazaal   geneva University hospitals grand pré  70c, 1206 geneva, switzerland   Tel +41 22 372 5550   Fax +41 22 320 2840   email yasser.khazaal@hcuge.c hBackground:  The Internet is increasingly used as a source of information for mental health  issues.",Non-OADS,/arxiv_data1/oa_pdf/f7/b5/ndt-9-1717.PMC3821751.pdf
"readability Readability was evaluated with the Flesch-Kincaid grade  level score and the Flesch-Kincaid readability index, using  the following link: http://www.online-utility.org/english/ readability_test_and_improve.js p. The first score provides an  idea of the level of studies by estimating the difficulty of the  text in comparison with a US grade level, with higher scores  reflecting higher levels of difficulty.",Non-OADS,/arxiv_data1/oa_pdf/f7/b5/ndt-9-1717.PMC3821751.pdf
"Neuropsychiatric Disease and Treatment 2013:9submit your manuscript | www.dovepress.co m Dove press Dove press 1720Klila et al 1. http://en.wikipedia.org/wiki/Obsessive%E2%80%93compulsive_disorde r 2. http://www.nimh.nih.gov/health/topics/obsessive-compulsive-disorder-ocd/index.shtm l 3. http://fqtoc.mtl.rtss.qc.ca/accueil_en.ht m 4. http://www.mentalhealth.com/dis/p20-an05.htm l 5. http://www.ocfoundation.org / 6. http://familydoctor.org/online/famdocen/home/common/mentalhealth/anxiety/133.htm l 7. http://www.anxietybc.com/resources/ocd.ph p 8. http://www.mayoclinic.com/health/obsessive-compulsive-disorder/DS0018 9 9. http://www.mentalhelp.net/poc/center_index.php?id= 6 10. http://au.reachout.com/find/articles/obsessive-compulsive-disorder-oc d 11. http://www.webmd.com/anxiety-panic/guide/obsessive-compulsive-disorde r 12. http://helpguide.org/mental/obsessive_compulsive_disorder_ocd.ht m 13. http://kidshealth.org/kid/feeling/emotion/ocd.html # 14. http://psychcentral.com/disorders/sx25.ht m 15. http://www.nami.org/Template.cfm?Section =By_Illness&Template=/TaggedPage/TaggedPageDisplay.cfm&TPLID=54&   ContentID=2303 5 16. http://www.ocduk.org/ 17. http://emedicine.medscape.com/article/1934139-overvie w 18. http://www.patient.co.uk/health/Obsessive-Compulsive-Disorder.ht m 19. http://www.nhs.uk/conditions/Obsessive-compulsive-disorder/Pages/Introduction.asp x 20. http://www.ocdaction.org.uk / 21. http://www.medicinenet.com/obsessive_compulsive_disorder_ocd/article.ht m 22. http://www.aafp.org/afp/980401ap/eddy.htm l 23. http://camh.net/About_Addiction_Mental_Health/Mental_Health_Information/OCD/ocd_treatments.htm l 24. http://www.epigee.org/mental_health/ocdtreatment.htm l 25. http://health.nytimes.com/health/guides/disease/obsessive-compulsive-disorder / 26. http://ocd.about.com / 27. http://www.mclean.harvard.edu/patient/adult/ocd.ph p 28. http://austinocd.com/about.htm l 29. http://www.ocdchicago.org / 30. http://www.brainphysics.com/therapy.ph p 31. http://ocd.stanford.edu/treatment/resources.htm l 32. http://www.ocdtribe.com / 33. http://bbrfoundation.org/oc d 34. http://www.nlm.nih.gov/medlineplus/obsessivecompulsivedisorder.htm l 35. http://www.healthline.com/adamcontent/obsessive-compulsive-disorde r 36. http://www.womenshealth.gov/mental-health/illnesses/obsessive-compulsive-disorder.cf m 37. http://www.hopkinsmedicine.org/healthlibrary/conditions/adult/mental_health_disorders/obsessive-compulsive_disorder_ocd_85,P00737 / 38. http://www.healthcentral.com/anxiety/related-disorders-1909-108.html?ic=50604 8 39. http://mbhs.org/health-library?ArticleId=1990 5 40. http://www.uhseast.com/ADAM/HIE%20MultiMedia/1/000929.ht m 41. http://www.mydr.com.au/mental-health/obsessive-compulsive-disorder-what-is-i t 42. http://my.clevelandclinic.org/psychiatry/services/obsessive_compulsive.asp x 43. https://healthatoz.myuhc.com/portal/Atoz/common/standard/transform.jsp?requestURI=/portal/Atoz/dc/caz/ment/anxi/anxobs.js p 44. http://www.eap.partners.org/WorkLife/MentalHealth/AnxietyDisorders/ObsessiveCompulsiveDisorder.as p 45. http://www.health.harvard.edu/fhg/updates/treating-obsessive-compulsive-disorder.shtm l 46. http://www.aboutourkids.org/articles/when_how_obsessivecompulsive_disorder_treate d 47. http://www.waisman.wisc.edu/kennedy/lib_ocd.ht m 48. http://www.virtualmedicalcentre.com/diseases.asp?did=88&title=Obsessive-Compulsive-Disorder-(OCD ) 49. http://www.nasponline.org/publications/cq/mocq362ocdho.asp x 50. http://www.netdoctor.co.uk/brain-nervous-system/obsessive-compulsive-disorder.ht m 51. http://health.yahoo.net/experts/managinghealthcare/ocd-common-and-troublesom e 52. http://www.muschealth.com/gs/healthtopic.aspx?action= showpage&pageid=P0073 7 53. http://www.nmha.org/go/information/get-info/anxiety-disorders/obsessive-compulsive-disorder-oc d Figure  1 list of the websites.",Non-OADS,/arxiv_data1/oa_pdf/f7/b5/ndt-9-1717.PMC3821751.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/f7/b5/ndt-9-1717.PMC3821751.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/f7/b5/ndt-9-1717.PMC3821751.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/09/7f/ijwh-5-765.PMC3821752.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2013:5 765–771International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  765OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S5365 2Effectiveness of a modified version of the  applied relaxation technique in treatment of  perimenopausal and postmenopausal symptoms suprawita saensak1,2 T eraporn Vutyavanich3 Woraluk somboonporn4 Manit srisurapanont5 1academic Department, Faculty of  Medicine, Mahasarakham University,   Maha sarakham, 2Department of  community Medicine, Faculty of  Medicine, chiang Mai University,   chiang Mai, 3Department of  Obstetrics and gynecology,   chiang Mai University, chiang Mai,   4Department of Obstetrics and  gynecology, KhonKaen University,   KhonKaen, 5Department of Psychiatry,   Faculty of Medicine, chiang Mai  University, chiang Mai, Thailand correspondence: suprawita saensak   Faculty of Medicine, Maha sarakham  University, nakornsawan road,   44000 Maha sarakham, Thailand   Tel +06 60 4371 2992   Fax +06 60 4371 2991   email psaensak@gmail.co mBackground:  Awareness of the risks associated with hormone therapy for menopausal  symptoms has sparked a global decline in this treatment.",Non-OADS,/arxiv_data1/oa_pdf/09/7f/ijwh-5-765.PMC3821752.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/09/7f/ijwh-5-765.PMC3821752.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/09/7f/ijwh-5-765.PMC3821752.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/33/54/opth-7-2113.PMC3821753.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2113–2122Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2113Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S3780 9Clinical characteristics and visual outcomes   in infectious scleritis: a review emeline Radhika Ramenaden veena Rao Raiji Department of Ophthalmology,   George washington University,   washington, DC, USA Correspondence: emeline Radhika  Ramenaden   Department of Ophthalmology,   George washington University,   2150 Pennsylvania Ave, Nw, Suite 2A,  washington, DC 20037, USA   T el +1 202 741 2800   Fax +1 202 741 2805   email radhikar@gwmail.gwu.ed uAbstract:  Infection is a very important but rare cause of scleritis, occurring in about 5%–10%  of all patients presenting with scleral inflammation.",Non-OADS,/arxiv_data1/oa_pdf/33/54/opth-7-2113.PMC3821753.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/33/54/opth-7-2113.PMC3821753.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/33/54/opth-7-2113.PMC3821753.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4d/80/opth-7-2207.PMC3821754.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2207–2214Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2207Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5322 3Retinal thickness changes after phacoemulsification gede Pardianto1 nila Moeloek2 Julia reveny1 sutarman Wage1 imsyah satari3 rosita sembiring1 nuttamon srisamran4,5 1sumatera Utara University, Medan,   2University of indonesia, Jakarta,   3sumatera eye Center, Medan,   indonesia; 4Thammasat University,   Pathum Thani, Thailand; 5The World  Medical Center, nonthaburi, Thailand Correspondence: gede Pardianto   sumatera Utara University, iskandar   Muda 278, Medan 20112, indonesia   Tel +62 81 5500 0300   Fax +62 61 414 2217   email gedepardianto@yahoo.co mPurpose:  To determine the effect of phacoemulsification on macular volume and thickness  using spectral domain optical coherence tomography examinations.",Non-OADS,/arxiv_data1/oa_pdf/4d/80/opth-7-2207.PMC3821754.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/4d/80/opth-7-2207.PMC3821754.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/4d/80/opth-7-2207.PMC3821754.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ba/da/mder-6-169.PMC3821755.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpMedical Devices: Evidence and Research 2013:6 169–174Medical Devices: Evidence and Research Dove press submit your manuscript | www.dovepress.co m Dove press  169ORiginal REsEaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/MDER.S5175 7syringeless power injector versus dual-syringe   power injector: economic evaluation of user   performance, the impact on contrast enhanced   computed tomography (CECT) workflow   exams, and hospital costs giorgio l colombo1,2 ivo a Bergamo andreis3 sergio Di Matteo2 giacomo M Bruno2 claudio Mondellini3 1Department of Drug sciences,   University of Pavia, italy;    2studi analisi Valutazioni Economiche  (s.a.V.E.",Non-OADS,/arxiv_data1/oa_pdf/ba/da/mder-6-169.PMC3821755.pdf
"Medical Devices: Evidence and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/medical-devices-evidence-and-research-journa lMedical Devices: Evidence and Research is an international, peer- reviewed, open access journal that focuses on the evidence, technology,  research, and expert opinion supporting the use and application of  medical devices in the diagnosis, treatment and management of clini - cal conditions and physiological processes.",Non-OADS,/arxiv_data1/oa_pdf/ba/da/mder-6-169.PMC3821755.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/40/df/btt-7-233.PMC3821756.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpBiologics: Targets and Therapy 2013:7 233–241Biologics: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  233Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/BTT .S5087 0immunization of rabbits with synthetic peptides  derived from a highly conserved β-sheet epitope  region underneath the receptor binding site   of influenza A virus shoji ideno1,3 Kaoru sakai1 Mikihiro Yunoki2–4 ritsuko Kubota-Koketsu3,5 Yuji inoue3 shota nakamura6 T eruo Yasunaga6 Y oshinobu Okuno5 Kazuyoshi ikuta3 1infectious Pathogen research  section, central research laboratory,   research and Development Division,   Japan Blood Products Organization,   Kobe, Japan; 2research and  Development Promotion section,   research and Development Division,   Japan Blood Products Organization,   T okyo, Japan; 3Department of  Virology, research institute for  Microbial Diseases, Osaka University,   suita, Osaka, Japan; 4Department of  Veterinary Microbiology, school of  Veterinary Medicine, rakuno gakuen  University, ebetsu, hokkaido, Japan;   5Kanonji institute, The research  Foundation for Microbial Diseases  of Osaka University, Kanonji, Kagawa,   Japan; 6Department of genome  informatics, genome information  research center, research institute  for Microbial Diseases, Osaka  University, suita, Osaka, Japan correspondence: shoji ideno   central research laboratory, Japan Blood   Products Organization, 8F Kobe KiMec   center Building 1-5-2, Minatojima-   minamimach, chuo-ku, Kobe city, hyogo  650-0047, Japan   email ideno-shouji@jbpo.or.j pBackground:  There is increasing concern about the speed with which health care providers  can administer prophylaxis and treatment in an influenza pandemic.",Non-OADS,/arxiv_data1/oa_pdf/40/df/btt-7-233.PMC3821756.pdf
"Biologics: Targets & Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/biologics-targets--therapy-journa lBiologics: Targets & Therapy is an international, peer-reviewed journal  focusing on the patho-physiological rationale for and clinical applica - tion of Biologic agents in the management of autoimmune diseases,  cancers or other pathologies where a molecular target can be identified.",Non-OADS,/arxiv_data1/oa_pdf/40/df/btt-7-233.PMC3821756.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/40/df/btt-7-233.PMC3821756.pdf
"Available from:  http://www.rcsb.org/pdb/home/home.d o. Accessed Sep 23, 2013.",Non-OADS,/arxiv_data1/oa_pdf/40/df/btt-7-233.PMC3821756.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9e/b1/ott-6-1563.PMC3821789.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1563–1572OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1563Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5297 3Transcatheter arterial embolization promotes   liver tumor metastasis by increasing   the population of circulating tumor cells Zhu-Ting Fang1,2,* guang-Zhi Wang1,* Wei Zhang1 Xu-Dong Qu1 rong liu1 sheng Qian1 liang Zhu1 Bo Zhou1 Jian-hua Wang1 1Department of intervention  radiology, Zhongshan hospital, Fudan  University, shanghai, People’s republic  of china; 2Department of intervention  radiology, Provincial hospital of  Fujian Province, Teaching hospital  of Fujian Medical University, Fuzhou,   People’s republic of china *authors who have contributed  equally to this article correspondence: Jian-hua Wang   Department of intervention   radiology, Zhongshan hospital,   Fudan University, no180 Fenglin road,   Xuhui, shanghai, People’s republic of  china   Tel +86 021 6404 1990 ext 3088   email wang.jianhua@zs-hospital.sh.c nAbstract:  Transcatheter arterial embolization (TAE) is widely used as an effective palliative  treatment for hepatocellular carcinoma (HCC), and can prolong survival time.",Non-OADS,/arxiv_data1/oa_pdf/9e/b1/ott-6-1563.PMC3821789.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9e/b1/ott-6-1563.PMC3821789.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9e/b1/ott-6-1563.PMC3821789.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/c3/ba/vhrm-9-695.PMC3821790.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpVascular Health and Risk Management 2013:9 695–701Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  695ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S5007 7Titration of amlodipine to higher doses:   a comparison of asian and Western experience Kazuomi Kario1 Jeffery Robbins2 Barrett W Jeffers2 1Division of cardiovascular Medicine,   Jichi Medical University, shimotsuke,   Japan; 2Pfizer, new Y ork, nY, Usa correspondence: Kazuomi Kario   Division of cardiovascular Medicine,  school of Medicine, Jichi Medical  University, 3311-1 Yakushiji, shimotsuke,  T ochigi 329-0498, Japan   email kkario@jichi.ac.j pAbstract:  In this retrospective analysis, data pooled from two Phase III/IV open-label Asian  studies were used to quantify the additional blood pressure efficacy achieved when titrating  amlodipine from 5 mg to 10 mg in mild/moderate hypertensive patients, and compared to data  pooled from three Western studies.",Non-OADS,/arxiv_data1/oa_pdf/c3/ba/vhrm-9-695.PMC3821790.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/c3/ba/vhrm-9-695.PMC3821790.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/c3/ba/vhrm-9-695.PMC3821790.pdf
Available from: http://nz.nielsen.,Non-OADS,/arxiv_data1/oa_pdf/c3/ba/vhrm-9-695.PMC3821790.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/82/ott-6-1553.PMC3821791.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1553–1557OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1553Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S4501 3Diagnostic efficacy of computed   tomography-guided transthoracic needle aspiration  and biopsy in patients with pulmonary disease Tibel T una1 sevket Ozkaya2 adem Dirican2 serhat Findik3 atilla g atici3 levent erkan3 1Department of Pulmonary Medicine,   samsun chest Diseases and Thoracic  surgery hospital, 2Department of  Pulmonary Medicine, Medical Park  samsun hospital, 3Department   of Pulmonary Medicine, Faculty of  Medicine, samsun Ondokuzmayis  University, samsun, T urkey correspondence: sevket Ozkaya   Medical Park samsun hospital,   Department of Pulmonary Medicine,   samsun, Turkey   Tel +90 53 2474 1309   email ozkayasevket@yahoo.co mBackground:  Computed tomography-guided transthoracic needle aspiration (TTNA) and biopsy  (TTNB) is a well established, safe, and rapid method of reaching a definitive diagnosis for most  thoracic lesions.",Non-OADS,/arxiv_data1/oa_pdf/50/82/ott-6-1553.PMC3821791.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/50/82/ott-6-1553.PMC3821791.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/82/ott-6-1553.PMC3821791.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/59/13/ott-6-1573.PMC3821792.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1573–1587OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1573Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OTT .S5083 8Should a T oll-like receptor 4 (TLR-4) agonist   or antagonist be designed to treat cancer?,Non-OADS,/arxiv_data1/oa_pdf/59/13/ott-6-1573.PMC3821792.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/59/13/ott-6-1573.PMC3821792.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/59/13/ott-6-1573.PMC3821792.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/5f/ott-6-1559.PMC3821793.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1559–1562OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1559Case repO rTopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5381 3successful treatment of paraganglioma   with sorafenib: a case report and brief   review of the literature Yun Lin1,* Qun Li1,* Wei Huang1 Xinyan Jia1 Hong Jiang1 Y ong Gao1 Qi Li1,2 1Department of Oncology, shanghai  east Hospital, 2Department of  Oncology, shanghai First people’s  Hospital, shanghai, people’s republic  of China *These authors contributed equally to  this work, and are joint first authors Correspondence: Qi Li/Yong Gao   Department of Oncology,   shanghai First people’s Hospital,   shanghai Jiaotong University,   100 Haining road, shanghai 200080/   Department of Oncology, shanghai east   Hospital, Tongji University school of   Medicine, 150 Jimo road, shanghai 200120,   people’s republic of China   Tel +86 138 1820 7333/21 6156 9716   email l eeqi2001@hotmail.com/gaoyon@ hotmail.co mIntroduction:  To date, no effective systemic therapies have been made available for  paraganglioma.",Non-OADS,/arxiv_data1/oa_pdf/e4/5f/ott-6-1559.PMC3821793.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e4/5f/ott-6-1559.PMC3821793.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/5f/ott-6-1559.PMC3821793.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/52/a2/ppa-7-1139.PMC3821835.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2013:7 1139–1146Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1139CAse rePortopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/PPA.S5128 5Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/52/a2/ppa-7-1139.PMC3821835.pdf
"Or use: http://dvpr.es/1dKlDd JUse of an interdisciplinary, participatory   design approach to develop a usable patient   self-assessment tool in atrial fibrillation Lori MacCallum1,2 Heather McGaw1 Nazanin Meshkat3 Alissia Valentinis4 Leslie Beard Ashley5 rajan sacha Bhatia3,6,7 Kaye Benson7 Noah Ivers6,8 Kori Leblanc2,7 Dante Morra3,5,7 1Li Ka shing Knowledge Institute, st  Michael’s Hospital, toronto, 2Leslie Dan  Faculty of Pharmacy, University of toronto,   3Department of Medicine, University of  toronto, toronto, 4taddle Creek Family  Health team, toronto, 5trillium Health  Partners, Mississauga, 6Women’s College  Hospital, toronto, 7Centre for Innovation  in Complex Care, University Health  Network, toronto, 8Department of Family  and Community Medicine, University of  toronto, toronto, oN, Canada Correspondence: Lori MacCallum   Banting and Best Diabetes Centre,   Faculty of Medicine, University of  toronto, 200 elizabeth st eaton Building,  12e252, oN M5G 2C4, Canada   tel +1 416 340 4800 ext 2784   Fax +1 416 978 4108   email lori.maccallum@uhnresearch.c aAbstract:  After identifying that significant care gaps exist within the management of atrial  fibrillation (AF), a patient-focused tool was developed to help patients better assess and man - age their AF .",Non-OADS,/arxiv_data1/oa_pdf/52/a2/ppa-7-1139.PMC3821835.pdf
"Available from: http://www.improvingchroniccare.or g.  Accessed February 25, 2010.",Non-OADS,/arxiv_data1/oa_pdf/52/a2/ppa-7-1139.PMC3821835.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal focusing on the growing importance of patient  preference and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/52/a2/ppa-7-1139.PMC3821835.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/52/a2/ppa-7-1139.PMC3821835.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 291-292  http://dx.doi.org/10.4097/kjae.2013.65.4.291 Editorial",Non-OADS,/arxiv_data1/oa_pdf/1c/96/kjae-65-291.PMC3822018.pdf
"Tel: 98-21-64359, Fax: 98-21-66509059, E-mail: p-rahimzadeh@tums.ac.ir     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 293-298  http://dx.doi.org/10.4097/kjae.2013.65.4.293",Non-OADS,/arxiv_data1/oa_pdf/7c/e3/kjae-65-293.PMC3822019.pdf
"Tel: 82-2-3010-3855, Fax: 82-2-3010-6790, E-mail: nohgj@amc.seoul.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 299-305  http://dx.doi.org/10.4097/kjae.2013.65.4.299",Non-OADS,/arxiv_data1/oa_pdf/0c/cb/kjae-65-299.PMC3822020.pdf
"The pooled-data approach was used to obtain population  estimates for bias and inaccuracy (fit4NM 3.5.1, Eun-Kyung Lee  and Gyu-Jeong Noh, http://www.fit4nm.org/download, last ac - cessed: Oct 17, 2011).",OADS,/arxiv_data1/oa_pdf/0c/cb/kjae-65-299.PMC3822020.pdf
"Tel: 91-9013000543, Fax: 91-11-26163072, E-mail: drkumath@gmail.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 306-311  http://dx.doi.org/10.4097/kjae.2013.65.4.306",Non-OADS,/arxiv_data1/oa_pdf/f5/46/kjae-65-306.PMC3822021.pdf
"Tel: 82-2-2228-2414, Fax: 82-2-2228-7897, E-mail:  hkkil@yuhs.ac     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 312-316  http://dx.doi.org/10.4097/kjae.2013.65.4.312",Non-OADS,/arxiv_data1/oa_pdf/60/0b/kjae-65-312.PMC3822022.pdf
"Tel: 82-2-2227-3831, Fax: 82-2-2227-7897, E-mail: ysshin@ yuhs.ac     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 317-321  http://dx.doi.org/10.4097/kjae.2013.65.4.317",Non-OADS,/arxiv_data1/oa_pdf/a9/f3/kjae-65-317.PMC3822023.pdf
"Tel: 82-2-829-5230, Fax: 82-2-2227-7897,  E-mail: emchoi96@hallym.or.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 322-326  http://dx.doi.org/10.4097/kjae.2013.65.4.322",Non-OADS,/arxiv_data1/oa_pdf/3d/ad/kjae-65-322.PMC3822024.pdf
Materials and Methods This study was approved by the Institutional Review Board  of our hospital and registered at http://cris.nih.go.kr.,Non-OADS,/arxiv_data1/oa_pdf/3d/ad/kjae-65-322.PMC3822024.pdf
"Tel: 82-2-2650-2670, Fax: 82- 2-2655-2924, E-mail: leehee@ewha.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 327-330  http://dx.doi.org/10.4097/kjae.2013.65.4.327",Non-OADS,/arxiv_data1/oa_pdf/fe/fb/kjae-65-327.PMC3822025.pdf
"Tel: 82-62-220-6895, Fax: 82-62-232-6294, E-mail: aneszzz@naver.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CCKorean J Anesthesiol 2013 October 65(4): 331-336  http://dx.doi.org/10.4097/kjae.2013.65.4.331",Non-OADS,/arxiv_data1/oa_pdf/57/f6/kjae-65-331.PMC3822026.pdf
"When the patient arrived at the operating room, blood  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 337-340  http://dx.doi.org/10.4097/kjae.2013.65.4.337 Case Report",Non-OADS,/arxiv_data1/oa_pdf/bc/84/kjae-65-337.PMC3822027.pdf
"Past  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 341-344  http://dx.doi.org/10.4097/kjae.2013.65.4.341 Case Report",Non-OADS,/arxiv_data1/oa_pdf/64/55/kjae-65-341.PMC3822028.pdf
"He was  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 345-348  http://dx.doi.org/10.4097/kjae.2013.65.4.345 Case Report",Non-OADS,/arxiv_data1/oa_pdf/35/89/kjae-65-345.PMC3822029.pdf
"Intra-operative monitoring (using a  Datex Ohmeda S5) included heart rate, ECG, oxygen saturation  by pulse oximetry, RR, end-tidal carbon dioxide (EtCO2), cen - tral venous pressure (CVP) (via the basilic vein), invasive blood  pressure, airway pressure, volume of intravenous fluids infused,  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 349-352  http://dx.doi.org/10.4097/kjae.2013.65.4.349 Case Report",Non-OADS,/arxiv_data1/oa_pdf/ac/12/kjae-65-349.PMC3822030.pdf
"She was born by normal spontaneous vaginal  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 353-356  http://dx.doi.org/10.4097/kjae.2013.65.4.353 Case Report",Non-OADS,/arxiv_data1/oa_pdf/52/bb/kjae-65-353.PMC3822031.pdf
"Therefore, the cuff’s position of the endotracheal  tube should be located at more than 15 mm below the vocal  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 357-358  http://dx.doi.org/10.4097/kjae.2013.65.4.357 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/ca/4e/kjae-65-357.PMC3822032.pdf
"There were 12 patients with dif - Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 359-360  http://dx.doi.org/10.4097/kjae.2013.65.4.359 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/11/42/kjae-65-359.PMC3822033.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 361-362  http://dx.doi.org/10.4097/kjae.2013.65.4.361 Letter to the Editor Fig.",Non-OADS,/arxiv_data1/oa_pdf/60/89/kjae-65-361.PMC3822034.pdf
"Fluid management with intermittent bolus infusion from RIS  is associated with more rapid decrease of BT in LT recipients  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 363-364  http://dx.doi.org/10.4097/kjae.2013.65.4.363 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/6f/31/kjae-65-363.PMC3822035.pdf
"Epidural analgesia has been reported to be superior to intra - venous analgesia with respect to postoperative pain relief, bowel  recovery, and patient satisfaction [1,2]; epidural analgesia has  also been reported to be similar to intravenous analgesia in  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 365-367  http://dx.doi.org/10.4097/kjae.2013.65.4.365 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/f2/d8/kjae-65-365.PMC3822036.pdf
"Then, the fiberoptic cable, over which  the tracheal tube is placed, is inserted through the anterior  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 October 65(4): 368-369  http://dx.doi.org/10.4097/kjae.2013.65.4.368 Opinion Fig.",Non-OADS,/arxiv_data1/oa_pdf/c5/01/kjae-65-368.PMC3822037.pdf
Tremor Other Hyperkinet Mov 2013; 3: http://tremorjournal.org/article/view/200 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/a9/cf/tre-03-200-4597-1.PMC3822047.pdf
"Our primary aim was to document their gait/balanceimpairments, and the overarching aim was to advance discussion about the boundaries of what is clinically observable in ET.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/a9/cf/tre-03-200-4597-1.PMC3822047.pdf
"In fact, scores on clinicaltests indicate that most of our participants were at a moderate orLouis ED, Galecki M, Rao AK Gait in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/a9/cf/tre-03-200-4597-1.PMC3822047.pdf
"Abbreviations: CV, coefficient of variation; Gab, gabapentin; m, meters; mg/d, mg/day; m/s, meters/second; POMA, Tinetti Performance Oriented Mo bility Assessment; Pro, propranolol; Top, topiramate.Gait in Essential Tremor Louis ED, Galecki M, Rao AK Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/a9/cf/tre-03-200-4597-1.PMC3822047.pdf
"Mov Disord 2009;24:386–391, doi: http://dx.doi.org/10.1002/mds.22356.",OADS,/arxiv_data1/oa_pdf/a9/cf/tre-03-200-4597-1.PMC3822047.pdf
"Gait Posture 2011;34:65–70, doi: http://dx.doi.org/10.1016/j.gaitpost.2011.03.013.",OADS,/arxiv_data1/oa_pdf/a9/cf/tre-03-200-4597-1.PMC3822047.pdf
"Exp Neurol 2007;208: 257–263, doi: http://dx.doi.org/10.1016/j.expneurol.2007.08.014.",OADS,/arxiv_data1/oa_pdf/a9/cf/tre-03-200-4597-1.PMC3822047.pdf
"Neuroepidemiology 1997;16:124–133, doi: http://dx.doi.org/10.1159/ 000109681.",Non-OADS,/arxiv_data1/oa_pdf/a9/cf/tre-03-200-4597-1.PMC3822047.pdf
"Mov Disord 2004;19:190–192, doi: http://dx.doi.org/10.1002/mds.10657.",OADS,/arxiv_data1/oa_pdf/a9/cf/tre-03-200-4597-1.PMC3822047.pdf
"J Gerontol A Biol Sci Med Sci 1995;50A:M28–34, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/a9/cf/tre-03-200-4597-1.PMC3822047.pdf
"Age Ageing 1997;26:15–19, doi: http://dx.doi.org/10.1093/ageing/26.1.15.",Non-OADS,/arxiv_data1/oa_pdf/a9/cf/tre-03-200-4597-1.PMC3822047.pdf
"Mov Disord 2010;25:1633–1638, doi: http://dx.doi.org/10.1002/mds.23144.",OADS,/arxiv_data1/oa_pdf/a9/cf/tre-03-200-4597-1.PMC3822047.pdf
"Cerebellum 2013;12:27–34, doi: http://dx.doi.org/10.1007/s12311-012-0384-4.",Non-OADS,/arxiv_data1/oa_pdf/a9/cf/tre-03-200-4597-1.PMC3822047.pdf
"Cerebellum 2008;7:189–197, doi: http://dx.doi.org/10.1007/s12311-008-0028-x.Louis ED, Galecki M, Rao AK Gait in Essential Tremor Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/a9/cf/tre-03-200-4597-1.PMC3822047.pdf
Tremor Other Hyperkinet Mov 2013; 3: http://tremorjournal.org/article/vie w/191 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
On theFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
Long-Term Safety and Efficacy of Tetrabenazine Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
Long-Term Safety and Efficacy of Tetrabenazine Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
Long-Term Safety and Efficacy of Tetrabenazine Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
Long-Term Safety and Efficacy of Tetrabenazine Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
Long-Term Safety and Efficacy of Tetrabenazine Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services10,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services11,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
Long-Term Safety and Efficacy of Tetrabenazine Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services12,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
"Expert Rev Neurother 2011;11:1509–1523, doi: http://dx.doi.org/10.1586/ern.11.149.",Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
"Expert Opin Orphan Drugs 2013;1:423–436, doi: http://dx.doi.org/10.1517/21678707.2013.787358.",Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
"Neurology 2006;66: 366–372, doi: http://dx.doi.org/10.1212/01.wnl.0000198586.85250.13.",Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
"BMC Neurology 2009;9: 62–72, doi: http://dx.doi.org/10.1186/1471-2377-9-62.5.Frank S, Ondo W, Fahn S, et al.",Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
"Clin Neuropharmacol 2008;31: 127–133, doi: http://dx.doi.org/10.1097/WNF.0b013e3180ca77ea.",Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
"Neurology 1997;48:358–62, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
"Mov Disord 2007;22:193– 7, doi: http://dx.doi.org/10.1002/mds.21222.",OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
"Neurology 1988;38:391–4, doi: http://dx.doi.org/10.1212/ WNL.38.3.391.",Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
Available at http://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/CST/.,OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
"PLoS One 2012;7:e29522, doi: http://dx.doi.org/10.1371/journal.pone.0029522.",Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
"Mov Disord 2013; 28:210–5, doi: http://dx.doi.org/10.1002/mds.25278.",OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
"J Neuropsychiatry Clin Neurosci 2005;17:496–502, doi: http://dx.doi.org/10.1176/appi.neuropsych.17.4.496.",Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
"J Neurol Neurosurg Psychiatry 1984;47:1283–1287, doi: http://dx.doi.org/10.1136/jnnp.47.12.1283.",Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
"J Neuropsychiatry Clin Neurosci 2005;17:496–502, doi: http://dx.doi.org/10.1176/appi.neuropsych.17.4.496.",Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services13,Non-OADS,/arxiv_data1/oa_pdf/e0/2b/tre-03-191-4337-1.PMC3822048.pdf
- Korean J Orthod 2013;43:147-158 http://dx.doi.org/10.4041/kjod.2013.43.5.207207www.e-kjo.orgpISSN 2234-7518 eISSN 2005-372X,Non-OADS,/arxiv_data1/oa_pdf/d6/df/kjod-43-207.PMC3822059.pdf
"208 www.e-kjo.org http://dx.doi.org/10.4041/kjod.2013.43.5.207This is an Open Access article distributed under the terms of the  Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted  non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.optimal efficiency in clinical orthodontics.",Non-OADS,/arxiv_data1/oa_pdf/d6/df/kjod-43-207.PMC3822059.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2013.43.5.209",Non-OADS,/arxiv_data1/oa_pdf/12/82/kjod-43-209.PMC3822060.pdf
"Kim et al • Comparision of condyle-fossa relationship in Class III www.e-kjo.org 210 http://dx.doi.org/10.4041/kjod.2013.43.5.209 INTRODUCTION   Temporomandibular joint (TMJ) differences such as  condyle-fossa relationships and condylar morphology in  relation to different malocclusions have been previously  studied.1-5 Compared to a class II malocclusion patient,  in a class III malocclusion patient, the condyle was  reported to be closer to the fossa roof.1 Meanwhile, other  studies showed that the condyle was positioned more  forward in class II division 1 and more backward in class  III patients.6 However, the influence of occlu  sions on the  TMJ is still controversial.",Non-OADS,/arxiv_data1/oa_pdf/12/82/kjod-43-209.PMC3822060.pdf
"Kim et al • Comparision of condyle-fossa relationship in Class III www.e-kjo.org 211 http://dx.doi.org/10.4041/kjod.2013.43.5.209 anterior joint space (AS), superior joint space (SS), and  posterior joint space (PS) were measured from the most  prominent anterior, posterior, and superior condylar  points to the glenoid fossa.7 The plane parallel to the  FH plane was used as the reference plane (Figure 2).",OADS,/arxiv_data1/oa_pdf/12/82/kjod-43-209.PMC3822060.pdf
Kim et al • Comparision of condyle-fossa relationship in Class III www.e-kjo.org 212 http://dx.doi.org/10.4041/kjod.2013.43.5.209 examiner error between the 2 measurements was  determined using a paired t-test.,OADS,/arxiv_data1/oa_pdf/12/82/kjod-43-209.PMC3822060.pdf
Kim et al • Comparision of condyle-fossa relationship in Class III www.e-kjo.org 213 http://dx.doi.org/10.4041/kjod.2013.43.5.209 statistically superior position ( p < 0.01).,OADS,/arxiv_data1/oa_pdf/12/82/kjod-43-209.PMC3822060.pdf
"Kim et al • Comparision of condyle-fossa relationship in Class III www.e-kjo.org 214 http://dx.doi.org/10.4041/kjod.2013.43.5.209 patients with or without symmetry as to the right-sided  or left-sided condylar positioning or deviated or non- deviated sides, as well as how much of a difference  between the right and left sides exists.",OADS,/arxiv_data1/oa_pdf/12/82/kjod-43-209.PMC3822060.pdf
Kim et al • Comparision of condyle-fossa relationship in Class III www.e-kjo.org 215 http://dx.doi.org/10.4041/kjod.2013.43.5.209 condylar angle was steeper or larger on the deviated  side with more shape variability.,OADS,/arxiv_data1/oa_pdf/12/82/kjod-43-209.PMC3822060.pdf
Kim et al • Comparision of condyle-fossa relationship in Class III www.e-kjo.org 216 http://dx.doi.org/10.4041/kjod.2013.43.5.209 CONCLUSION   The hypothesis was rejected.,Non-OADS,/arxiv_data1/oa_pdf/12/82/kjod-43-209.PMC3822060.pdf
Kim et al • Comparision of condyle-fossa relationship in Class III www.e-kjo.org 217 http://dx.doi.org/10.4041/kjod.2013.43.5.209 plane.,OADS,/arxiv_data1/oa_pdf/12/82/kjod-43-209.PMC3822060.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2013.43.5.218",Non-OADS,/arxiv_data1/oa_pdf/3e/52/kjod-43-218.PMC3822061.pdf
"Lee et al • Effect of bite force on OMIs: FE analysis www.e-kjo.org 219 http://dx.doi.org/10.4041/kjod.2013.43.5.218 INTRODUCTION   Orthodontic mini-implants (OMIs) are now frequently  used in orthodontics, owing to their small size, place - ment versatility, and biocompatibility.1,2 However,  stability is a prerequisite for the successful use of OMIs  in clinical practice.",Non-OADS,/arxiv_data1/oa_pdf/3e/52/kjod-43-218.PMC3822061.pdf
Lee et al • Effect of bite force on OMIs: FE analysis www.e-kjo.org 220 http://dx.doi.org/10.4041/kjod.2013.43.5.218 resolution.,OADS,/arxiv_data1/oa_pdf/3e/52/kjod-43-218.PMC3822061.pdf
"Lee et al • Effect of bite force on OMIs: FE analysis www.e-kjo.org 221 http://dx.doi.org/10.4041/kjod.2013.43.5.218 RESULTS   To evaluate the differences between placement sites,  models A, B, and D were compared.",OADS,/arxiv_data1/oa_pdf/3e/52/kjod-43-218.PMC3822061.pdf
Lee et al • Effect of bite force on OMIs: FE analysis www.e-kjo.org 222 http://dx.doi.org/10.4041/kjod.2013.43.5.218 The magnitude of the difference in Von Mises stress  between OMIs placed at 45° and 90° was relatively  smaller in the anterior mandibular molar region (Figure  5).,OADS,/arxiv_data1/oa_pdf/3e/52/kjod-43-218.PMC3822061.pdf
"Lee et al • Effect of bite force on OMIs: FE analysis www.e-kjo.org 223 http://dx.doi.org/10.4041/kjod.2013.43.5.218 more strongly inclined loading was applied, greater  stress was observed (Figure 6).",Non-OADS,/arxiv_data1/oa_pdf/3e/52/kjod-43-218.PMC3822061.pdf
Lee et al • Effect of bite force on OMIs: FE analysis www.e-kjo.org 224 http://dx.doi.org/10.4041/kjod.2013.43.5.218 A literature review.,OADS,/arxiv_data1/oa_pdf/3e/52/kjod-43-218.PMC3822061.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2013.43.5.225",Non-OADS,/arxiv_data1/oa_pdf/b2/8f/kjod-43-225.PMC3822062.pdf
"Han et al • The upper incisor exposure and cephalometric variables www.e-kjo.org 226 http://dx.doi.org/10.4041/kjod.2013.43.5.225 INTRODUCTION   A smile is a facial expression formed by flexing the  mus cles near both ends of the mouth and is used to  express enjoyment, appreciation, and concurrence.1 A  smile can provide a basis for social interactions and  can also influence a person’s mating success, kinship  opportunities, personality evaluations, performance, and  employment prospects.2,3 Because of the influence of the  smile on the perceived attractiveness of an individual, a  large number of patients seek the help of orthodontists  to address esthetic concerns with their smiles.",Non-OADS,/arxiv_data1/oa_pdf/b2/8f/kjod-43-225.PMC3822062.pdf
Han et al • The upper incisor exposure and cephalometric variables www.e-kjo.org 227 http://dx.doi.org/10.4041/kjod.2013.43.5.225 the distance between the labial surface of the upper  incisors and the film was set at 160 cm.,OADS,/arxiv_data1/oa_pdf/b2/8f/kjod-43-225.PMC3822062.pdf
Han et al • The upper incisor exposure and cephalometric variables www.e-kjo.org 228 http://dx.doi.org/10.4041/kjod.2013.43.5.225 (Figure 1).,OADS,/arxiv_data1/oa_pdf/b2/8f/kjod-43-225.PMC3822062.pdf
"Han et al • The upper incisor exposure and cephalometric variables www.e-kjo.org 229 http://dx.doi.org/10.4041/kjod.2013.43.5.225 gingival length upon smiling to the upper right central  incisor clinical crown length.1,4,11 The standards for  dividing the subjects into the respective three groups  using UIER values were as follows:  Group 1: subjects with UIER values less than 75%   Group 2: subjects with UIER values between 75% and  100%   Group 3: subjects with UIER values greater than 100% Statistical analyses   In order to determine intra-examiner errors, 15 samples  were randomly selected and remeasured by the same  examiner.",Non-OADS,/arxiv_data1/oa_pdf/b2/8f/kjod-43-225.PMC3822062.pdf
Han et al • The upper incisor exposure and cephalometric variables www.e-kjo.org 230 http://dx.doi.org/10.4041/kjod.2013.43.5.225 0.05).,OADS,/arxiv_data1/oa_pdf/b2/8f/kjod-43-225.PMC3822062.pdf
"Han et al • The upper incisor exposure and cephalometric variables www.e-kjo.org 231 http://dx.doi.org/10.4041/kjod.2013.43.5.225 low smiles were the most frequent (37%), followed by  high smiles (32.3%) and average smiles (30.7%).",OADS,/arxiv_data1/oa_pdf/b2/8f/kjod-43-225.PMC3822062.pdf
Han et al • The upper incisor exposure and cephalometric variables www.e-kjo.org 232 http://dx.doi.org/10.4041/kjod.2013.43.5.225 higher frequencies of low smiles.,Non-OADS,/arxiv_data1/oa_pdf/b2/8f/kjod-43-225.PMC3822062.pdf
"Han et al • The upper incisor exposure and cephalometric variables www.e-kjo.org 233 http://dx.doi.org/10.4041/kjod.2013.43.5.225 groups, which were classified into high smile and low  smile types on the basis of UIER and gingiva at smiling.",OADS,/arxiv_data1/oa_pdf/b2/8f/kjod-43-225.PMC3822062.pdf
Han et al • The upper incisor exposure and cephalometric variables www.e-kjo.org 234 http://dx.doi.org/10.4041/kjod.2013.43.5.225 Prosthodont 1999;12:9-19.,OADS,/arxiv_data1/oa_pdf/b2/8f/kjod-43-225.PMC3822062.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2013.43.5.235",Non-OADS,/arxiv_data1/oa_pdf/e7/7f/kjod-43-235.PMC3822063.pdf
Sung et al • Debonding forces of lingual bracket www.e-kjo.org 236 http://dx.doi.org/10.4041/kjod.2013.43.5.235 INTRODUCTION   Lingual orthodontic treatment is an alternative ortho- dontic treatment modality developed to overcome the  unaesthetic nature of traditional orthodontic treatment.,Non-OADS,/arxiv_data1/oa_pdf/e7/7f/kjod-43-235.PMC3822063.pdf
Sung et al • Debonding forces of lingual bracket www.e-kjo.org 237 http://dx.doi.org/10.4041/kjod.2013.43.5.235 in group 1 served as the control group for comparisons.,OADS,/arxiv_data1/oa_pdf/e7/7f/kjod-43-235.PMC3822063.pdf
Sung et al • Debonding forces of lingual bracket www.e-kjo.org 238 http://dx.doi.org/10.4041/kjod.2013.43.5.235 significant differences.,Non-OADS,/arxiv_data1/oa_pdf/e7/7f/kjod-43-235.PMC3822063.pdf
"Sung et al • Debonding forces of lingual bracket www.e-kjo.org 239 http://dx.doi.org/10.4041/kjod.2013.43.5.235 ding occurred within the adhesive, whereas the extended  gold alloy custom base showed significantly more  bracket-adhesive fracture (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/e7/7f/kjod-43-235.PMC3822063.pdf
Sung et al • Debonding forces of lingual bracket www.e-kjo.org 240 http://dx.doi.org/10.4041/kjod.2013.43.5.235 thods of intraoral positioning and bonding have been  introduced for the lingual bracket systems tested in this  study.,OADS,/arxiv_data1/oa_pdf/e7/7f/kjod-43-235.PMC3822063.pdf
Sung et al • Debonding forces of lingual bracket www.e-kjo.org 241 http://dx.doi.org/10.4041/kjod.2013.43.5.235 16:49-54.,Non-OADS,/arxiv_data1/oa_pdf/e7/7f/kjod-43-235.PMC3822063.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Original Article pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2013.43.5.242",Non-OADS,/arxiv_data1/oa_pdf/f7/32/kjod-43-242.PMC3822064.pdf
"Nascimento et al • Bleaching, adhesion of orthodontic brackets www.e-kjo.org 243 http://dx.doi.org/10.4041/kjod.2013.43.5.242 INTRODUCTION    The success of orthodontic treatment with fixed  applia  nces depends on several factors, including  adequate bracket bonding and the longevity of these  accessories on the teeth.",Non-OADS,/arxiv_data1/oa_pdf/f7/32/kjod-43-242.PMC3822064.pdf
"Nascimento et al • Bleaching, adhesion of orthodontic brackets www.e-kjo.org 244 http://dx.doi.org/10.4041/kjod.2013.43.5.242 ficial saliva at 37oC.",Non-OADS,/arxiv_data1/oa_pdf/f7/32/kjod-43-242.PMC3822064.pdf
"Nascimento et al • Bleaching, adhesion of orthodontic brackets www.e-kjo.org 245 http://dx.doi.org/10.4041/kjod.2013.43.5.242 among the tested groups ( p < 0.0001).",Non-OADS,/arxiv_data1/oa_pdf/f7/32/kjod-43-242.PMC3822064.pdf
"Nascimento et al • Bleaching, adhesion of orthodontic brackets www.e-kjo.org 246 http://dx.doi.org/10.4041/kjod.2013.43.5.242 of the unbleached enamel within 3 weeks following  blea ching.",Non-OADS,/arxiv_data1/oa_pdf/f7/32/kjod-43-242.PMC3822064.pdf
"Nascimento et al • Bleaching, adhesion of orthodontic brackets www.e-kjo.org 247 http://dx.doi.org/10.4041/kjod.2013.43.5.242 (Chic.)",Non-OADS,/arxiv_data1/oa_pdf/f7/32/kjod-43-242.PMC3822064.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and  reproduction in any medium, provided the original work is properly cited.THE KOREAN JOURNAL of  ORTHODONTICS Case Report pISSN 2234-7518 • eISSN 2005-372X http://dx.doi.org/10.4041/kjod.2013.43.5.248",Non-OADS,/arxiv_data1/oa_pdf/17/32/kjod-43-248.PMC3822065.pdf
"Park et al • Mangement of CCD www.e-kjo.org 249 http://dx.doi.org/10.4041/kjod.2013.43.5.248 INTRODUCTION   Cleidocranial dysplasia (CCD), also known as cleido - cranial dysostosis or Marie-Sainton syndrome, is an autosomal dominant disorder with a prevalence of 1 in  1,000,000 individuals.",Non-OADS,/arxiv_data1/oa_pdf/17/32/kjod-43-248.PMC3822065.pdf
"Park et al • Mangement of CCD www.e-kjo.org 250 http://dx.doi.org/10.4041/kjod.2013.43.5.248 present deafness, hypertelorism, and low nasal bridge.",OADS,/arxiv_data1/oa_pdf/17/32/kjod-43-248.PMC3822065.pdf
"Park et al • Mangement of CCD www.e-kjo.org 251 http://dx.doi.org/10.4041/kjod.2013.43.5.248 et al.7 study, an individual with CCD having a missense  mutation in RUNX2 showed reduced basal expression of  mRNA for receptor activator of nuclear factor kappa-  B ligand (RANKL), which is normally expressed on the  cell membrane of osteoblasts.",OADS,/arxiv_data1/oa_pdf/17/32/kjod-43-248.PMC3822065.pdf
"Park et al • Mangement of CCD www.e-kjo.org 252 http://dx.doi.org/10.4041/kjod.2013.43.5.248 not have any apparent genetic cause.10 A possible role  of environmental and other nongenetic factors in the  varia tion of CCD symptoms, especially in the formation  of supernumerary teeth, has been suggested by Suda et  al.,11 who studied a case of monozygotic twins with an  identical mutation in RUNX2 showing different numbers  and positions of supernumerary teeth.",Non-OADS,/arxiv_data1/oa_pdf/17/32/kjod-43-248.PMC3822065.pdf
"Park et al • Mangement of CCD www.e-kjo.org 253 http://dx.doi.org/10.4041/kjod.2013.43.5.248 CASE REPORT Case 1 Features   A 12-year-old Asian boy diagnosed with CCD presented  with his father, who had the same condition.",Non-OADS,/arxiv_data1/oa_pdf/17/32/kjod-43-248.PMC3822065.pdf
Park et al • Mangement of CCD www.e-kjo.org 254 http://dx.doi.org/10.4041/kjod.2013.43.5.248 logram confirmed the skeletal class III relationship due  to maxillary underdevelopment (Figure 1F).,OADS,/arxiv_data1/oa_pdf/17/32/kjod-43-248.PMC3822065.pdf
"Park et al • Mangement of CCD www.e-kjo.org 255 http://dx.doi.org/10.4041/kjod.2013.43.5.248 breathing, tongue thrusting, and clenching habits were  also noted.",Non-OADS,/arxiv_data1/oa_pdf/17/32/kjod-43-248.PMC3822065.pdf
Park et al • Mangement of CCD www.e-kjo.org 256 http://dx.doi.org/10.4041/kjod.2013.43.5.248 achieved 11 mm of expansion (Figure 7C).,OADS,/arxiv_data1/oa_pdf/17/32/kjod-43-248.PMC3822065.pdf
Park et al • Mangement of CCD www.e-kjo.org 257 http://dx.doi.org/10.4041/kjod.2013.43.5.248 postsurgical lateral cephalograms (Figure 9).,OADS,/arxiv_data1/oa_pdf/17/32/kjod-43-248.PMC3822065.pdf
"Park et al • Mangement of CCD www.e-kjo.org 258 http://dx.doi.org/10.4041/kjod.2013.43.5.248   Regarding the dental features, congenital hypodontia  was observed in 12% of this population.",Non-OADS,/arxiv_data1/oa_pdf/17/32/kjod-43-248.PMC3822065.pdf
Park et al • Mangement of CCD www.e-kjo.org 259 http://dx.doi.org/10.4041/kjod.2013.43.5.248 period and a second surgical phase of exposing and  bonding the impacted permanent teeth.,Non-OADS,/arxiv_data1/oa_pdf/17/32/kjod-43-248.PMC3822065.pdf
"Park et al • Mangement of CCD www.e-kjo.org 260 http://dx.doi.org/10.4041/kjod.2013.43.5.248 before the introduction of cone-beam computed tomo- graphy (CBCT), this technology is now routinely used  to provide a three-dimensional image of the dentition,  reducing guesswork and ensuring better anatomical  loca li zation of supernumerary and impacted teeth.",Non-OADS,/arxiv_data1/oa_pdf/17/32/kjod-43-248.PMC3822065.pdf
To viewplease visit the journal online(http://dx.doi.org/10.1136/ amiajnl-2012-001110).,OADS,/arxiv_data1/oa_pdf/94/7e/amiajnl-2012-001110.PMC3822103.pdf
"▸W e make our trained CRF classi ﬁer, ADEPT (Automatic Detection of Patient T erminology) freely available as a webservice from our website (http://vis.stanford.edu/projects/adept).",Non-OADS,/arxiv_data1/oa_pdf/94/7e/amiajnl-2012-001110.PMC3822103.pdf
"Datasets MedHelp (http://www.medhelp.com) is an online health com-munity designed to aid users in the diagnosis, exploration, andmanagement of personal medical conditions.",OADS,/arxiv_data1/oa_pdf/94/7e/amiajnl-2012-001110.PMC3822103.pdf
"CureT ogether (http://www.curetogether.com) is an online health community where members share primarily categorical and quantitative data, but also hold short discussions.",Non-OADS,/arxiv_data1/oa_pdf/94/7e/amiajnl-2012-001110.PMC3822103.pdf
PAT medical word identi ﬁcation task Amazon ’s Mechanical T urk (http://www.mturk.com) is an online crowdsourcing platform where workers (T urkers) can browse‘human intelligence tasks ’(or HITs) posted by requesters and complete them for a small payment.,OADS,/arxiv_data1/oa_pdf/94/7e/amiajnl-2012-001110.PMC3822103.pdf
"Our experts comprised 30 registered nurses from ODesk (http://www.odesk.com), an online professional contractingservice.",OADS,/arxiv_data1/oa_pdf/94/7e/amiajnl-2012-001110.PMC3822103.pdf
"W e use the Stanford Named EntityRecognizer package (http://nlp.stanford.edu/software/CRF-NER.shtml), a trainable, Java implementation of a CRF classi ﬁer, and its default feature set.",OADS,/arxiv_data1/oa_pdf/94/7e/amiajnl-2012-001110.PMC3822103.pdf
"W e have made ourtrained CRF model, named ADEPT (Automatic Detection ofPatient T erminology), available to the public both for downloadand as a web service (http://vis.stanford.edu/projects/adept).",Non-OADS,/arxiv_data1/oa_pdf/94/7e/amiajnl-2012-001110.PMC3822103.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Neal L, Oakley K, Lindgaard G, et al.",Non-OADS,/arxiv_data1/oa_pdf/94/7e/amiajnl-2012-001110.PMC3822103.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ amiajnl-2012-001414).,OADS,/arxiv_data1/oa_pdf/23/49/amiajnl-2012-001414.PMC3822109.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 McKibbon K, Lokker C, Handler S, et al.Enabling medication management through health information technology .",Non-OADS,/arxiv_data1/oa_pdf/23/49/amiajnl-2012-001414.PMC3822109.pdf
To view please visit the journal online (http://dx.doi.org/10.1136/amiajnl-2012-001540).,Non-OADS,/arxiv_data1/oa_pdf/c5/b4/amiajnl-2012-001540.PMC3822114.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Gabril MY, Yousef GM.",Non-OADS,/arxiv_data1/oa_pdf/c5/b4/amiajnl-2012-001540.PMC3822114.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ amiajnl-2013-001745).,OADS,/arxiv_data1/oa_pdf/30/ed/amiajnl-2013-001745.PMC3822121.pdf
"See: http://creativecommons.org/ licenses/by-nc/3.0/ REFERENCES 1 Ash JS, Berg M, Coiera E. Some unintended consequences of information technology in health care: the nature of patient care information system-related errors.",Non-OADS,/arxiv_data1/oa_pdf/30/ed/amiajnl-2013-001745.PMC3822121.pdf
"Malawi is seriously affected by the HIV pandemic, and the national HIV prevalence in adults between 15 and 49 years of age was 10% in 2011 according to the UN (http://www.unaids.org/en/regionscountries/countries/malawi/).",Non-OADS,/arxiv_data1/oa_pdf/88/4c/ORT-84-460.PMC3822130.pdf
"Malawi is rated as number 170 of 186 countries in the United Nation’s Human Development index (http://hdrstats.undp.org/en/coun-tries/profiles/MWI.html), and as such is one of the poorest countries in the world.",Non-OADS,/arxiv_data1/oa_pdf/88/4c/ORT-84-460.PMC3822130.pdf
Tremor Other Hyperkinet Mov 2013; 3: http://tremorjournal.org/article/view/196 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
5It is not clear why long-termFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
Evaluating Deep Brain Stimulation Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
Evaluating Deep Brain Stimulation Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
Evaluating Deep Brain Stimulation Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
Evaluating Deep Brain Stimulation Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Curr Neurol Neurosci Rep2009;9:273–277, doi: http://dx.doi.org/10.1007/s11910-009-0041-6.",Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"2010;25:1550–1559, doi: http://dx.doi.org/10.1002/mds.23195.",Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Neurotherapeutics 2008;5:331–338, doi: http://dx.doi.org/10.1016/j.nurt.2008.01.004.",OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"J Neurosurg 2008;109:640–646, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Mov Disord 2006;21:1920–1928, doi: http://dx.doi.org/10.1002/ mds.21087.",Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Crit Rev Biomed Eng 2007;35:343–362, doi: http://dx.doi.org/10.1615/CritRevBiomedEng.v35.i5.10.",Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Clin Neurol Neurosurg 2009;111:376–379, doi: http://dx.doi.org/10.1016/j.clineuro.2008.10.017.12.Beuter A, de Geoffroy A, Edwards R. Quantitative analysis of rapid pointing movements in Cree subjects exposed to methylmercury and in subjectswith neurological deficits.",OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Environ Res 1999;80:50–63, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Mov Disord 2007;22:833–838, doi: http://dx.doi.org/10.1002/mds.21412.",OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Mov Disord 2002;17:313–316, doi: http://dx.doi.",OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Exp Neurol 2007;208: 257–263, doi: http://dx.doi.org/10.1016/j.expneurol.2007.08.014.",OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Arch Neurol 2003;60:405–410, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Parkinsonism Rel Disord 2006;12:49–55, doi: http://dx.doi.org/10.1016/j.parkreldis.2005.07.",OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Neurology 2000; 55:1547–1551, doi: http://dx.doi.org/10.1212/WNL.55.10.1547.",Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Clin Neurophysiol 2009;120:431–435, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Mov Disord 2006;21:373–379, doi: http://dx.doi.org/10.1002/ mds.20729.",OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Eur J Neurosci 2009;30:1971–1979, doi: http://dx.doi.org/10.1111/j.1460-9568.2009.06984.x.",Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Mov Disord 2006;21:1196–1199, doi: http://dx.doi.org/10.",OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Brain 2006;129: 2660–2666, doi: http://dx.doi.org/10.1093/brain/awl190.Evaluating Deep Brain Stimulation Wastensson G, Holmberg B, Johnels B, et al.",OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9,Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Br J Clin Pharmacol 1980;10:83–86, doi: http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Neurotoxicology 2007;28:569–575, doi: http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Clin Pharmacol Ther 1983;33:800–805, doi: http://dx.doi.org/10.1038/clpt.1983.109.30.Maykoski KA, Rubin MB, Day AC.",Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Nurs Res 1976;25:39–43, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"Parkinsonism Relat Disord 2012;18:859–863, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
Evaluating Deep Brain Stimulation Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services10,Non-OADS,/arxiv_data1/oa_pdf/ea/44/tre-03-196-196-4279-2.PMC3822146.pdf
"See: http://creativecommons.org/licenses/by-nc-nd/3.0 To cite Gagnier JJ, Kienle G, Altman DG, et al.Global Adv Health Med Published online: [ please include Day Month Year] doi:10.1136/bcr-2013-201554 Received 28 August 2013 Accepted 5 September 2013Reproduced with permission from Global Advances in Health and Medicine.",Non-OADS,/arxiv_data1/oa_pdf/c2/88/bcr-2013-201554.PMC3822203.pdf
"Bethesda, MD: PubMed, US National Library of Medicine, 2013. http://www.ncbi.nlm.nih.gov/pubmed/?term=case +reports (accessed 10 Jun 2013).",Non-OADS,/arxiv_data1/oa_pdf/c2/88/bcr-2013-201554.PMC3822203.pdf
http://www.casesdatabase.com/ (accessed 17 Jun 2013).,OADS,/arxiv_data1/oa_pdf/c2/88/bcr-2013-201554.PMC3822203.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003471).,Non-OADS,/arxiv_data1/oa_pdf/db/2b/bmjopen-2013-003471.PMC3822298.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/db/2b/bmjopen-2013-003471.PMC3822298.pdf
http://data.worldbank.org/indicator/NY.GDP.DEFL.KD.ZG/countries 13.,Non-OADS,/arxiv_data1/oa_pdf/db/2b/bmjopen-2013-003471.PMC3822298.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003304).,Non-OADS,/arxiv_data1/oa_pdf/7a/ef/bmjopen-2013-003304.PMC3822299.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/7a/ef/bmjopen-2013-003304.PMC3822299.pdf
2011. http://www.who.int/tobacco/global_report/2011/qanda/en/index.html 2.,Non-OADS,/arxiv_data1/oa_pdf/7a/ef/bmjopen-2013-003304.PMC3822299.pdf
2005. http://www.who.int/substance_abuse/terminology/who_lexicon/en/ 18.,Non-OADS,/arxiv_data1/oa_pdf/7a/ef/bmjopen-2013-003304.PMC3822299.pdf
To view these files pleasevisit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003640).,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/bmjopen-2013-003640.PMC3822300.pdf
"Sri Lanka: Traffic Police, Sri Lanka Police; 2010. http://www.police.lk/index.php/traffic-police (accessed 2012).",Non-OADS,/arxiv_data1/oa_pdf/a7/4e/bmjopen-2013-003640.PMC3822300.pdf
http://www.police.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/bmjopen-2013-003640.PMC3822300.pdf
Brussels: European Transport Safety Council; 2007. http://www.etsc.,Non-OADS,/arxiv_data1/oa_pdf/a7/4e/bmjopen-2013-003640.PMC3822300.pdf
Institute for Health Metrics and Evaluation (IHME)2012 [cited 2013]; http://www.healthmetricsandevaluation.org/gbd/visualizations/gbd-arrow-diagram 19.,OADS,/arxiv_data1/oa_pdf/a7/4e/bmjopen-2013-003640.PMC3822300.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003428).,Non-OADS,/arxiv_data1/oa_pdf/60/09/bmjopen-2013-003428.PMC3822301.pdf
2012. http://www.healthcheck.nhs.uk/5.,Non-OADS,/arxiv_data1/oa_pdf/60/09/bmjopen-2013-003428.PMC3822301.pdf
"Circa 2001-2013, updated 15 Apr 2013, http://www.sign.",Non-OADS,/arxiv_data1/oa_pdf/60/09/bmjopen-2013-003428.PMC3822301.pdf
http://www.sst.dk/English/Health_promotion/Physical_activity/Recommendations_for_adults.aspx 49.,Non-OADS,/arxiv_data1/oa_pdf/7a/7d/bmjopen-2013-003556.PMC3822303.pdf
http://www.dbcg.dk/PDF%20Filer/07-READ%20Prtotokol%20161009.pdf 50.,Non-OADS,/arxiv_data1/oa_pdf/7a/7d/bmjopen-2013-003556.PMC3822303.pdf
[cited 2013 July 3].http://www.controlled-trials.com/ISRCTN59757862 51.,Non-OADS,/arxiv_data1/oa_pdf/7a/7d/bmjopen-2013-003556.PMC3822303.pdf
http://www.walk-up.dk/inspiration/skridttaelleren/13-skridttaellerprogrammet 69.,Non-OADS,/arxiv_data1/oa_pdf/7a/7d/bmjopen-2013-003556.PMC3822303.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003531).,Non-OADS,/arxiv_data1/oa_pdf/ae/78/bmjopen-2013-003531.PMC3822304.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003414).,Non-OADS,/arxiv_data1/oa_pdf/8d/eb/bmjopen-2013-003414.PMC3822306.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/eb/bmjopen-2013-003414.PMC3822306.pdf
"Tampere: Finnish Diabetes Association, 2009. http://www.diabetes.fi/files/1167/DehkoFinDM_Raportti_ENG.pdf (accessed May 2013).",Non-OADS,/arxiv_data1/oa_pdf/8d/eb/bmjopen-2013-003414.PMC3822306.pdf
"WHO, 2006. http://www.whocc.no/atcddd/ (accessed May 2013).35.",OADS,/arxiv_data1/oa_pdf/8d/eb/bmjopen-2013-003414.PMC3822306.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003541).,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/bmjopen-2013-003541.PMC3822307.pdf
"From the Global Strategy for the Diagnosis, Management and Prevention of COPD , Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2011. http://www.goldcopd.org/ (accessed 12 Dec2012).",Non-OADS,/arxiv_data1/oa_pdf/cc/5c/bmjopen-2013-003541.PMC3822307.pdf
2011. http://www.ginasthma.org/ (accessed 20 June 2012).,Non-OADS,/arxiv_data1/oa_pdf/cc/5c/bmjopen-2013-003541.PMC3822307.pdf
doi:10.1136/bmjopen-2013- 003696 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003696).,Non-OADS,/arxiv_data1/oa_pdf/70/ad/bmjopen-2013-003696.PMC3822308.pdf
Retrieved 10 June 2013. http://www.ssb.no/akutidord 4.,Non-OADS,/arxiv_data1/oa_pdf/70/ad/bmjopen-2013-003696.PMC3822308.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2013-004030).,Non-OADS,/arxiv_data1/oa_pdf/d7/21/bmjopen-2013-004030.PMC3822309.pdf
"Autosomal dominant RP (adRP) accounts for 20 –25% of all RP patients.4To date, more than 24 genes (Best 1, C1QTNF5, CA4, CRX, FSCN2, GUCA1B, IMPDH1, KLHL7, NR2E3, NRL, PRPF3, PRPF31, PRPF6,PRPF8, PRPH2, RDH12, RHO, ROM1, RP1, RP9, RPE65, SEMA4A, SNRP200 and TOPORS) have been reported to be asso-ciated with adRP (https://sph.uth.edu/ retnet/disease.htm).",Non-OADS,/arxiv_data1/oa_pdf/d7/21/bmjopen-2013-004030.PMC3822309.pdf
Splice-site variants were analysed using the prediction program AUGUSTUS (http://bioinf.uni-greifswald.de/augustus/submission).,OADS,/arxiv_data1/oa_pdf/d7/21/bmjopen-2013-004030.PMC3822309.pdf
Primer pairs for indi- vidual exons were designed using the primer program (http://www.yeastgenome.org/cgi-bin/web-primer)(DNA reference number NG_009759).,OADS,/arxiv_data1/oa_pdf/d7/21/bmjopen-2013-004030.PMC3822309.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/d7/21/bmjopen-2013-004030.PMC3822309.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003135).,Non-OADS,/arxiv_data1/oa_pdf/e3/b7/bmjopen-2013-003135.PMC3822311.pdf
doi:10.1136/bmjopen-2013- 003573 ▸Prepublication history for this paper is available online.To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2013-003573).,Non-OADS,/arxiv_data1/oa_pdf/69/e2/bmjopen-2013-003573.PMC3822313.pdf
"Summaries of Product Characteristics (Soliris): The electronic Medicines Compendium, 2012. http://www.medicines.org.uk/emc/ medicine/19966 32.",Non-OADS,/arxiv_data1/oa_pdf/69/e2/bmjopen-2013-003573.PMC3822313.pdf
US Food and Drug Administration; 2007. http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/125166s172lbl.pdf35.,Non-OADS,/arxiv_data1/oa_pdf/69/e2/bmjopen-2013-003573.PMC3822313.pdf
"London: European Medicines Agency, 2006. http://www.ema.europa.eu/docs/en_GB/...guideline/.../WC500003615.pdf 48.",Non-OADS,/arxiv_data1/oa_pdf/69/e2/bmjopen-2013-003573.PMC3822313.pdf
"Statement from AGNSS regarding eculizumab and tafamidis, 2013. http://www.specialisedservices.nhs.uk/news/view/132 10 Rathbone J, Kaltenthaler E, Richards A, et al.BMJ Open 2013; 3:e003573.",Non-OADS,/arxiv_data1/oa_pdf/69/e2/bmjopen-2013-003573.PMC3822313.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003306).,Non-OADS,/arxiv_data1/oa_pdf/ab/c1/bmjopen-2013-003306.PMC3822314.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2013-003325).,Non-OADS,/arxiv_data1/oa_pdf/9b/cc/bmjopen-2013-003325.PMC3822315.pdf
See: http://creativecommons.org/licenses/by-nc/3.0/ REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9b/cc/bmjopen-2013-003325.PMC3822315.pdf
http://www.ncbi.nlm.nih.gov/pubmed/15485411 6.,Non-OADS,/arxiv_data1/oa_pdf/9b/cc/bmjopen-2013-003325.PMC3822315.pdf
"China statistical yearbook , 2006. http://www.stats.gov.cn/tjsj/ndsj/2006/indexeh.htm (accessed26 Feb 2010).",OADS,/arxiv_data1/oa_pdf/9b/cc/bmjopen-2013-003325.PMC3822315.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/47/87/IJU-29-271.PMC3822339.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcementsupported by the Urological Society of India and I would  like to thank all the office bearers of Urological Society of India during the last 8 years who have offered unqualified support to the  Indian Journal of Urology .,Non-OADS,/arxiv_data1/oa_pdf/47/87/IJU-29-271.PMC3822339.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/34/57/IJU-29-277.PMC3822341.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/34/57/IJU-29-277.PMC3822341.pdf
Available from: http://www.hesonline.nhs.uk.,Non-OADS,/arxiv_data1/oa_pdf/8f/3b/IJU-29-328.PMC3822350.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/8f/3b/IJU-29-328.PMC3822350.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/d5/9f/IJU-29-351.PMC3822354.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/8f/81/IJU-29-355.PMC3822356.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/35/38/srep03175.PMC3822378.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3175 | DOI: 10.1038/srep03175 6",Non-OADS,/arxiv_data1/oa_pdf/35/38/srep03175.PMC3822378.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3179 | DOI: 10.1038/srep03179 5",Non-OADS,/arxiv_data1/oa_pdf/52/0d/srep03179.PMC3822379.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/da/2a/srep03176.PMC3822381.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3176 | DOI: 10.1038/srep03176 6",Non-OADS,/arxiv_data1/oa_pdf/da/2a/srep03176.PMC3822381.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/97/d7/srep03181.PMC3822382.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3181 | DOI: 10.1038/srep03181 6",Non-OADS,/arxiv_data1/oa_pdf/97/d7/srep03181.PMC3822382.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3178 | DOI: 10.1038/srep03178 10",Non-OADS,/arxiv_data1/oa_pdf/c4/41/srep03178.PMC3822384.pdf
"To construct the assembled transcriptome, all raw reads were assembled using the Trinity (http://trinityrnaseq.sourceforge.net/) 38de novo transcriptome assembly software packages.",OADS,/arxiv_data1/oa_pdf/99/4c/srep03184.PMC3822385.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/99/4c/srep03184.PMC3822385.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3184 | DOI: 10.1038/srep03184 9",Non-OADS,/arxiv_data1/oa_pdf/99/4c/srep03184.PMC3822385.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/50/30/srep03185.PMC3822391.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3185 | DOI: 10.1038/srep03185 7",Non-OADS,/arxiv_data1/oa_pdf/50/30/srep03185.PMC3822391.pdf
"Taxonomic classification was conducted using the online RDP Classifier version 2.5 (http://rdp.cme.msu.edu) with a confidence threshold of 50% for clas- sification at the KEGG (version 67.0) 51, CAZy52and COG (version 9.05)53prokaryote databases on local servers, using an E-value of ,1025.",OADS,/arxiv_data1/oa_pdf/1b/f6/srep03180.PMC3822395.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/1b/f6/srep03180.PMC3822395.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3180 | DOI: 10.1038/srep03180 7",Non-OADS,/arxiv_data1/oa_pdf/1b/f6/srep03180.PMC3822395.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/8f/ec/srep03177.PMC3822396.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3177 | DOI: 10.1038/srep03177 7",Non-OADS,/arxiv_data1/oa_pdf/8f/ec/srep03177.PMC3822396.pdf
"H e is currently employed at Pfizer, Inc. in Cambridge, Massachusetts.Conflict of interest: J.J. has served on the following editorial boards without financial compensation: Medlink: Neurology ,Expert Review of Neurotherapeutics ,a n d Neurology in Clinical Practice and has served as an associate editor of The Botulinum Journal ,Therapeutic Advances in Neurological Disorders ,Neurotherapeutics ,Tremor and Other Hyperkinetic Movements ,Journal of Parkinson’s Disease ,a n d UpToDate .Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
Epidemiology of CD Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
Epidemiology of CD Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5,Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
Epidemiology of CD Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6,Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Parkinsonism Relat Disord 2007;13:411–416, doi: http://dx.doi.org/10.1016/j.parkreldis.2007.02.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 2011;26:1106–1126, doi: http://dx.doi.org/10.1002/mds.23775.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"3.Phukan J, Albanese A, Gasser T, Warner T. Primary dystonia and dystonia-plus syndromes: clinical characteristics, diagnosis, and pathogenesis.Lancet Neurol 2011;10:1074–1085, doi: http://dx.doi.org/10.1016/S1474- 4422(11)70232-0.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Neurobiol Dis 2012;46:1–18, doi: http://dx.doi.org/10.1016/j.nbd.2011.12.054.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Neurol Clin 2008;26 Suppl 1:23–42, doi: http://dx.doi.org/10.1016/ S0733-8619(08)80003-5.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 2011;26:1789– 1792, doi: http://dx.doi.org/10.1002/mds.23837.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 2010;25:407–412, doi: http://dx.doi.org/10.1002/mds.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 2010;25:527–528, doi: http://dx.doi.org/10.1002/mds.23139.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Brain 1990;113(Pt 2):379–395, doi: http://dx.doi.org/10.1093/brain/113.2.379.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 1997;12:1000–1006, doi: http://dx.doi.org/10.1002/mds.870120625.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Ann Neurol 1991;29:320–324, doi: http://dx.doi.org/ 10.1002/ana.410290315.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Neurology2007;69:676–680, doi: http://dx.doi.org/10.1212/01.wnl.0000267425.51598.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"J Neurol Neurosurg Psychiatry 2003;74:348–350, doi: http://dx.doi.org/10.1136/ jnnp.74.3.348.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Arch Neurol 1985;42:655–657, doi: http://dx.doi.org/10.1001/archneur.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 1988;3:188–194, doi: http://dx.doi.org/10.1002/mds.870030302.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Neuroepidemiology 1994;13:202–210, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 1995;10: 440–443, doi: http://dx.doi.org/10.1002/mds.870100406.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Neuroepidemiology 2002;21:202–206, doi: http://dx.doi.org/10.1159/000059525.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 2003;18:1196–1198, doi: http://dx.doi.org/10.1002/mds.10480.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 2003;18:1389–1392, doi: http://dx.doi.org/10.1002/mds.10615.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Neurology 2003;61:1294–1296, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 2006;21:293– 298, doi: http://dx.doi.org/10.1002/mds.20674.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 2007;22:2031–2036, doi: http://dx.doi.org/10.1002/mds.21446.Epidemiology of CD Defazio G, Jankovic J, Giel JL, et al.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7,Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Neuroepidemiology 2009;33:117–123, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 1995;10:608–614, doi: http://dx.doi.org/10.1002/ mds.870100513.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Neurology 2004;63: 1423–1426, doi: http://dx.doi.org/10.1212/01.WNL.0000142035.26034.C2.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"J Nerv Ment Dis 2003;191:465–473, doi: http://dx.doi.org/10.1097/01.NMD.0000081667.02656.21.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 2010;25:459–465, doi: http://dx.doi.org/10.1002/mds.22983.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Neurology 2003;60:1012–1015, doi: http://dx.doi.org/10.1212/01.WNL.0000049932.22065.60.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Acta Neurol Scand 2004;109:369–373, doi: http://dx.doi.org/10.1111/j.1600-0404.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"J Neurol Neurosurg Psychiatry 1998;64:25–32, doi: http://dx.doi.org/10.1136/jnnp.64.1.25.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Neurology 1991;41:1088–1091, doi: http://dx.doi.org/10.1212/WNL.41.7.1088.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"J Neurol Neurosurg Psychiatry 1996;60:204–205, doi: http://dx.doi.org/10.1136/ jnnp.60.2.204.44.Steeves TD, Day L, Dykeman J, Jette N, Pringsheim T. The prevalence of primary dystonia: a systematic review and meta-analysis.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 2012;27: 1789–1796, doi: http://dx.doi.org/10.1002/mds.25244.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Neurology 1999;53:1871–1873, doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"J Neurol Neurosurg Psychiatry 2003;74:265–267, doi: http://dx.doi.org/10.1136/jnnp.74.2.265.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"47.Maniak S, Sieberer M, Hagenah J, Klein C, Vieregge P. Focal and segmental primary dystonia in north-western Germany--a clinico-genetic study.Acta Neurol Scand 2003;107:228–232, doi: http://dx.doi.org/10.1034/j.1600- 0404.2003.01362.x.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 2005;20:822–825, doi: http://dx.doi.org/10.1002/mds.20398.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Ann Neurol 2012;71:458–469, doi: http://dx.doi.org/ 10.1002/ana.23547.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"53.Papapetropoulos S, Rosa K, Comella C, Boo L, Brin M. Validity and reliability of the Pictorial Spasmodic Torticollis Rating Scale (P-STRS).Neurology 2011;76:A587 [abstract], doi: http://dx.doi.org/10.1212/WNL.",Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
"Mov Disord 2006;21:571–575, doi: http://dx.doi.org/10.1002/ mds.20760.Defazio G, Jankovic J, Giel JL, et al.",OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
Epidemiology of CD Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8,Non-OADS,/arxiv_data1/oa_pdf/90/aa/tre-03-193-4374-2.PMC3822401.pdf
Tremor Other Hyperkinet Mov 2013; 3: http://tremorjournal.org/article/view/170 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
3Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"A summary of the active DBS contacts and lead locations is provided in Table 2.Motlagh MG, Smith ME, Landeros-Weisenberger A, et al Deep Brain Stimulation for Tourette Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"(2012) 3311 (anteromedial) 4–30 51Deep Brain Stimulation for Tourette Syndrome Motlagh MG, Smith ME, Landeros-Weisenberger A, et al Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"(2009)2311 2 7 6 Abbreviations: A/C, Anterior Limb of Internal Capsule; CM–Pf, Centromedial–Parafascicular Complex; GPe, Globus Pallidus, Pars Externus; GPi, Gl obus Pallidus, Pars Internus; MRVRS, Modified Rush Videotape Rating Scale; NA, Nucleus Accumbens; STN, Subthalamic Nucleus; Voi, Ventralis Oralis; YGTSS, Yale Global Tic Severity Scale.Motlagh MG, Smith ME, Landeros-Weisenberger A, et al Deep Brain Stimulation for Tourette Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"5 V, 90 ms, 185 Hz X (mm lateral to intercommissural) 517 L 2-C+, 2.0 V, 90 ms, 185 Hz Y (mm anterior to mid-commissural) 54 Z (mm deep to mid-commissural) 55 5 GPi (posteroventral/sensorimotor) Leksell frame, MRI intraoperative guidance, deep sedation, macrostimulation used, nomicroelectrode recordingR 4+6-5-7+, 2.1 V, 180 ms, 185 Hz X (mm lateral to intercommissural) 517 L 2-1-0-C+, 2.1 V, 180ms, 185 Hz Y (mm anterior to mid-commissural) 54 Z (mm deep to mid-commissural) 55Deep Brain Stimulation for Tourette Syndrome Motlagh MG, Smith ME, Landeros-Weisenberger A, et al Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services5",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"Table 2.Continued Patient Location Identification of the Anatomic Target DBS Settings 6 Thalamus Leksell frame, MRI/CT fusion, procedure performed under local anesthesia withdexmedetomidine used for sedationR 1-C+, 3.0 V, 90 ms, 130 Hz X (mm lateral AC-PC) 55 L 1-C+, 3.2 V, 90 ms, 130 Hz Y (mm posterior AC-PC) 54 Z (mm beneath AC-PC) 50 Physiologic confirmation with microelectrode recording andmacrostimulation 7 GPi, anterior mesial (limbic) Leksell frame, MRI intraoperative guidance, sedation with dexmedetomidine/propofol,physiologic confirmation withmicroelectrodes recording only*R 1-C+, 3.0 V, 150 ms, 90 Hz X (mm lateral to intercommissural) 514 *L 1-C+, 2.5 V, 180 ms, 120 Hz Y (mm anterior to mid-commissural) 518 Z (mm deep to mid-commissural) 55 Thalamus *R 11-C+, 2.0 V, 60 ms, 120 Hz X (mm lateral AC-PC) 56 *L 9-10-C+, 3.0 V, 60 ms, 120 Hz Y (mm posterior AC-PC) 53 Z (mm beneath AC-PC) 50 GPi (posteroventral/sensorimotor) R 8-C+, 2.5 V, 90 ms, 185 Hz X (mm lateral to intercommissural) 517 *L 8-C+, 2.5 V, 90 ms, 180 Hz Y (mm anterior to mid-commissural) 54 Z (mm deep to mid-commissural) 55 8 Thalamus Leksell frame, MRI/CT fusion, procedure performed under general anesthesia with propofol and remifentanilR C+1-, 2.1 V, 90 ms, 130 Hz X (mm lateral AC-PC) 55 L C+1-, 1.9 V, 90 ms, 130 Hz Y (mm posterior AC-PC) 54 Z (mm beneath AC-PC) 50Motlagh MG, Smith ME, Landeros-Weisenberger A, et al Deep Brain Stimulation for Tourette Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services6",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"*Electrodes are currently turned OFF.Deep Brain Stimulation for Tourette Syndrome Motlagh MG, Smith ME, Landeros-Weisenberger A, et al Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services7",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"Table 3.Baseline Clinical Characteristics of the Eight Patients with Tourette Syndrome Subject Sex Age (Years)Disease Duration (Years)Tic SymptomsTypical Waxing and Waning CourseSelf- InjuryComorbid DisordersFamily HistoryLiving and Work SituationMedication Before SurgeryCurrent Medication 1 M 48 45 Eye blinking, violent headjerks,throwingelbow against ribs, abdominaltensing,snapping,grunting,screeching,coprolaliaNo Yes, slammingforearmagainstforeheadOCD (mild tomoderate),depressionNo Separated, employedpart timeHaloperidol, pimozide,risperidone,clonidine,fluoxetine, clonazepam, pergolideHaloperidol, fluoxetinegabapentin,tizanidine,diazepam, temazepam, aspirin 2 aM 44 41 Eye movements,facial tics,head jerkingand snapping, shoulder shrugs,grunting,throatclearingYes Yes, skin pickingOCD (severe)Yes Unmarried, self-employedPimozide, risperidone,olanzapine,quetiapine,fluoxetine, fluvoxamine, sertraline,clomipramine,clonazepamSertraline, clonazepamMotlagh MG, Smith ME, Landeros-Weisenberger A, et al Deep Brain Stimulation for Tourette Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services8",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"Table 3.Continued Subject Sex Age (Years)Disease Duration (Years)Tic SymptomsTypical Waxing and Waning CourseSelf- InjuryComorbid DisordersFamily HistoryLiving and Work SituationMedication Before SurgeryCurrent Medication 3bM 37 27 Head and neckmovements,body jerking,shifting bodyposition,tonguemovements, hand and arm tensing,bumpingobjects intoteeth, toecurling,diaphragmaticdystonic tics limiting ability to breatheNo No OCD, attention-deficitdisorder,anxietysymptomsNo Unmarried, employedHaloperidol, pimozide,clonidine,fluoxetine,sertraline,clonazepamClonidine, clonazepam, 4 M 42 38 Facial grimacing, flopping hands infront of face,pointingfinger backand front,chestrubbing, grunting, yelling,whistling,curse wordsNo No OCD, history of ADHDNo Unmarried, unemployedHaloperidol, pimozide, clonazepam, methylphenidateClonazepamDeep Brain Stimulation for Tourette Syndrome Motlagh MG, Smith ME, Landeros-Weisenberger A, et al Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services9",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"Table 3.Continued Subject Sex Age (Years)Disease Duration (Years)Tic SymptomsTypical Waxing and Waning CourseSelf- InjuryComorbid DisordersFamily HistoryLiving and Work SituationMedication Before SurgeryCurrent Medication 5 M 24 15 Head jerks, snapping armagainst side,kicking,licking items,headgrabbing,copropraxia, loud screaming,sniffingYes Yes, punching,hittinghimselfOCD Yes Married, one child,unemployedHaloperidol, pimozide,risperidone,fluphenazine,clonidine,fluvoxamine,imipramine,nortriptyline, clonazepam, pergolideClonazepam, quetiapine,zolpidem,topiramate,nicotinepatches,ketamine,opiates 6 M 16 13 Eye blinking, head and shoulderjerking, headbobbing,flexion andextension ofarms andfingers, spinning in place, throatclearing,coprolaliaYes No ADHD No Unmarried, high-school studentRisperidone, aripiprazole, ziprasidone,sertraline,tetrabenazine,methylphenidate,topiramateNoneMotlagh MG, Smith ME, Landeros-Weisenberger A, et al Deep Brain Stimulation for Tourette Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services10",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"Table 3.Continued Subject Sex Age (Years)Disease Duration (Years)Tic SymptomsTypical Waxing and Waning CourseSelf- InjuryComorbid DisordersFamily HistoryLiving and Work SituationMedication Before SurgeryCurrent Medication 7 M 19 11 Dystonic posturing,exclusivelyleft-sided ticsand self-injuriousbehaviorssuch as poking left cornea andpulling on lefteye lid,repeatingsingle wordsor syllablesNo Yes poking lefteye andpulling onleft eyelid, leftcheekbitingOCD, somesymptomsof ADHDNo Unmarried, unemployedHaloperidol, risperidone,aripiprazole,fluphenazine,sertraline,clonazepam,tetrabenazine,guanfacine, topiramate, etanercept, N- acetyl cysteineHaloperidol, clonazepam,clonidine,clonazepam,sertraline,carbamazepineDeep Brain Stimulation for Tourette Syndrome Motlagh MG, Smith ME, Landeros-Weisenberger A, et al Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services11",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"bThe electrodes removed due to a lack of therapeutic benefit.Motlagh MG, Smith ME, Landeros-Weisenberger A, et al Deep Brain Stimulation for Tourette Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services12",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"cThis patient does not have any vocal tics.Deep Brain Stimulation for Tourette Syndrome Motlagh MG, Smith ME, Landeros-Weisenberger A, et al Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services13",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"Am J Psychiatry 2012;169:860–866.Motlagh MG, Smith ME, Landeros-Weisenberger A, et al Deep Brain Stimulation for Tourette Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services14",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"J Comp Neurol 2010;518:277–291.Deep Brain Stimulation for Tourette Syndrome Motlagh MG, Smith ME, Landeros-Weisenberger A, et al Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services15",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
"J Child Adolesc Psychopharmacol 2010;20:317–331.Motlagh MG, Smith ME, Landeros-Weisenberger A, et al Deep Brain Stimulation for Tourette Syndrome Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services16",Non-OADS,/arxiv_data1/oa_pdf/4f/ab/tre-03-170-4428-1.PMC3822402.pdf
Tremor Other Hyperkinet Mov 2013; 3: http://tremorjournal.org/article/view/195 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
His blood test results showed mild renal dysfunction: urea nitrogen was 29.6 mg/dL (reference valueFreely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1,Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"Neurology 1960;10:868–873, doi: http://dx.doi.org/10.1212/WNL.10.9.868.",Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"Sleep Med 2003;4:101–119, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"Sleep Med 2012;13:402–408, doi: http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"J Intern Med 2009;266:419– 431, doi: http://dx.doi.org/10.1111/j.1365-2796.2009.02159.x.",Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"Lancet 2008;371:530, doi: http://dx.doi.org/10.1016/S0140-6736(08)60240-8.",OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"Neurology 2011;77:1283–1286, doi: http://dx.doi.org/10.1212/WNL.0b013e318230207a.",Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"J Sex Med 2006;3:296–302, doi: http://dx.doi.org/10.1111/j.1743-6109.2005.00167.x.",Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"Arch Neurol 2003;60:1013–1015, doi: http://dx.doi.org/ 10.1001/archneur.60.7.1013.",Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"Arch Neurol 2002;59:421–424, doi: http://dx.doi.org/10.1001/archneur.59.3.421.",OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"Neurology 2004;63:S12–16, doi: http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"Mov Disord 2009;24:579–582, doi: http://dx.doi.org/10.1002/mds.22410.13.Chaudhuri KR, Healy DG, Schapira AH, National Institute for Clinical E. Non-motor symptoms of Parkinson’s disease: diagnosis and management.Lancet Neurol 2006;5:235–245, doi: http://dx.doi.org/10.1016/S1474- 4422(06)70373-8.",Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"Neurology 2006;67:125– 130, doi: http://dx.doi.org/10.1212/01.wnl.0000223316.53428.c9.",Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"Mov Disord 2007; 22 Suppl 18: S440–448, doi: http://dx.doi.org/10.1002/mds.21607.",OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"Mov Disord 1999;14:141–145, doi: http://dx.doi.org/10.1002/1531-8257(199901)14:1 ,141::AID-MDS1024 .3.",OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"Mov Disord 2010; 25 Suppl 1: S98– 103, doi: http://dx.doi.org/10.1002/mds.22716.",OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
"Neurology 2011;77:1936–1937, doi: http://dx.doi.org/ 10.1212/WNL.0b013e31823a0f0f.Suzuki K, Miyamoto M, Miyamoto T, et al.",Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4,Non-OADS,/arxiv_data1/oa_pdf/bb/59/tre-03-195-4313-2.PMC3822403.pdf
Tremor Other Hyperkinet Mov 2013; 3: http://tremorjournal.org/article/ view/179 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/4d/98/tre-03-179-4181-1.PMC3822404.pdf
"Before this, thecharity ‘‘John Grooms’’ handled the Advocacy’s finances.Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/4d/98/tre-03-179-4181-1.PMC3822404.pdf
"We are grateful toProfessor Bernard Landwehrmeyer for his support of patients with NA.Irvine G, Irvine G Advocacy for a Rare Disease Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2",Non-OADS,/arxiv_data1/oa_pdf/4d/98/tre-03-179-4181-1.PMC3822404.pdf
"The red blood cell investigations have been a part of the European Multidisciplinary Initiative onNeuroacanthocytosis (EMINA).Advocacy for a Rare Disease Irvine G, Irvine G Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3",Non-OADS,/arxiv_data1/oa_pdf/4d/98/tre-03-179-4181-1.PMC3822404.pdf
"Orphanet J Rare Dis 2011;6:68, doi: http://dx.doi.org/10.1186/1750-1172-6-68.",Non-OADS,/arxiv_data1/oa_pdf/4d/98/tre-03-179-4181-1.PMC3822404.pdf
"Nat Genet 2001;28:119– 120, doi: http://dx.doi.org/10.1038/88821.",Non-OADS,/arxiv_data1/oa_pdf/4d/98/tre-03-179-4181-1.PMC3822404.pdf
https://www.rareconnect.org/en/community/ neuroacanthocytosis.,Non-OADS,/arxiv_data1/oa_pdf/4d/98/tre-03-179-4181-1.PMC3822404.pdf
https://www.euro-hd.net/edit/na/network/docs/chorein-wb-info.pdf?tm 51345833311.,Non-OADS,/arxiv_data1/oa_pdf/4d/98/tre-03-179-4181-1.PMC3822404.pdf
"Ann Neurol 2004;56:299– 302, doi: http://dx.doi.org/10.1002/ana.20200.",Non-OADS,/arxiv_data1/oa_pdf/4d/98/tre-03-179-4181-1.PMC3822404.pdf
http://www.euro-hd.net/ html/na/registry?eurohdsid 5d049393bc7418cc71edf6e73bcb7c2f6.,Non-OADS,/arxiv_data1/oa_pdf/4d/98/tre-03-179-4181-1.PMC3822404.pdf
"Cell1994;77:869–880, doi: http://dx.doi.org/10.1016/0092-8674(94)90136-8.",OADS,/arxiv_data1/oa_pdf/4d/98/tre-03-179-4181-1.PMC3822404.pdf
"Nat Genet 2001;28:121–122, doi: http://dx.doi.org/10.1038/88825.Irvine G, Irvine G Advocacy for a Rare Disease Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services4",Non-OADS,/arxiv_data1/oa_pdf/4d/98/tre-03-179-4181-1.PMC3822404.pdf
Tremor Other Hyperkinet Mov 2013; 3: http://tremorjournal.org/article/view/138 * To whom correspondence should be addressed.,Non-OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
"These symptoms usually respond to low dose levodopa without dyskinesia or wearing-off episodes commonly obser v e di nc o m m o nP a r k i n s o n ’ sd i s e a s e (PD).2-4,6DYT-5 dystonia is associated w ith mutations in the guanosine triphosphate cyclohydrolase 1 gene ( GCH1 ) on chromosome 14 q21.1- q22.2.4,7More than 200 mutations have been reported in the gene (see The Human Gene Mutation Database [HGMD]: http://www.hgmd.cf.ac.uk/ac/gene.php?gene 5GCH1 for a complete published list of mutations).",Non-OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
"6Tremor, writer’s cramp, and cerebellar signs with saccadic eye alterations can also occur in DYT-5 dystonia cases.9Due to the variety of clinical presentations, the disease can be misdiagnosed, and cerebral palsy or parkinsonism are the most common misdiagnoses.10,11Freely available online Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services1",Non-OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
Novel DYT-5 Mutation Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services2,Non-OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
"Brain Dev 2011;33:195–201, doi: http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
"Nat Genet 1993;5:386–391, doi: http://dx.doi.org/10.1038/ng1293-386.4.Tassin J, Durr A, Bonnet AM, et al.",OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
"Brain 2002;125:695–721, doi: http://dx.doi.org/10.1093/brain/awf090.",OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
"Neurology 1999;52:877–879, doi: http://dx.doi.org/10.1212/WNL.52.4.877.",Non-OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
"Nat Gen 1994;8:236–242, doi: http://dx.doi.org/10.1038/ ng1194-236.",OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
"Neurology 2001;57:1121–1124, doi: http://dx.doi.org/10.1212/WNL.57.6.1121.",Non-OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
"J Neurol Neurosurg Psychiatry 2009;80:839–845, doi: http://dx.doi.org/10.1136/jnnp.2008.155861.",Non-OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
"Pediatr Neurol 1994;11:236–240, doi: http://dx.doi.org/10.1016/0887-8994(94)90109-0.",OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
"Neurol Sci 2001;22:51–52, doi: http://dx.doi.org/10.1007/ s100720170042.",Non-OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
"Biol Chem 1999;380:1355–1364, doi: http://dx.doi.org/10.1515/BC.1999.175.",Non-OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
"Ann Neurol 1998;43:634–639, doi: http://dx.doi.org/ 10.1002/ana.410430512.",Non-OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
Tremor and Other Hyperkinetic Movements http://www.tremorjournal.orgThe Center for Digital Research and ScholarshipColumbia University Libraries/Information Services3,Non-OADS,/arxiv_data1/oa_pdf/73/47/tre-03-138-4462-2.PMC3822405.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/bc/9d/IJNM-28-138.PMC3822412.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/2e/09/IJNM-28-152.PMC3822414.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/92/8f/IJNM-28-165.PMC3822416.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/9c/73/IJNM-28-180.PMC3822422.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/9c/73/IJNM-28-180.PMC3822422.pdf
"[5] AONE guiding principles for the newly licensed nurse’s transition  into practice; [cited 2013 January 15] Available from:  http://www.aone.org/resources/PDFs/AONE_GP_Newly_Licensed _Nurses.pdf  [6] Van Maanen J, Shein EH.",Non-OADS,/arxiv_data1/oa_pdf/21/a9/TONURSJ-7-157.PMC3822705.pdf
Early tur nover situations of  newly graduated nurses 2004; [cited 2013 January 10] Available  from: http://www.mhlw.go.jp/shingi/ 2006/03/dl/s0329-13b-5-3.pdf.,Non-OADS,/arxiv_data1/oa_pdf/21/a9/TONURSJ-7-157.PMC3822705.pdf
"We  used the string database (http://string-db.org/) to reconstitute possible interaction networks between identified cellular proteins associated with AAV2 RCs in presence of Ad (Table 1, Fig.",OADS,/arxiv_data1/oa_pdf/fd/54/TOVJ-7-98.PMC3822785.pdf
The String database (http://string-db.org/) was used to reconstitut e  the interaction networks between identified cellular proteins (as described in Figure 1) associ ated with HSV-1 supported AAV2 R Cs and/or  the AAV2 Rep78 protein.,OADS,/arxiv_data1/oa_pdf/fd/54/TOVJ-7-98.PMC3822785.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/49/120805,Non-OADS,/arxiv_data1/oa_pdf/fb/cc/JCIS-3-49.PMC3823385.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/47/120787Received : 09‑07‑2013 Accepted : 09‑09‑2013 Published : 29‑10‑2013Address for correspondence:   Dr. Berhan Genç,   Department of Radiology,   Şifa University School of Medicine,   Fevzi Pasa Bulvarı, No.",Non-OADS,/arxiv_data1/oa_pdf/35/44/JCIS-3-47.PMC3823386.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/44/120779,Non-OADS,/arxiv_data1/oa_pdf/31/f5/JCIS-3-44.PMC3823387.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/46/120786CASE REPORT Address for correspondence:   Dr. Prashant Jolepalem,   William Beaumont Hospital, 3601 W. 13  Mile Road, Royal Oak, MI 48073, USA.",Non-OADS,/arxiv_data1/oa_pdf/ca/09/JCIS-3-46.PMC3823388.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/48/120803Access this article online Quick Response Code: Website: www.clinicalimagingscience.org DOI: 10.4103/2156-7514.120803 Address for correspondence:   Prof. Jean H. D. Fasel,   Department of Cellular Physiology  and Metabolism, University Medical  Center, Rue M. Servet 1, CH ‑ 1211  Geneva 4, Switzerland.",Non-OADS,/arxiv_data1/oa_pdf/ea/00/JCIS-3-48.PMC3823389.pdf
Available  from: http://www.passport‑liver.eu/News_files/Passport D1.3_1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ea/00/JCIS-3-48.PMC3823389.pdf
Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/43/120776,Non-OADS,/arxiv_data1/oa_pdf/70/93/JCIS-3-43.PMC3823390.pdf
"Available FREE in open access from: http://www.clinicalimagingscience.org/text.asp?2013/3/1/45/120785RADIOLOGIC‑PATHOLOGIC CORRELATION Access this article online Quick Response Code: Website: www.clinicalimagingscience.org DOI: 10.4103/2156-7514.120785 Key words: Choledochal cysts, computed  tomography, gallbladder hydrops, magnetic resonance  cholangiopancreaticographyReceived : 07‑07‑2013 Accepted : 21‑09‑2013 Published : 29‑10‑2013 INTRODUCTION Choledochal cysts are rare, congenital malformations  of the biliary tree.",Non-OADS,/arxiv_data1/oa_pdf/06/0f/JCIS-3-45.PMC3823391.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/ed/ccid-6-273.PMC3823615.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dermatology 2013:6 273–280Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  273OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCID.S4523 3Comparison of commercial fibrin sealants   in facelift surgery: a prospective study giovanni Botti1 Michele Pascali2 Chiara Botti1 Florian Bodog3 Pietro gentile2 Valerio Cervelli2 1Villa Bella Clinic, salò, 2Department  of Plastic and reconstructive surgery,   University of rome T or Vergata, Italy;    3University of Oradea, Oradea,   romania Correspondence: Pietro gentile   University of rome Tor Vergata,   san salvatore in lauro Place 15,   00186 rome, Italy   email pietrogentile2004@libero.i tBackground:  The aim of this study was to compare the effects of two types of fibrin glue in  patients undergoing facelift surgery.",Non-OADS,/arxiv_data1/oa_pdf/88/ed/ccid-6-273.PMC3823615.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/88/ed/ccid-6-273.PMC3823615.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/ed/ccid-6-273.PMC3823615.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial re-use, distribution, and reproduction in any medium, provided the original work is prope rly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/6c/rrt033.PMC3823770.pdf
"Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/38/f1/rrt034.PMC3823771.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/de/rrt044.PMC3823772.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/37/ab/rrt046.PMC3823773.pdf
"Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/62/rrt047.PMC3823774.pdf
"Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/ac/rrt049.PMC3823776.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bd/50/rrt061.PMC3823782.pdf
"Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/e6/rrt062.PMC3823783.pdf
"Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8f/88/rrt066.PMC3823786.pdf
"Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/91/0b/rrt068.PMC3823787.pdf
"Published by Oxford University Press on behalf of The Japan Radiation Research Society and Japanese Society for Therapeutic Radiology and Oncology.This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/44/rrt069.PMC3823788.pdf
"375Korean J Physiol Pharmacol Vol 17: 375 －383, October, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.5.375 ABBREVIATIONS: HCC, hepatocellular carcinoma; HBV, hepatitis  B virus; HCV, hepatitis C virus; CypA, cyclophilin A; Cyps,  cyclophilins; CsA, cyclosporine A; PPIase, peptidyl prolyl isomerase;  ER, endoplasmic reticulum; MPTP, mitochondrial permeability transition pore; HIV-1, human immunodeficiency virus-1; IFN, inter- feron; IL, interleukin.",Non-OADS,/arxiv_data1/oa_pdf/de/5a/kjpp-17-375.PMC3823949.pdf
"385Korean J Physiol Pharmacol Vol 17: 385 －392, October, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.5.385 ABBREVIATIONS: VDR, Vitamin D receptors; DBP, vitamin D  binding protein; RXR, retinoid X receptor; VDRE, vitamin D response elements; CRP, C-reactive protein; TNF- α, tumor necrosis  factor-α; IU, international unit; BMD, bone mineral density; RAAS,  renin-angiotensin-aldosterone system; ANP, atrial natriuretic pep-tide; c-AMP, cyclic adenosine monophosphate; CREB, cyclic ade- nosine monophosphate (c-AMP) response element binding protein;  PKA, protein kinase A; SD, standard deviation; FMD, flow-mediated vasodilation; IMT, intima medial thickness; LDL, low density  lipoprotein.",Non-OADS,/arxiv_data1/oa_pdf/7f/5f/kjpp-17-385.PMC3823950.pdf
"Available at http://clinicaltrialsfeeds.org/ clinical-trials/show/NCT01758081 [Accessed on Jun 23, 2013] 53.",Non-OADS,/arxiv_data1/oa_pdf/7f/5f/kjpp-17-385.PMC3823950.pdf
"Available at http://clinicaltrials.gov/ show/NCT01145703 [Accessed on Jun 23, 2013]",Non-OADS,/arxiv_data1/oa_pdf/7f/5f/kjpp-17-385.PMC3823950.pdf
"393Korean J Physiol Pharmacol Vol 17: 393 －403, October, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.5.393 ABBREVIATIONS: BA, Baicalein; HPA, hypothalamic-pituitary-  adrenal; FST, forced swimming test; CRF, corticotrophin-releasing factor; BDNF, brain-derived neurotrophic factor; ERK, extracellular  signal-regulated kinase; CORT, corticosterone; GC, glucocorticoid;  DA, dopamine; 5-HT, serotonin; FLX, fluoxetine; ELISA, enzyme- linked immunoassay; TH, tyrosine hydroxylase; PBS, phosphate-  buffered saline; VTA, ventral tegmental area; ABC, avidin-biotin-  peroxidase complex; DAB, diaminobenzidine; RT-PCR, reverse tran-scription-polymerase chain reaction; GAPDH, glyceraldehydes-3-  phosphate dehydrogenase.",Non-OADS,/arxiv_data1/oa_pdf/12/68/kjpp-17-393.PMC3823951.pdf
"405Korean J Physiol Pharmacol Vol 17: 405 －409, October, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.5.405 ABBREVIATIONS: ePSA, evoked population spike amplitude; nAChR,  nicotinic acetylchoiline receptors; NT-0.5, nicotine bitartrate, 0.5 mg/kg; NT-5.0, nicotine bitartrate, 5.0 mg/kg; Cx36, connexin 36;  Cx43, connexin 43.",Non-OADS,/arxiv_data1/oa_pdf/49/d0/kjpp-17-405.PMC3823952.pdf
"411Korean J Physiol Pharmacol Vol 17: 411 －415, October, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.5.411 ABBREVIATIONS: QGC, quercetin-3-O- β-D-glucuronopyranoside;  AQC, apigenin-7-O- β-D-glucuropyranoside; LQC, luteolin-7-O- β-  D-glucuropyranoside; PI-LPC, phosphatidyl choline-phospholipase C; MPO, myeloperoxidase; GSH, glutathione sulfhydryl; ROS, re- active oxygen species; SOD, superoxide dismutase; CAT, catalase.",Non-OADS,/arxiv_data1/oa_pdf/55/7c/kjpp-17-411.PMC3823953.pdf
"417Korean J Physiol Pharmacol Vol 17: 417 －422, October, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.5.417 ABBREVIATIONS: NSAID, non-steroidal anti-inflammatory drugs;  i.p, intraperitoneally; s.c, subcutaneously; TF, tail flick; TFL, tail  flick latencies; HP, hot plate.",Non-OADS,/arxiv_data1/oa_pdf/8e/5c/kjpp-17-417.PMC3823954.pdf
"423Korean J Physiol Pharmacol Vol 17: 423 －426, October, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.5.423 Received June 3, 2013, Revised June 30, 2013,  Accepted July 15, 2013 Corresponding to: Jong-Yeon Kim, Obesity-Diabetes Advanced Re- search Center, Yeungnam University School of Medicine, 274  Hyunchungro, Nam-gu, Daegu 705-717, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a8/7d/kjpp-17-423.PMC3823955.pdf
"427Korean J Physiol Pharmacol Vol 17: 427 －433, October, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.5.427 ABBREVIATIONS: RANKL, receptor activator of NF- κB ligand;  NFATc1, nuclear factor of activated T cells cytoplasmic 1; AlF 4−,  aluminum fluoride; BMMs, bone marrow-derived macrophages;  TRAP, tartrate-resistant acid phosphatase; MAPK, mitogen-activated protein kinase; FcR γ, Fc receptor common γ subunit; ROS, reactive  oxygen species; OGR1, ovarian cancer G protein-coupled receptor 1;  GAP, GTPase activating protein; MNCs, multinucleated cells; RGS, regulator of G-protein signaling; CREB, cAMP response element  binding proten.",Non-OADS,/arxiv_data1/oa_pdf/d8/c1/kjpp-17-427.PMC3823956.pdf
"435Korean J Physiol Pharmacol Vol 17: 435 －440, October, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.5.435 ABBREVIATIONS: GM, gentamicin; JNK, Jun-N-terminal kinase;  PBS, phosphate buffer saline; OSOM, outer stripe of outer medulla;  TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP nick-  end labeling; MAPK, mitogen-activated protein kinase; NO, nitric oxide; EMT, epithelial-to-mesenchymal transition; ERK, extracel- lular signal-regulated kinases; iNOS, inducible nitric oxide synthase.",Non-OADS,/arxiv_data1/oa_pdf/bd/3d/kjpp-17-435.PMC3823957.pdf
"441Korean J Physiol Pharmacol Vol 17: 441 －446, October, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.5.441 ABBREVIATIONS: RRS, repeated restraint stress; BDG, blood  glucose; TST, tail suspension test; FST, forced swim test.",Non-OADS,/arxiv_data1/oa_pdf/b9/a2/kjpp-17-441.PMC3823958.pdf
"447Korean J Physiol Pharmacol Vol 17: 447 －453, October, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.5.447 ABBREVIATIONS: ALP, Alkaline phosphatase; BMP, bone morpho- genetic protein; BRE, BMP-responsive element; Col-I, type I  collagen; Id, inhibitor of DNA binding/differentiation; MAPK, mitogen-activated protein kinase; OC N, osteocalcin; Osx, osterix;  TGF-β, transforming growth factor- β.",Non-OADS,/arxiv_data1/oa_pdf/3b/3b/kjpp-17-447.PMC3823959.pdf
"455Korean J Physiol Pharmacol Vol 17: 455 －461, October, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.5.455 ABBREVIATIONS: ATRA, all- trans  retinoic acid; CRABP, cellular  retinoic acid-binding protein; CRBP, cellular retinol-binding protein;  CYP26A1, cytochrome p450 26A1; eWAT, epididymal white adipose  tissue; FABP5, fatty acid binding protein 5; HBV, hepatitis B virus; HBx, HBV x antigen; HCC, hepatocellular carcinoma; LRAT,  lecithin:retinol acyltransferase; NAFLD, non-alcoholic fatty liver  disease; PPAR, peroxisome proliferation-activated receptor; RAR, retinoic acid receptor; RXR, retinoid X receptor; Tg, transgenic;  Tgm2, tissue transglutaminase 2.",Non-OADS,/arxiv_data1/oa_pdf/38/8c/kjpp-17-455.PMC3823960.pdf
"463Korean J Physiol Pharmacol Vol 17: 463 －468, October, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.5.463 ABBREVIATIONS: HPV, hypoxic pulmonary vasoconstriction; PASMC,  pulmonary artery smooth muscle cell; PAP, pulmonary artery  pressure; 2d-H, exposure to hypoxic condicion for two days; CH, chronic hypoxia; TXA 2, thromboxane A 2; IKv, voltage gated K+ (Kv)  current.",Non-OADS,/arxiv_data1/oa_pdf/a0/b5/kjpp-17-463.PMC3823961.pdf
"469Korean J Physiol Pharmacol Vol 17: 469 －477, October, 2013 http://dx.doi.org/10.4196/kjpp.2013.17.5.469 ABBREVIATIONS: CMC, Carboxymethylcellulose; ECQ, extract con- taining QGC; GAPDH, glyceraldehyde-3-phosphate dehydrogenase;  GSH, glutathione; HETAB, hexadecyl trimethyl ammonium bromide;  IA, iodoacetamide; iNOS, inducible nitric oxide synthase; MDA, malondialdehyde; MPO, myeloperoxidase; NSAIDs, non-steroidal  anti-inflammatory drugs; PBS, phosphate-buffered saline; QGC,  quercetin-3-O- β-D-glucuronopyranoside; ROS, reactive oxygen species;  SOD, superoxide dismutase; TBARS, thiobarbituric acid reactive  substance.",Non-OADS,/arxiv_data1/oa_pdf/9c/32/kjpp-17-469.PMC3823962.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1093/cercor/bhj12 1 Avery, M.A., T.M.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/   10.1016/j.cub.2012.02.04 3These findings indicate that the apoptotic machinery acts  at different levels in the cell, ranging from driving sub-lethal deg - radation of a compartment (Fig.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/0896-6273(95)90263- 5 Fang, Y., L. Soares, X. Teng, M. Geary, and N.M. Bonini.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/   10.1016/j.cub.2012.01.06 5 Fariñas, I., K.R.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/369658a 0 Finn, J.T., M. Weil, F. Archer, R. Siman, A. Srinivasan, and M.C.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/   10.1089/ars.2010.359 6 Furne, C., V. Corset, Z. Hérincs, N. Cahuzac, A.O.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/j.devbrainres.2004.03.02 0 Grimes, M.L., J. Zhou, E.C.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1002/neu.48023090 4 Hamburger, V., J.K. Brunso-Bechtold, and J.W.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi   .org/10.1016/j.nbd.2004.03.01 3 Hardingham, G.E., Y. Fukunaga, and H. Bading.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/j.cell.2011.07.00 8 Hartikka, J., and F. Hefti.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1002/   jnr.49021022 7 Heck, N., A. Golbs, T. Riedemann, J.J. Sun, V. Lessmann, and H.J.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi   .org/10.1093/cercor/bhm16 5 Henderson, C.E., H.S.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10   .1126/science.797366 4 Heyden, A., M.C.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1007/s00441-011-1233- 3 Hoopfer, E.D., T. McLaughlin, R.J. Watts, O. Schuldiner, D.D.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"50:883– 895. http://dx.doi.org/10.1016/j.neuron.2006.05.01 3 Howe, C.L., J.S.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/nrn322 8Banks, G.B., R. Kanjhan, S. Wiese, M. Kneussel, L.M.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/0896-6273(89)90040- 8 Bibel, M., E. Hoppe, and Y.A.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1093/emboj/18.3.61 6 Bredesen, D.E., P. Mehlen, and S. Rabizadeh.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi   .org/10.1038/sj.cdd.440168 0 Buss, R.R., T.W.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"26:13413– 13427. http://dx.doi.org/10.1523/JNEUROSCI.3528-06.200 6 Buss, R.R., W. Sun, and R.W.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1146/annurev.neuro.29.051605.11280 0 Campenot, R.B.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10   .1073/pnas.74.10.451 6 Chen, S.K., K.S.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/j.neuron   .2012.11.02 8 Conradt, B.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1146/   annurev.genet.42.110807.09153 3 Corty, M., and M.R.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1083/jcb.20130609 9 Crowley, C., S.D.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/0092-8674(94)90378- 6 Cusack, C.L., V. Swahari, W. Hampton Henley, J. Michael Ramsey, and M.  Deshmukh.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"4:1876. http://dx.doi   .org/10.1038/ncomms291 0 Davis, A.R., G. Lotocki, A.E.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1089/neu.2006.022 7 DeChiara, T.M., R. Vejsada, W.T.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/   10.1016/0092-8674(95)90172- 8 Deckwerth, T.L., R.M.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1006/exnr.1998.684 6 Dekkers, M.P., and Y.A.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi   .org/10.1126/science.123615 2 Edwards, R.H., W.J.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/   0092-8674(89)90412- 1 Ellis, H.M., and H.R.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/   10.1016/0092-8674(86)90004- 8 Ernfors, P., A. Henschen, L. Olson, and H. Persson.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/0896-6273(89)90049- 4 Ernfors, P., K.F.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
http://dx.doi.org/10.1016/   0092-8674(94)90213- 5,Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/j.neuron.2008.06.02 3 Li, Z., J. Jo, J.M.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
http://dx.doi.org/10.1111/j.1460-9568   .1989.tb00771.,Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/   10.1146/annurev.neuro.28.061604.13563 2 Martin-Zanca, D., S.H.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/319743a 0 Martin-Zanca, D., M. Barbacid, and L.F. Parada.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/   10.1002/cne.90355010 4 Müller, M., V. Triaca, D. Besusso, M. Costanzi, J.M.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2849-12.201 2 Nikolaev, A., T. McLaughlin, D.D.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/nature0776 7 Nikoletopoulou, V., H. Lickert, J.M.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"467:59– 63. http://dx.doi.org/10.1038/nature0933 6 Ninkovic, J., T. Mori, and M. Götz.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.2572-07.200 7 Nykjaer, A., T.E.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/j.conb.2005.01.00 4 O’Riordan, M.X., L.D.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/   j.devcel.2008.09.01 2 Okado, N., and R.W.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1146/annurev.ne   .14.030191.00232 1 Oppenheim, R.W., Q.W.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/360755a 0 Oppenheim, R.W., J. Calderó, D. Cuitat, J. Esquerda, J.J. McArdle, B.M.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1002/dneu.2063 6 Patel, T.D., A. Jackman, F.L.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80899- 5 Peter, M.E., and P.H.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/sj.cdd.440118 6 Petreanu, L., and A. Alvarez-Buylla.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/271364a 0 Plachta, N., C. Annaheim, S. Bissière, S. Lin, M. Rüegg, S. Hoving, D. Müller,  F. Poirier, M. Bibel, and Y.A.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/nn189 7Ikonomidou, C., F. Bosch, M. Miksa, P. Bittigau, J. Vöckler, K. Dikranian, T.I.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1126/science.283.5398.7 0 Iscru, E., T. Ahmed, V. Coremans, Y. Bozzi, M. Caleo, E.M. Conway, R.  D’Hooge, and D. Balschun.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/j   .neuroscience.2012.10.04 9 Jiao, S., and Z. Li.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi   .org/10.1016/j.neuron.2011.04.00 4 Jo, J., D.J.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi   .org/10.1038/nn.278 5 Jones, K.R., I. Fariñas, C. Backus, and L.F. Reichardt.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi   .org/10.1016/0092-8674(94)90377- 8 Kempermann, G., D. Gast, G. Kronenberg, M. Yamaguchi, and F.H.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1242/dev.0020 3 Kempermann, G., E.J.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10   .1073/pnas.051029110 3 Kim, W.R., Y. Kim, B. Eun, O.H.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"27:14392– 14403. http://dx.doi.org/10.1523/JNEUROSCI.3903-07.200 7 Kim, W.R., O.H.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
http://dx.doi.org/10.1111/j.1460-9568.2009.06693.,Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"65:189– 197. http://dx.doi.org/10.1016/0092-8674(91)90419- Y Klein, R., I. Silos-Santiago, R.J. Smeyne, S.A. Lira, R. Brambilla, S. Bryant,  L. Zhang, W.D.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/   10.1038/368249a 0 Korsching, S., and H. Thoenen.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/   10.1016/j.neuron.2006.07.01 4 Lakhani, S.A., A. Masud, K. Kuida, G.A.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi   .org/10.1126/science.111503 5 Lavebratt, C., A. Trifunovski, A.S. Persson, F.H.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/j.nbd.2006.07.01 8 LeBlanc, H.N., and A. Ashkenazi.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/   sj.cdd.440118 7 Leonard, J.R., B.J.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.5115-09.201 0 Li, H., Y. Chen, A.F.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
http://dx.doi   .org/10.1046/j.1471-4159.1999.0720102.,Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"4:751– 763. http://dx.doi.org/10.1016/j.celrep.2013.07.01 5 Urano, Y., I. Hayashi, N. Isoo, P.C.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1194/jlr.M400333-JLR20 0 Vaux, D.L., and J. Silke.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/nrm162 1 Vila, M., and S. Przedborski.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/   10.1038/nrn110 0 Vohra, B.P.S., Y. Sasaki, B.R.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2939-10.201 0 Wang, X., Y. Wang, J. Zhang, H.P.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1128/MCB.25.11.4742-4751.200 5 Wang, J.T., Z.A.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0709-12.201 2 Williams, D.W., S. Kondo, A. Krzyzanowska, Y. Hiromi, and J.W.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/nn177 4 Wu, C., C.F.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/360753a 0 Youle, R.J., and A. Strasser.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/S0896-6273(03)00355- 6 Puthalakath, H., L.A. O’Reilly, P. Gunn, L. Lee, P.N.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1016/j.cell.2007.04.02 7 Raff, M.C., A.V.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1126/   science.106861 3 Rauskolb, S., M. Zagrebelsky, A. Dreznjak, R. Deogracias, T. Matsumoto, S.  Wiese, B. Erne, M. Sendtner, N. Schaeren-Wiemers, M. Korte, and Y.A.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.5100-09.201 0 Riedl, S.J., and G.S.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/   nrm215 3 Sanchez-Ortiz, E., D. Yui, D. Song, Y. Li, J.L.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"274:1541– 1548. http://dx.doi.org/10.1074/jbc.274.3.154 1 Sendtner, M., B. Holtmann, R. Kolbeck, H. Thoenen, and Y.A.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi   .org/10.1038/360757a 0 Simon, D.J., R.M.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3012-12.201 2 Smeyne, R.J., R. Klein, A. Schnapp, L.K.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/368246a 0 Sobreviela, T., D.O.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1002/cne.90350040 7 Song, J.H., M.C.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-06-389 6 Southwell, D.G., M.F.",Non-OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10.1038/nature1152 3 Sperka, T., J. Wang, and K.L.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/10   .1038/sj.embor.740051 2 Tauszig-Delamasure, S., L.Y.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
"http://dx.doi.org/   10.1073/pnas.94.26.1477 6 Tremblay, R., K. Hewitt, H. Lesiuk, G. Mealing, P. Morley, and J.P. Durkin.",OADS,/arxiv_data1/oa_pdf/ce/92/JCB_201306136.PMC3824005.pdf
http://dx.doi.org/10.1083/jcb.201308116) show  that axonal II spectrin maintains the diffusion barrier at  the paranodal junction.,Non-OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"Developmental analysis of the mutant revealed a dra - matic increase in the number of paranodes and nodes containing  juxtaparanodal components with age, an observation suggesting Axonal spectrins: All-purpose fences Yael Eshed-Eisenbach and Elior Peles Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 76100, Israel © 2013 Eshed-Eisenbach and Peles  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described  at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"http://dx.doi.org/   10.1016/S0896-6273(01)00294- X Boyle, M.E., E.O.",OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1015-11   .2011 Caudron, F., and Y. Barral.",OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"http://dx.doi.org/10.1016/   j.devcel.2009.04.00 3 Cifuentes-Diaz, C., F. Chareyre, M. Garcia, J. Devaux, M. Carnaud, G. Levasseur,  M. Niwa-Kawakita, S. Harroch, J.A.",OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
http://dx.doi.org/10.1371/ journal.pone.002504 3that a II spectrin–based diffusion barrier mainly contributes to  the maintenance of a paranodal membrane barrier.,Non-OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"http://dx.doi.org/10.1002/glia.2243 0 Eshed-Eisenbach, Y., and E. Peles.",Non-OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"http://dx.doi.org/   10.1016/j.conb.2012.12.00 1 Feinberg, K., Y. Eshed-Eisenbach, S. Frechter, V. Amor, D. Salomon, H.  Sabanay, J.L.",OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"65:490– 502. http://dx.doi.org/10.1016/j.neuron.2010.02.00 4 Galiano, M.R., S. Jha, T.S.",OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"http://dx.doi.org/10.1016/j.cell.2012.03.03 9 Horresh, I., V. Bar, J.L.",OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.5225-   09.201 0 Jou, T.S., E.E.",OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"http://dx.doi.org/10.1083/jcb.142.1.10 1 Katsuki, T., R. Joshi, D. Ailani, and Y. Hiromi.",OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"71:458– 473. http://dx.doi.org/10.1002/dneu.2085 9 Lasiecka, Z.M., C.C.",Non-OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"http://dx.doi   .org/10.1016/S1937-6448(08)01607- 9 Nakada, C., K. Ritchie, Y. Oba, M. Nakamura, Y. Hotta, R. Iino, R.S.",OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"http://dx.doi.org/10.1038/ncb100 9 Nans, A., S. Einheber, J.L.",Non-OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"89:310– 319. http://dx.doi.org/10.1002/jnr.2256 1 Ogawa, Y., D.P.",OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0425-06.200 6 Perkins, G.A., G.E.",Non-OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"http://dx.doi.org/10.1016/j.jsb.2007   .10.00 5 Poliak, S., and E. Peles.",OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"http://dx.doi.org/10   .1038/nrn125 3 Rios, J.C., M. Rubin, M. St Martin, R.T. Downey, S. Einheber, J. Rosenbluth,  S.R.",Non-OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
"http://dx.doi.org/10.1016/   j.neuron.2013.03.00 5 Zhang, C., K. Susuki, D.R.",OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
http://dx.doi.org/10.1083/jcb.20130811 6,Non-OADS,/arxiv_data1/oa_pdf/d4/c3/JCB_201310070.PMC3824006.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described  at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi   .org/10.1371/journal.pgen.100138 1 Borde, V., N. Robine, W. Lin, S. Bonfils, V. Géli, and A. Nicolas.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1038/emboj.2008.25 7 Bunting, S.F., E. Callén, N. Wong, H.T.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi   .org/10.1016/j.cell.2010.03.01 2 Celeste, A., O. Fernandez-Capetillo, M.J. Kruhlak, D.R.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1038/ncb100 4 Cheung, V.G., S.L.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1126/science   .118715 5 Chiolo, I., A. Minoda, S.U.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1016/j.cell.2011.02.01 2 Chou, D.M., B. Adamson, N.E.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10   .1073/pnas.101294610 7 Ciccia, A., and S.J.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10   .1016/j.molcel.2010.09.01 9 Cloos, P.A., J. Christensen, K. Agger, and K. Helin.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1101/gad.165290 8 Coster, G., and M. Goldberg.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/   10.1016/j.molcel.2011.08.03 9 Daniel, J.A., and A. Nussenzweig.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1016/   j.bbagrm.2012.01.01 9 Doil, C., N. Mailand, S. Bekker-Jensen, P. Menard, D.H. Larsen, R. Pepperkok,  J. Ellenberg, S. Panier, D. Durocher, J. Bartek, et al.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi   .org/10.1016/j.cell.2008.12.04 1 FitzGerald, J.E., M. Grenon, and N.F.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1042/BST037089 7 Fradet-Turcotte, A., M.D.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi   .org/10.1038/nature1231 8 Garcia-Bassets, I., Y.S.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi   .org/10.1016/j.cell.2006.12.03 8 Gatti, M., S. Pinato, E. Maspero, P. Soffientini, S. Polo, and L. Penengo.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi   .org/10.4161/cc.2091 9 Ginjala, V., K. Nacerddine, A. Kulkarni, J. Oza, S.J.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1128/MCB.00981-1 0 Hakimi, M.A., D.A.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201302092/DC1.,Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
Additional data are available in the  JCB DataViewer at http://dx.doi.org/10.1083/jcb.201302092.dv.,OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1038/nsmb.218 8 Bedford, M.T., and S.G. Clarke.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1016/   j.molcel.2008.12.01 3 Berkovich, E., R.J. Monnat Jr., and M.B.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1038/ncb159 9 Berkovich, E., R.J. Monnat Jr., and M.B.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi   .org/10.1038/nprot.2008.5 4 Bohgaki, T., M. Bohgaki, R. Cardoso, S. Panier, D. Zeegers, L. Li, G.S.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"8:91– 99. http://dx.doi.org/10.1038/ncb134 3 Nakatani, Y., and V. Ogryzko.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi   .org/10.1016/S0076-6879(03)70037- 8 Nottke, A.C., S.E.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1016/j.cell.2007.12.03 3 Scoumanne, A., and X. Chen.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1074/jbc   .M70102320 0 Shanbhag, N.M., I.U.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/   10.1016/j.cell.2004.12.01 2 Shi, Y.J., C. Matson, F. Lan, S. Iwase, T. Baba, and Y. Shi.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1016/j.molcel.2005.08.02 7 Smeenk, G., W.W. Wiegant, H. Vrolijk, A.P.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1038/nature0144 6 Stewart, G.S., S. Panier, K. Townsend, A.K.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi   .org/10.1016/j.cell.2008.12.04 2 Strahl, B.D., and C.D.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1038/4741 2 Stucki, M., J.A.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"123:1213– 1226. http://dx.doi.org/10.1016/j.cell.2005.09.03 8 Toledo, L.I., M. Murga, R. Zur, R. Soria, A. Rodriguez, S. Martinez, J.  Oyarzabal, J. Pastor, J.R. Bischoff, and O. Fernandez-Capetillo.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1038/nsmb.207 6 van Attikum, H., and S.M.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1016/j.tcb.2009.03.00 1 Wang, H., L. Wang, H. Erdjument-Bromage, M. Vidal, P. Tempst, R.S.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1038/nature0298 5 Wang, J., K. Scully, X. Zhu, L. Cai, J. Zhang, G.G.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1038/nature0567 1 Wang, Y., H. Zhang, Y. Chen, Y.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1016/j.cell.2009.05.05 0 Ward, I.M., S. Difilippantonio, K. Minn, M.D.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
http://dx.doi.org/10   .1128/MCB.25.22.10079-10086.200 5family of histone deacetylase-containing complexes.,Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1074/jbc.M20899220 0 Huang, J., R. Sengupta, A.B.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"449:105– 108. http://dx.doi.org/10.1038/nature0609 2 Huen, M.S., R. Grant, I. Manke, K. Minn, X. Yu, M.B.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi   .org/10.1016/j.cell.2007.09.04 1 Huen, M.S., S.M.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1083/jcb.20100303 4 Jackson, S.P., and J. Bartek.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1038/   nature0846 7 Klose, R.J., and Y. Zhang.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1038/nrm214 3 Kolas, N.K., J.R. Chapman, S. Nakada, J. Ylanko, R. Chahwan, F.D.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1126/science.115003 4 Larsen, D.H., C. Poinsignon, T. Gudjonsson, C. Dinant, M.R.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10   .1083/jcb.20091213 5 Lee, M.G., C. Wynder, N. Cooch, and R. Shiekhattar.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1038/emboj.2012.10 4 Lv, S., W. Bu, H. Jiao, B. Liu, L. Zhu, H. Zhao, J. Liao, J. Li, and X. Xu.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1016/j.ejcb.2010.01.00 4 Mailand, N., S. Bekker-Jensen, H. Faustrup, F. Melander, J. Bartek, C. Lukas,  and J. Lukas.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1016/j.cell.2007.09.04 0 Mallette, F.A., F. Mattiroli, G. Cui, L.C.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1038/emboj.2012.4 7 Mattiroli, F., J.H.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1016/j.cell.2012.08.00 5 Meerang, M., D. Ritz, S. Paliwal, Z. Garajova, M. Bosshard, N. Mailand, P.  Janscak, U. Hübscher, H. Meyer, and K. Ramadan.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10   .1038/ncb236 7 Metzger, E., M. Wissmann, N. Yin, J.M.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1038/nsmb.189 9 Mosammaparast, N., and Y. Shi.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1146/annurev.biochem   .78.070907.10394 6 Mulligan, P., T.F.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi   .org/10.1016/j.molcel.2008.10.02 5 Murr, R., J.I.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1016/S0076-6879(05)09031- 2 Xie, A., A. Hartlerode, M. Stucki, S. Odate, N. Puget, A. Kwok, G. Nagaraju,  C. Yan, F.W.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1016/j.molcel.2007.12.00 5 Yang, M., C.B.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1016/j.molcel.2006.07.01 2 You, A., J.K. Tong, C.M.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1073/   pnas.98.4.145 4 Zibetti, C., A. Adamo, C. Binda, F. Forneris, E. Toffolo, C. Verpilli, E. Ginellli,  A. Mattevi, C. Sala, and E. Battaglioli.",Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.5500-09.201 0 Ziv, Y., D. Bielopolski, Y. Galanty, C. Lukas, Y. Taya, D.C. Schultz, J. Lukas,  S. Bekker-Jensen, J. Bartek, and Y. Shiloh.",OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
http://dx.doi   .org/10.1038/ncb144 6,Non-OADS,/arxiv_data1/oa_pdf/2c/36/JCB_201302092.PMC3824007.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201305053/DC1.,Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
Additional  data are available in the JCB DataViewer at http://dx.doi.org/10.1083/ jcb.201305053.dv.,OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1091/mbc.11.9.312 3 Agromayor, M., J.G.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi   .org/10.1091/mbc.E08-05-047 4 Albertson, R., B. Riggs, and W. Sullivan.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10   .1016/j.tcb.2004.12.00 8 Barr, F.A., and U. Gruneberg.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1016/j.cell.2007.11.01 1 Bassi, Z.I., K.J.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1083/jcb.20110513 6 Bassi, Z.I., M. Audusseau, M.G.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1083/jcb.20050113 1 Carlton, J.G., A. Caballe, M. Agromayor, M. Kloc, and J. Martin-Serrano.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10   .1083/jcb.20051106 1 Haglund, K., I.P.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi   .org/10.1042/BST036043 9 Hickson, G.R., and P.H.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/   10.1083/jcb.20070900 5 Hu, C.K., M. Coughlin, and T.J. Mitchison.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi   .org/10.1091/mbc.E11-08-072 1 Kechad, A., S. Jananji, Y. Ruella, and G.R.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1016/j.cub.2011.11.06 2 Liu, J., G.D. Fairn, D.F.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1016/j.cub.2011.11.04 0 Madaule, P., M. Eda, N. Watanabe, K. Fujisawa, T. Matsuoka, H. Bito, T.  Ishizaki, and S. Narumiya.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi   .org/10.1038/2887 3 McKay, H.F., and D.R.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
http://dx.doi.org/10.1111/ j.1600-0854.2010.01139.,Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1083/jcb.73.3.67 2 Naim, V., S. Imarisio, F. Di Cunto, M. Gatti, and S. Bonaccorsi.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1091/mbc.E04-06-053 6 Neto, H., L.L.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi   .org/10.1042/BJ2011015 3 Neufeld, T.P., and G.M.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10   .1016/0092-8674(94)90152- X Oegema, K., M.S.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1016/j.cub.2007.11.06 8 Piekny, A.J., and A.S. Maddox.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1016/   j.semcdb.2010.08.00 2 Pollard, T.D.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1016/j.ceb.2009.11.01 0 Riedl, J., A.H. Crevenna, K. Kessenbrock, J.H.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi   .org/10.1038/nmeth.122 0 Schroeder, T.E.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1083/jcb.53.2.41 9 Sedzinski, J., M. Biro, A. Oswald, J.Y .",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1038/nature1028 6 Shandala, T., S.L.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1242/dev.0138 2 Smurnyy, Y., A.V.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1021/cb100168 5 Somma, M.P., B. Fasulo, G. Cenci, E. Cundari, and M. Gatti.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
http://dx.doi.org/10.1091/   mbc.01-12-058 9through CHMP4C.,Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1126/   science.121718 0 Carvalho, A., A. Desai, and K. Oegema.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1016/j.cell.2009.03.02 1 D’Avino, P.P.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1083/jcb.20040215 7 D’Avino, P.P., T. Takeda, L. Capalbo, W. Zhang, K.S.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/   10.1242/jcs.02671 6 Dean, S.O., and J.A.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi   .org/10.1371/journal.pone.000013 1 Di Cunto, F., S. Imarisio, E. Hirsch, V. Broccoli, A. Bulfone, A. Migheli,  C. Atzori, E. Turco, R. Triolo, G.P.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1016/   S0896-6273(00)00090- 8 Di Cunto, F.D., S. Imarisio, P. Camera, C. Boitani, F. Altruda, and L. Silengo.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1242/jcs   .0016 3 Dorn, J.F., and A.S. Maddox.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1016/j.cub.2011   .09.01 2 Dubreuil, V., A.M. Marzesco, D. Corbeil, W.B.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1083/jcb   .20060813 7 Echard, A., G.R.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1016/j.cub.2004.08.06 3 Eda, M., S. Yonemura, T. Kato, N. Watanabe, T. Ishizaki, P. Madaule, and S.  Narumiya.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi   .org/10.1146/annurev.biochem.74.082803.13342 5 Elia, N., R. Sougrat, T.A.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10   .1073/pnas.110271410 8 Field, C.M., and B.M.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1083/jcb.131.1.16 5 Field, C.M., M. Coughlin, S. Doberstein, T. Marty, and W. Sullivan.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1242/dev.0184 3 Gai, M., P. Camera, A. Dema, F. Bianchi, G. Berto, E. Scarpa, G. Germena, and  F. Di Cunto.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1091/mbc   .E10-12-095 2 Gilden, J.K., S. Peck, Y.C.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1083/jcb.20110512 7 Glotzer, M. 2005.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1126/science.109689 6 Goldbach, P., R. Wong, N. Beise, R. Sarpal, W.S.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1091/ mbc.E09-08-071 4 Green, R.A., E. Paluch, and K. Oegema.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1146/annurev-   cellbio-101011-15571 8 Gregory, S.L., S. Ebrahimi, J. Milverton, W.M.",Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/   10.1016/j.tcb.2009.07.00 8 Straight, A.F., C.M.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1091/mbc.E04-08-075 8 Tanaka-Takiguchi, Y., M. Kinoshita, and K. Takiguchi.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1016/j.cub.2008.12.03 0 Watanabe, S., T. De Zan, T. Ishizaki, and S. Narumiya.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10   .1242/jcs.11660 8 Yamashiro, S., G. Totsukawa, Y .",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
"http://dx.doi.org/10.1091/mbc.E02-07-042 7 Zhao, W.M., and G. Fang.",OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
http://dx.doi   .org/10.1074/jbc.M50465720 0,Non-OADS,/arxiv_data1/oa_pdf/07/b0/JCB_201305053.PMC3824009.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201303071/DC1.,Non-OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"Additional data are available in the JCB DataViewer at http://dx.doi   .org/10.1083/jcb.201303071.d v. The authors thank M. Uji, A. Hagiwara-Yano, and F. Takenaga for technical  assistance, and members of our laboratories for discussion.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi   .org/10.1083/jcb.54.2.24 6 Azimzadeh, J., and W.F.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1016/j.cub.2010.08.01 0Materials and methods Antibodies Rabbit anti-CEP164 polyclonal antibodies (pAbs) were a gift from G. Pereira  (DKFZ-ZMBH Alliance, German Cancer Research Center, Heidelberg, Ger - many).",Non-OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1016/j   .cell.2011.10.05 2 Lange, B.M., and K. Gull.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi   .org/10.1083/jcb.130.4.91 9 Mogensen, M.M., A. Malik, M. Piel, V. Bouckson-Castaing, and M. Bornens.",Non-OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1091/mbc.12.6.168 7 Nigg, E.A., and T. Stearns.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1038/ncb234 5 Oko, R., and Y. Clermont.",Non-OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1016/1047-8477(92)90011- X Reed, W., J. Avolio, and P. Satir.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/   10.1083/jcb.20120212 6 Seeley, E.S., and M.V.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1002/cm.2053 6 Sorokin, S. 1962.",Non-OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi   .org/10.1083/jcb.15.2.36 3 Steere, N., V. Chae, M. Burke, F.Q.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1371/journal.pone.004107 7 Tanaka, N., W. Meng, S. Nagae, and M. Takeichi.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi   .org/10.1101/gad.207043.11 2 Tsukita, S., K. Oishi, N. Sato, J. Sagara, A. Kawai, and S. Tsukita.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1083/jcb.126.2.39 1 Ullrich, O., S. Reinsch, S. Urbé, M. Zerial, and R.G.",Non-OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1083/jcb.135.4.91 3 Vladar, E.K., and T. Stearns.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi   .org/10.1083/jcb.20070306 4 Vorobjev, I.A., and Y.S.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1083/jcb.93.3.93 8 Voronina, V.A., K. Takemaru, P. Treuting, D. Love, B.R.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi   .org/10.1083/jcb.20080914 4 Westlake, C.J., L.M.",Non-OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/   10.1073/pnas.101882310 8Bornens, M. 2002.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1016/   S0955-0674(01)00290- 3 Bornens, M., M. Paintrand, J. Berges, M.C.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1002/cm.97008030 5 Bouckson-Castaing, V., M. Moudjou, D.J.",Non-OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1074/jbc.272   .15.1032 7 Chang, P., T.H.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1038/ncb90 0 Dawe, H.R., H. Farr, and K. Gull.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1242/jcs.0330 5 Dirksen, E.R., and P. Satir.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"4:389– 403. http://dx.doi.org/10.1016/S0040-8166(72)80017- X Gaglio, T., A. Saredi, J.B. Bingham, M.J. Hasbani, S.R.",Non-OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"135:399– 414. http://dx.doi.org/10.1083/jcb.135.2.39 9 Gibbons, I.R.",Non-OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1083/jcb.11.1.17 9 Graser, S., Y.-D. Stierhof, S.B.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1083/jcb.20030110 5 Gromley, A., C. Yeaman, J. Rosa, S. Redick, C.-T. Chen, S. Mirabelle, M. Guha,  J. Sillibourne, and S.J.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1016/j.cell.2005.07.02 7 Guarguaglini, G., P.I.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1091/mbc.E04-10-093 9 Hehnly, H., C.T.",Non-OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1016/j.semcdb.2009   .07.00 2 Ibi, M., P. Zou, A. Inoko, T. Shiromizu, M. Matsuyama, Y. Hayashi, M.  Enomoto, D. Mori, S. Hirotsune, T. Kiyono, et al.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1242/jcs.07570 5 Ishikawa, H., R. Bischoff, and H. Holtzer.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1083/jcb.43.2.31 2 Ishikawa, H., A. Kubo, S. Tsukita, and S. Tsukita.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1038/ncb125 1 Knödler, A., S. Feng, J. Zhang, X. Zhang, A. Das, J. Peränen, and W. Guo.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1083/ jcb  .20110100 5 Kremer, J.R., D.N.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
"http://dx.doi.org/10.1006/jsbi.1996.001 3 Kunimoto, K., Y. Yamazaki, T. Nishida, K. Shinohara, H. Ishikawa, T.  Hasegawa, T. Okanoue, H. Hamada, T. Noda, A. Tamura, et al.",OADS,/arxiv_data1/oa_pdf/84/24/JCB_201303071.PMC3824012.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)   80888- 0 Heidinger-Pauli, J.M., O. Mert, C. Davenport, V. Guacci, and D. Koshland.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1016/j.cub.2010.04.01 8 Hill, A., and K. Bloom.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1038/ncb141 4 Lam, W.W., E.A.",Non-OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1101/gad.146880 6 Lavoie, B.D., K.M.",Non-OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1091/ mbc  .11.4.129 3 Lavoie, B.D., E. Hogan, and D. Koshland.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1083/jcb.20010905 6 Lavoie, B.D., E. Hogan, and D. Koshland.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/   10.1101/gad.115040 4 Manning, A.L., M.S.",Non-OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1101/gad.191731 0 Ng, T.M., W.G.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1091/mbc.E09-04-033 0 Pearson, C.G., P.S.",Non-OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1083/jcb.152.6.125 5 Ribeiro, S.A., J.C. Gatlin, Y. Dong, A. Joglekar, L. Cameron, D.F.",Non-OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1091/ mbc.E08-11-112 7 Rohner, S., S.M.",Non-OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi   .org/10.1371/journal.pone.000683 1 Saunders, W.S., and M.A.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi   .org/10.1016/0092-8674(92)90169- D Stephens, A.D., J. Haase, L. Vicci, R.M.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi   .org/10.1083/jcb.20110313 8 Stephens, A.D., R.A. Haggerty, P.A.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/   10.1083/jcb.20120816 3 Surcel, A., D. Koshland, H. Ma, and R.T. Simpson.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1371/journal.pone   .000245 3 Tada, K., H. Susumu, T. Sakuno, and Y. Watanabe.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1038/nature1017 9 Tanaka, T., J. Fuchs, J. Loidl, and K. Nasmyth.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1038/   3501952 9 Thadani, R., F. Uhlmann, and S. Heeger.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1016/j.cub.2012.10.02 3Kinetochore declustering Population images were acquired of strains containing a kinetochore  marker (Nuf2, Ndc80, or Ame1) with labeled spindle poles (Spc29).",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
Online supplemental material is available at http://www.jcb   .org/cgi/content/full/jcb.201307104/DC1.,Non-OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"9:1169– 1182. http://dx.doi.org/10.1016/S1097-2765(02)00543- 9 Bouck, D.C., and K. Bloom.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/   10.1016/j.cub.2007.03.03 3 Cuylen, S., J. Metz, and C.H.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1038/nsmb.208 7 D’Ambrosio, C., C.K.",Non-OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1126/   science.106779 9 Eckert, C.A., D.J.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/   10.1101/gad.149870 7 Gardner, M.K., D.C. Bouck, L.V .",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1016/j.cell   .2008.09.04 6 Goshima, G., and M. Yanagida.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi   .org/10.1016/S0092-8674(00)80699- 6 Gruber, S., C.H.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1016/S0092-8674   (03)00162- 4 Guacci, V ., D. Koshland, and A. Strunnikov.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/   10.1016/S0092-8674(01)80008- 8 Haering, C.H., and R. Jessberger.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1016/   j.yexcr.2012.03.01 6 Haering, C.H., A.M. Farcas, P. Arumugam, J. Metson, and K. Nasmyth.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
454:297– 301. http://dx.doi.org/10.1038/nature0709 8,Non-OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10   .1083/jcb.20050910 1 Uchida, K.S., K. Takagaki, K. Kumada, Y. Hirayama, T. Noda, and T.  Hirota.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10.1083/   jcb.20081102 8 Yeh, E., J. Haase, L.V.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
"http://dx.doi.org/10   .1016/j.cub.2007.12.01 9 Yong-Gonzalez, V., B.D.",OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
http://dx.doi.org/10.1111/j.1365-   2443.2007.01109. x,Non-OADS,/arxiv_data1/oa_pdf/67/c9/JCB_201307104.PMC3824013.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi   .org/10.1002/glia.1028 4 Rios, J.C., M. Rubin, M. St Martin, R.T. Downey, S. Einheber, J. Rosenbluth,  S.R.",Non-OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10   .1002/jnr.2201 3 Saitsu, H., J. Tohyama, T. Kumada, K. Egawa, K. Hamada, I. Okada, T. Mizuguchi,  H. Osaka, R. Miyata, T. Furukawa, et al.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1016/j.ajhg.2010.04.01 3 Salzer, J.L.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1016/S0896-6273(03)00628- 7 Schafer, D.P., and M.N.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/   10.1523/JNEUROSCI.5427-03.200 4 Stankewich, M.C., C.D.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1242/   jcs.08037 4 Susuki, K., A.R.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10   .1016/j.neuron.2013.03.00 5 Tang, Y ., V .",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1126/   science.107599 4 Thaxton, C., A.M. Pillai, A.L.",Non-OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/   10.1016/j.neuron.2010.12.01 6 Traka, M., L. Goutebroze, N. Denisenko, M. Bessa, A. Nifli, S. Havaki, Y.  Iwakura, F. Fukamauchi, K. Watanabe, B. Soliven, et al.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1083/jcb.20030507 8 Vabnick, I., J.S.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/   10.1073/pnas.091472510 7 Zonta, B., S. Tait, S. Melrose, H. Anderson, S. Harroch, J. Higginson, D.L.",Non-OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
http://dx.doi.org/   10.1083/jcb.20071215 4neurexin IV/Caspr/Paranodin.,Non-OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10   .1016/S0896-6273(01)00294- X Boyle, M.E., E.O.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1698-10.201 0 Dupree, J.L., J.-A.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"147:1145– 1152. http://dx.doi.org/10.1083/jcb.147.6.114 5 Feinberg, K., Y .",Non-OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1016/j.neuron.2010.02.00 4 Galiano, M.R., S. Jha, T.S.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1016/j.cell.2012.03.03 9 Garrido, J.J., P. Giraud, E. Carlier, F. Fernandes, A. Moussif, M.P.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1126/science.108516 7 Gasser, A., T.S.-Y .",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.5434-11.201 2 Hammarlund, M., E.M. Jorgensen, and M.J. Bastiani.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/   10.1083/jcb.20061111 7 Hill, A.S., A. Nishino, K. Nakajo, G. Zhang, J.R. Fineman, M.E.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1371/journal.pgen.100031 7 Mierzwa, A.J., J.C. Arevalo, R. Schiff, M.V.",Non-OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0425-06.200 6 Ogawa, Y., I. Horresh, J.S.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1016/   S0896-6273(01)00306- 3 Pillai, A.M., C. Thaxton, A.L.",Non-OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1002/jnr.2201 5 Poliak, S., and E. Peles.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10   .1038/nrn125 3 Poliak, S., L. Gollan, D. Salomon, E.O.",Non-OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1083/jcb.20030501 8 Rasband, M.N.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"76:749– 757. http://dx.doi.org/10.1002/jnr.2007 3 Rasband, M.N.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
"http://dx.doi.org/10.1038/   nrn285 2 Rasband, M.N., E. Peles, J.S.",OADS,/arxiv_data1/oa_pdf/b9/2f/JCB_201308116.PMC3824014.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1074/ jbc.M01000220 0 Allen, P .B., O. Hvalby, V .",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1038/8182 3 Bito, H., K. Deisseroth, and R.W.",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/   10.1016/S0092-8674(00)81816- 4 Blitzer, R.D., J.H.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi   .org/10.1126/science.280.5371.194 0 Bollen, M., W. Peti, M.J. Ragusa, and M. Beullens.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1016/j.tibs.2010.03.00 2 Carmody, L.C., A.J.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1096/fj.07-09284 1 Chung, H.J., X. Qian, M. Ehlers, Y.N.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1146/annurev.bi.58   .070189.00232 1 Cohen, P.T.",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"24:8404– 8409. http://dx.doi.org/10.1523/JNEUROSCI.3602-04.200 4 Dancheck, B., M.J. Ragusa, M. Allaire, A.C. Nairn, R. Page, and W. Peti.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1021/bi101774 g Dohadwala, M., E.F. da Cruz e Silva, F.L.",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1038/nature0092 8 Glausier, J.R., M. Maddox, H.C. Hemmings Jr., A.C. Nairn, P. Greengard,  and E.C.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1016/   j.neuroscience.2010.02.01 4 Goldberg, J., H.B.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/   10.1038/376745a 0 Hardingham, G.E., F.J. Arnold, and H. Bading.",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1038/8510 9 Hardingham, G.E., Y. Fukunaga, and H. Bading.",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.6017-08.200 9 Hsieh-Wilson, L.C., F. Benfenati, G.L.",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201303035/DC1.,Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"273:24057– 24064. http://dx.doi.org/10.1074/jbc.273.37.2405 7 Peti, W., A.C. Nairn, and R. Page.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
http://dx.doi   .org/10.1111/j.1742-4658.2012.08509.,Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1016/j.mcn.2005.03.01 3 Petralia, R.S., Y.X.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1016/   j.neuroscience.2010.01.02 2 Picking, W.D., W. Kudlicki, G. Kramer, B. Hardesty, J.R. Vandenheede, W.  Merlevede, I.K.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"30:10280– 10287. http://dx.doi.org/10.1021/bi00106a02 8 Sakagami, H., and H. Kondo.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1016/   0891-0618(95)00051- 8 Sanderson, J.L., and M.L.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1177/107385841038474 0 Strack, S., M.A.",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
http://dx.doi.org/10.1046/j.1471-4159.1997.68052119.,Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1002/ (SICI)1096-9861(19991025)413:3<373::AID-CNE2>3.0.CO;2- Z Terry-Lorenzo, R.T., M. Inoue, J.H.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1074/jbc.275.4.243 9 Terry-Lorenzo, R.T., L.C.",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1074/jbc.M20336520 0 Terry-Lorenzo, R.T., E. Elliot, D.C. Weiser, T.D.",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1074/jbc.M20696020 0 Thiels, E., E.D.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1016/S0306-4522(98)00135- 3 Tung, H.Y., W. Wang, and C.S.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1111/j.1471- 4159.2005.03058. x Wu, J.Q., J.Y.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1038/ncb187 1 Xu, J., P. Kurup, Y. Zhang, S.M.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
http://dx.doi.org/10.1523/JNEUROSCI   .2212-09.200 9with actin filaments.,OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/   10.1074/jbc.M20575420 0 Hu, X.D., Q. Huang, D.W. Roadcap, S.S. Shenolikar, and H. Xia.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1111/j   .1471-4159.2006.04070. x Hu, X.D., Q. Huang, X. Yang, and H. Xia.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1523/JNEUROSCI   .5365-06.200 7 Huang, H.B., A. Horiuchi, T. Watanabe, S.R.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1074/jbc.274.12.787 0 Hurley, T.D., J. Yang, L. Zhang, K.D.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1074/jbc.M70347220 0 Ivanov, A., C. Pellegrino, S. Rama, I. Dumalska, Y. Salyha, Y. Ben-Ari, and I.  Medina.",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1113/jphysiol.2006.10551 0 Jouvenceau, A., G. Hédou, B. Potier, M. Kollen, P. Dutar, and I.M.",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
http://dx.doi.org/10   .1111/j.1460-9568.2006.04938.,Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi   .org/10.1073/pnas.94.6.216 8 Lee, H.K.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1016/j.pharmthera.2006.06.00 3 Li, M., B. Stefansson, W. Wang, E.M. Schaefer, and D.L.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1016/j.cellsig.2005.10.02 0 Li, T., L.E.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1074/jbc.M60634720 0 Lisman, J.",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1016/S0896-6273(01)00194- 5 Marie, H., W. Morishita, X. Yu, N. Calakos, and R.C.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1016/j.neuron.2005.01.03 9 Misonou, H., D.P.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1038/nn126 0 Morishita, W., J.H.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1016/S0896-6273(01)00554- 2 Morishita, W., H. Marie, and R.C.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1038/nn150 6 Mulkey, R.M., C.E.",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1126/science.839460 1 Mulkey, R.M., S. Endo, S. Shenolikar, and R.C.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1038/369486a 0 Nigavekar, S.S., Y.S.",Non-OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
"http://dx.doi.org/10.1016/S0003-9861(02)00231- X Ouimet, C.C., E.F. da Cruz e Silva, and P. Greengard.",OADS,/arxiv_data1/oa_pdf/92/94/JCB_201303035.PMC3824016.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1126/science.836224 2 Browman, D.T., M.E.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1242/jcs.0306 0 Browman, D.T., M.B.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1016/j.tcb.2007.06.00 5 Brown, M.S., and J.L.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1146/annurev.cellbio.22.010305.10465 6 Chen, I.H., M. Huber, T. Guan, A. Bubeck, and L. Gerace.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"7:38. http://dx.doi.org/10.1186/1471-2121-7-3 8NaCl, and 1% Triton X-100.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1074/jbc   .M70186220 0 Pearce, M.M., D.B.",Non-OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1074/   jbc.M80980120 0 Radhakrishnan, A., L.P. Sun, H.J.",Non-OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi   .org/10.1016/j.cmet.2008.10.00 8 Sakai, J., E.A.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81304- 5 Sambrook, J., E.F. Fritsch, and T. Maniatis.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/   10.1038/nmeth.208 9 Simons, K., and M.J. Gerl.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1038/   nrm297 7 Stewart, J.C. 1980.",Non-OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10   .1016/0003-2697(80)90269- 9 Walter, P., and G. Blobel.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi   .org/10.1126/science.120903 8 Walther, T.C., and R.V.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1016/j.bbalip.2008   .10.00 9Ellenberg, J., E.D.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi   .org/10.1083/jcb.138.6.119 3 Goldstein, J.L., R.A. DeBose-Boyd, and M.S.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1016/j.cell.2005   .12.02 2 Gong, Y., J.N.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1016/S0026-   0495(00)80010- 4 Greenfield, J.J., and S. High.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1074/jbc.M80912720 0 Horton, J.D., J.L.",Non-OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"271:10379– 10384. http://dx.doi.org/10.1074/jbc.271.17.1037 9 Hulce, J.J., A.B.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1038/nmeth.236 8 Ikonen, E. 2008.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1038/nrm233 6 Infante, R.E., A. Radhakrishnan, L. Abi-Mosleh, L.N.",Non-OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1074/jbc.M70794420 0 Infante, R.E., L. Abi-Mosleh, A. Radhakrishnan, J.D.",Non-OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1074/jbc.M70794320 0 Jo, Y., P.V.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1074/jbc.M110.21132 6 Kamisuki, S., Q. Mao, L. Abu-Elheiga, Z. Gu, A. Kugimiya, Y. Kwon, T.  Shinohara, Y. Kawazoe, S. Sato, K. Asakura, et al.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1016/j.chembiol.2009.07.00 7 Klemm, J.D., C.R.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10   .1016/S0960-9822(06)00290- 9 Koopman, R., G. Schaart, and M.K.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1007/s00018-005-5166- 4 Lee, J.N., and J. Ye.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1074/jbc.M40823520 0 Lingwood, D., and K. Simons.",Non-OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1126/science.117462 1 Livak, K.J., and T.D.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
"http://dx.doi.org/10.1006/meth.2001.126 2 Motamed, M., Y. Zhang, M.L.",OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
http://dx.doi.org/10.1074/jbc.M111.23831 1,Non-OADS,/arxiv_data1/oa_pdf/39/a4/JCB_201305076.PMC3824017.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201306036/DC1.,Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1016/j.tcb.2013.04.00 6 Audhya, A., F. Hyndman, I.X.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi   .org/10.1083/jcb.20050612 4 Audhya, A., I.X.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1371/journal.pone.000095 6 Bastos, R.N., and F.A.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1083/jcb.20100810 8 Bembenek, J.N., K.J.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"23:937– 946. http://dx.doi.org/10.1016/j.cub.2013.04.02 8 Brenner, S. 1974.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
http://dx.doi   .org/10.1111/j.1600-0854.2011.01244.,Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"316:1908– 1912. http://dx.doi.org/10.1126/science.114342 2 Carlton, J.G., M. Agromayor, and J. Martin-Serrano.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi   .org/10.1038/nrm347 4 Chai, Y., D. Tian, Y. Yang, G. Feng, Z. Cheng, W. Li, and G. Ou.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
http://dx.doi.org/10.1083/jcb.20120905 0Plots of furrow diameter versus time Plots of furrow diameter versus time (Fig.,OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi   .org/10.1091/mbc.E09-01-008 9 Lo, C.W., and N.B.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10   .1016/0092-8674(79)90059- X Madaule, P., M. Eda, N. Watanabe, K. Fujisawa, T. Matsuoka, H. Bito, T.  Ishizaki, and S. Narumiya.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi   .org/10.1038/2887 3 Maddox, A.S., B. Habermann, A. Desai, and K. Oegema.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1242/dev.0182 8 Maddox, A.S., L. Lewellyn, A. Desai, and K. Oegema.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.02.01 8 McCullough, J., L.A. Colf, and W.I.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"82:663– 692. http://dx.doi.org/10.1146/annurev-biochem-072909-10105 8 Michelet, X., A. Alberti, L. Benkemoun, N. Roudier, C. Lefebvre, and R. Legouis.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1042/BC2009002 5 Mollinari, C., J.-P. Kleman, W. Jiang, G. Schoehn, T. Hunter, and R.L.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1083/jcb.20011105 2 Mollinari, C., J.-P. Kleman, Y. Saoudi, S.A. Jablonski, J. Perard, T.J.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1091/mbc.E04-04-034 6 Morita, E., V. Sandrin, H.-Y.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1038/sj.emboj.760185 0 Mostowy, S., and P. Cossart.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1016/j.tcb.2010.11.00 6 Piekny, A.J., and A.S. Maddox.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1016/   j.semcdb.2010.08.00 2 Sanger, J.M., M.B.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1007/BF0022233 7 Schiel, J.A., and R. Prekeris.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1016/j.ceb.2012.10.01 2 Steigemann, P., C. Wurzenberger, M.H.A.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi   .org/10.1016/j.cell.2008.12.02 0 Verbrugghe, K.J.C., and J.G.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi   .org/10.1016/j.cub.2004.09.05 5 Vernì, F., M.P.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1016/j.cub.2004.08.05 4 Waddle, J.A., J.A.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1016/j.cell.2010.07.02 3 White, E.A., and M. Glotzer.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1002/cm   .2106 5 Zhao, W.-M., A. Seki, and G. Fang.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"23:118– 128. http://dx.doi.org/10.1016/j.tcb.2012.10.01 2 D’Avino, P.P.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1371/journal.pone.000057 2 Elia, N., R. Sougrat, T.A.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/   10.1083/jcb.20100603 1 Fabbro, M., B.-B.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1016/j.devcel.2005.09.00 3 Fededa, J.P., and D.W. Gerlich.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1038/ncb248 2 Gai, M., P .",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1091/mbc.E10-12-095 2 Glotzer, M. 2009.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10   .1038/nrm260 9 Green, R.A., H.-L. Kao, A. Audhya, S. Arur, J.R. Mayers, H.N.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi   .org/10.1016/j.cell.2011.03.03 7 Green, R.A., E. Paluch, and K. Oegema.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1146/annurev-   cellbio-101011-15571 8 Guizetti, J., L. Schermelleh, J. Mäntler, S. Maar, I. Poser, H. Leonhardt, T.  Müller-Reichert, and D.W. Gerlich.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1126/science.120184 7 Hall, P.A., and S.E.H.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1002/path.302 4 Henne, W.M., N.J. Buchkovich, and S.D.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.05.01 5 Hu, C.-K., M. Coughlin, and T.J. Mitchison.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi   .org/10.1091/mbc.E11-08-072 1 Hyman, A.A. 1989.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1083/jcb.109.3.118 5 John, C.M., R.K. Hite, C.S.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"26:3296– 3307. http://dx.doi.org/10.1038/sj.emboj.760177 5 Keating, H.H., and J.G.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1016/j.cub.2011.11.06 2 Lafaurie-Janvore, J., P. Maiuri, I. Wang, M. Pinot, J.-B.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1126/science.123386 6 Lee, H.H., N. Elia, R. Ghirlando, J. Lippincott-Schwartz, and J.H.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10   .1126/science.116204 2 Lekomtsev, S., K.-C. Su, V .E.",OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
"http://dx.doi.org/10.1038/nature1177 3 Lewellyn, L., J. Dumont, A. Desai, and K. Oegema.",Non-OADS,/arxiv_data1/oa_pdf/dd/df/JCB_201306036.PMC3824018.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201305086/DC1.,Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
Additional data are available in the JCB DataViewer at http://dx.doi   .org/10.1083/jcb.201305086.dv.,OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1016/S0955-   0674(02)00344- 7 Asensio, C.S., D.W. Sirkis, and R.H. Edwards.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1083/jcb.20100613 1 Bolte, S., and F.P.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
http://dx.doi   .org/10.1111/j.1365-2818.2006.01706.,Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"These VPS10 domains were assembled and aligned with MUS - CLE (http://www.ebi.ac.uk/Tools/msa/muscle/), and phylogenetic trees  were constructed with MEGA5 (Molecular Evolutionary Genetics Analysis;  http://www.megasoftware.net/).",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1007/s00018-009-0043- 1 Hünseler, P., and A. Tiedtke.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1002/   dvg.102013021 1 Hünseler, P., G. Scheidgen-Kleyboldt, and A. Tiedtke.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1128/ EC  .00195-0 6 Kim, T., M.C.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1242/jcs.08159 6 Kronforst, M.R., G.S.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
http://dx.doi.org/10.1111/j.1755-148X.2012.01014.,Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi   .org/10.1083/jcb.118.3.52 1 Kurz, S., and A. Tiedtke.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
http://dx.doi.org/10.1111/j.1550- 7408.1993.tb04874.,Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/   10.1177/40.1.137030 9 Madeddu, L., M.C.",Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/   10.1091/mbc.6.6.64 9 Marcusson, E.G., B.F. Horazdovsky, J.L.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi   .org/10.1016/0092-8674(94)90219- 4 Meldolesi, J., E. Chieregatti, and M. Luisa Malosio.",Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1007/s00418-008-0377- z Ngô, H.M., M. Yang, and K.A.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1111/j.1365-2958.2004   .04056. x Nusblat, A.D., L.J.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1016/   B978-0-12-385967-9.00006- 2 Odorizzi, G., C.R.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi   .org/10.1016/S0962-8924(98)01295- 1 Orias, E., M. Flacks, and B.H.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
http://dx.doi.org/10.1111/j.1600-0854.2005.00273.,Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1111/j.1550- 7408.2005.00045. x Braulke, T., and J.S.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1016/j.bbamcr .2008   .10.01 6 Bright, L.J., N. Kambesis, S.B.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1371/journal.pgen.100115 5 Burgess, J., M. Jauregui, J. Tan, J. Rollins, S. Lallet, P.A.",Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1091/mbc.E11-01-005 4 Canuel, M., Y .",Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1083/jcb.115.6.150 5 Chen, Z.Y ., A. Ieraci, H. Teng, H. Dall, C.X.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.1017-05.200 5 Collins, T., and J.M.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"16:4046– 4060. http://dx.doi.org/10.1091/mbc.E05-01-002 8 Edwards, S.L., N.K.",Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi   .org/10.1083/jcb.20090209 5 Elde, N.C., G. Morgan, M. Winey, L. Sperling, and A.P.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1371/journal.pgen.001005 2 Elde, N.C., M. Long, and A.P.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi   .org/10.1016/j.tcb.2007.02.00 7 Funkelstein, L., M. Beinfeld, A. Minokadeh, J. Zadina, and V. Hook.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi   .org/10.1016/j.npep.2010.08.00 3 Garreau de Loubresse, N. 1993.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1055/s-2004-83567 4 Gurkan, C., H. Lapp, C. Alory, A.I.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1091/mbc   .E05-01-006 2 Haddad, A., and A.P.",Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
http://dx.doi.org/10.1128/EC.1.4.583-593   .2002,Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1128/EC.00151-0 9 Rosati, G., and L. Modeo.",Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
http://dx.doi.org/10.1111/j.1550-7408.2003.tb00260.,Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1016/0309-   1651(77)90012- 1 Shang, Y., X.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi   .org/10.1016/j.chom.2012.03.00 6 Stechmann, A., and T. Cavalier-Smith.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi   .org/10.1007/s00239-003-2490- x Sumakovic, M., J. Hegermann, L. Luo, S.J.",Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi   .org/10.1083/jcb.20090209 6 Tiedtke, A.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"63:93. http://dx.doi.org/10.1007/BF0062241 5 Tooze, S.A., and W.B.",Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi   .org/10.1016/0092-8674(90)90097- X Turkewitz, A.P.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
http://dx.doi.org/10.1046/ j.1600-0854.2003.00155.,Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1016/j.cell.2012.01.05 4 Vayssié, L., N. Garreau de Loubresse, and L. Sperling.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1091/mbc.9.2.49 7 Xiong, J., X. Lu, Y. Lu, H. Zeng, D. Yuan, L. Feng, Y. Chang, J. Bowen, M.  Gorovsky, C. Fu, and W. Miao.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi   .org/10.1007/s11427-010-4114- 1 Yao, M.C., and C.H.",Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1073/   pnas.88.21.949 3 Yates, L.R., and P.J.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10.1038/nrg331 7 Zacharias, D.A., J.D.",Non-OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"http://dx.doi.org/10   .1126/science.106853 9 Zakon, H.H.",OADS,/arxiv_data1/oa_pdf/a5/09/JCB_201305086.PMC3824020.pdf
"Recent  findings illustrate the importance of glial cells in shaping  the nervous system by controlling the number and con - nectivity of neurons.Cell biology in neuroscience Architects in neural circuit design: Glia control  neuron numbers and connectivity Megan M. Corty and Marc R. Freeman Department of Neurobiology, University of Massachusetts Medical School, Howard Hughes Medical Institute, Worcester, MA 01605 © 2013 Corty and Freeman  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1038/486473 e Antony, J.M., A. Paquin, S.L.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1002/   jnr.2253 3 Awasaki, T., and K. Ito.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/j.cub.2004.04.00 1 Awasaki, T., R. Tatsumi, K. Takahashi, K. Arai, Y. Nakanishi, R. Ueda, and K.  Ito.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/j.neuron.2006.04.02 7 Awasaki, T., Y. Huang, M.B.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1038/nn.283 3 Bergles, D.E., J.D.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1038/3501208 3 Bishop, D.L., T. Misgeld, M.K.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/j.neuron.2004.10.02 6 Britton, J.S., and B.A.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/j.brainres.2012.03.04 2 Cao, G., and C.P.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"27:6712– 6722. http://dx.doi.org/10.1523/JNEUROSCI.1329-07.200 7 Chanock, S.J., J. el Benna, R.M.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi   .org/10.1016/j.cell.2010.12.00 7 Chotard, C., and I. Salecker.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/j.tins   .2004.09.00 1 Christopherson, K.S., E.M. Ullian, C.C.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/   j.cell.2004.12.02 0 Colman, H., J. Nabekura, and J.W.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi   .org/10.1126/science.275.5298.35 6 Cunningham, C.L., V .",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.3441-12.201 3 Darabid, H., D. Arbour, and R. Robitaille.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2935-12.201 3 Davalos, D., J. Grutzendler, G. Yang, J.V.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1038/nn.319 0 Marín-Teva, J.L., I. Dusart, C. Colin, A. Gervais, N. van Rooijen, and M. Mallat.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/S0896-6273(04)00069- 8 Mathis, C., L. Collin, and E. Borrelli.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi   .org/10.1242/dev.0067 5 McGee, A.W., Y. Yang, Q.S.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1126/science   .111436 2 Mócsai, A., C.L.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1038/ni140 7 Morrens, J., W. Van Den Broeck, and G. Kempermann.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1002/glia.2124 7 Müller, C.M., and J.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1038/342427a 0 Nägler, K., D.H. Mauch, and F.W.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
http://dx.doi.org/10.1111/j.1469-7793.2001.00665.,Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1126/science.111064 7 Noctor, S.C., A.C. Flint, T.A.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1038/3505555 3 Paolicelli, R.C., G. Bolasco, F. Pagani, L. Maggi, M. Scianni, P. Panzanelli, M.  Giustetto, T.A.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1126/science.120252 9 Peng, H.B., J.F.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1126/science.277   .5332.168 4 Potter, C.J., B. Tasic, E.V.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/j   .cell.2010.02.02 5 Rakic, P. 1971.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10   .1002/cne.90141030 3 Reddien, P.W., S. Cameron, and H.R.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi   .org/10.1038/3508409 6 Reddy, L.V., S. Koirala, Y. Sugiura, A.A. Herrera, and C.P.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi   .org/10.1016/S0896-6273(03)00682- 2 Schafer, D.P., E.K.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/   10.1016/j.neuron.2012.03.02 6 Seri, B., J.M.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/ j.stem   .2010.08.01 4 Song, H., C.F.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi   .org/10.1038/417039 aDe Biase, L.M., A. Nishiyama, and D.E.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.6000-09.201 0 Dekkers, M.P.J., V. Nikoletopoulou, and Y.A.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10   .1016/S0092-8674(00)80783- 7 Doretto, S., M. Malerba, M. Ramos, T. Ikrar, C. Kinoshita, C. De Mei, E. Tirotta,  X. Xu, and E. Borrelli.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1371/journal.pone.001984 9 Ebens, A.J., H. Garren, B.N.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/   0092-8674(93)90291- W Eroglu, Ç., N.J. Allen, M.W.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/j.cell.2009.09.02 5 Feng, Z., and C.P.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2589-08.200 8 Fuentes-Medel, Y., M.A.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1371/journal.pbio.100018 4 Fuentes-Medel, Y., J. Ashley, R. Barria, R. Maloney, M. Freeman, and V.  Budnik.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1126/science.119463 7 Hirasawa, T., K. Ohsawa, Y. Imai, Y. Ondo, C. Akazawa, S. Uchino, and S.  Kohsaka.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/   10.1002/jnr.2048 0 Hoeppner, D.J., M.O.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1038/3508410 3 Huberman, A.D., M.B.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1146/annurev.neuro.31.060407.12553 3 Hughes, E.G., S.B.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4757-10.201 1 Koirala, S., L.V.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1023/B:NEUR.0000020637.71452.3 c Kucukdereli, H., N.J. Allen, A.T. Lee, A. Feng, M.I.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi   .org/10.1073/pnas.110497710 8 Lai, S.L., and T. Lee.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10   .1038/nn168 1 Lee, T., A. Lee, and L. Luo.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi   .org/10.1016/S0896-6273(00)00155- 0 Levi-Montalcini, R. 1987.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.0720-08.200 8 Sousa-Nunes, R., L.L.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1038/nature0986 7 Stevens, B., N.J. Allen, L.E.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/j.cell.2007.10.03 6 Tamamaki, N., K. Nakamura, K. Okamoto, and T. Kaneko.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/S0168-0102(01)00259- 0 Tremblay, M.È., R.L.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1371/journal.pbio.100052 7 Truman, J.W., and M. Bate.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/0012-1606(88)90067- X Ullian, E.M., S.K.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi   .org/10.1126/science.291.5504.65 7 Ullian, E.M., B.T.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10   .1016/j.mcn.2003.10.01 1 Wake, H., A.J.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4363-08.200 9 Wakselman, S., C. Béchade, A. Roumier, D. Bernard, A. Triller, and A. Bessis.",Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1006-08.200 8 Walsh, M.K., and J.W.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/S0896-6273(02)01142- X Watts, R.J., E.D.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10   .1016/S0896-6273(03)00295- 2 Watts, R.J., O. Schuldiner, J. Perrino, C. Larsen, and L. Luo.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/j.cub.2004.03.03 5 Yan, Y.P., K.A.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
http://dx.doi   .org/10.1111/j.1460-9568.2006.04872.,Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00072- 2 Zhou, Z., E. Hartwieg, and H.R.",OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
104:43– 56. http://dx.doi.org/10.1016/S0092-8674(01)00190- 8,Non-OADS,/arxiv_data1/oa_pdf/3a/15/JCB_201306099.PMC3824021.pdf
This article is distributed under the terms of an Attribution–Noncommercial–   Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
Online supplemental material is available at http://www.jcb.org/ cgi/content/full/jcb.201303045/DC1.,Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
Additional data are available in  the JCB DataViewer at http://dx.doi.org/10.1083/jcb.201303045.dv.,OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi   .org/10.1016/S1534-5807(03)00199- 0 Jensen, S., A.H. Andersen, E. Kjeldsen, H. Biersack, E.H. Olsen, T.B.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"9:272. http://dx.doi   .org/10.1186/1471-2164-9-27 2 Kimura, K., and T. Hirano.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)   80524- 3 Linka, R.M., A.C.G.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1093/nar/gkm10 2 Li, M.Z., and S.J.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1038/nmeth101 0 Liu, H., and J.H.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"8:91. http://dx.doi.org/10.1186/1472-6750-8-9 1 Luo, K., J. Yuan, J. Chen, and Z. Lou.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi   .org/10.1038/ncb182 8 Maeshima, K., and U.K. Laemmli.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/   10.1016/S1534-5807(03)00092- 3 McClendon, A.K., A.C. Gentry, J.S.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1021/bi800453 h Mirski, S.E., J.H.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi   .org/10.1006/excr.1997.380 5 Mo, Y.Y., K.A.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"31:1644– 1653. http://dx.doi.org/10.1038/emboj.2012.3 5 Nitiss, J.L.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1038/nrc260 7 Ono, T., A. Losada, M. Hirano, M.P.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00724- 4 Orrego, M., I. Ponte, A. Roque, N. Buschati, X. Mora, and P .",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"5:22. http://dx.doi.org/10.1186/1741-7007-5-2 2 Park, S.-W., A.M. Parrott, D.T.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1016/0092-   8674(77)90280- X Phair, R.D., P. Scaffidi, C. Elbi, J. Vecerová, A. Dey, K. Ozato, D.T.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1128/MCB.24.14.6393-6402.200 4 Phair, R.D., S.A. Gorski, and T. Misteli.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1016/S0076-6879   (03)75025- 3 Raymond, C.S., and P. Soriano.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/   10.1073/pnas.74.11.493 7 Campoy, F.J., R.R.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1074/   jbc.270.44.2647 3 Carpenter, A.J., and A.C.G.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi   .org/10.1091/mbc.E04-08-073 2 Coelho, P.A., J. Queiroz-Machado, and C.E.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1242/jcs.0079 9 Cokol, M., R. Nair, and B. Rost.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1093/embo-reports/kvd09 2 Conti, E., M. Uy, L. Leighton, G. Blobel, and J. Kuriyan.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi   .org/10.1016/S0092-8674(00)81419- 1 Cuvier, O., and T. Hirano.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1016/j.cell.2008   .01.04 5 Earnshaw, W.C., B. Halligan, C.A.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1083/jcb.100.5   .1706 Eltsov, M., K.M.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10   .1073/pnas.081005710 5 Galande, S., and K. Muniyappa.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/   10.1016/S0006-2952(96)00897- 0 Gasser, S.M., and U.K. Laemmli.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1016/0014-4827(87)90334- X Giménez-Abián, J.F., and D.J.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1007/978-1-   60761-340-4_1 5 Giménez-Abián, J.F., D.J.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
http://dx.doi.org/10.1083/jcb.131.1.,Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1046/j.1356- 9597.2001.00498. x Grue, P., A. Grässer, M. Sehested, P.B.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1074/jbc   .273.50.3366 0 Hudson, D.F., P. Vagnarelli, R. Gassmann, and W.C. Earnshaw.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1038/nrm229 8 Sakaguchi, A., and A. Kikuchi.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"117:1047– 1054. http://dx.doi.org/10.1242/jcs.0097 7 Schones, D.E., K. Cui, S. Cuddapah, T.-Y.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10   .1016/j.cell.2008.02.02 2 Strukov, Y.G., T.H.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1371/journal   .pbio.100057 4 Studier, F.W.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/   10.1016/j.pep.2005.01.01 6 Sumner, A.T. 1991.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi   .org/10.1007/BF0033751 9 Swedlow, J.R., and T. Hirano.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"158:23– 29. http://dx.doi.org/10.1083/jcb.20020205 3 Tennyson, R.B., and J.E.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"36:6107– 6114. http://dx.doi.org/10.1021/bi970152 f Tseng, H., J.A.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1038/   nrm83 1 Weidenfeld, I., M. Gossen, R. Löw, D. Kentner, S. Berger, D. Görlich, D.  Bartsch, H. Bujard, and K. Schönig.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1093/nar/gkp10 8 Wessel, I., P.B.",OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1007/978-1-60761-340-4_ 5 Yogo, K., T. Ogawa, M. Hayashi, Y. Harada, T. Nishizaka, and K. Kinosita Jr.  2012.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
"http://dx.doi.org/10.1371/   journal.pone.003492 0 Zacharias, D.A., J.D.",Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
http://dx.doi.org/10   .1126/science.106853 9,Non-OADS,/arxiv_data1/oa_pdf/a1/22/JCB_201303045.PMC3824022.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1083/jcb.152.5.103 3 Kreitzer, G., J. Schmoranzer, S.H.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1038/ncb91 7 Lasek, R.J., and S.T.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1038/316645a 0 Martiny-Baron, G., M.G.",Non-OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1002/bies.20110008 6 Piston, D.W., and G.J.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi   .org/10.1016/j.tibs.2007.08.00 3 Redford, G.I., and R.M.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1007/s10895-005-2990- 8 Ruiz-Canada, C., J. Ashley, S. Moeckel-Cole, E. Drier, J. Yin, and V. Budnik.",Non-OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1038/nature0160 1 Vale, R.D.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1016/S0092-8674(03)00111- 9 Verhey, K.J., and J.W.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10   .1038/nrm278 2 Wallrabe, H., and A. Periasamy.",Non-OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi   .org/10.1016/j.copbio.2004.12.00 2 Wu, X., X. Xiang, and J.A.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
http://dx.doi.org/10.1016/j   .tcb.2006.01.00 4preformed tetraspanin nanoplatforms.,OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1016/S0962-8924(98)01410- X Borisy, G.G., J.M.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
http://dx.doi.org/10.1111/ j.1749-6632.1975.tb19196.,Non-OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1074/jbc   .M41362020 0 Cai, D., A.D. Hoppe, J.A.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/   10.1083/jcb.20060509 7 Caiolfa, V.R., M. Zamai, G. Malengo, A. Andolfo, C.D.",Non-OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi   .org/10.1083/jcb.20070215 1 Clayton, A.H., Q.S.",Non-OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
http://dx.doi.org/10.1111/ j.1365-2818.2004.01265.,Non-OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1038/1300 1 Dietrich, K.A., C.V. Sindelar, P.D.",Non-OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1091/mbc.E05-10-091 4 Fan, S., T.W.",Non-OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi   .org/10.1016/j.cub.2004.08.02 5 Gierke, S., and T. Wittmann.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1016/j.cub.2012.02.06 9 Gundersen, G.G.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1038/   nrm77 7 Gurland, G., and G.G.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/   10.1073/pnas.90.19.882 7 Hackney, D.D., and M.F.",Non-OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1371/journal.pbio.100007 2 Hammond, J.W., T.L.",Non-OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10.1083/jcb   .20100105 7 Imanishi, M., N.F.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/   10.1083/jcb.20060517 9 Jaulin, F., and G. Kreitzer.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"http://dx.doi.org/10   .1083/jcb.20100604 4 Jaulin, F., X. Xue, E. Rodriguez-Boulan, and G. Kreitzer.",OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
http://dx.doi.org/   10.1016/j.devcel.2007.08.00 1,OADS,/arxiv_data1/oa_pdf/23/bf/JCB_201305023.PMC3824023.pdf
"Structure Short Article Structural Analysis of the G-Box Domain of the Microcephaly Protein CPAP Suggests a Role in Centriole Architecture Georgios N. Hatzopoulos,1Miche `le C. Erat,1Erin Cutts,1Kacper B. Rogala,1Leanne M. Slater,1Philip J. Stansfeld,1 and Ioannis Vakonakis1,* 1Department of Biochemistry, University of Oxford, South Parks Road, Oxford OX1 3QU, UK *Correspondence: ioannis.vakonakis@bioch.ox.ac.uk http://dx.doi.org/10.1016/j.str.2013.08.019 SUMMARY Centrioles are evolutionarily conserved eukaryotic organelles composed of a protein scaffold sur- rounded by sets of microtubules organized with a 9-fold radial symmetry.",Non-OADS,/arxiv_data1/oa_pdf/7f/1d/main.PMC3824074.pdf
"SUPPLEMENTAL INFORMATION Supplemental Information includes Supplemental Experimental Procedures, three ﬁgures, one movie, and three 3D molecular models and can be foundwith this article online at http://dx.doi.org/10.1016/j.str.2013.08.019 .",OADS,/arxiv_data1/oa_pdf/7f/1d/main.PMC3824074.pdf
http://dx.doi.org/10.1016/j.schres.2013.08.030 Contents lists available at ScienceDirect Schizophrenia Research journal homepage: www.elsevier.com/locate/schres Open access under CC BY-NC-SA license.,Non-OADS,/arxiv_data1/oa_pdf/a4/3a/main.PMC3824077.pdf
http://dx.doi.org/10.1016/j.schres.2013.08.035 Contents lists available at ScienceDirect Schizophrenia Research journal homepage: www.elsevier.com/locate/schres Open access under CC BY-NC-ND license .Open access under CC BY-NC-ND license .,Non-OADS,/arxiv_data1/oa_pdf/9b/9c/main.PMC3824078.pdf
The web interface was implemented in PHP using an EBI framework and the Crystal Clear icon set by Everaldo Coelho as provided byWikimedia Commons (https://commons.wikimedia.org/wiki/Crys- tal_Clear).,OADS,/arxiv_data1/oa_pdf/0b/7a/acel0012-0910.PMC3824079.pdf
Available at http://www.oisca-international.org/projects/default.aspx?cid 546&pid 58 (accessed 1 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/b4/6d/emi201348a.PMC3824111.pdf
Available at http://www.who.int/ influenza/human_animal_interface/influenza_h7n9/en/ (accessed 3 June 2013).,Non-OADS,/arxiv_data1/oa_pdf/b4/6d/emi201348a.PMC3824111.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0Review and risk assessment on H7N9 KY Lai et al 5 Emerging Microbes and Infections",Non-OADS,/arxiv_data1/oa_pdf/b4/6d/emi201348a.PMC3824111.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3192 | DOI: 10.1038/srep03192 4",Non-OADS,/arxiv_data1/oa_pdf/d3/04/srep03192.PMC3824161.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3189 | DOI: 10.1038/srep03189 4",Non-OADS,/arxiv_data1/oa_pdf/8b/88/srep03189.PMC3824162.pdf
Processing of pyrosequencing data .The methanogenic archaeal 16 s rRNA gene data were processed using the Quantitative Insights Into Microbial Ecology (QIIME)1.4.0-dev pipeline ( 53; http://www.qiime.org) with the default parameters unless otherwise noted.,OADS,/arxiv_data1/oa_pdf/dc/59/srep03193.PMC3824163.pdf
Taxonomy was assigned to methanogenic archaeal OTUs against a subset of the Silva 104 database (http://www.arb-silva.de/ download/archive/qiime/).,OADS,/arxiv_data1/oa_pdf/dc/59/srep03193.PMC3824163.pdf
"http://www.grida.no/ publications/other/ipcc_tar/?src 5/climate/ipcc_tar/wg1/, accessed 16 October 2013.",OADS,/arxiv_data1/oa_pdf/dc/59/srep03193.PMC3824163.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/dc/59/srep03193.PMC3824163.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3193 | DOI: 10.1038/srep03193 9",Non-OADS,/arxiv_data1/oa_pdf/dc/59/srep03193.PMC3824163.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0b/5f/srep03191.PMC3824164.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3191 | DOI: 10.1038/srep03191 5",Non-OADS,/arxiv_data1/oa_pdf/0b/5f/srep03191.PMC3824164.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.How to cite this article: Takemae, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/db/46/srep03199.PMC3824165.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3199 | DOI: 10.1038/srep03199 9",Non-OADS,/arxiv_data1/oa_pdf/db/46/srep03199.PMC3824165.pdf
"telling instance, a ferry service connects twice per week the ports of Plymouth and Santander (http://www.brittany-ferries.co.uk/), two localities showing no genetic differentiation (Fig.",Non-OADS,/arxiv_data1/oa_pdf/4c/a1/srep03197.PMC3824166.pdf
"The significance of thevalues was evaluated by performing 16,000 permutations with the Arlequin software.The measure of differentiation Dproposed by Jost 59was also obtained using SPADE (available at http://chao.stat.nthu.edu.tw), with 1,000 bootstrap replicates used to estimate confidence intervals.",OADS,/arxiv_data1/oa_pdf/4c/a1/srep03197.PMC3824166.pdf
Accessed at http://www.marinespecies.org/ascidiacea on 2013-10-03 (2013).,Non-OADS,/arxiv_data1/oa_pdf/4c/a1/srep03197.PMC3824166.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3197 | DOI: 10.1038/srep03197 10",Non-OADS,/arxiv_data1/oa_pdf/4c/a1/srep03197.PMC3824166.pdf
"Statistical analyses .Experiments were analysed using the R (R Development Core Team, 2011, URL http://www.R-project.org/) package ASReml-R38.",OADS,/arxiv_data1/oa_pdf/3c/d8/srep03194.PMC3824167.pdf
http://www.drops-project.eu.,Non-OADS,/arxiv_data1/oa_pdf/3c/d8/srep03194.PMC3824167.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/3c/d8/srep03194.PMC3824167.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3194 | DOI: 10.1038/srep03194 7",Non-OADS,/arxiv_data1/oa_pdf/3c/d8/srep03194.PMC3824167.pdf
All authors contributed todiscussions and writing of the paper.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/11/f7/srep03190.PMC3824169.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3190 | DOI: 10.1038/srep03190 10",Non-OADS,/arxiv_data1/oa_pdf/11/f7/srep03190.PMC3824169.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4a/56/srep03195.PMC3824170.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3195 | DOI: 10.1038/srep03195 5",Non-OADS,/arxiv_data1/oa_pdf/4a/56/srep03195.PMC3824170.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0 www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 3198 | DOI: 10.1038/srep03198 6",Non-OADS,/arxiv_data1/oa_pdf/f3/34/srep03198.PMC3824171.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/MSC exosome promotes functional recovery of stroke H Xin et al 1715 &2013 ISCBFM Journal of Cerebral Blood Flow & Metabolism (2013), 1711 – 1715",Non-OADS,/arxiv_data1/oa_pdf/7b/8f/jcbfm2013152a.PMC3824189.pdf
http://www.purl.oclc.,Non-OADS,/arxiv_data1/oa_pdf/ae/c2/248_2013_Article_266.PMC3824195.pdf
http://www.R-project.org .,Non-OADS,/arxiv_data1/oa_pdf/ae/c2/248_2013_Article_266.PMC3824195.pdf
http://www.cap.org/apps/docs/committees/ cancer/cancer_protocols/2012/GIST_12protocol_3021.pdf .,Non-OADS,/arxiv_data1/oa_pdf/e4/26/11605_2013_Article_2243.PMC3824223.pdf
World Health Organization; 2013 [cited 2013 Mar 15].Available from: http://www.who.int/mediacentre/factsheets/fs311/ en/index.html .,OADS,/arxiv_data1/oa_pdf/5f/bc/13679_2013_Article_72.PMC3824226.pdf
http://www.nature.com/app_notes/ nmeth/2011/111406/full/an7998.html .,Non-OADS,/arxiv_data1/oa_pdf/e3/77/11626_2013_Article_9655.PMC3824271.pdf
http://resources.arcgis.,Non-OADS,/arxiv_data1/oa_pdf/31/d6/11270_2013_Article_1692.PMC3824274.pdf
http://www.cehq.gouv.qc.ca/hydrometrie/reseau/ index.htm .,Non-OADS,/arxiv_data1/oa_pdf/31/d6/11270_2013_Article_1692.PMC3824274.pdf
http://www.hc-sc.gc.ca/ewh-semt/ pubs/eval/inventory-repertoire/ climatologie_f.html .,Non-OADS,/arxiv_data1/oa_pdf/31/d6/11270_2013_Article_1692.PMC3824274.pdf
http://twri.tamu.edu/reports/ 2011/tr406.pdf .,Non-OADS,/arxiv_data1/oa_pdf/31/d6/11270_2013_Article_1692.PMC3824274.pdf
312] (2013) http://www.who.int/mediacentre/factsheets/fs312/en/index.html .,Non-OADS,/arxiv_data1/oa_pdf/80/ab/40261_2013_Article_128.PMC3824340.pdf
http://www.fda.gov/downloads/Drugs/GuidanceCompliance RegulatoryInformation/Guidances/UCM070107.pdf .,Non-OADS,/arxiv_data1/oa_pdf/80/ab/40261_2013_Article_128.PMC3824340.pdf
http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/d4/f7/10549_2013_Article_2689.PMC3824346.pdf
Blotswere quantified using ImageJ 1.45 s ( http://imagej.nih.gov/ij ).,OADS,/arxiv_data1/oa_pdf/6e/82/125_2013_Article_3029.PMC3824349.pdf
http://ctep.cancer.gov/ protocolDevelopment/electronic_ applications/docs/ctcaev3.pdf .,Non-OADS,/arxiv_data1/oa_pdf/80/92/10549_2013_Article_2697.PMC3824350.pdf
"Statistical analyses The analysis plan was finalised prior to preparation of the endpoint dataset ( http://www.addition.au.dk/ , accessed 10 July 2013).",OADS,/arxiv_data1/oa_pdf/15/b9/125_2013_Article_3011.PMC3824356.pdf
"Analyses were undertaken using SAS v9.2 (SAS Institute, Cary, NC, USA) and Review Manager v5.1 (Cochrane Collaboration, http://ims.cochrane.org/revman ).",OADS,/arxiv_data1/oa_pdf/15/b9/125_2013_Article_3011.PMC3824356.pdf
"These questions have been addressed by two European research networks, namely Euraqua (the European Network ofFreshwater Research Organisations, http://www.euraqua.org/ ) and PEER (Partnership for European Environmental Research, http://www.peer.eu/ ), which organised a workshop aiming to identify research needs and strategies induced by these questions in October 2011 in Montpellier, France.",Non-OADS,/arxiv_data1/oa_pdf/aa/2b/11356_2013_Article_2004.PMC3824372.pdf
"Several European projects have recently been carried out for similar purposes,such as TOPPS (Train Operators to prevent Pollution from Point Sources), EOS (Environmentally Optimized Sprayers) or TOPPS-Prowadis (Protect Water from Diffuse Sourceshttp://www.topps-life.org/ ).",Non-OADS,/arxiv_data1/oa_pdf/aa/2b/11356_2013_Article_2004.PMC3824372.pdf
"http://abe.ufl.edu/carpena/files/pdf/software/vfsmod/ VFSMOD_UsersManual_v6.pdf Neitsch SL, Arnold JG, Kiniry JR, Williams JR (2009) Soil and water assessment tool.",OADS,/arxiv_data1/oa_pdf/aa/2b/11356_2013_Article_2004.PMC3824372.pdf
"http://ec.europa.eu/environment/soil/ pdf/biodiversity_report.pdf Udikovic-Kolic N, Devers-Lamrani M, Petric I, Hrsak D, Martin- Laurent F (2011) Evidence for taxonomic and functional drift ofan atrazine-degrading culture in response to high atrazine input.",Non-OADS,/arxiv_data1/oa_pdf/aa/2b/11356_2013_Article_2004.PMC3824372.pdf
"gnu.org/fortran/ ) and Perl-speaks-NONMEM (PSN) [ 29, 30](http://psn.sourceforge.net/ ).",OADS,/arxiv_data1/oa_pdf/e1/00/40262_2013_Article_85.PMC3824374.pdf
Materials and methods Genomic dataData from the TCGA study is accessible through the TCGA web portal at https://tcga-data.nci.nih.gov/tcga/ tcgaHome2.jsp .,OADS,/arxiv_data1/oa_pdf/eb/02/10549_2013_Article_2699.PMC3824397.pdf
Uniﬁed breakpoint proﬁles were computed using the R package CNTools [ 24] from Bioconductor [ 25]( http://bioc.ism.ac.jp/2.5/bioc/html/ CNTools.html ).,OADS,/arxiv_data1/oa_pdf/eb/02/10549_2013_Article_2699.PMC3824397.pdf
"Worldwatch Paper 150, March 2000, available from http://www.worldwatch.",Non-OADS,/arxiv_data1/oa_pdf/0d/69/13679_2013_Article_74.PMC3824563.pdf
"Analysis of microarray data obtained from 1,036 human cancer cell lines ( http://www.broadinstitute.org/ccle/ home ) is presented.",OADS,/arxiv_data1/oa_pdf/3d/e3/281_2013_Article_390.PMC3824572.pdf
"Microarray analysis of 1,036 human cancer cell lines gen- erated at the Broad Institute, i.e., the Cancer Cell Line Ency- clopedia ( http://www.broadinstitute.org/ccle/home )( F i g .",OADS,/arxiv_data1/oa_pdf/3d/e3/281_2013_Article_390.PMC3824572.pdf
"These studies also point to a possible role for the AhR in B cell malignancies, the incidence of which has risen considerably since 1975 ( http://seer.cancer.gov/statfacts/html/nhl.html )[135].",Non-OADS,/arxiv_data1/oa_pdf/3d/e3/281_2013_Article_390.PMC3824572.pdf
Available from URL: http://www.nccmerp.,Non-OADS,/arxiv_data1/oa_pdf/20/db/40264_2013_Article_90.PMC3824584.pdf
Available from URL: https://www.eforms.nrls.nhs.uk/ staffreport/help/ALL/eForm_Help.htm .,Non-OADS,/arxiv_data1/oa_pdf/20/db/40264_2013_Article_90.PMC3824584.pdf
Available from URL http://www.gmc- uk.org/FINAL_Report_prevalence_and_causes_of_prescribing_errors.pdf_28935150.pdf .,Non-OADS,/arxiv_data1/oa_pdf/20/db/40264_2013_Article_90.PMC3824584.pdf
"1,2The ﬁrst animal miRNA, lin-4, was discovered during a genetic screen in Caenorhabditis elegans (C. elegans) and was found to repress the expression of the protein-coding gene lin-14 .3,4In 2000, a second miRNA, the well-conserved let-7, was discovered and functionally characterized as important for C. elegans development.5 Since then, thousands of miRNAs have been predicted and identiﬁed in animals, plants and viruses (see http://www.mir- base.org).6–8 Herein, we focus on the miR-17/92 cluster of miRNAs and review the current knowledge to date as to the roles of its members in health and disease.",Non-OADS,/arxiv_data1/oa_pdf/ef/fd/cdd2013125a.PMC3824591.pdf
The two panels were created using the UCSC genome browser (http://genome.ucsc.edu/)The miR-17/92 cluster in health and disease E Mogilyansky and I Rigoutsos 1604 Cell Death and Differentiation,OADS,/arxiv_data1/oa_pdf/ef/fd/cdd2013125a.PMC3824591.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)The miR-17/92 cluster in health and disease E Mogilyansky and I Rigoutsos 1614 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/ef/fd/cdd2013125a.PMC3824591.pdf
The data discussed in this publication have been deposited inNCBI’s Gene Expression Omnibus 60and are accessible through GEO Series accession number GSE39145 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc¼GSE39145).,OADS,/arxiv_data1/oa_pdf/0e/9d/cdd2013126a.PMC3824592.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)DNA damage leads to replicative decline H Lans et al 1718 Cell Death and Differentiation",Non-OADS,/arxiv_data1/oa_pdf/0e/9d/cdd2013126a.PMC3824592.pdf
http://www.ema.europa .eu/docs/en_GB/docum ent_library/EPAR_-_ Product_Information/human/000942/WC500039537.pdf (Accessed 11 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/0c/dd/40258_2013_Article_44.PMC3824633.pdf
http://www.ema.europa .eu/docs/en_GB/docum ent_library/EPAR_-_ Product_Information/human/001110/WC500089964.pdf (Accessed 25 Oct 2011).,Non-OADS,/arxiv_data1/oa_pdf/0c/dd/40258_2013_Article_44.PMC3824633.pdf
Guidelines for the economic evaluation of health technologies in Ireland(Appendix 4); 2010. http://www.hiqa.ie/publication/guidelines- economic-evaluation-health-technologies-ireland (Accessed 8 July 2012).,Non-OADS,/arxiv_data1/oa_pdf/0c/dd/40258_2013_Article_44.PMC3824633.pdf
2011 (updated 2013).http://www.nicedsu.org.uk (Accessed 13 May 2013).,Non-OADS,/arxiv_data1/oa_pdf/0c/dd/40258_2013_Article_44.PMC3824633.pdf
http://www.cso.ie/en/newsandevents/pressreleases/2009 pressreleases/irishlifetableno152005-2007/ (Accessed 11 Dec 2012).,Non-OADS,/arxiv_data1/oa_pdf/0c/dd/40258_2013_Article_44.PMC3824633.pdf
http://www.casemix.ie (Acces- sed 20 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/0c/dd/40258_2013_Article_44.PMC3824633.pdf
http://data.gov.uk/dataset/nhs-reference- costs-2009-10 (Accessed 2 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/0c/dd/40258_2013_Article_44.PMC3824633.pdf
http://www.ncpe.ie/wp-content/ uploads/2012/03/Summary-for-Thrombocytopenic-purpura.pdf (Accessed 13 May 2013).Romiplostim Cost Effectiveness in Ireland 469,Non-OADS,/arxiv_data1/oa_pdf/0c/dd/40258_2013_Article_44.PMC3824633.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Signaling pathways in chronic myeloid leukemia K Airiau et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ae/a4/cddis2013309a.PMC3824646.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)R-CICs show mesenchymal and drug-resistant features C-W Fan et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b9/3d/cddis2013337a.PMC3824647.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Autophagy protects MSCs against irradiation injury J Hou et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/a4/0c/cddis2013338a.PMC3824648.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)TAK1 modulates epithelial–mesenchymal transition CRI Lam et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/95/8c/cddis2013339a.PMC3824649.pdf
Lentivirus production and tittering were carried out according to the following protocolsfrom Trono Lab (http://tronolab.epﬂ.ch).,Non-OADS,/arxiv_data1/oa_pdf/60/69/cddis2013340a.PMC3824650.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Multilineage differentiation potential of CSCs H Liu et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/60/69/cddis2013340a.PMC3824650.pdf
The densityof protein bands from the scanned images was analyzed using ImageJ(http://www.rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/fc/80/cddis2013341a.PMC3824651.pdf
"The IMODpackage (http://bio3d.colorado.edu/imod/) was used for rough alignment withthe ﬁne alignment and reconstruction was performed using the TxBR package(National Center for Microscopy and Imaging Research, San Diego, CA, USA).Volume segmentation was performed by manual tracing in the planes of highestresolution with the program Xvoxtrace.",OADS,/arxiv_data1/oa_pdf/fc/80/cddis2013341a.PMC3824651.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/CoQ 10preserves mitochondria in astrocytes YH Noh et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/fc/80/cddis2013341a.PMC3824651.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)GSKbinhibitor as a possible treatment for OPMD A Abu-Baker et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f3/e3/cddis2013342a.PMC3824652.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/P2X7 receptor induces Schwann cell death J Luo et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/3b/46/cddis2013343a.PMC3824653.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ROS-dependent Bax phosphorylation S-A Quast et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f8/b9/cddis2013344a.PMC3824654.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)EMT markers expressed in CTCs in HCC patients Y-M Li et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f6/0a/cddis2013347a.PMC3824657.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/Dexamethasone inhibits C/EBPalpha methylation JL i et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/4f/c6/cddis2013348a.PMC3824658.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Patulin induces autophagy inhibition X Guo et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/02/a8/cddis2013349a.PMC3824659.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Suppression of protein toxicity by an HSP40 and an HSP100 Y Kuo et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/e5/a3/cddis2013351a.PMC3824661.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)FAK contributes to microtubule depolymerization K Rea et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/d7/7c/cddis2013353a.PMC3824663.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Necro-Inﬂammatory response of pancreatic acinar cells HG u et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/68/19/cddis2013354a.PMC3824664.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/CFTR and cisplatin side effects I Rubera et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/51/32/cddis2013355a.PMC3824665.pdf
targetscan.org/) and PicTar (http://pictar.mdc-berlin.de/).,Non-OADS,/arxiv_data1/oa_pdf/da/d6/cddis2013356a.PMC3824666.pdf
A search for predicted target mRNAs was performed using the data bases TargetScan (http://www.targetscan.org/) andPicTar (http://pictar.mdc-berlin.de/).,OADS,/arxiv_data1/oa_pdf/da/d6/cddis2013356a.PMC3824666.pdf
Sequence conservation was examined using University of California Santa Cruz genome browser (http://genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/da/d6/cddis2013356a.PMC3824666.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/miR-30e regulates adipocytes and osteoblasts J Wang et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/da/d6/cddis2013356a.PMC3824666.pdf
"Initially, the cDNA sequence and corresponding genomic sequence were analyzed usingthe Spidey software (http://www.ncbi.nlm.nih.gov/spidey) in order to establish theexon–intron organization.",OADS,/arxiv_data1/oa_pdf/82/9b/cddis2013357a.PMC3824667.pdf
"Next, the mRNA sequence was subjected into the open-reading frame (ORF) ﬁnder software (http://www.ncbi.nlm.nih.gov/gorf/gorf.html) to ﬁnd the ORF and to acquire the amino acid sequence.",OADS,/arxiv_data1/oa_pdf/82/9b/cddis2013357a.PMC3824667.pdf
The amino acid sequence was aligned using the protein blast software (http://blast.ncbi.nlm.nih.gov/Blast.cgi)and the DNAMAN 6.0.40 (LynnonBiosoft) software (http://lynnon-biosoft-dnaman-eng.software.informer.com/).,OADS,/arxiv_data1/oa_pdf/82/9b/cddis2013357a.PMC3824667.pdf
The theoretical pI and Mw of the pJAB1 protein wascomputed using the Compute pI/Mw Tool (http://web.expasy.org/compute_pi/).The conservative domains were predicted using the SBASE web tool(http://hydra.icgeb.trieste.it/sbase/sbase.php?sec=analyse&sub=predict).,OADS,/arxiv_data1/oa_pdf/82/9b/cddis2013357a.PMC3824667.pdf
The subcellularlocalization of the pJAB1 protein was predicted using the protein localizationsoftware (http://chemdata.shu.edu.cn/subcell/subcell4.jsp).,OADS,/arxiv_data1/oa_pdf/82/9b/cddis2013357a.PMC3824667.pdf
"50GO analysis of proteins interacting with pJAB1 was carried out using the GO Term Enrichment tool inAmiGO (http://amigo.geneontology.org/cgi-bin/amigo/term_enrichment?session_id),the bar chart of which was constructed using metasee software.",OADS,/arxiv_data1/oa_pdf/82/9b/cddis2013357a.PMC3824667.pdf
"Calculation of means and s.d., and statistical analysis were performed with SPSS 17.0 (IBM SPSS; http://www-01.ibm.com/software/analytics/spss/).",OADS,/arxiv_data1/oa_pdf/82/9b/cddis2013357a.PMC3824667.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/pJAB1 enhances apoptosis induced by staurosporine P Jiang et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/82/9b/cddis2013357a.PMC3824667.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Piperlongumine induces autophagy Y Wang et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/7a/44/cddis2013358a.PMC3824668.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)rhArg induced apoptosis and autophagy in NHL cells Zeng et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ba/66/cddis2013359a.PMC3824669.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Bcl-2 proteins in mitotic death JM Eichhorn et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/e5/47/cddis2013360a.PMC3824670.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Mechanism of siramesine-induced cell death M Hafner C ˇesen et al 13 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/7c/d5/cddis2013361a.PMC3824671.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Effect of HB-EGF and miR-1192 on osteogenesis SY u et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/40/38/cddis2013363a.PMC3824672.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/CD44-hyaluronan control of CXCL12-CXCR4 signaling K Fuchs et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/90/55/cddis2013364a.PMC3824673.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/TBX2 in DNA repair and drug resistance S Wansleben et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/cb/76/cddis2013365a.PMC3824674.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)LHX6 as a tumour suppressor in lung cancer W-b Liu et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/9f/06/cddis2013366a.PMC3824675.pdf
"Update 49 - SARS case fatality ratio, incubation period 2003. http://www.who.int/csr/sars/archive/2003_05_07a/en/.",Non-OADS,/arxiv_data1/oa_pdf/c8/19/cddis2013367a.PMC3824676.pdf
World Health Organization (WHO)The A/ 2009 H1N1 inﬂuenza virus pandemic 2009. http://www.who.int/vaccine_research/diseases/ari/en/index5.html.,Non-OADS,/arxiv_data1/oa_pdf/c8/19/cddis2013367a.PMC3824676.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Drugs to cure avian inﬂuenza infection S Yuan 7 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/c8/19/cddis2013367a.PMC3824676.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NANOS3 and premature ovarian insufﬁciency XW u et al 6 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/1f/77/cddis2013368a.PMC3824677.pdf
"Total RNA was isolated using Trizol (Invitrogen), treated with ampliﬁcation grade DNAse I (Invitrogen) and reverse transcribed to cDNA (Superscript III First-Strand Synthesis System; Invitrogen).Real-time PCR was carried out on an ABI7900HT (Applied Biosystems,Life Technologies, Carlsbad, CA, USA) using either the Taqman GeneExpression Assay or the SybrGreen PCR Master Mix (Applied Biosystems), anddata were analyzed with REST (Relative Expression Software Tool) software(http://www.gene-quantiﬁcation.de/rest.html).",OADS,/arxiv_data1/oa_pdf/01/90/cddis2013369a.PMC3824678.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)CaMKII inhibition in iPSC-derived CPVT-CMs E Di Pasquale et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/01/90/cddis2013369a.PMC3824678.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)RanBP2 depletion induced mitotic catastrophe C Hashizume et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/1e/0a/cddis2013370a.PMC3824679.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)NIPBL : canonical Wnt pathway and apoptosis A Pistocchi et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/33/ff/cddis2013371a.PMC3824680.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Correspondence 2 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/16/4b/cddis2013372a.PMC3824681.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Figure 1 Schematic representation of the results of Liu et al.1showing that intrahepatic infusion of ABM resulted in enhanced liver function and sustainedCD4 þcell increases in patients with liver cirrhosis and AIDSNews and Commentary 2 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/40/e4/cddis2013373a.PMC3824682.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)HIV gp120 and/or MA, oxidative stress, and cell death A Shah et al 15 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/64/29/cddis2013374a.PMC3824683.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)AKT1/NF-kappaB/Notch1/PTEN axis and gastric cancer W Zhou et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/4b/89/cddis2013375a.PMC3824684.pdf
"81272268) (http://www.nsfc.gov.cn), Nature Science Fund of Guangdong Province No.S2013010014724), new star plan of Pearl River Science and Technology fromGuangzhou City (No.",Non-OADS,/arxiv_data1/oa_pdf/7c/68/cddis2013376a.PMC3824685.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)PDCD4 and miR-184 in NPC YZ h e n et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/7c/68/cddis2013376a.PMC3824685.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Mitochondrial apoptosis induced by Met cleavage J Lefebvre et al 14 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/1d/5f/cddis2013377a.PMC3824686.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)TRAP1 in translational control of cancer cells DS Matassa et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/91/9c/cddis2013379a.PMC3824688.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/IBP-induced autophagy suppression and breast cancer S Chen et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ce/d4/cddis2013380a.PMC3824689.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Regulation of c-Jun multisite phosphorylation CE Reddy et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/c7/2c/cddis2013381a.PMC3824690.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)LOX activity, FAK and oncogene-induced senescence C Wiel et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/fe/9d/cddis2013382a.PMC3824691.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Correspondence 2 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/9e/a8/cddis2013383a.PMC3824692.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Microenvironment MSCs M Castells et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ee/14/cddis2013384a.PMC3824693.pdf
http://www.nice.co.uk .,Non-OADS,/arxiv_data1/oa_pdf/e3/3f/384_2013_Article_1739.PMC3824723.pdf
http://www.clinicaltrials.gov/show/ NCT00292318 .,Non-OADS,/arxiv_data1/oa_pdf/e3/3f/384_2013_Article_1739.PMC3824723.pdf
http://clinicaltrials.gov/show/ NCT00303030 .,Non-OADS,/arxiv_data1/oa_pdf/e3/3f/384_2013_Article_1739.PMC3824723.pdf
http://www.controlled-trials.com/ISRCTN45147456 .,Non-OADS,/arxiv_data1/oa_pdf/e3/3f/384_2013_Article_1739.PMC3824723.pdf
http://clinicaltrials.gov/show/NCT00124904 .,Non-OADS,/arxiv_data1/oa_pdf/e3/3f/384_2013_Article_1739.PMC3824723.pdf
https://drks-neu.uniklinik -freiburg.de/drks_web/nav- igate.do?navigationId=tria l.HTML&TRIAL_ID=DRKS00000138 .,Non-OADS,/arxiv_data1/oa_pdf/e3/3f/384_2013_Article_1739.PMC3824723.pdf
"Presented 54th Annual Meeting AmericanSociety of Hematology, Atlanta, Dec 8 –11, 2012 ( https://ash.confex.",Non-OADS,/arxiv_data1/oa_pdf/97/4a/12471_2013_Article_473.PMC3824737.pdf
Rapport Nieuwe antistollingsmiddelen: een gedoseerde introductie: ( http://www.gezondheidsraad.nl/nl/ adviezen/optimale-gezondheidszorg/nieuwe-antistollingsmiddelen-een-gedoseerde-introductie ).,Non-OADS,/arxiv_data1/oa_pdf/97/4a/12471_2013_Article_473.PMC3824737.pdf
( http://www.orde.nl/over-oms/nieuws/ leidraad-voor-zorgvuldi ge-introductie-nieuwe- antistollingsmiddel.html ).,Non-OADS,/arxiv_data1/oa_pdf/97/4a/12471_2013_Article_473.PMC3824737.pdf
"For thisreason, the ESC decided to provide a better search experience for ESC site visitors http://www.escardio.org/about/corporate- news/Pages/Search-the-ESC.aspx .",Non-OADS,/arxiv_data1/oa_pdf/fd/79/12471_2013_Article_470.PMC3824739.pdf
The ESC search engine uses semantic analysis to provide the best results from the keywords typed in http://www.escardio.org/about/welcome/ Pages/Search-the-ESC.aspx .,OADS,/arxiv_data1/oa_pdf/fd/79/12471_2013_Article_470.PMC3824739.pdf
"Not surprisingly, this tool is a major success, already being the second most visited page of the ESC website, with 49,853page views, in October and November of 2012 http://snack.to/ fukiqkmc .",Non-OADS,/arxiv_data1/oa_pdf/fd/79/12471_2013_Article_470.PMC3824739.pdf
"With the help of this search engine, it is now extremely easy to obtain information by just typing in thekeywords on the top right hand side of the screen inside the http://www.escardio.org landing page (Fig.",Non-OADS,/arxiv_data1/oa_pdf/fd/79/12471_2013_Article_470.PMC3824739.pdf
http://www.hhs.gov/recovery/programs/ cer/execsummary.html .,OADS,/arxiv_data1/oa_pdf/77/ba/40263_2013_Article_102.PMC3824845.pdf
"Conﬂict of interest All authors (Eelko Hak, Bianca Mulder, Nynke CM Schuiling-Veninga, Tjalling W. de Vries, Susan S Jick) have completed the Uniﬁed Competing Interest form at http://www.icmje.",Non-OADS,/arxiv_data1/oa_pdf/e3/b2/40264_2013_Article_93.PMC3824882.pdf
"The Barrie Examiner , February 21. http://www.consciencelaws.org/re- pression/repression017-001.aspx .",Non-OADS,/arxiv_data1/oa_pdf/85/cc/11673_2013_Article_9451.PMC3824976.pdf
1985. http://laws-lois.justice.gc.ca/ eng/acts/C-46/index.html .,Non-OADS,/arxiv_data1/oa_pdf/85/cc/11673_2013_Article_9451.PMC3824976.pdf
"Mercatornet , March 11. http://consciencelaws.org/law/ commentary/legal029.aspx .",Non-OADS,/arxiv_data1/oa_pdf/85/cc/11673_2013_Article_9451.PMC3824976.pdf
http://www.consciencelaws.org/ethics/ ethics052.aspx .,Non-OADS,/arxiv_data1/oa_pdf/85/cc/11673_2013_Article_9451.PMC3824976.pdf
http://www.consciencelaws.org/ethics/ethics081.aspx .,Non-OADS,/arxiv_data1/oa_pdf/85/cc/11673_2013_Article_9451.PMC3824976.pdf
Submission to the College of Physicians and Surgeons of Ontario regarding the draft policy :“Physicians and the Ontario Human Rights Code .” http://www.ohrc.on.ca/en/submission-ontario-- human-rights-commission-college-physicians-and-surgeons- ontario-regarding-draft-0 .,Non-OADS,/arxiv_data1/oa_pdf/85/cc/11673_2013_Article_9451.PMC3824976.pdf
Reproductive Health (Access to Terminations) Bill 2013. http://www.dhhs.tas.gov.au/__data/assets/pdf_file/0018/Bioethical Inquiry (2013) 10:347 –354 353,Non-OADS,/arxiv_data1/oa_pdf/85/cc/11673_2013_Article_9451.PMC3824976.pdf
"The Hastings Center Bioethics Forum , September 17. http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=5999&blogid=140 .",Non-OADS,/arxiv_data1/oa_pdf/85/cc/11673_2013_Article_9451.PMC3824976.pdf
"San Diego, CA: Soc iety for Neuroscience, 2007. http://www.abstracts online.com/viewer/ viewAbstractPrintFriendly.asp?CKey={640B86E7-F9F0- 4897-90C5-C4AD3B2A6752}&SKey={3622AB3D-ED1E-481C-8D4F-599FBAFF2D22}&MKey={FF8B70E5-B7F9-4D07-A58A-C1068FDE9D25}&AKey={3A7DC0B9- D787-44AA-BD08-FA7BB2FE9004} Biello SM (2009) Circadian clock resetting in the mouse changes with age.",Non-OADS,/arxiv_data1/oa_pdf/c0/0e/11357_2012_Article_9502.PMC3825002.pdf
Code is available by visiting the website: http://people.brandeis.edu/~pmiller/Decision_ code.,Non-OADS,/arxiv_data1/oa_pdf/61/7f/10827_2013_Article_452.PMC3825033.pdf
The primer pairs was designed using the PIRA PCR programme at http://cedar.genetics.soton.ac.uk/public_html/primer2.html.,Non-OADS,/arxiv_data1/oa_pdf/5e/65/0392-100X-33-320.PMC3825038.pdf
"Statistical analysis The association of the rs39335 SNP with otosclerosis was analyzed by an exact chi-square test, comparing SNP frequencies using the software FINETTI (http://ihg2.helmholtz-muenchen.de.).",OADS,/arxiv_data1/oa_pdf/5e/65/0392-100X-33-320.PMC3825038.pdf
"Available from: http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp 2 Bon FD, Piazza C, Mangili S, et  al.",Non-OADS,/arxiv_data1/oa_pdf/75/93/0392-100X-33-311.PMC3825044.pdf
"According to the European Guidelines on Cardiovas- cular Prevention and its Spanish adaptation by the Spanish Interdisciplinary Committee for Cardiovascular Prevention (CEIPC) of 2008 ( http://www.CEIPC.org ), pharmacologi- cal treatment for the prevention of CHD and therapeutic objectives in relation to the CHD risk in high-risk patients are one of the priorities in cardiovascular prevention.",Non-OADS,/arxiv_data1/oa_pdf/ef/60/40258_2013_Article_53.PMC3825137.pdf
http://www.ine.es .,Non-OADS,/arxiv_data1/oa_pdf/ef/60/40258_2013_Article_53.PMC3825137.pdf
http://www.ine.es .,Non-OADS,/arxiv_data1/oa_pdf/ef/60/40258_2013_Article_53.PMC3825137.pdf
"2006 )a n d post-hoc pair-wise proportion comparison tests were carriedout between all countries by two methods: (1) as in Zar (1999 ): tests analogous to, and refered to here as, “Tukey tests ”(critical values from R package DKT; Lau 2011); (2) z-tests with Bonferroni correction (Microsoft Excel 2007, Redmond, WA, USA; http://www.csun.edu/~vchsc006/469/ z.html ).",Non-OADS,/arxiv_data1/oa_pdf/79/c9/13353_2013_Article_166.PMC3825156.pdf
The second step included the collection of DNA sequences relevant for the chosen targets retrieved from the NCBI public database(http://www.ncbi.nlm.nih.gov/sites/entrez ).,OADS,/arxiv_data1/oa_pdf/9b/12/253_2013_Article_5234.PMC3825158.pdf
"The primer pairs were designed, preferentially within conserved regions, using the “Primer 3 ”program ( http://frodo.wi.mit.edu/ primer3/ (Rozen and Skaletsky 2000 )w i t ht h e “product size range”specification set at “60 to 120 bp ”and“primer size ” optimal set at “22 bases ”.",Non-OADS,/arxiv_data1/oa_pdf/9b/12/253_2013_Article_5234.PMC3825158.pdf
"Good output to work on can provide web tools for primer design: PrimerQuest software (Integrated DNA Technologies, http://eu.idtdna.com/scitools/applications/primerquest/default.",OADS,/arxiv_data1/oa_pdf/30/5c/13353_2013_Article_173.PMC3825189.pdf
"aspx), Primer3Plus ( http://www.bioinformatics.nl/cgi-bin/ primer3plus/primer3plus.cgi ) or Primer-Blast ( http://www.",Non-OADS,/arxiv_data1/oa_pdf/30/5c/13353_2013_Article_173.PMC3825189.pdf
"Therefore, primers should be validated in silco for possible secondary structures (e.g., MFOLD program: http://mfold.rit.albany.edu/ ), amplicon length, single nucleotide polymorphisms (SNP) etc., which tosome extent can provide NCBI BLAST tool.",Non-OADS,/arxiv_data1/oa_pdf/30/5c/13353_2013_Article_173.PMC3825189.pdf
CurrentlygeNorm ’s use makes it a standard program and according to Google Scholar more than 6300 papers cited this method as was provided by the official site ( http://medgen.ugent.,OADS,/arxiv_data1/oa_pdf/30/5c/13353_2013_Article_173.PMC3825189.pdf
"Smads are intracellular proteins characterized by Mad homologous domain at N-terminus (MH-1) and at C-Invited Review Biomol  Ther 21(5), 323-331 (2013) *Corresponding Author E-mail: yysheen@ewha.ac.kr Tel: +82-2-3277-3028, Fax: +82-2-3277-2851Received  Sep 12, 2013  Accepted  Sep 24, 2013http://dx.doi.org/10.4062/biomolther.2013.072 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8b/7a/ooomb4-21-323.PMC3825194.pdf
"324Biomol  Ther  21(5), 323-331 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.072terminus (MH-2), and linker connecting between these two  MH-1 and MH-2 domains.",OADS,/arxiv_data1/oa_pdf/8b/7a/ooomb4-21-323.PMC3825194.pdf
"326Biomol  Ther  21(5), 323-331 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.072granzyme, perforin, interferon-g and FAS ligand (Thomas and  Massagué, 2005; Meulmeester and ten Dijke, 2011).",OADS,/arxiv_data1/oa_pdf/8b/7a/ooomb4-21-323.PMC3825194.pdf
"328Biomol  Ther  21(5), 323-331 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.072which is T βRI-speci ﬁ c (Ki= 38 nM for T βRI kinase vs IC50  of 300 nM for T βRII) inhibitor, and is relatively metabolically  stable and suitable for in vivo  studies.",Non-OADS,/arxiv_data1/oa_pdf/8b/7a/ooomb4-21-323.PMC3825194.pdf
"330Biomol  Ther  21(5), 323-331 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.072Micalizzi, D. S., Wang, C.-A., Farabaugh, S. M., Schiemann, W. P.  and Ford, H. L. (2010) Homeoprotein Six1 increases TGF- β Type  I receptor and converts TGF- β signaling from suppressive to sup- portive for tumor growth.",Non-OADS,/arxiv_data1/oa_pdf/8b/7a/ooomb4-21-323.PMC3825194.pdf
"Although several papers reported on the anti-in ﬂ ammatory Original Article Biomol  Ther 21(5), 332-337 (2013) *Corresponding Author E-mail: hskimp@ ewha.ac.kr Tel: +82-2-2650-5823, Fax: +82-2-2653-8891Received  Sep 4, 2013  Accepted  Sep 23, 2013http://dx.doi.org/10.4062/biomolther.2013.069 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/04/c2/ooomb4-21-332.PMC3825195.pdf
"334Biomol  Ther  21(5), 332-337 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.069rated by SDS-PAGE gel electrophoresis and transferred to ni- trocellulose membranes.",Non-OADS,/arxiv_data1/oa_pdf/04/c2/ooomb4-21-332.PMC3825195.pdf
"336Biomol  Ther  21(5), 332-337 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.069pathways play a pivotal role in anti-in ﬂ ammatory effects of ka- lopanaxsaponin A in LPS-stimulated microglia.",Non-OADS,/arxiv_data1/oa_pdf/04/c2/ooomb4-21-332.PMC3825195.pdf
"In addition to cata- lyzing Ca 2+-dependent transamidation reactions, it can bind Original Article Biomol  Ther 21(5), 338-342 (2013) *Corresponding Author E-mail: uatheone@dongguk.edu Tel: +82-31-961-5213, Fax: +82-31-961-5206Received  Sep 2, 2013  Revised  Sep 12, 2013  Accepted  Sep 16, 2013http://dx.doi.org/10.4062/biomolther.2013.066 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/08/ooomb4-21-338.PMC3825196.pdf
"340Biomol  Ther  21(5), 338-342 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.066Ser431 (Abcam, Cambridge, MA, USA) primary antibody was  incubated with coverslips overnight at 4oC (Park et al., 2011).",Non-OADS,/arxiv_data1/oa_pdf/10/08/ooomb4-21-338.PMC3825196.pdf
"342Biomol  Ther  21(5), 338-342 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.066led to increased migration of PANC-1 cells and Tgase-2 in- hibition by ECA suppressed the SPC-induced migration and invasion (Fig.",Non-OADS,/arxiv_data1/oa_pdf/10/08/ooomb4-21-338.PMC3825196.pdf
"To identify natural melanosome transport suppres- sor as binding blocker of Rab27A- Melanophilin, we collect-ed the structural information of natural products from herbal medicine information systems of Korea Food & Drug Admin- istration (KFDA, http://www.mfds.go.kr/herbmed/index.do) and performed docking simulation with Melanophilin.",OADS,/arxiv_data1/oa_pdf/6f/b2/ooomb4-21-343.PMC3825197.pdf
"Hesperi-din found in orange peel is a ﬂ avanone glycoside consisting Original Article Biomol  Ther 21(5), 343-348 (2013) *Corresponding Author E-mail: jshwang@khu.ac.kr Tel: +82-31-888-6179, Fax: +82-31-888-6173Received  Apr 17, 2013  Revised  Aug 8, 2013  Accepted  Aug 9, 2013http://dx.doi.org/10.4062/biomolther.2013.032 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/b2/ooomb4-21-343.PMC3825197.pdf
"344Biomol  Ther  21(5), 343-348 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.032of the ﬂ avone hesperidin bound to the disaccharide rutinose.",Non-OADS,/arxiv_data1/oa_pdf/6f/b2/ooomb4-21-343.PMC3825197.pdf
The information of activity of natural compounds is manually extracted from the Database of Stan-dardization of Herbal Medicines (http://www.herbdb.co.kr).,OADS,/arxiv_data1/oa_pdf/6f/b2/ooomb4-21-343.PMC3825197.pdf
"346Biomol  Ther  21(5), 343-348 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.032MLPH.",Non-OADS,/arxiv_data1/oa_pdf/6f/b2/ooomb4-21-343.PMC3825197.pdf
"348Biomol  Ther  21(5), 343-348 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.032area of melanocytes where they are produced toward the  plasma membrane as they become more melanized due to the functions of microtubules, actin ﬁ laments, and myosin,  which is similar to the movement of other organelles in other types of cells (Hirokawa and Noda, 2008).",OADS,/arxiv_data1/oa_pdf/6f/b2/ooomb4-21-343.PMC3825197.pdf
"Cell and tissue defense systems against ROS con- sist of various antioxidant enzymes (Mn-SOD, Cu/Zn-SOD, Original Article Biomol  Ther 21(5), 349-357 (2013) *Corresponding Author E-mail: jinwonh@jejunu.ac.kr Tel: +82-64-754-3838, Fax: +82-64-702-2687Received  Aug 29, 2013  Revised  Sep 23, 2013  Accepted  Sep 24, 2013http://dx.doi.org/10.4062/biomolther.2013.064 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/3c/ooomb4-21-349.PMC3825198.pdf
"350Biomol  Ther  21(5), 349-357 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.064extracellular (EC)-SOD, catalase, glutathione peroxidase, and  the peroxiredoxins) and non-enzymatic antioxidants (gluta-thione (GSH), thioredoxin, ascorbate, α-tocopherol, and uric  acid) (Pryor, 2000).",Non-OADS,/arxiv_data1/oa_pdf/8e/3c/ooomb4-21-349.PMC3825198.pdf
"352Biomol  Ther  21(5), 349-357 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.064of variance (ANOVA) and Tukey’s post hoc test to analyze dif- ferences between conditions.",OADS,/arxiv_data1/oa_pdf/8e/3c/ooomb4-21-349.PMC3825198.pdf
"354Biomol  Ther  21(5), 349-357 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.064GPF attenuates H2O2-generated macromolecular damage  in HaCaT keratinocytes Disturbance of the balance between antioxidant defense  systems and the production of H2O2 and other ROS produces  oxidative stress, resulting in DNA strand breaks and consider-able DNA damage (Hoffmann et al., 1984).",Non-OADS,/arxiv_data1/oa_pdf/8e/3c/ooomb4-21-349.PMC3825198.pdf
"356Biomol  Ther  21(5), 349-357 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.064of ROS-linked clinical conditions and disorders.",Non-OADS,/arxiv_data1/oa_pdf/8e/3c/ooomb4-21-349.PMC3825198.pdf
"Experimental depletion of cellular GSH can be produced by  using L-buthionine-S,R-sulfoximine (BSO), a potent and spe-Original Article Biomol  Ther 21(5), 358-363 (2013) *Corresponding Author E-mail: yisjung@ajou.ac.kr Tel: +82-31-219-3444, Fax: +82-31-219-3435Received  Sep 2, 2013  Revised  Sep 16, 2013  Accepted  Sep 23, 2013http://dx.doi.org/10.4062/biomolther.2013.065 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/31/ooomb4-21-358.PMC3825199.pdf
"360Biomol  Ther  21(5), 358-363 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.065Lactate dehydrogenase (LDH) assay Cell death was analyzed by measuring LDH release into  medium as described previously (Lee and Jung, 2012).",OADS,/arxiv_data1/oa_pdf/7e/31/ooomb4-21-358.PMC3825199.pdf
"362Biomol  Ther  21(5), 358-363 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.065DISCUSSION In the present study, using a heart-derived H9c2 cell line,  we observed that BSO-induced GSH depletion was associat-ed with: 1) increased apoptosis, 2) increased ROS production, 3) increased caspase-3 activity, and 4) increased PKC- δ activ- ity.",Non-OADS,/arxiv_data1/oa_pdf/7e/31/ooomb4-21-358.PMC3825199.pdf
"NO triggers cartilage destruction by induc-ing apoptosis, dedifferentiation, and in ﬂ ammatory responses Original Article Biomol  Ther 21(5), 364-370 (2013) *Corresponding Author E-mail: ksj85@kongju.ac.kr Tel: +82-41-850-8507, Fax: +82-41-850-0927 Received  Apr 16, 2013  Revised  Jul 24, 2013  Accepted  Jul 26, 2013http://dx.doi.org/10.4062/biomolther.2013.029 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/74/ooomb4-21-364.PMC3825200.pdf
"366Biomol  Ther  21(5), 364-370 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.029Data analyses and statistics The results are expressed as the means ± SD.",OADS,/arxiv_data1/oa_pdf/a9/74/ooomb4-21-364.PMC3825200.pdf
"368Biomol  Ther  21(5), 364-370 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.029proliferation and regulated differentiation and COX-2 expres- sion by ERK, p38, and Akt signaling (submitted).",OADS,/arxiv_data1/oa_pdf/a9/74/ooomb4-21-364.PMC3825200.pdf
"370Biomol  Ther  21(5), 364-370 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.029ratrol suppresses interleukin-1beta-induced in ﬂ ammatory signaling  and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis.",Non-OADS,/arxiv_data1/oa_pdf/a9/74/ooomb4-21-364.PMC3825200.pdf
"Looking at doxorubicin induced cardiomyopathy in a histo- logical point of view, cell damage caused by isolation oxidation, hence, loss of myo ﬁ bril and vacuolization of a myocardium  have been observed and in organelles loss of mitochondria and degeneration of a nucleus were also observed in a micro-Original Article Biomol  Ther 21(5), 371-380 (2013) *Corresponding Author E-mail: LIM5@catholic.ac.kr Tel: +82-2-2164-6595, Fax: +82-2-2164-4059Received  Apr 19, 2013  Revised  Sep 17, 2013  Accepted  Sep 23, 2013http://dx.doi.org/10.4062/biomolther.2013.034 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/90/ooomb4-21-371.PMC3825201.pdf
"372Biomol  Ther  21(5), 371-380 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.034histological point of view.",Non-OADS,/arxiv_data1/oa_pdf/35/90/ooomb4-21-371.PMC3825201.pdf
"374Biomol  Ther  21(5), 371-380 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.034Fibrosis measurement and histological modifi  cation of ca- rdiomyopathy After the administration of doxorubicin were ﬁ nished, each  mouse of the 3, 5, 7, and 14 day groups were injected into the abdominal cavity with a mix of anesthetics, 10 mg/kg Xyla-zine and 100 mg/kg ketamine.",Non-OADS,/arxiv_data1/oa_pdf/35/90/ooomb4-21-371.PMC3825201.pdf
"376Biomol  Ther  21(5), 371-380 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.034Histologic examination  After gathering heart tissue on the ﬁ xed dates (3rd, 5th, 7th,  14th day), each of the tissues were dyed with H/E.",Non-OADS,/arxiv_data1/oa_pdf/35/90/ooomb4-21-371.PMC3825201.pdf
"378Biomol  Ther  21(5), 371-380 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.034had a instantaneous rise but afterwards starting from the 7th  day the results fell below the control group.",Non-OADS,/arxiv_data1/oa_pdf/35/90/ooomb4-21-371.PMC3825201.pdf
"380Biomol  Ther  21(5), 371-380 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.034Cleutjens, J. P., Kandala, J. C., Guarda, E., Guntaka, R. V. and Weber,  K.T.",OADS,/arxiv_data1/oa_pdf/35/90/ooomb4-21-371.PMC3825201.pdf
"It is likely that the interaction of proin ﬂ ammatory cyto-Original Article Biomol  Ther 21(5), 381-390 (2013) Copyright  © 2013 The Korean Society of Applied Pharmacology www.biomolther.org   *Corresponding Author E-mail: bombi@khu.ac.kr (Lee BB), dhhahm@khu.ac.kr (Hahm DH) Tel: +82-2-961-0943 (Lee BB), +82-2-961-0366 (Hahm DH)Fax: +82-2-963-2175 (Lee BB), +82-2-963-2175 (Hahm DH)Received  Jun 17, 2013  Revised  Sep 12, 2013  Accepted  Sep 23, 2013 http://dx.doi.org/10.4062/biomolther.2013.053 Open  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.The purpose of this study was to examine whether ginsenoside Rg3 (GRg3) could improve learning and memory impairments  and in ﬂ ammatory reactions induced by injecting lipopolysaccharide (LPS) into the brains of rats.",Non-OADS,/arxiv_data1/oa_pdf/2b/6c/ooomb4-21-381.PMC3825202.pdf
"382Biomol  Ther  21(5), 381-390 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.053kines with neuronal elements during development may alter  the brain in a manner that makes it more susceptible to LPS-induced hippocampus-dependent memory impairment or syn-aptic plasticity in rats (Min et al., 2009; Hwang et al., 2011; Yin  et al., 2013).",Non-OADS,/arxiv_data1/oa_pdf/2b/6c/ooomb4-21-381.PMC3825202.pdf
"384Biomol  Ther  21(5), 381-390 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.053test was initiated on the 21st day after the LPS and GRg3 ad- ministration commenced.",Non-OADS,/arxiv_data1/oa_pdf/2b/6c/ooomb4-21-381.PMC3825202.pdf
"386Biomol  Ther  21(5), 381-390 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.053in all groups had no physiological defect (i.e.",Non-OADS,/arxiv_data1/oa_pdf/2b/6c/ooomb4-21-381.PMC3825202.pdf
"388Biomol  Ther  21(5), 381-390 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.053DISCUSSION RG is one of several processed versions of  Panax ginseng ,  and its saponin fraction possesses a variety of neurodegen-erative effects, such as anti-AD and anti-stress activities (Jin et al., 1999).",Non-OADS,/arxiv_data1/oa_pdf/2b/6c/ooomb4-21-381.PMC3825202.pdf
"390Biomol  Ther  21(5), 381-390 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.053Guo, J., Li, F., Wu, Q., Gong, Q., Lu, Y. and Shi, J.",OADS,/arxiv_data1/oa_pdf/2b/6c/ooomb4-21-381.PMC3825202.pdf
"(Nymphaceae), a medicinal plant Original Article Biomol  Ther 21(5), 391-397 (2013) *Corresponding Author E-mail: subashbabu80@hotmail.com Tel: +996-1-467-7122, Fax: +966-1-467-8394Received  Mar 5, 2013  Revised  May 22, 2013  Accepted  July 2, 2013http://dx.doi.org/10.4062/biomolther.2013.022 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9c/4b/ooomb4-21-391.PMC3825203.pdf
"392Biomol  Ther  21(5), 391-397 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.022has been mentioned for the treatment of liver disorders in  Ayurveda, an ancient system of medicine.",Non-OADS,/arxiv_data1/oa_pdf/9c/4b/ooomb4-21-391.PMC3825203.pdf
"394Biomol  Ther  21(5), 391-397 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.022stastical signi ﬁ cance and a probability level lower than 0.05  was considered statistically signi ﬁ cant (Tallarida and Murria,  1987).",OADS,/arxiv_data1/oa_pdf/9c/4b/ooomb4-21-391.PMC3825203.pdf
"396Biomol  Ther  21(5), 391-397 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.022DISCUSSION In the present study we evaluated the antinociceptive, im- munomodulatory and antipyretic effects of nymphayol, a com-pound isolated from N. stellata , employing various experimen- tal test models.",Non-OADS,/arxiv_data1/oa_pdf/9c/4b/ooomb4-21-391.PMC3825203.pdf
"Berberine was proved to have biological activities Original Article Biomol  Ther 21(5), 398-404 (2013) *Corresponding Author E-mail: dhkim@khu.ac.kr Tel: +82-2-961-0374, Fax: +82-2-957-5030Received  Jun 10, 2013  Revised  Aug 24, 2013  Accepted  Aug 29, 2013http://dx.doi.org/10.4062/biomolther.2013.048 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/85/ooomb4-21-398.PMC3825204.pdf
"400Biomol  Ther  21(5), 398-404 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.048scored according to a previously reported scoring system and  the colon tissue was then used for ELISA and immunoblotting (Joh et al.",Non-OADS,/arxiv_data1/oa_pdf/ea/85/ooomb4-21-398.PMC3825204.pdf
"402Biomol  Ther  21(5), 398-404 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.048IKKβ and I κBα and the activation of NF- κB.",Non-OADS,/arxiv_data1/oa_pdf/ea/85/ooomb4-21-398.PMC3825204.pdf
"404Biomol  Ther  21(5), 398-404 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.048lated IRAK1 activates a multimeric protein complex, leading  to NF- κB activation and proin ﬂ ammatory cytokine expression.",Non-OADS,/arxiv_data1/oa_pdf/ea/85/ooomb4-21-398.PMC3825204.pdf
"Thus, scopolamine-induced memory impairments  model, which blocks cholinergic neurotransmission, was wi-dely adopted as a model to test cognitive functions including Original Article Biomol  Ther 21(5), 405-410 (2013) *Corresponding Author E-mail: cjma@kangwon.ac.kr Tel: +82-33-250-6565 Fax: +82-33-253-6560Received  Jun 28, 2013  Revised  Aug 5, 2013  Accepted  Sep 2, 2013http://dx.doi.org/10.4062/biomolther.2013.055 Copyright  © 2013 The Korean Society of Applied PharmacologyOpen  Access This is an Open Access article distributed under the terms of the Creative Com- mons Attribution Non-Commercial License (http://creativecommons.org/licens-es/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/57/93/ooomb4-21-405.PMC3825205.pdf
"406Biomol  Ther  21(5), 405-410 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.055learning and memory (Izquierdo, 1989).",Non-OADS,/arxiv_data1/oa_pdf/57/93/ooomb4-21-405.PMC3825205.pdf
"408Biomol  Ther  21(5), 405-410 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.055(5,144)=2.26, p<0.001], with respect to days [F(3,144)=2.06,  p<0.05], and with respect to interaction between the treat- ment and day [F(15,144)=1.49, p=0.89].",OADS,/arxiv_data1/oa_pdf/57/93/ooomb4-21-405.PMC3825205.pdf
"410Biomol  Ther  21(5), 405-410 (2013) http://dx.doi.org/ 10.4062/biomolther.2013.055lectively, these data suggest that SFCE could be useful in the  therapy of AD.",Non-OADS,/arxiv_data1/oa_pdf/57/93/ooomb4-21-405.PMC3825205.pdf
"The .csfasta and .qual sequencing filesgenerated have been deposited, together with the processed data, at the EBI ArrayExpress database ( http://www.ebi.ac.uk/ arrayexpress/ ) under accession number E-MTAB-1126.",OADS,/arxiv_data1/oa_pdf/60/39/253_2013_Article_5186.PMC3825213.pdf
2010 ) and the .obo gene ontology mapping file and P.pastoris proteome annotation file (34378.P_pastoris_GS115.goa) downloaded from EBI ( http://www.ebi.ac.uk ) on 25th June 2012.,OADS,/arxiv_data1/oa_pdf/60/39/253_2013_Article_5186.PMC3825213.pdf
"doi: 10.1186/gb-2010-11-10-r106 Anders S, Huber W (2011) HTSeq: analysing high-throughput sequencing data with Python ( http://www-huber.embl.de/ users/anders/HTSeq/ ).",OADS,/arxiv_data1/oa_pdf/60/39/253_2013_Article_5186.PMC3825213.pdf
R package version 1.8.0. http://www.bioconductor.,Non-OADS,/arxiv_data1/oa_pdf/60/39/253_2013_Article_5186.PMC3825213.pdf
"Online Resource: Pichia pastoris : http://bioinformatics.psb.uge nt.be/orcae/overview/Picpa andhttps:// bioinformatics.psb.ugent.be/gdb/pichia/ Summers DW, Cyr DM (2011) Use of yeast as a system to study amyloid toxicity.",Non-OADS,/arxiv_data1/oa_pdf/60/39/253_2013_Article_5186.PMC3825213.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/f5/c4/simycol_76_1_001.PMC3825230.pdf
"2011) and MAFFT v. 6 (http://mafft.cbrc.jp/alignment/ server/), respectively.",OADS,/arxiv_data1/oa_pdf/f5/c4/simycol_76_1_001.PMC3825230.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/c1/1f/simycol_76_1_002.PMC3825231.pdf
Available from: http://mesquiteproject.org.,Non-OADS,/arxiv_data1/oa_pdf/c1/1f/simycol_76_1_002.PMC3825231.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/be/d5/simycol_76_1_003.PMC3825232.pdf
"Further genera were included over the years and  the addition of separate generic names for asexual and sexual morphs resulted in the inclusion of at least 78 genera in the family (MycoBank, http://www.mycobank.org, accessed May 2013).",Non-OADS,/arxiv_data1/oa_pdf/be/d5/simycol_76_1_003.PMC3825232.pdf
Biomatter 2013; 3:e25414; http://dx.doi.org/10.4161/biom.25414Introduction Tissue engineering aims at producing artificial constructs with  the suitable mechanical and biological properties to replace or regenerate damaged tissue in vivo.,Non-OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Prog Polym Sci 2003; 28:963-1014; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Food Chem Toxicol  2003; 41:319-26; PMID:12504164; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
J  Med Device 2010; 4:031002-6; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
J Biomed  Mater Res B Appl Biomater 2013; 101B:346-54;  http://dx.doi.org/10.1002/jbm.b.32845 6.,Non-OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Acta Biomater 2009; 5:1647-55; PMID:19195945;  http://dx.doi.org/10.1016/j.actbio.2008.12.005 7.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Macromol Biosci 2011;  11:1293-313; PMID:21793217; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Prog Polym Sci 2009;  34:969-81; http://dx.doi.org/10.1016/j.progpolym- sci.2009.05.003 9.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Adv Funct Mater 2008; 18:2855-61; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Acta Biomater  2011; 7:258-67; PMID:20688197; http://dx.doi.org/10.1016/j.actbio.2010.07.038 11.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Mater Sci Eng C 2013; 33:461-5;  http://dx.doi.org/10.1016/j.msec.2012.09.014 13.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Eur J Pharm Sci 2010; 41:617-22; PMID:20833248;  http://dx.doi.org/10.1016/j.ejps.2010.09.001 14.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Carbohydr Polym  2008; 73:401-8; http://dx.doi.org/10.1016/j.carb- pol.2007.12.00815.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Biomaterials 2012; 33:3880-6; PMID:22364701; http://dx.doi.org/10.1016/j.bioma- terials.2012.02.017 17.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Surf Coat Tech 2005; 193:29-34; http://dx.doi.org/10.1016/j.surfcoat.2004.07.042 19.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Eur J Pharm Biopharm  2007; 66:11-20; PMID:17085025; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Nanoscale 2011; 3:4625- 31; PMID:21904762; http://dx.doi.org/10.1039/ c1nr10739a 21.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
J Biomed  Mater Res 1998; 42:597-603; PMID:9827684;  http://dx.doi.org/10.1002/(SICI)1097- 4636(19981215)42:4<597::AID-JBM16>3.0.CO;2-R 22.,Non-OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Eur Polym J 2003; 39:2217-24;  http://dx.doi.org/10.1016/S0014-3057(03)00160-5 23.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
J Biomed Mater Res 1997;  36:29-37; PMID:9212386; http://dx.doi.org/10.1002/(SICI)1097-4636(199707)36:1<29::AID- JBM4>3.0.CO;2-N 24.,Non-OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Biomaterials  2003; 24:3989-99; PMID:12834594; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Biomaterials 1994; 15:705-11; PMID:7948593;  http://dx.doi.org/10.1016/0142-9612(94)90169-4 26.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
J  Biomed Mater Res 1998; 42:188-98; PMID:9773815;  http://dx.doi.org/10.1002/(SICI)1097- 4636(199811)42:2<188::AID-JBM4>3.0.CO;2-L 27.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Langmuir 2009; 25:9432-40; PMID:19572502;  http://dx.doi.org/10.1021/la900652y28.,Non-OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
J Phys Chem B 2001;  105:12490-7; http://dx.doi.org/10.1021/jp011607k 29.,Non-OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Bioconjug Chem  2004; 15:1146-56; PMID:15366971; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Polymers 2012; 4:296-315; http://dx.doi.org/10.3390/ polym4010296 31.,Non-OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Langmuir 2007; 23:9745-51; PMID:17705411; http://dx.doi.org/10.1021/ la701323q 32.,Non-OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Biomaterials 2007; 28:5319-31;  PMID:17888510; http://dx.doi.org/10.1016/j.bioma- terials.2007.08.028 34.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Biomacromolecules 2006;  7:331-8; PMID:16398533; http://dx.doi.org/10.1021/ bm050693h 35.,Non-OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Plasma Process Polym  2006; 3:392-418; http://dx.doi.org/10.1002/ppap.200600021 37.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Biomaterials  2010; 31:7021-31; PMID:20579729; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Rev Sci Instrum 2007;  78:013705; PMID:17503926; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/80/44/biom-3-e25414.PMC3825233.pdf
Biomatter 2013; 3:e26395; http://dx.doi.org/10.4161/biom.26395Introduction Poly-α-hydroxyacids degrade mainly because of hydrolysis.,Non-OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
Mater Lett 2007; 61:3009-13; http://dx.doi.org/10.1016/j.mat- let.2006.10.064 3.,Non-OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
J Mech Behav Biomed Mater 2011; 4:1283- 90; http://dx.doi.org/10.1016/j.jmbbm.2011.04.015;  PMID:21783137 5.,OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
Adv Mater 2009; 21:3900-4; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
Biomaterials 1995; 16:305-11;  http://dx.doi.org/10.1016/0142-9612(95)93258-F;  PMID:7772670 7.,OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
J  Biomed Mater Res B Appl Biomater 2006; 76:403- 11; PMID:16184534; http://dx.doi.org/10.1002/ jbm.b.303888.,Non-OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
J Appl Polym Sci 2011; 119:2996-3003; http://dx.doi.org/10.1002/ app.33027 9.,OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
J Biomed Mater Res 1999; 48:342-53; PMID:10398040;  http://dx.doi.org/10.1002/(SICI)1097- 4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7 10.,Non-OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
J Mater Sci Mater Med 1990; 1:123-30; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
Adv Polym  Technol 2005; 24:69-82; http://dx.doi.org/10.1002/ adv.20032 21.,OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
J  Biomed Mater Res B Appl Biomater 2007; 82:325- 33; PMID:17238162; http://dx.doi.org/10.1002/ jbm.b.30737 18.,Non-OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
J Mater Sci Mater Med 2013; 24:1131- 44; PMID:23471499; http://dx.doi.org/10.1007/ s10856-013-4886-5 19.,Non-OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
Biomaterials 2011; 32:3166-77; http://dx.doi.org/10.1016/j.biomaterials.2011.01.033;PM ID:2131544612.,OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
Polym Degrad Stabil 2009; 94:438-42; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
J Mater Sci Mater Med 2008; 19:2063-70;  PMID:17968505; http://dx.doi.org/10.1007/s10856- 007-3292-2 14.,Non-OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
Biomaterials 1993; 14:291- 8; PMID:8476999; http://dx.doi.org/10.1016/0142- 9612(93)90121-H 15.,OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
"J Mater  Sci Mater Med 1999; 10:1-8; PMID:15347988; http://dx.doi.org/10.1023/A:1008828925090 16. van Dijk M, T unc DC, Smit TH, Higham P , Burger  EH, Wuisman PI.",OADS,/arxiv_data1/oa_pdf/34/a2/biom-3-e26395.PMC3825234.pdf
Bioinformatics 21:263 –265 24. eQTL resources @ the pritchard lab http://eqtl.uchicago.edu/cgi-bin/ gbrowse/eqtl ; accessed 28 August 2012 25.,Non-OADS,/arxiv_data1/oa_pdf/65/29/125_2013_Article_3047.PMC3825282.pdf
The siRNAs were converted to shRNAs by using the siRNA target finder program for the pSilencer vector on the web page ( http://www.ambion.com/ techlib/misc/psilencer_converter.html ).,OADS,/arxiv_data1/oa_pdf/f1/46/11626_2013_Article_9666.PMC3825316.pdf
Functional categorization o f gene families over-represented was performed using the program from the NIAID web site(http://david.abcc.ncifcrf.gov/summary.jsp ).,OADS,/arxiv_data1/oa_pdf/f1/46/11626_2013_Article_9666.PMC3825316.pdf
"The time and reflection needed to develop the relational account of personal identity relied upon in thisarticle would not have been possible without the generous support of the Brocher Foundation, http://www.brocher.ch .I n addition, this work is supported by the Canadian Institutes ofHealth Research NNF 80045, States of Mind: Emerging Issuesin Neuroethics, and the Canada Research Chairs program (2004 –2011).",Non-OADS,/arxiv_data1/oa_pdf/a0/7c/12152_2011_Article_9137.PMC3825414.pdf
http://www.medtronicneuro.com.au/ ambassadors_richard.html accessed 20110822.,Non-OADS,/arxiv_data1/oa_pdf/a0/7c/12152_2011_Article_9137.PMC3825414.pdf
http://www.medtronic.com/health-consumers/ parkinsons-disease/personal-stories/chris/index.htm accessed 20110822.,Non-OADS,/arxiv_data1/oa_pdf/a0/7c/12152_2011_Article_9137.PMC3825414.pdf
2009. http://www.pr.uni-freiburg.de/pm/ 2009/pm.2009-04-01.114/ accessed 20110822.,Non-OADS,/arxiv_data1/oa_pdf/a0/7c/12152_2011_Article_9137.PMC3825414.pdf
http://www.ema.europa.,Non-OADS,/arxiv_data1/oa_pdf/1d/3b/436_2013_Article_3568.PMC3825486.pdf
"2007. Review of Rahel Jaeggi: Entfremdung: Zur Aktualität eines sozialphilosophischenProblems ’,Notre Dame Philosophical Reviews , online http://ndpr.nd.edu/review.cfm?id=10243 , December 2010.",Non-OADS,/arxiv_data1/oa_pdf/4b/2c/12152_2011_Article_9115.PMC3825521.pdf
PN-EN ISO 17294 –1:2007. http://www.khgi.agh.edu.pl/i/pdf/ ibok-ab1050/ab1050.pdf9842 Environ Monit Assess (2013) 185:9825 –9842,Non-OADS,/arxiv_data1/oa_pdf/9d/03/10661_2013_Article_3295.PMC3825522.pdf
http://www.ted.com/talks/aimee_mullins_ prosthetic_aesthetics.html .,Non-OADS,/arxiv_data1/oa_pdf/61/93/12152_2011_Article_9120.PMC3825540.pdf
http://www.youtube.com/ watch?v= −qMz0QwyqPw .,Non-OADS,/arxiv_data1/oa_pdf/61/93/12152_2011_Article_9120.PMC3825540.pdf
Ambient Corp. http://www.theaudeo.com/tech.html .,Non-OADS,/arxiv_data1/oa_pdf/61/93/12152_2011_Article_9120.PMC3825540.pdf
http://openthefuture.com /2007/06/the_accidental_ cyborg.html .,Non-OADS,/arxiv_data1/oa_pdf/61/93/12152_2011_Article_9120.PMC3825540.pdf
http://fatknowledge.blogspot.com/2006/ 04/pimp-my-cochlear-implant.html .,Non-OADS,/arxiv_data1/oa_pdf/61/93/12152_2011_Article_9120.PMC3825540.pdf
https://papyrus.bib.umontreal.ca/jspui/bitstream/1866/2804/ 4/Forlini_Cynthia_2008_memoire.pdf .,Non-OADS,/arxiv_data1/oa_pdf/61/93/12152_2011_Article_9120.PMC3825540.pdf
http://transhumanism.org/ index.php/th/more/509/ .,Non-OADS,/arxiv_data1/oa_pdf/61/93/12152_2011_Article_9120.PMC3825540.pdf
http://www.audiologist.org/academy-documents/ code-of-ethics.html .,Non-OADS,/arxiv_data1/oa_pdf/61/93/12152_2011_Article_9120.PMC3825540.pdf
http://www.audiology.,Non-OADS,/arxiv_data1/oa_pdf/61/93/12152_2011_Article_9120.PMC3825540.pdf
http://www.caslpo.com/Practice Standards/CodeOfEthics/tabid/102/Default.aspx .,Non-OADS,/arxiv_data1/oa_pdf/61/93/12152_2011_Article_9120.PMC3825540.pdf
http://www.caslpa.ca/PDF/ code%20of%20ethics.pdf .,Non-OADS,/arxiv_data1/oa_pdf/61/93/12152_2011_Article_9120.PMC3825540.pdf
http://www.cplol.eu/eng/ethical_practice.htm .,Non-OADS,/arxiv_data1/oa_pdf/61/93/12152_2011_Article_9120.PMC3825540.pdf
http://www.transhumanism.org/resources/ transhumanism.htm .A c c e s s e d1 0M a y2 0 1 1 .,Non-OADS,/arxiv_data1/oa_pdf/61/93/12152_2011_Article_9120.PMC3825540.pdf
http://www.aaas.org/ spp/sfrl/projects/human_enhancement/pdfs/HESummary Report.pdf .,OADS,/arxiv_data1/oa_pdf/61/93/12152_2011_Article_9120.PMC3825540.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/f4/cia-8-1489.PMC3825547.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2013:8 1489–1496Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  1489RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S5115 2The aging lung erin M Lowery1 Aleah L Brubaker2 erica Kuhlmann1 elizabeth J Kovacs3 1Division of Pulmonary and Critical  Care Medicine, Department  of Internal Medicine at Loyola  University Medical Center, 2Loyola  University Stritch School of Medicine,   3Department of Surgery, Loyola  University Medical Center,    Maywood, IL, USA Correspondence: erin M Lowery   Division of Pulmonary and Critical   Care Medicine, Department of Internal   Medicine at Loyola University Medical   Center, 2160 S First Ave, Building 54,   Room 131A, Maywood, IL 60153, USA   Tel +1 708 216 0461   Fax +1 708 216 6839   email elowery@lumc.ed uAbstract:  There are many age-associated changes in the respiratory and pulmonary immune   system.",Non-OADS,/arxiv_data1/oa_pdf/8d/f4/cia-8-1489.PMC3825547.pdf
Available  at: http://www.census.gov/prod/cen2010/briefs/c2010br-09.pdf.,OADS,/arxiv_data1/oa_pdf/8d/f4/cia-8-1489.PMC3825547.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treat - ments intended to prevent or delay the onset of maladaptive correlates  of aging in human beings.",Non-OADS,/arxiv_data1/oa_pdf/8d/f4/cia-8-1489.PMC3825547.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/f4/cia-8-1489.PMC3825547.pdf
The choice ofan appropriate biocide is limited by the European Union ’s Biocidal Products Directive (BPD) ( http://ec.europa.eu/ environment/biocides/index.htm ).,Non-OADS,/arxiv_data1/oa_pdf/42/ae/253_2013_Article_5283.PMC3825568.pdf
http://clinicaltrials.gov/ct2/show/NCT00658125?term=alzheimer+dbs&rank=1 .,Non-OADS,/arxiv_data1/oa_pdf/cd/3a/12152_2010_Article_9093.PMC3825573.pdf
http://www.justitie.nl/images/ Handreiking%20beoordeling%20wilsonbekwaamheid% 20dec2006_tcm34-34470.pdf .A c c e ssed March 2010.,Non-OADS,/arxiv_data1/oa_pdf/cd/3a/12152_2010_Article_9093.PMC3825573.pdf
http://plato.stanford.,Non-OADS,/arxiv_data1/oa_pdf/cd/3a/12152_2010_Article_9093.PMC3825573.pdf
http://wetten.overheid.,Non-OADS,/arxiv_data1/oa_pdf/cd/3a/12152_2010_Article_9093.PMC3825573.pdf
"BMC Geno-mics 10:414 –428 Sarma RN, Fish L, Gill BS, Snape JW (2000) Physical characterization of the homoeologous group 5 chromosomes of wheat in terms of rice linkage blocks, and physical mapping of some important genes.Genome 43:191 –198Schlegel R (2012) Current list of wheats with rye and alien introgression V06-12, 1 –18,http://www.rye-gene-map.de/rye-introgression Schlegel R, Korzun V (2008) Notes on the origin of 4BL-5RL rye translocations in common wheat ( Triticum aestivum L.).",Non-OADS,/arxiv_data1/oa_pdf/13/07/13353_2013_Article_171.PMC3825594.pdf
http://www.telegraph.,Non-OADS,/arxiv_data1/oa_pdf/23/4d/12152_2011_Article_9132.PMC3825606.pdf
http://www.economist.com/node/7904258 .,Non-OADS,/arxiv_data1/oa_pdf/23/4d/12152_2011_Article_9132.PMC3825606.pdf
BBC News Science & Environment.http://www.bbc.c o.uk/news/science-environment- 11635625 .,Non-OADS,/arxiv_data1/oa_pdf/23/4d/12152_2011_Article_9132.PMC3825606.pdf
http://news.bbc.co.uk/2/hi/ 8497148.stm .,Non-OADS,/arxiv_data1/oa_pdf/23/4d/12152_2011_Article_9132.PMC3825606.pdf
"Most of the province ’sa r e ai sa g r i c u l t u r a l( 3 8% ) and forested (35 %), and several percent of the area is coveredby water (numerous lakes, rivers, the Odra estuary with Dabie Lake and Szczecin Lagoon) ( http://www.stat.gov.pl/cps/rde/ xbcr/szczec/ASSETS_przegl_2.pdf ).Material The material was collected in 2008 –2009.",Non-OADS,/arxiv_data1/oa_pdf/b2/09/12011_2013_Article_9809.PMC3825612.pdf
"References Aquatic Species Program Closeout Report (1998), National Renewable Energy Laboratory http://www.nrel.gov/ docs/legosti/fy98/ 24190.pdf Ball S, Marianne T, Diriek L, Fresnoy M, Delrue B, Decq A (1991) A Chlamydomonas reinhardtii low-starch mutant is defective for 3-phosphoglycerate activation and orthophos- phate inhibition of ADP-glucose pyrophosphorylase.",OADS,/arxiv_data1/oa_pdf/ca/45/10811_2013_Article_21.PMC3825614.pdf
Available fromURL: http://www.cmpa-acpm.ca /cmpapd04/docs/resource_ ﬁles/risk_id/2005/com_ri0507-e.cfm (accessed May 2013).,OADS,/arxiv_data1/oa_pdf/88/74/12630_2013_Article_19.PMC3825644.pdf
Available at: http://www.who.int/ csr/don/13_04_01/en/index.html .2.,Non-OADS,/arxiv_data1/oa_pdf/4b/8d/10096_2013_Article_1922.PMC3825647.pdf
Available at: http://www.moh.,Non-OADS,/arxiv_data1/oa_pdf/4b/8d/10096_2013_Article_1922.PMC3825647.pdf
Available at: http://www.moh.gov.cn/ mohjbyfkzj/s3578/201304/c1ab8e a6b2bf447dbfda724cc0afbb6e.,Non-OADS,/arxiv_data1/oa_pdf/4b/8d/10096_2013_Article_1922.PMC3825647.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/18/a7/ijn-8-4229.PMC3825670.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4229–4246International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4229OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5156 6The impact of Pegylation patterns on the in vivo  biodistribution of mixed shell micelles hongjun gao2#  Jinjian liu1#  cuihong Yang1  Tangjian cheng2  liping chu1  hongyan Xu1  aimin Meng1  saijun Fan1  linqi shi2  Jianfeng liu1 1Tianjin Key laboratory of   radiation Medicine and Molecular  Nuclear Medicine, Institute of  radiation Medicine, chinese academy  of Medical science & Peking Union  Medical college, Tianjin, People’s  republic of china; 2Key laboratory of  Functional Polymer Materials, Ministry  of education, and Institute of Polymer  chemistry, Nankai University, Tianjin,   People’s republic of china #These two authors contributed  equally in the present work correspondence: Jianfeng liu   Institute of radiation Medicine,   chinese academy of Medical science,  Tianjin 300071, People’s republic   of china   Tel +86 22 8568 3019   Fax +86 22 8568 3033   email lewis78@163.co m    linqi shi   Institute of Polymer chemistry,   Nankai University, Tianjin 300071,  People’s republic of china   email lqshi@nankai.edu.c nAbstract:  Polyethylene glycol (PEG)-ylation is a widely used strategy to fabricate nanocar - riers with a long blood circulation time.",Non-OADS,/arxiv_data1/oa_pdf/18/a7/ijn-8-4229.PMC3825670.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/18/a7/ijn-8-4229.PMC3825670.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/a7/ijn-8-4229.PMC3825670.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8d/6d/ijnrd-6-241.PMC3825672.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nephrology and Renovascular Disease 2013:6 241–243International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  241Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJNRD.S5481 8a case of bismuth intoxication with irreversible  renal damage abdulsamet erden samet Karahan Kadir Bulut Mustafa Basak tuncay aslan ali Cetinkaya Hatice Karagoz Deniz avci Internal Medicine Department,   Kayseri training and Research  Hospital, Kayseri, turkey Correspondence: samet Karahan   Internal Medicine Department, Kayseri  training and Research Hospital, Kayseri  Eg ˘itim Araştırma Hastanesi,   iç Hastalıkları Klinig ˘i, 9.",Non-OADS,/arxiv_data1/oa_pdf/8d/6d/ijnrd-6-241.PMC3825672.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/8d/6d/ijnrd-6-241.PMC3825672.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8d/6d/ijnrd-6-241.PMC3825672.pdf
"Available from: http://www.who.int/selection_ medicines/committees/expert/18/applications/succimer.pd f. Accessed  October 15, 2013.",Non-OADS,/arxiv_data1/oa_pdf/8d/6d/ijnrd-6-241.PMC3825672.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/24/9d/copd-8-533.PMC3825673.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2013:8 533–535International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  533Letteropen access to scientific and medical research Open Access Full text Article http: //dx.doi.org/10.2147/COPD.S5331 8Chronic obstructive pulmonary disease  exacerbation frequency and severity eirini Stafyla theodora Kerenidi Konstantinos I  Gourgoulianis respiratory Medicine Department,   University of thessaly Medical School,   University Hospital of Larissa, Larissa,   Greece Correspondence: eirini Stafyla   respiratory Medicine Department,  University Hospital of Larissa, Mezourlo  (Biopolis), 41110, Larissa, Greece   tel +30 24 1350 2896   Fax +30 24 1350 1563   email eirinistaf@hotmail.co mDear editor We read with great interest the original work by Motegi et al1 comparing three mul - tidimensional assessment systems – BODE (body mass index, obstruction, dyspnea,  and exercise capacity) index, DOSE (dyspnea, obstruction, smoking, exacerbations)  index and ADO (age, dyspnea, obstruction) index – for predicting COPD (chronic  obstructive pulmonary disease) exacerbations.",Non-OADS,/arxiv_data1/oa_pdf/24/9d/copd-8-533.PMC3825673.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/24/9d/copd-8-533.PMC3825673.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/24/9d/copd-8-533.PMC3825673.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2c/25/cmar-5-367.PMC3825674.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpCancer Management and Research 2013:5 367–375Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  367Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S3829 4The claudin family of proteins in human  malignancy: a clinical perspective Lei Ding1,2 Zhe Lu2,4 Qun Lu2,3 Yan-Hua Chen2,3 1Department of Oncology, Beijing  Shijitan Hospital, Capital Medical  University, Beijing, People’s Republic  of China; 2Department of Anatomy  and Cell Biology, 3Leo w. Jenkins  Cancer Center, Brody School of  Medicine, east Carolina University,  Greenville, NC, USA; 4Department  of Basic Medicine, Hangzhou Normal  University, Hangzhou, People’s  Republic of China Correspondence: Yan-Hua Chen   Department of Anatomy and Cell  Biology, Brody School of Medicine, east  Carolina University, Greenville,   NC 27834, USA   Tel +1 252 744 1341   Fax +1 252 744 2850   email cheny@ecu.ed u    Lei Ding   Department of Oncology, Beijing Shijitan  Hospital, Capital Medical University,  Tieyilu 10, Yangfangdian,   Haidian District, Beijing 100038,   People’s Republic of China   email dinglei1005@126.co mAbstract:  Tight junctions, or zonula occludens, are the most apical component of the junc - tional complex and provide one form of cell–cell adhesion in epithelial and endothelial cells.",Non-OADS,/arxiv_data1/oa_pdf/2c/25/cmar-5-367.PMC3825674.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/2c/25/cmar-5-367.PMC3825674.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/2c/25/cmar-5-367.PMC3825674.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d5/e0/idr-6-175.PMC3825675.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInfection and Drug Resistance 2013:6 175–186Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  175ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S4903 9Pseudomonas aeruginosa  induces pigment  production and enhances virulence in a white  phenotypic variant of Staphylococcus aureus Vlado antonic1–3 alexander stojadinovic3–5 Binxue Zhang1–3 Mina J Izadjoo1–3,5 Mohammad alavi1–3 1henry M Jackson Foundation for the  advancement of Military Medicine,   Bethesda, MD, Usa; 2Diagnostic  and Translational Research center,   gaithersburg, MD, Usa; 3combat  Wound Initiative Program, Bethesda,   MD, Usa; 4Walter Reed national  Military Medical center, Bethesda,   MD, Usa; 5Uniformed services  University of the health sciences,   Bethesda, MD, Usa correspondence: Mohammad alavi   henry M Jackson Foundation for the   advancement of Military Medicine,   Diagnostic and Translational Research   center and combat Wound Initiative   Program, 401 Professional Dr, suite 210,  gaithersburg, MD 20879, Usa   Tel +1 301 254 2890   email alavimr@gmail.co mAbstract:  Staphyloxanthin is a virulence factor which protects Staphylococcus aureus  in  stress conditions.",Non-OADS,/arxiv_data1/oa_pdf/d5/e0/idr-6-175.PMC3825675.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/d5/e0/idr-6-175.PMC3825675.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/d5/e0/idr-6-175.PMC3825675.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/88/95/ijn-8-4315.PMC3825676.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4315–4326International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4315OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5162 9synthesis, characterization, and evaluation  of paclitaxel loaded in six-arm star-shaped  poly(lactic-co-glycolic acid) Y ongxia chen1,3,* Ziying Yang1,* chao liu1 cuiwei Wang1 shunxin Zhao2  Jing Yang1 hongfan sun1 Zhengpu Zhang2 Deling Kong1 cunxian song1 1Tianjin Key laboratory of Biomaterial  research, Institute of Biomedical  engineering, chinese academy of  Medical science and Peking Union  Medical college, 2Institute of Polymer  chemistry, Nankai University, 3center  for Medical Device evaluation of  Tianjin, Tianjin, People’s republic of  china  *These authors contributed equally to  this work correspondence: Jing Yang   236 Baidi road, Nankai District,   Tianjin 300192, People’s republic of china   Tel +86 22 8789 0153   Fax +86 22 8789 0153   email yangjing37@hotmail.co mBackground:  Star-shaped polymers provide more terminal groups, and are promising for  application in drug-delivery systems.",Non-OADS,/arxiv_data1/oa_pdf/88/95/ijn-8-4315.PMC3825676.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/88/95/ijn-8-4315.PMC3825676.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/88/95/ijn-8-4315.PMC3825676.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/93/fb/clep-5-439.PMC3825685.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpClinical Epidemiology 2013:5 439–448Clinical Epidemiology Dove press submit your manuscript | www.dovepress.co m Dove press  439Original rEsEarChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CLEP .S4948 5The impact of cardiac and noncardiac  comorbidities on the short-term outcomes  of patients hospitalized with acute myocardial  infarction: a population-based perspective han-Yang Chen1 Jane s saczynski1–3 David D McManus1,4 Darleen lessard1 Jorge Yarzebski1 Kate l lapane1 Joel M gore4 robert J goldberg1,3 1Department of Quantitative health  sciences, 2Department of Medicine,   3Meyers Primary Care institute,   4Division of Cardiovascular Medicine,   University of Massachusetts Medical  school, Worcester, M a, Usa Correspondence: robert J goldberg   Division of Epidemiology of Chronic  Diseases and Vulnerable Populations,  Department of Quantitative health  sciences, University of Massachusetts  Medical school, 55 lake avenue north,  Worcester, Ma 01655, Usa   Tel +1 508 856 3991   Fax +1 508 856 8993   Email r obert.",Non-OADS,/arxiv_data1/oa_pdf/93/fb/clep-5-439.PMC3825685.pdf
Available from: http://www.rwjf.org/pr/product.jsp?id =5096 8.,Non-OADS,/arxiv_data1/oa_pdf/93/fb/clep-5-439.PMC3825685.pdf
"Clinical Epidemiology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-epidemiology-journa lClinical Epidemiology is an international, peer-reviewed, open access  journal focusing on disease and drug epidemiology, identification of  risk factors and screening procedures to develop optimal preventative  initiatives and programs.",Non-OADS,/arxiv_data1/oa_pdf/93/fb/clep-5-439.PMC3825685.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/ijn-8-4339.PMC3825686.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4339–4350International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4339OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5162 1antitumor activity of tripterine via   cell-penetrating peptide-coated nanostructured  lipid carriers in a prostate cancer model ling Yuan1 congyan liu2 Yan chen2 Zhenhai Zhang2 lei Zhou1 Ding Qu2 1Department of Pharmaceutics,   school of Pharmacy, Jiangsu University,   Zhenjiang, Jiangsu, 2Key laboratory  of New Drug Delivery system of  chinese Materia Medica, Jiangsu  Provincial academy of chinese  Medicine, Nanjing, Jiangsu, People’s  republic of china correspondence: Yan chen   Key laboratory of New Drug Delivery  system of chinese Materia Medica,  Jiangsu Provincial academy of chinese  Medicine, 100 shizi road, Nanjing, Jiangsu  210028, People’s republic of china   Tel +86 25 8560 8672   Fax +86 25 8563 7809   email ychen202@hotmail.co mBackground:  The purpose of this study was to evaluate the antitumor effect of cell-penetrating  peptide-coated tripterine-loaded nanostructured lipid carriers (CT -NLC) on prostate tumor cells  in vitro and in vivo.",Non-OADS,/arxiv_data1/oa_pdf/01/ca/ijn-8-4339.PMC3825686.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/01/ca/ijn-8-4339.PMC3825686.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/ca/ijn-8-4339.PMC3825686.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/75/4d/ijn-8-4291.PMC3825687.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2013:8 4291–4302International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  4291OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S5183 7Fate of paclitaxel lipid nanocapsules in intestinal  mucus in view of their oral delivery anne-claire groo1,2 Patrick saulnier1 Jean-christophe gimel1 Julien gravier3 caroline ailhas2 Jean-Pierre Benoit1,4 Frederic lagarce1,4 1lUNaM Université, IN serM  U1066 Micro et nanomédecines  biomimétiques, angers, France;   2ethypharm, grand-Quevilly, France;   3Institut albert Bonniot, IN serM/UJF  U823, la Tronche, France; 4Pharmacy  Department, angers University  hospital, angers, France correspondence: Frederic lagarce   lUNaM Université, INserM U1066   Micro et nanomédecines biomimétiques,   Bâtiment IBs-IrIs, 4 rue larrey,   F-49933 angers, France   Tel +33 244 688 568   Fax +33 244 688 546   email frederic.lagarce@univ-angers.f rAbstract:  The bioavailability of paclitaxel (Ptx) has previously been improved via its encapsu - lation in lipid nanocapsules (LNCs).",Non-OADS,/arxiv_data1/oa_pdf/75/4d/ijn-8-4291.PMC3825687.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology  in diagnostics, therapeutics, and drug delivery systems throughout  the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/75/4d/ijn-8-4291.PMC3825687.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/75/4d/ijn-8-4291.PMC3825687.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a0/74/dmso-6-421.PMC3825688.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2013:6 421–426Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  421Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S3636 8importance of family/social support and impact  on adherence to diabetic therapy Tricia A Miller M Robin DiMatteo Department of Psychology,    University of California, Riverside,    Riverside, CA, USA Correspondence: Tricia A Miller   Department of Psychology,   University of California, Riverside,   900 University Avenue,   Riverside, CA 92521, USA   email trishmiller122@gmail.co mAbstract:  Diabetes mellitus affects 24 million individuals in the US.",Non-OADS,/arxiv_data1/oa_pdf/a0/74/dmso-6-421.PMC3825688.pdf
Available from: http://www.cdc.gov/diabetes /.,Non-OADS,/arxiv_data1/oa_pdf/a0/74/dmso-6-421.PMC3825688.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/a0/74/dmso-6-421.PMC3825688.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/a0/74/dmso-6-421.PMC3825688.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/e0/dddt-7-1329.PMC3825689.pdf
"Permissions beyond the scope of the License are administered by Dove Medical Press Ltd. Information on how to  request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2013:7 1329–1340Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1329Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S3232 8New and emerging treatments for symptomatic   tardive dyskinesia Abdul Qayyum Rana1–4 Zishan M Chaudry5 Pierre J Blanchet6 1Parkinson’s Clinic of eastern T oronto  and Movement Disorders Centre,   T oronto, ON, Canada; 2Scarborough  Memory Program, T oronto, ON,   Canada; 3Journal of Parkinsonism and  RLS, T oronto, ON, Canada; 4Bulletin   of world Parkinson’s Program,   T oronto, ON, Canada; 5Saba   University School of Medicine,    The Bottom, Saba, Dutch Caribbean;   6Department of Stomatology,   University of Montreal, Montreal,    QC, Canada Correspondence: Abdul Qayyum Rana   Parkinson’s Clinic of eastern T oronto &  Movement Disorders Centre, 111-1371  Neilson Rd, Toronto, ON, Canada  M1B4Z8   Tel +1 416 724 8531   Fax +1 647 766 8531   email ranaaq@yahoo.co mAbstract:  The aim of this review is to assess new, emerging, and experimental treatment  options for tardive dyskinesia (TD).",Non-OADS,/arxiv_data1/oa_pdf/e8/e0/dddt-7-1329.PMC3825689.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/e8/e0/dddt-7-1329.PMC3825689.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/e0/dddt-7-1329.PMC3825689.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e6/6e/jmdh-6-409.PMC3825693.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpJournal of Multidisciplinary Healthcare 2013:6 409–414Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  409Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S5226 2association of primary care physicians’ exercise  habits and their age, specialty, and workplace Y oshiyuki Morishita1 atushi Miki1 Mari Okada1 satoshi Tsuboi2 Kenichi ishibashi3 Yasuhiro ando1 eiji Kusano4 1Division of nephrology, Department  of Medicine, 2Department of Public  Health, Jichi Medical University,  Tochigi, 3Department of Medical  Physiology, Meiji Pharmaceutical  University, Tokyo, 4Utsunomiya social  insurance Hospital, Tochigi, Japan correspondence: Yoshiyuki Morishita   Division of nephrology, Department   of Medicine, Jichi Medical University,   3311-1, Yakushiji, shimotsuke city,   Tochigi 329-0498, Japan   Tel +812 8558 7346   Fax +812 8544 4869   email ymori@jichi.ac.j pBackground:  In this study, we investigated primary care physicians’ exercise habits, and the  association of this variable with their age, specialty, and workplace.",Non-OADS,/arxiv_data1/oa_pdf/e6/6e/jmdh-6-409.PMC3825693.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/e6/6e/jmdh-6-409.PMC3825693.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/e6/6e/jmdh-6-409.PMC3825693.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/6b/bc/imcrj-6-081.PMC3825694.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Medical Case Reports Journal 2013:6 81–84International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  81Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S5261 4MUC1 positive cutaneous metastasis   with transepidermal elimination   from a breast carcinoma amalia Luna Maria emilia Merino Cecilio G alberdi Martin C abba amada segal-eiras Maria Virginia Croce Center of Basic and applied  Immunological Research, Faculty of  Medical sciences, National University  of La plata, argentina Correspondence: María Virginia Croce   Center of Basic and applied  Immunological Research, Faculty   of Medical sciences, National   University of La plata, Calle 60   and 120, 1900 La plata, argentina   tel +54 22 1423 6711   Fax +54 22 1425 8989   email crocevir@hotmail.co mAbstract:  Breast cancer is the most common cause of cutaneous metastases from internal  malignancies.",Non-OADS,/arxiv_data1/oa_pdf/6b/bc/imcrj-6-081.PMC3825694.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/6b/bc/imcrj-6-081.PMC3825694.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/6b/bc/imcrj-6-081.PMC3825694.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/38/21/ott-6-1589.PMC3825695.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2013:6 1589–1596OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  1589Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S5094 5nimotuzumab combined with radiotherapy for  esophageal cancer: preliminary study of a Phase ii  clinical trial Jun liang1 Mingyan e2 gang Wu3 lujun Zhao4 Xia li5 Xia Xiu6 ning li1 Bo chen1 Zhouguang hui1 Jima lv1 hui Fang1 Yu Tang1 nan Bi1 Wenqing Wang1 Yirui Zhai1 Tao li1 Dongfu chen1 shuangmei Zou 7 ning lu7 rolando Perez-rodríguez8 Junqi Zheng9 luhua Wang1 1Department of radiotherapy, cancer  hospital, chinese academy of Medical  sciences, Beijing, People’s republic of china;   2Department of radiotherapy, cancer  hospital of harbin Medical University,   harbin, People’s republic of china;   3Department of radiotherapy, T ongji cancer  center hospital, Wuhan, People’s republic of  china; 4Department of radiotherapy, cancer  hospital of Tianjin Medical University, Tianjin,   People’s republic of china; 5Department  of radiotherapy, liaoning Province cancer  hospital, shenyang, People’s republic of  china; 6Department of radiotherapy, Beijing  hospital, Beijing, People’s republic of china;   7Department of Pathology, cancer hospital,   chinese academy of Medical sciences,   Beijing, People’s republic of china; 8center  of Molecular immunology, havana, cuba;   9school of Medicine, T ongji University,   shanghai, People’s republic of china correspondence: luhua Wang   cancer hospital, chinese academy   of Medical sciences, 17 Panjiayuan,  chaoyang District, Beijing 100021,    People’s republic of china   Tel +86 10 6778 1331   Fax +86 10 8778 7458   email wlhwq@yahoo.co mObjective:  To determine the safety and therapeutic effects of nimotuzumab (h-R3) combined  with radiotherapy in esophageal cancer.",Non-OADS,/arxiv_data1/oa_pdf/38/21/ott-6-1589.PMC3825695.pdf
"Available from: http://ctep.cancer.gov/protocolDevelopment/ electronic   _applications/docs/ctcaev3.pd f. Accessed September 25,  2013.",OADS,/arxiv_data1/oa_pdf/38/21/ott-6-1589.PMC3825695.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/38/21/ott-6-1589.PMC3825695.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/21/ott-6-1589.PMC3825695.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3d/fb/ndt-9-1673.PMC3825696.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1673–1682Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1673Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/NDT .S5380 2Identification of common predictors of surgical  outcomes for epilepsy surgery Jing Zhang1 Weifang Liu1 Hui Chen1 Hong Xia1 Zhen Zhou1 Shanshan Mei2 Qingzhu Liu2 Yunlin Li2 1School of Biomedical Engineering,   Capital Medical University,   2Department of Functional   Neurology and Neurosurgery,    Beijing Haidian Hospital, Beijing,    People’s Republic of China Correspondence: Jing Zhang   School of Biomedical Engineering,   Capital Medical University, Number 10  Xitoutiao, You An Men St,   Beijing 100069, People’s   Republic of China   Tel +86 10 8391 1543   Fax +86 10 8391 1544   email jzhang0000@163.co mAbstract:  Although epilepsy surgery is an effective treatment for patients with drug-resistant  epilepsy, surgical outcomes vary across patient groups and studies.",Non-OADS,/arxiv_data1/oa_pdf/3d/fb/ndt-9-1673.PMC3825696.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/3d/fb/ndt-9-1673.PMC3825696.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/fb/ndt-9-1673.PMC3825696.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3b/4f/opth-7-2215.PMC3825697.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2013:7 2215–2218Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  2215Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S5446 7neodymium:yttrium-aluminum garnet  capsulotomy rates after combined cataract  surgery with implantation of a 4% water   content hydrophobic acrylic intraocular   lens and vitrectomy Y oshiaki Kabata1 genichiro Takahashi1 hiroshi Tsuneoka2 1Department of Ophthalmology,   Jikei University school of Medicine,   Katsushika Medical Center,   2Department of Ophthalmology, Jikei  University school of Medicine,    T okyo, Japan Correspondence: Yoshiaki Kabata   Department of Ophthalmology, Jikei  University school of Medicine, Katsushika  Medical Center, 6-41-2 aoto, Katsushika,  Tokyo 125-8506, Japan   Tel +813 3603 2111   Fax +813 3602 2839   email kabata22122@gmail.co mBackground:  The purpose of this study was to examine neodymium:yttrium-aluminum garnet  (Nd:YAG) capsulotomy rates after combined cataract surgery with implantation of a three-piece  4% water content hydrophobic acrylic intraocular lens (X-70, Eternity®) and vitrectomy, and  compare diabetic retinopathy with nondiabetic retinopathy.",Non-OADS,/arxiv_data1/oa_pdf/3b/4f/opth-7-2215.PMC3825697.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/3b/4f/opth-7-2215.PMC3825697.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/4f/opth-7-2215.PMC3825697.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/71/ndt-9-1737.PMC3825698.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2013:9 1737–1750Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  1737OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S5063 5switching to olanzapine long-acting injection   from either oral olanzapine or any other  antipsychotic: comparative post hoc analyses antonio ciudad1 ernie anand2 lovisa Berggren3 Marta casillas4 alexander schacht3 elena Perrin5 1Department of clinical research  and Development, eli lilly & co,   Madrid, spain; 2Neuroscience Medical  affairs – eU, lilly research centre,   Windlesham, surrey, UK; 3global  statistical sciences, eli lilly & co,   Bad homburg, germany; 4european  scientific communications, eli  lilly & co, Madrid, spain; 5Medical  Department, eli lilly & co, suresnes,   Paris, France correspondence: antonio ciudad   Department of clinical research and  Development, eli lilly & co, sa avda  de la industria 30, 28108 alcobendas,  Madrid, spain   Tel +349 1623 3570   Fax +349 1663 3471   email ciudad_antonio@lilly.co mBackground:  A considerable proportion of patients suffering from schizophrenia show   suboptimal responses to oral antipsychotics due to inadequate adherence.",Non-OADS,/arxiv_data1/oa_pdf/56/71/ndt-9-1737.PMC3825698.pdf
Available from:  http://clinicaltrials.gov/show/NCT00320489 .,Non-OADS,/arxiv_data1/oa_pdf/56/71/ndt-9-1737.PMC3825698.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing  on concise rapid reporting of clinical or pre-clinical studies on a  range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/56/71/ndt-9-1737.PMC3825698.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/56/71/ndt-9-1737.PMC3825698.pdf
Available from: http://www.medicines.org.uk/EMC/ medicine/21361/SPC/ZYPADHERA +210+mg%2c +300+mg%2c +an d+405+mg%2c +powder +and+solvent +for+prolonged +release +suspe nsion +for+injection /.,Non-OADS,/arxiv_data1/oa_pdf/56/71/ndt-9-1737.PMC3825698.pdf
Available from: http://www.medicines.org.uk/EMC/medicine/614/ SPC/Zyprexa ++2.5 mg%2c +5 mg%2c +7.5 mg%2c +10 mg%2c +  15 mg%2c ++and+20 mg+coated +table ts.+Zyprexa +Velotab ++  5 mg%2c +10 mg%2c +15 mg%2c ++and+20 mg++orodispersible +tabl ets/.,Non-OADS,/arxiv_data1/oa_pdf/56/71/ndt-9-1737.PMC3825698.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/aa/14/ndt-9-1725.PMC3825699.pdf
